data_2ma5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ma5 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 t . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.76 80.96 0.61 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.101 2.534 . . . . 0.0 112.413 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.31 130.56 19.69 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.475 1.11 . . . . 0.0 108.894 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.43 -55.23 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.227 0.611 . . . . 0.0 109.693 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.7 m -78.12 74.21 4.67 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.499 0.719 . . . . 0.0 109.251 174.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.707 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 19.7 t -97.93 92.29 5.74 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.101 0.477 . . . . 0.0 110.491 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.3 mt -71.88 113.6 9.09 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.438 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -105.27 107.77 59.81 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.47 1.108 . . . . 0.0 109.491 -175.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.12 -145.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.459 2.773 . . . . 0.0 110.953 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -68.52 -6.66 26.47 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.669 0.388 . . . . 0.0 111.742 167.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.64 -86.14 0.41 Allowed Glycine 0 C--N 1.346 1.122 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -95.39 66.49 2.85 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.396 1.093 . . . . 0.0 108.841 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -114.8 -58.71 2.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.916 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -86.18 -177.87 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 124.742 1.217 . . . . 0.0 112.065 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -98.23 140.93 31.8 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.925 0.49 . . . . 0.0 110.313 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -105.71 -177.96 3.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.492 1.117 . . . . 0.0 110.803 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.574 HG12 HG23 ' A' ' 37' ' ' VAL . 7.5 p -157.94 136.57 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 125.162 1.385 . . . . 0.0 108.22 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -95.88 112.52 24.23 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.4 t -77.9 91.01 4.13 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -57.24 -80.34 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 O-C-N 123.942 0.776 . . . . 0.0 109.851 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 43.35 -83.8 0.01 OUTLIER Glycine 0 N--CA 1.484 1.883 0 C-N-CA 124.423 1.011 . . . . 0.0 115.309 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.8 p -159.81 26.96 0.18 Allowed 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.999 1.32 . . . . 0.0 110.222 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.8 p -143.11 -41.29 0.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.315 0.646 . . . . 0.0 111.387 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 65.29 19.29 11.64 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.029 0.931 . . . . 0.0 112.101 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -79.82 137.08 36.87 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.217 0.607 . . . . 0.0 111.059 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -86.59 128.61 35.0 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.465 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -129.33 143.39 50.83 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.284 1.034 . . . . 0.0 109.044 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.632 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -69.29 141.35 54.36 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 169.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -53.32 -40.47 64.84 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.935 0.494 . . . . 0.0 111.369 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.31 -38.24 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.55 0.74 . . . . 0.0 111.677 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.707 ' SG ' ' HA ' ' A' ' 9' ' ' CYS . 8.4 t -56.29 -50.22 72.02 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.073 0.949 . . . . 0.0 112.047 -175.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.1 m -109.26 5.91 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.283 -174.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.45 52.73 51.39 Favored Glycine 0 C--N 1.355 1.638 0 C-N-CA 123.575 0.607 . . . . 0.0 113.98 174.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.574 HG23 HG12 ' A' ' 20' ' ' VAL . 13.1 t -74.66 119.3 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.054 0.541 . . . . 0.0 109.581 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.606 ' HB2' ' SD ' ' A' ' 41' ' ' MET . 41.7 m -63.14 135.6 96.3 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 123.575 0.547 . . . . 0.0 109.589 175.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.69 -15.43 16.19 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.373 2.716 . . . . 0.0 114.499 -175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.03 -52.11 18.53 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.606 ' SD ' ' HB2' ' A' ' 38' ' ' SER . 1.4 mpt? -67.61 -33.36 74.83 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.109 0.964 . . . . 0.0 110.405 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.81 -36.37 70.24 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.178 0.991 . . . . 0.0 110.831 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.17 -45.23 85.72 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -70.61 -15.4 62.74 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.951 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 65.34 12.84 8.4 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.921 1.288 . . . . 0.0 110.979 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -102.34 91.61 4.34 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.099 1.359 . . . . 0.0 109.239 -170.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -132.23 106.59 8.04 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.9 mp -100.66 113.22 35.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.5 p -74.26 164.04 27.09 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.903 0.481 . . . . 0.0 110.475 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.4 t -50.54 -47.72 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 124.508 1.123 . . . . 0.0 112.441 -174.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -54.13 -44.12 71.09 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.071 0.549 . . . . 0.0 111.702 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 68.7 m -67.62 -36.11 80.19 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.044 0.537 . . . . 0.0 111.824 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.1 m -74.42 -44.15 53.13 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.181 0.593 . . . . 0.0 110.791 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.3 t -78.11 -16.11 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.229 1.011 . . . . 0.0 111.114 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -117.01 25.28 10.61 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.91 0.862 . . . . 0.0 109.696 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 . . . . . 0 N--CA 1.475 0.787 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.602 173.622 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 82.1 m . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.53 39.34 0.84 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.727 2.285 . . . . 0.0 111.061 162.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.26 108.72 8.93 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.1 t -63.76 -43.88 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 m -70.57 106.3 3.43 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 165.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.6 t -151.27 86.11 1.35 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.725 0.41 . . . . 0.0 111.149 -173.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.4 mt -71.12 114.44 9.18 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 166.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -93.11 107.11 22.7 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.709 1.204 . . . . 0.0 111.033 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.62 178.62 6.88 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.098 2.532 . . . . 0.0 111.052 168.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -74.49 -17.34 60.78 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.338 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.79 143.68 14.77 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.0 t70 58.59 34.04 23.55 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.293 1.044 . . . . 0.0 109.559 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -123.91 -71.96 0.7 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.057 -169.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.1 m -91.74 145.85 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -69.79 150.38 46.94 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.872 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -95.09 -178.12 4.37 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.712 0.805 . . . . 0.0 111.223 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.1 p -153.64 116.44 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.949 1.299 . . . . 0.0 108.706 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 52.0 tt0 -98.66 107.94 20.51 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.548 0.739 . . . . 0.0 109.392 -177.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 8.7 t -79.99 64.49 4.84 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.362 0.665 . . . . 0.0 111.278 -173.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -53.04 -36.3 60.44 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.215 1.406 . . . . 0.0 113.638 -169.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -39.35 -58.09 2.09 Favored Glycine 0 N--CA 1.477 1.392 0 O-C-N 124.865 1.353 . . . . 0.0 115.496 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.489 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 48.2 m -157.61 32.54 0.27 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.375 0.67 . . . . 0.0 110.672 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 75.4 m -132.74 -48.38 0.88 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 173.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 74.37 -6.65 1.83 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.939 1.296 . . . . 0.0 112.383 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -93.75 146.25 24.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.845 0.858 . . . . 0.0 109.882 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 8.3 p-90 -103.5 111.81 24.44 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.203 1.001 . . . . 0.0 109.635 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -100.71 163.24 12.42 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.627 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -63.32 145.71 55.0 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 166.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -62.85 -32.24 73.43 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 122.046 -0.409 . . . . 0.0 111.085 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.4 HG22 ' HB2' ' A' ' 31' ' ' HIS . 33.5 m -68.73 -26.8 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 C-N-CA 123.105 0.562 . . . . 0.0 111.815 174.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.627 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.2 t -61.43 -55.53 30.27 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 123.958 0.903 . . . . 0.0 111.819 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.42 HG23 HG22 ' A' ' 37' ' ' VAL . 18.4 m -101.43 -5.22 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.285 -168.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.66 31.86 20.27 Favored Glycine 0 C--N 1.348 1.245 0 O-C-N 123.204 0.315 . . . . 0.0 113.401 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.42 HG22 HG23 ' A' ' 35' ' ' VAL . 55.0 t -97.3 125.73 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.559 0.744 . . . . 0.0 109.577 175.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.6 m -82.89 159.29 63.44 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 123.891 0.876 . . . . 0.0 110.067 175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -45.82 -50.78 9.17 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.631 2.887 . . . . 0.0 114.439 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 47.5 mt-10 -71.85 -12.95 61.52 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.094 0.558 . . . . 0.0 112.322 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.6 mtt -79.3 -57.09 3.89 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . . . -61.48 -36.62 80.99 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.94 0.896 . . . . 0.0 112.14 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -87.39 -65.13 1.05 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.901 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 39.5 ttmt -81.68 -48.49 11.63 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.451 0.469 . . . . 0.0 112.215 -163.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -162.32 118.88 2.0 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -167.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.0 t70 61.74 107.18 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.618 1.567 . . . . 0.0 114.067 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.525 ' H ' HD12 ' A' ' 48' ' ' ILE . 42.0 p90 -126.29 12.55 7.63 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 114.297 -1.319 . . . . 0.0 108.677 165.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.525 HD12 ' H ' ' A' ' 47' ' ' TYR . 3.5 mp -85.13 106.16 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.129 -172.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.1 p -61.52 159.86 12.22 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 123.837 0.711 . . . . 0.0 111.771 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.4 t -52.44 -39.68 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.748 1.219 . . . . 0.0 112.538 -172.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 27.4 mmt180 -64.78 -44.83 88.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.316 0.646 . . . . 0.0 111.701 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 25' ' ' SER . 64.7 m -62.71 -38.85 92.08 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.682 0.393 . . . . 0.0 111.075 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.9 m -69.36 -45.13 70.11 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.928 0.891 . . . . 0.0 110.834 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.46 -25.98 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.261 0.624 . . . . 0.0 111.101 -173.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 51' ' ' ARG . 68.2 mttm -56.77 -50.94 70.8 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 123.317 0.385 . . . . 0.0 110.233 173.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 . . . . . 0 N--CA 1.491 1.61 0 C-N-CA 125.243 1.417 . . . . 0.0 113.059 173.138 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.559 1.298 0 CA-C-O 120.471 0.177 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.34 108.33 2.59 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.222 2.615 . . . . 0.0 113.756 -170.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.29 -170.88 2.15 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.148 0.979 . . . . 0.0 109.74 168.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.9 m -54.89 -31.35 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.159 0.984 . . . . 0.0 112.109 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.4 m -147.42 -35.79 0.23 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.202 1.401 . . . . 0.0 109.188 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.3 t 70.18 97.02 0.07 Allowed 'General case' 0 C--N 1.36 1.031 0 C-N-CA 125.231 1.412 . . . . 0.0 109.491 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.4 mt -80.43 100.47 8.51 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -85.78 105.67 7.71 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.378 1.071 . . . . 0.0 108.302 171.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.56 162.39 42.16 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 122.423 2.082 . . . . 0.0 111.112 172.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.75 -22.33 66.48 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.407 0.683 . . . . 0.0 111.677 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.9 136.17 4.45 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.15 66.53 7.78 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.297 1.048 . . . . 0.0 111.16 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.54 -9.23 55.03 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.976 164.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -63.16 151.62 8.27 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 C-N-CA 124.659 1.184 . . . . 0.0 110.143 165.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -85.39 149.3 25.52 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.056 0.455 . . . . 0.0 110.114 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 22.1 m0 -111.75 -179.95 3.84 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.537 1.135 . . . . 0.0 110.83 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -161.75 131.78 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.551 1.14 . . . . 0.0 109.549 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 63.5 tt0 -69.82 149.45 47.9 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.659 0.784 . . . . 0.0 110.067 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 0.7 OUTLIER -127.7 50.12 2.06 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.552 0.741 . . . . 0.0 110.164 -171.303 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -57.53 -21.45 38.26 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.913 1.685 . . . . 0.0 114.564 -174.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.24 -58.59 6.33 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 114.76 0.664 . . . . 0.0 114.76 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.714 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 40.6 m -161.36 60.32 0.28 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 89.5 m -155.85 -45.67 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.939 0.896 . . . . 0.0 108.818 173.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 68.93 20.76 7.78 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.427 1.091 . . . . 0.0 111.652 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -140.48 163.18 33.53 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.829 0.852 . . . . 0.0 109.867 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 23.9 m95 -82.93 151.6 25.86 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.203 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -139.85 141.1 36.67 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.16 1.384 . . . . 0.0 108.395 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.654 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -56.12 144.96 27.42 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.457 0.703 . . . . 0.0 109.285 166.159 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -57.4 -41.05 79.56 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.12 0.418 . . . . 0.0 111.327 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -63.25 -26.22 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.246 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.654 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.6 t -67.59 -45.37 75.7 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.789 0.835 . . . . 0.0 111.913 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.5 m -100.82 -8.59 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.354 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.21 16.02 72.81 Favored Glycine 0 CA--C 1.536 1.392 0 O-C-N 123.358 0.411 . . . . 0.0 113.67 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 68.8 t -84.25 131.56 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 123.649 0.78 . . . . 0.0 109.558 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.4 m -67.8 157.33 86.84 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 123.751 0.82 . . . . 0.0 111.324 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -49.48 -50.79 12.11 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.174 2.583 . . . . 0.0 113.49 174.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.02 -30.74 68.11 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.556 0.742 . . . . 0.0 111.44 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 74.9 mtp -68.34 -47.61 67.04 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.785 0.434 . . . . 0.0 110.351 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.6 -34.5 72.83 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.362 0.665 . . . . 0.0 110.221 176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -75.14 -43.54 51.97 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.522 -176.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -103.55 -59.78 1.67 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -173.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -172.75 165.16 5.33 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.222 0.609 . . . . 0.0 111.636 -170.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.4 t70 63.11 57.71 1.56 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.481 1.112 . . . . 0.0 110.279 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -104.58 6.97 34.97 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.414 -1.267 . . . . 0.0 110.038 168.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.5 mp -78.52 104.24 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -173.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 51' ' ' ARG . 13.0 p -66.37 164.7 15.61 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.556 -175.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.8 t -51.92 -46.15 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.94 0.896 . . . . 0.0 110.699 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.532 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 72.9 mtp180 -53.3 -43.55 67.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 123.937 0.773 . . . . 0.0 112.244 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 25' ' ' SER . 14.5 m -61.09 -47.3 86.95 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.825 0.703 . . . . 0.0 111.109 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.2 m -67.23 -45.21 77.45 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 124.015 0.822 . . . . 0.0 111.185 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.19 -34.2 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.025 0.93 . . . . 0.0 110.828 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -73.17 0.19 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 CA--C 1.538 0.499 0 C-N-CA 123.706 0.802 . . . . 0.0 109.944 -172.927 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.565 1.529 0 N-CA-C 110.744 -0.095 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -71.07 60.76 2.42 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.505 2.137 . . . . 0.0 111.922 165.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.55 108.45 2.72 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.437 1.095 . . . . 0.0 108.056 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -66.87 -17.06 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.904 0.882 . . . . 0.0 111.458 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.0 m -86.56 26.35 1.1 Allowed 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.527 1.131 . . . . 0.0 111.292 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.7 t -77.7 101.97 6.89 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.6 mt -62.3 -27.81 69.3 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.76 0.824 . . . . 0.0 112.297 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 58.8 60.04 5.37 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.342 1.057 . . . . 0.0 111.573 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -81.96 160.78 18.42 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.036 1.824 . . . . 0.0 111.59 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -23.25 59.05 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.614 170.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.47 -76.18 0.17 Allowed Glycine 0 C--N 1.343 0.952 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.3 t70 65.08 14.79 9.61 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.775 1.23 . . . . 0.0 112.359 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 64.86 61.07 0.8 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.084 1.353 . . . . 0.0 110.664 -176.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -101.34 134.99 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 170.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.57 160.99 22.42 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -114.3 164.91 13.28 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.45 0.643 . . . . 0.0 111.066 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 p -153.25 142.76 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.321 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -101.19 121.18 41.39 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.3 t -63.76 141.49 58.75 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.011 0.524 . . . . 0.0 110.155 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.438 ' H ' ' HE1' ' A' ' 47' ' ' TYR . 25.0 t70 -94.4 -78.55 0.44 Allowed 'General case' 0 C--O 1.239 0.509 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 154.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 33.04 -98.61 0.01 OUTLIER Glycine 0 C--N 1.357 1.732 0 O-C-N 125.039 1.462 . . . . 0.0 116.287 172.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.4 t -157.33 15.36 0.26 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.964 0.906 . . . . 0.0 109.898 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 14.1 p -159.21 57.37 0.41 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -49.87 80.49 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.528 1.931 . . . . 0.0 112.275 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -127.91 159.2 35.67 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 125.498 1.519 . . . . 0.0 107.402 170.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -82.16 108.48 15.66 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.491 0.663 . . . . 0.0 109.569 170.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -99.55 155.87 17.35 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.963 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.595 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -71.79 146.44 48.05 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 162.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -69.59 -22.26 63.53 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.36 0.527 . . . . 0.0 111.149 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.2 m -78.04 -19.99 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.366 0.667 . . . . 0.0 111.796 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.595 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 7.2 t -69.65 -28.02 65.54 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.596 0.758 . . . . 0.0 111.567 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 m -116.12 -8.53 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 124.364 1.066 . . . . 0.0 111.608 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.28 5.05 87.65 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 114.188 0.435 . . . . 0.0 114.188 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.2 t -80.12 138.26 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 123.282 0.633 . . . . 0.0 110.43 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 m -86.75 143.33 35.46 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.056 0.942 . . . . 0.0 109.709 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -50.38 -31.03 28.77 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 123.482 2.788 . . . . 0.0 114.407 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -58.24 -54.78 43.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.713 0.805 . . . . 0.0 109.505 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 72.2 mtm -71.99 -30.99 65.81 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.38 0.672 . . . . 0.0 111.47 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.51 -40.75 88.12 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.307 0.643 . . . . 0.0 110.937 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -82.51 -45.22 14.98 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.335 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -70.23 -56.47 6.7 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.885 0.474 . . . . 0.0 111.766 -166.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -174.49 127.68 0.33 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.355 0.662 . . . . 0.0 110.225 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.7 t70 73.16 133.83 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.906 1.682 . . . . 0.0 112.498 172.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.438 ' HE1' ' H ' ' A' ' 23' ' ' ASP . 14.5 p90 -151.25 20.77 0.75 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.569 1.548 . . . . 0.0 108.035 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.7 mt -88.82 133.91 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.273 -165.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.62 157.99 36.51 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.391 0.676 . . . . 0.0 110.627 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.7 m -56.65 -43.74 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.917 0.887 . . . . 0.0 113.072 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -69.8 -36.27 75.54 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.837 0.455 . . . . 0.0 110.869 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 96.3 m -68.41 -30.93 69.94 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.987 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.1 m -72.23 -42.86 65.2 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.268 1.027 . . . . 0.0 110.686 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.7 t -71.43 -32.65 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.076 0.55 . . . . 0.0 111.071 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -72.1 -17.37 61.99 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.825 0.45 . . . . 0.0 111.8 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t70 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 121.279 0.562 . . . . 0.0 110.675 174.361 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 119.957 -0.068 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.61 7.9 3.63 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.821 2.347 . . . . 0.0 113.542 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.428 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -83.72 119.76 25.19 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.9 t -60.13 -47.9 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.83 0.852 . . . . 0.0 111.059 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -90.06 63.02 5.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.744 0.817 . . . . 0.0 109.544 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.1 t -77.07 75.43 3.64 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.349 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.416 ' O ' HG21 ' A' ' 33' ' ' VAL . 68.7 mt -72.15 107.91 5.06 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 170.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -125.68 94.67 41.9 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.975 0.91 . . . . 0.0 110.261 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.64 148.1 92.45 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.956 2.438 . . . . 0.0 112.565 171.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.3 103.14 2.76 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.671 0.788 . . . . 0.0 109.281 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.98 -129.0 9.4 Favored Glycine 0 C--O 1.242 0.619 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -167.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -129.76 -80.73 0.55 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 53.51 12.22 0.35 Allowed 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 124.545 1.138 . . . . 0.0 112.487 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -142.29 153.23 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 125.116 1.367 . . . . 0.0 108.685 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -76.76 154.99 33.52 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -118.7 150.56 39.53 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.08 110.89 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.215 1.006 . . . . 0.0 108.753 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -88.76 143.5 26.87 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.602 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.8 t -85.42 101.33 12.52 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.19 -25.62 68.16 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.001 0.52 . . . . 0.0 110.384 170.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.18 164.71 9.9 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.653 170.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.9 t -75.07 80.09 2.24 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.623 1.169 . . . . 0.0 111.092 -159.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.8 p -176.01 -26.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.613 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.1 t30 70.2 9.29 6.98 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 124.788 1.235 . . . . 0.0 112.947 169.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -70.28 122.54 19.74 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.332 0.653 . . . . 0.0 111.588 -174.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -79.2 142.08 36.6 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.679 0.791 . . . . 0.0 109.31 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -132.26 120.61 22.39 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 122.847 0.459 . . . . 0.0 110.751 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.644 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -62.33 148.79 44.05 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 165.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -54.04 -41.03 67.62 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.015 0.926 . . . . 0.0 111.597 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 10' ' ' LEU . 27.5 m -80.69 -19.3 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.679 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.644 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 6.4 t -61.9 -36.26 80.78 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 123.311 0.644 . . . . 0.0 111.667 175.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -119.55 -13.93 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.247 1.019 . . . . 0.0 112.09 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.85 9.43 70.52 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-O 119.31 -0.717 . . . . 0.0 114.137 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.407 HG12 ' HB3' ' A' ' 47' ' ' TYR . 90.9 t -66.36 106.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 117.658 0.729 . . . . 0.0 110.096 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 m -64.98 145.41 99.09 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.517 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -47.69 -29.49 11.02 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.875 3.05 . . . . 0.0 114.476 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 35.5 tt0 -63.22 -53.82 47.11 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.061 0.544 . . . . 0.0 110.456 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 70.7 mtm -67.77 -36.76 81.06 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.057 0.543 . . . . 0.0 110.539 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.01 75.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.467 0.707 . . . . 0.0 111.081 176.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -73.13 -40.18 65.13 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.285 0.634 . . . . 0.0 110.237 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 1.2 mmmp? -77.4 -3.66 41.33 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.061 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 71.71 21.14 4.41 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.993 1.317 . . . . 0.0 111.463 174.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -89.78 77.9 6.97 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.568 172.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.407 ' HB3' HG12 ' A' ' 37' ' ' VAL . 35.8 p90 -149.58 1.11 0.51 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.597 175.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.03 135.28 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.1 m -56.89 145.84 28.53 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.588 0.755 . . . . 0.0 111.134 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.6 m -59.95 -32.34 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.667 0.787 . . . . 0.0 112.376 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -69.82 -44.72 69.4 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.143 0.577 . . . . 0.0 110.469 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 75.3 m -62.61 -34.02 76.17 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.851 176.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.7 m -73.69 -49.28 26.6 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.962 0.505 . . . . 0.0 110.852 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 p -67.34 -24.4 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 122.718 0.407 . . . . 0.0 112.058 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -55.06 -43.09 73.53 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.6 t70 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 121.07 0.462 . . . . 0.0 110.894 -177.505 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.0 t . . . . . 0 CA--C 1.558 1.279 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.38 112.16 2.95 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.541 2.161 . . . . 0.0 111.679 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.47 21.31 2.55 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.964 0.505 . . . . 0.0 111.962 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 85.6 t 62.62 -71.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.862 1.265 . . . . 0.0 110.533 -170.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -89.09 96.93 10.92 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 170.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.583 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 38.4 t -111.15 95.77 5.73 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.99 127.27 32.25 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.433 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -99.01 99.95 8.97 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.563 1.145 . . . . 0.0 108.543 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.492 ' HG3' HG23 ' A' ' 17' ' ' VAL . 88.3 Cg_endo -76.93 169.16 22.18 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.138 2.559 . . . . 0.0 111.284 170.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -91.34 16.09 10.79 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.299 0.639 . . . . 0.0 111.113 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.07 45.17 27.05 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -174.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.24 -72.19 0.19 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.179 0.992 . . . . 0.0 110.036 -174.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -162.37 25.83 0.11 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.218 0.607 . . . . 0.0 110.678 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.492 HG23 ' HG3' ' A' ' 12' ' ' PRO . 34.9 m -80.46 134.06 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 122.703 0.401 . . . . 0.0 110.258 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.473 ' HB3' ' NE2' ' A' ' 32' ' ' GLN . 28.9 t70 -98.24 141.36 31.24 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.774 0.83 . . . . 0.0 108.82 174.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -106.17 130.91 53.96 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.437 0.695 . . . . 0.0 110.082 -176.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.474 HG12 HG22 ' A' ' 37' ' ' VAL . 7.2 p -114.11 129.69 69.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 C-N-CA 124.735 1.214 . . . . 0.0 108.654 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 40.5 tt0 -103.09 128.96 49.8 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 41.9 t -65.13 -27.21 68.57 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 t70 62.41 -84.71 0.02 OUTLIER 'General case' 0 C--N 1.355 0.842 0 C-N-CA 125.294 1.438 . . . . 0.0 110.891 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -18.87 -83.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 C-N-CA 126.238 1.875 . . . . 0.0 116.754 -163.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.413 ' HG ' ' HG3' ' A' ' 55' ' ' LYS . 15.4 p -134.23 59.29 1.74 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.261 1.029 . . . . 0.0 108.52 174.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.503 ' HB3' ' HG2' ' A' ' 28' ' ' GLN . 94.1 m -146.28 -50.7 0.22 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 171.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 64.81 23.69 12.72 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.571 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.503 ' HG2' ' HB3' ' A' ' 26' ' ' CYS . 3.0 pt20 -130.35 142.9 50.51 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 124.376 1.07 . . . . 0.0 109.871 -175.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 12.5 p-90 -100.74 154.35 18.69 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.487 1.115 . . . . 0.0 110.466 -175.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -139.34 144.45 38.25 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.324 1.05 . . . . 0.0 108.931 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.61 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -68.47 150.6 47.91 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.071 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.473 ' NE2' ' HB3' ' A' ' 18' ' ' ASP . 72.1 mt-30 -55.08 -39.43 69.26 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.724 0.41 . . . . 0.0 111.31 176.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 31' ' ' HIS . 31.5 m -67.46 -29.66 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.479 0.712 . . . . 0.0 112.485 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.61 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.4 t -68.63 -46.93 67.91 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.723 0.809 . . . . 0.0 112.393 -174.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.461 HG22 HG23 ' A' ' 37' ' ' VAL . 6.9 m -118.65 16.85 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.793 0.837 . . . . 0.0 111.458 -172.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.82 24.42 69.89 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 114.182 0.433 . . . . 0.0 114.182 174.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 41' ' ' MET . 9.3 t -72.62 121.58 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.178 0.591 . . . . 0.0 110.102 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.3 p -75.31 157.72 84.52 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.094 0.958 . . . . 0.0 109.965 175.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -50.46 -27.17 18.02 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.973 2.449 . . . . 0.0 113.862 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.06 -50.66 65.31 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.944 0.898 . . . . 0.0 110.517 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.551 ' HB2' HG12 ' A' ' 37' ' ' VAL . 25.4 mmt -68.12 -33.38 74.39 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.788 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.19 -16.28 53.28 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.858 0.863 . . . . 0.0 112.239 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -80.87 -48.84 11.82 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.701 0.763 . . . . 0.0 109.473 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -70.27 -43.09 71.18 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.95 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 63.16 22.26 13.29 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.742 1.217 . . . . 0.0 113.444 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -89.31 20.35 3.86 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.076 0.55 . . . . 0.0 110.262 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -75.49 75.04 2.55 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 122.538 1.161 . . . . 0.0 110.736 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.09 105.63 19.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.1 p -58.39 155.83 11.25 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.107 0.563 . . . . 0.0 111.438 -173.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.45 -39.56 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.326 1.05 . . . . 0.0 113.09 -168.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -64.75 -37.34 87.26 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.206 0.603 . . . . 0.0 111.783 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.5 m -69.23 -30.57 68.74 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.229 0.611 . . . . 0.0 111.495 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 m -72.28 -33.92 67.8 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.206 0.602 . . . . 0.0 110.374 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.43 -41.88 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.975 0.91 . . . . 0.0 110.015 173.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.413 ' HG3' ' HG ' ' A' ' 25' ' ' SER . 73.2 mmtt -59.59 -36.84 77.04 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.586 0.754 . . . . 0.0 110.257 173.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 CA--C 1.558 1.264 0 O-C-N 124.461 1.1 . . . . 0.0 109.871 179.904 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.2 t . . . . . 0 CA--C 1.551 0.981 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.83 -20.52 51.82 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.277 2.651 . . . . 0.0 113.976 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.96 114.47 15.78 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -173.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -60.03 -39.77 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.732 0.813 . . . . 0.0 111.435 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 t -85.23 104.48 15.13 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 166.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.4 t -145.0 106.61 4.24 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.584 0.354 . . . . 0.0 110.054 -176.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.5 mt -69.83 153.11 43.76 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.319 168.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -110.78 88.78 8.36 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.79 169.31 22.5 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.524 2.15 . . . . 0.0 111.615 173.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -80.11 111.09 16.13 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.61 87.76 0.01 OUTLIER Glycine 0 C--N 1.349 1.289 0 O-C-N 123.842 0.714 . . . . 0.0 114.053 -175.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -174.1 -61.64 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.559 1.143 . . . . 0.0 109.471 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -99.9 23.93 9.13 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.264 1.031 . . . . 0.0 110.544 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.0 t -80.89 127.71 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.078 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -99.96 141.2 33.11 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 11.0 m0 -116.64 174.24 6.18 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.068 0.947 . . . . 0.0 110.432 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.39 133.62 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.819 1.248 . . . . 0.0 108.765 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -77.89 141.21 39.21 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.356 0.662 . . . . 0.0 109.582 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.2 t -106.37 66.82 0.71 Allowed 'General case' 0 C--O 1.248 1.022 0 CA-C-O 121.223 0.535 . . . . 0.0 109.642 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -81.18 25.81 0.47 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.063 0.545 . . . . 0.0 112.052 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -82.44 35.08 2.64 Favored Glycine 0 C--N 1.355 1.62 0 CA-C-O 119.326 -0.708 . . . . 0.0 113.836 172.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.1 t 82.64 54.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.649 1.58 . . . . 0.0 109.913 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.4 p -164.77 -40.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.545 170.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 65.0 t30 72.71 14.17 5.08 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.074 0.95 . . . . 0.0 111.919 167.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -67.53 127.72 33.78 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.536 0.734 . . . . 0.0 109.753 171.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -89.02 123.12 33.03 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.432 0.693 . . . . 0.0 110.255 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -116.18 148.8 40.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.277 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.625 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -69.51 143.67 53.38 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 166.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 21.6 mt-30 -57.37 -40.61 78.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.712 0.405 . . . . 0.0 111.572 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.2 m -71.95 -23.09 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 123.19 0.596 . . . . 0.0 112.494 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.625 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.4 t -60.53 -46.32 90.6 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.61 0.764 . . . . 0.0 111.051 176.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.459 HG21 HG23 ' A' ' 37' ' ' VAL . 15.7 m -118.9 11.03 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.134 -166.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.63 17.43 76.5 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 114.477 0.551 . . . . 0.0 114.477 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 32' ' ' GLN . 56.0 t -71.32 110.77 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.122 0.487 . . . . 0.0 109.983 175.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.8 m -72.66 158.09 87.87 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.839 174.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -48.44 -34.85 26.81 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.798 2.332 . . . . 0.0 113.32 169.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -68.08 -41.98 81.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.199 0.6 . . . . 0.0 111.317 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 87.2 mtp -64.51 -41.04 96.65 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.92 0.488 . . . . 0.0 110.215 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.76 68.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.73 0.812 . . . . 0.0 111.128 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -73.17 -36.11 66.53 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.628 0.771 . . . . 0.0 111.013 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -71.79 -52.41 17.71 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.956 0.902 . . . . 0.0 109.302 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -164.07 -164.96 0.92 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.67 0.788 . . . . 0.0 109.405 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.98 173.81 10.25 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.203 0.601 . . . . 0.0 111.252 174.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -84.89 138.04 32.77 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.387 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.46 117.09 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 172.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.8 p -89.37 168.93 11.84 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.376 0.67 . . . . 0.0 110.647 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.37 -28.02 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.266 0.627 . . . . 0.0 111.856 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -64.67 -36.26 83.69 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.695 0.398 . . . . 0.0 110.514 172.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 24' ' ' GLY . 36.4 m -67.02 -42.99 83.96 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.991 0.516 . . . . 0.0 110.174 170.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.0 m -61.53 -43.83 98.15 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.089 0.556 . . . . 0.0 111.072 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.6 -26.36 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 O-C-N 121.925 -0.485 . . . . 0.0 111.259 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.423 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -73.32 -75.24 0.15 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.231 0.612 . . . . 0.0 112.372 177.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -165.808 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.56 1.347 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.11 99.84 0.29 Allowed 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.481 2.787 . . . . 0.0 112.455 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.05 -174.95 4.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.671 0.788 . . . . 0.0 110.763 -174.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.4 m -79.16 82.61 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 121.938 0.875 . . . . 0.0 109.903 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.9 m 70.06 107.83 0.06 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.529 1.532 . . . . 0.0 111.257 -177.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.8 t -76.93 79.69 3.49 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.55 145.84 54.5 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.324 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -109.02 86.75 4.11 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.513 ' HG3' HG23 ' A' ' 33' ' ' VAL . 44.6 Cg_endo -79.76 162.41 24.12 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.044 2.496 . . . . 0.0 112.578 -174.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -118.39 84.89 2.26 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 168.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.83 166.71 26.51 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.384 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.33 -25.03 11.65 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.836 0.854 . . . . 0.0 110.266 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.79 5.94 41.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.486 1.114 . . . . 0.0 111.681 -175.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.6 m -76.64 72.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 123.227 1.489 . . . . 0.0 111.236 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.89 166.19 22.67 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 113.362 -1.745 . . . . 0.0 109.314 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -105.83 127.37 53.07 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.261 0.624 . . . . 0.0 111.109 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.46 130.37 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 124.575 1.15 . . . . 0.0 110.061 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -77.59 153.39 33.3 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.973 0.909 . . . . 0.0 109.955 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.8 t -114.48 51.15 0.9 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.9 0.88 . . . . 0.0 109.691 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -48.27 -55.98 9.18 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.467 1.107 . . . . 0.0 112.744 -170.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -19.65 -56.92 0.01 OUTLIER Glycine 0 C--N 1.373 2.636 0 C-N-CA 126.268 1.889 . . . . 0.0 116.8 -172.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.531 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 26.2 t -165.22 65.51 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 169.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.2 m -156.77 -52.48 0.08 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.562 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 72.92 -6.06 1.77 Allowed 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 125.181 1.392 . . . . 0.0 111.323 -172.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -67.64 150.77 48.32 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.761 1.224 . . . . 0.0 111.131 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -100.26 131.18 46.35 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.758 0.823 . . . . 0.0 110.14 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -128.22 147.11 50.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.856 1.263 . . . . 0.0 108.489 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.6 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -70.4 148.54 48.27 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 165.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -57.01 -40.44 76.66 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.553 0.341 . . . . 0.0 110.504 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.513 HG23 ' HG3' ' A' ' 12' ' ' PRO . 21.0 m -69.45 -27.28 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.628 0.771 . . . . 0.0 112.359 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.6 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.8 t -60.38 -35.76 76.49 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 123.888 0.875 . . . . 0.0 110.167 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 m -115.96 6.46 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.165 -171.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.78 49.48 73.91 Favored Glycine 0 C--N 1.357 1.71 0 O-C-N 123.574 0.546 . . . . 0.0 113.539 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.7 t -119.17 137.94 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.152 1.381 . . . . 0.0 109.027 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 38.6 m -74.59 146.88 84.12 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 123.328 0.651 . . . . 0.0 109.989 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.78 -34.36 98.12 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.554 2.169 . . . . 0.0 113.101 174.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -70.4 -32.06 69.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.619 0.368 . . . . 0.0 111.204 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.4 ttt -67.86 -43.55 79.17 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.095 0.558 . . . . 0.0 110.066 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.95 -22.89 67.07 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.517 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -76.71 -43.87 35.74 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.13 0.972 . . . . 0.0 111.007 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -83.03 -22.05 33.66 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -171.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -150.78 165.97 31.89 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.139 0.495 . . . . 0.0 111.101 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -87.18 143.42 27.3 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.32 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -72.66 88.51 1.28 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.252 0.549 . . . . 0.0 109.552 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 66.7 mt -92.61 103.17 14.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.628 ' SG ' ' HB2' ' A' ' 51' ' ' ARG . 19.0 p -81.73 175.03 10.8 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.844 -178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.07 -37.63 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.479 173.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.628 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 49.5 mtt-85 -61.24 -32.48 72.28 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.973 0.509 . . . . 0.0 111.165 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.531 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 24.0 m -67.62 -53.94 23.84 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.856 0.462 . . . . 0.0 110.214 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 t -68.93 -33.45 73.75 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.24 -172.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.8 t -73.92 -39.33 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 123.206 0.603 . . . . 0.0 110.667 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -63.5 -27.51 69.32 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 171.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 CA--C 1.56 1.351 0 C-N-CA 124.12 0.968 . . . . 0.0 110.83 171.952 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.563 1.473 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -43.76 86.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.398 3.144 0 C-N-CA 125.272 3.982 . . . . 0.0 115.87 -172.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.22 -170.32 2.17 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.072 1.349 . . . . 0.0 109.649 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.5 t -64.97 -57.1 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.125 0.57 . . . . 0.0 109.98 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.2 t -137.86 -22.64 1.07 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.278 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.0 t 69.72 100.93 0.06 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.597 1.159 . . . . 0.0 111.341 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.0 155.36 27.75 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.332 0.653 . . . . 0.0 110.499 171.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -117.94 81.24 15.53 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.411 1.084 . . . . 0.0 109.728 -175.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.13 165.47 11.24 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.587 2.192 . . . . 0.0 112.218 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.13 97.36 3.45 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.606 0.717 . . . . 0.0 109.454 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.94 93.43 0.22 Allowed Glycine 0 C--N 1.345 1.063 0 CA-C-N 114.658 -1.155 . . . . 0.0 114.375 -170.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -158.58 -61.3 0.08 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.525 0.73 . . . . 0.0 109.78 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -100.56 13.76 33.59 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.323 0.649 . . . . 0.0 111.025 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.06 130.84 35.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 123.04 0.536 . . . . 0.0 110.042 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.95 137.78 54.06 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.454 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -121.66 165.31 15.94 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.547 0.739 . . . . 0.0 109.858 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.77 133.24 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.623 -173.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -87.85 113.62 23.68 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 173.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 45.9 t -82.17 82.55 7.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.61 0.764 . . . . 0.0 110.535 -177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.41 1.46 0.78 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.369 1.067 . . . . 0.0 113.26 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.15 -162.7 0.57 Allowed Glycine 0 CA--C 1.539 1.55 0 O-C-N 121.549 -0.72 . . . . 0.0 113.087 162.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.518 ' N ' ' SG ' ' A' ' 52' ' ' CYS . 29.5 p -82.15 69.91 8.97 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.695 0.759 . . . . 0.0 111.134 -171.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.2 p -174.56 -41.16 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.921 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 74.6 -3.19 2.63 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 124.187 0.995 . . . . 0.0 112.607 168.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -77.34 157.89 30.43 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.752 0.821 . . . . 0.0 112.025 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -84.98 133.95 34.25 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.866 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.502 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 78.8 m-85 -126.91 158.75 35.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.866 1.266 . . . . 0.0 108.005 176.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.61 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -68.97 152.61 45.05 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 162.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.468 ' NE2' ' HA ' ' A' ' 39' ' ' PRO . 26.9 tt0 -62.62 -35.67 80.31 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.435 0.694 . . . . 0.0 110.018 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.4 m -70.57 -28.9 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.767 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.61 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 5.0 t -60.7 -41.54 95.39 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 123.698 0.799 . . . . 0.0 111.415 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.4 m -96.64 -19.7 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.086 0.955 . . . . 0.0 111.598 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.91 15.75 79.58 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.238 0.336 . . . . 0.0 113.32 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 78.2 t -79.46 140.43 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.781 0.832 . . . . 0.0 109.826 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 m -67.7 148.49 98.53 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.687 0.795 . . . . 0.0 111.134 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.468 ' HA ' ' NE2' ' A' ' 32' ' ' GLN . 5.7 Cg_endo -47.99 -48.37 16.52 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.895 3.063 . . . . 0.0 115.071 -176.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -61.14 -49.78 75.85 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 120.956 0.408 . . . . 0.0 110.419 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.633 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 93.0 mmm -58.69 -35.77 73.15 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.304 -177.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.49 -36.61 71.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.939 0.896 . . . . 0.0 111.824 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -89.33 -29.62 19.01 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 122.846 0.459 . . . . 0.0 111.989 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -127.73 -45.2 1.47 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.7 0.8 . . . . 0.0 112.637 -159.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.633 ' HB2' ' HA ' ' A' ' 41' ' ' MET . 22.4 mm-40 -112.81 -144.38 0.39 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.256 0.623 . . . . 0.0 110.798 -167.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.86 139.84 53.13 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.424 0.69 . . . . 0.0 111.231 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.66 27.97 1.08 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.891 1.277 . . . . 0.0 109.817 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.46 120.0 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.651 1.18 . . . . 0.0 109.545 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.6 p -78.22 167.2 21.76 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.356 0.662 . . . . 0.0 110.883 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.99 -39.46 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 124.132 0.973 . . . . 0.0 112.549 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -41.83 85.88 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.494 1.117 . . . . 0.0 110.269 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 25' ' ' SER . 18.3 m -64.47 -49.5 71.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.812 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.8 t -66.8 -28.46 68.4 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -173.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 82.0 t -72.36 -33.41 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.108 0.563 . . . . 0.0 110.732 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -71.27 -43.67 66.74 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.084 0.554 . . . . 0.0 110.912 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.484 1.273 0 C-N-CA 123.957 0.903 . . . . 0.0 111.641 -177.568 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -73.34 69.45 4.11 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.493 2.129 . . . . 0.0 111.68 172.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.454 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -141.75 79.94 1.7 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.338 0.655 . . . . 0.0 109.85 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.7 t 63.76 -69.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 125.528 1.531 . . . . 0.0 110.97 -172.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.1 t -140.26 -83.66 0.24 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 170.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.6 t 147.9 117.16 0.0 OUTLIER 'General case' 0 C--N 1.361 1.102 0 C-N-CA 127.41 2.284 . . . . 0.0 107.344 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.5 mt -56.67 -36.09 69.17 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.806 0.843 . . . . 0.0 111.472 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 57.14 75.14 0.59 Allowed Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.747 1.219 . . . . 0.0 111.365 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -87.2 175.89 4.59 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.496 2.131 . . . . 0.0 111.717 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.5 -24.55 59.02 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.01 171.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.52 ' HA2' HG21 ' A' ' 17' ' ' VAL . . . 78.59 58.9 2.96 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.378 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -82.5 -49.13 10.25 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.163 0.585 . . . . 0.0 110.842 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -131.47 11.68 4.91 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.128 0.971 . . . . 0.0 111.844 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.52 HG21 ' HA2' ' A' ' 14' ' ' GLY . 18.7 m -78.94 124.57 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 118.47 0.577 . . . . 0.0 109.773 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -89.86 136.0 33.3 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 14.0 m0 -99.84 126.34 45.93 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.203 0.601 . . . . 0.0 110.798 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.71 115.55 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 C-N-CA 124.764 1.226 . . . . 0.0 110.297 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -83.78 127.41 33.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.569 0.748 . . . . 0.0 109.933 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.3 t -82.65 108.89 16.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 169.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.11 -80.08 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 24.18 -91.1 0.01 OUTLIER Glycine 0 C--N 1.37 2.442 0 O-C-N 125.104 1.502 . . . . 0.0 115.6 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.409 ' N ' ' SG ' ' A' ' 52' ' ' CYS . 10.5 m -149.98 46.09 0.92 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.748 1.219 . . . . 0.0 109.435 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.5 m -133.77 -61.48 0.8 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.622 0.769 . . . . 0.0 109.431 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 74.14 -2.48 2.78 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.221 1.409 . . . . 0.0 110.941 -172.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -81.73 141.24 33.74 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.73 0.812 . . . . 0.0 110.28 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -87.76 120.3 28.95 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.049 0.94 . . . . 0.0 109.371 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -115.79 124.06 49.8 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 123.172 0.589 . . . . 0.0 109.712 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.618 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -57.68 143.33 41.96 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 167.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -62.33 -32.08 72.79 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 118.298 0.499 . . . . 0.0 110.925 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.452 HG23 ' HB2' ' A' ' 31' ' ' HIS . 32.8 m -65.73 -29.63 47.58 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 123.221 0.608 . . . . 0.0 111.726 172.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.618 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 3.9 t -68.53 -40.01 80.92 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.521 0.728 . . . . 0.0 111.707 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.52 -2.66 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.525 0.73 . . . . 0.0 112.668 -171.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.29 3.81 54.35 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.814 -0.437 . . . . 0.0 114.058 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' A' ' 41' ' ' MET . 53.2 t -70.79 111.93 5.12 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 123.557 0.743 . . . . 0.0 109.453 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.7 m -69.17 156.11 92.22 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 123.611 0.764 . . . . 0.0 110.485 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.88 -32.39 29.84 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 123.402 2.735 . . . . 0.0 113.342 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -57.49 -52.9 63.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.649 1.18 . . . . 0.0 111.807 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.41 ' HB2' HG12 ' A' ' 37' ' ' VAL . 25.7 mmt -72.75 -30.95 64.57 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.449 0.643 . . . . 0.0 110.515 -177.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.9 -36.38 67.28 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.666 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -78.91 -36.62 41.63 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.999 0.519 . . . . 0.0 110.395 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -75.17 -20.46 59.33 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.345 0.403 . . . . 0.0 110.587 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.507 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 42.8 mt-10 73.09 21.76 3.08 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.093 1.357 . . . . 0.0 112.505 170.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -86.22 21.23 2.09 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.182 0.993 . . . . 0.0 111.74 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.507 ' CE2' ' HA ' ' A' ' 45' ' ' GLU . 11.6 p90 -82.4 25.87 0.59 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.089 0.955 . . . . 0.0 112.184 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mp -72.86 119.08 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 173.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.8 m -62.4 159.38 15.51 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.656 0.782 . . . . 0.0 110.418 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.455 ' O ' HG21 ' A' ' 54' ' ' VAL . 99.2 t -60.7 -42.73 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 175.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -62.51 -37.37 85.76 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.555 0.742 . . . . 0.0 111.666 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 25' ' ' SER . 5.7 m -64.38 -36.05 82.88 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.753 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.2 m -74.6 -25.62 59.38 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.277 0.631 . . . . 0.0 110.804 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 50' ' ' VAL . 80.0 t -67.26 -36.76 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 122.87 0.468 . . . . 0.0 110.3 173.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -74.64 -49.39 21.65 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.187 0.595 . . . . 0.0 110.599 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 . . . . . 0 N--CA 1.482 1.133 0 O-C-N 123.992 0.808 . . . . 0.0 111.313 -179.871 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 4' ' ' CYS . 4.0 t . . . . . 0 CA--C 1.556 1.2 0 CA-C-O 119.761 -0.161 . . . . 0.0 111.386 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.49 -28.1 53.93 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.608 2.205 . . . . 0.0 113.212 -173.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 50.27 -96.92 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.277 1.431 . . . . 0.0 112.668 -177.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 90.0 t -130.63 -57.65 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.0 t -135.19 107.15 7.07 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 164.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 4' ' ' CYS . 42.3 t -78.78 87.56 4.66 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.094 0.558 . . . . 0.0 111.142 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.07 109.84 5.39 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -106.67 99.17 23.66 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.665 0.786 . . . . 0.0 109.425 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.498 ' HG2' HG23 ' A' ' 17' ' ' VAL . 88.3 Cg_endo -76.6 -170.61 0.92 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.144 2.563 . . . . 0.0 112.05 174.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -75.1 107.56 7.26 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.27 69.93 3.05 Favored Glycine 0 N--CA 1.467 0.729 0 CA-C-N 115.091 -0.959 . . . . 0.0 113.486 -171.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -92.53 -53.51 4.17 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.732 0.813 . . . . 0.0 109.276 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.71 32.82 0.55 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.595 1.158 . . . . 0.0 110.636 -173.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.498 HG23 ' HG2' ' A' ' 12' ' ' PRO . 43.5 t -68.81 125.97 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.074 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -76.88 135.41 38.84 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 123.675 0.609 . . . . 0.0 109.929 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 35.3 m0 -113.69 171.51 7.53 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.079 0.952 . . . . 0.0 111.121 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.78 118.75 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.057 1.343 . . . . 0.0 108.186 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 62.1 tt0 -76.68 145.86 38.47 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.967 0.507 . . . . 0.0 110.401 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.6 t -75.84 128.45 35.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.021 0.439 . . . . 0.0 111.68 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.625 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . 11.4 t70 -87.07 79.18 8.76 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.14 -179.41 44.75 Favored Glycine 0 C--O 1.239 0.418 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.844 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t -79.73 73.72 6.44 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.539 0.736 . . . . 0.0 109.754 -176.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.703 ' SG ' ' HG2' ' A' ' 28' ' ' GLN . 4.0 p -173.12 -37.58 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.312 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 61.83 17.2 8.62 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.027 1.331 . . . . 0.0 113.215 173.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.703 ' HG2' ' SG ' ' A' ' 26' ' ' CYS . 4.3 pt20 -73.11 134.2 44.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.288 0.635 . . . . 0.0 111.049 -177.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 48.2 m95 -81.43 155.32 25.93 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.022 0.929 . . . . 0.0 110.885 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -138.67 134.18 33.31 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.803 0.841 . . . . 0.0 109.427 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.632 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -62.51 145.86 53.17 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 164.551 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -49.87 -49.47 49.28 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 120.952 0.406 . . . . 0.0 111.199 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -67.06 -25.63 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.414 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.632 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 7.8 t -59.99 -35.18 74.47 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.305 0.642 . . . . 0.0 111.72 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.25 -3.77 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.347 1.059 . . . . 0.0 111.58 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.0 39.58 97.4 Favored Glycine 0 C--N 1.353 1.518 0 C-N-CA 123.602 0.62 . . . . 0.0 114.221 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.46 131.63 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.392 0.677 . . . . 0.0 109.407 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.3 m -68.32 149.32 98.11 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.388 1.075 . . . . 0.0 110.961 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.39 -52.69 6.96 Favored 'Trans proline' 0 C--N 1.393 2.873 0 C-N-CA 123.916 3.077 . . . . 0.0 114.157 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -68.29 -36.77 79.88 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.291 0.636 . . . . 0.0 111.682 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 61.2 mtt -72.67 -31.38 65.02 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.694 0.398 . . . . 0.0 110.884 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.09 -33.66 50.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.489 0.716 . . . . 0.0 110.814 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -76.31 -42.2 45.99 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.301 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -71.9 -58.43 3.46 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.454 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -101.48 106.25 17.34 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.625 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . 4.5 m-20 -56.25 110.2 0.72 Allowed 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.064 173.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -62.29 111.05 1.83 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.081 0.467 . . . . 0.0 110.779 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 41.0 mt -88.85 117.24 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 172.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.3 p -73.23 154.57 40.17 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.3 t -52.52 -44.74 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 124.457 1.103 . . . . 0.0 112.589 -171.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -60.74 -31.74 71.04 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.151 0.58 . . . . 0.0 112.45 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.6 m -76.31 -42.68 44.38 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.333 0.253 . . . . 0.0 111.12 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 m -61.21 -40.8 95.35 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.592 0.757 . . . . 0.0 110.707 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.9 -49.83 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.322 1.049 . . . . 0.0 110.819 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -74.53 -11.88 60.33 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.925 0.49 . . . . 0.0 111.834 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 N--CA 1.479 0.993 0 C-N-CA 123.617 0.767 . . . . 0.0 110.291 171.481 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.554 1.129 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.58 62.63 8.56 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 123.285 2.656 . . . . 0.0 112.304 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.75 177.78 4.72 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.212 176.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.77 -42.57 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 t -133.4 162.9 30.6 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.897 0.879 . . . . 0.0 109.188 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.4 t -153.6 94.46 1.79 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.229 0.538 . . . . 0.0 110.018 170.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.493 HD11 ' HB ' ' A' ' 33' ' ' VAL . 28.0 mt -61.72 -35.18 77.32 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.456 1.102 . . . . 0.0 111.049 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 52.49 65.77 5.72 Favored Pre-proline 0 CA--C 1.552 1.057 0 O-C-N 124.67 1.231 . . . . 0.0 110.071 -171.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HG2' HG21 ' A' ' 17' ' ' VAL . 61.4 Cg_endo -83.75 169.77 11.78 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.296 1.997 . . . . 0.0 112.39 -175.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -67.02 120.15 13.16 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.771 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.59 53.05 4.48 Favored Glycine 0 C--N 1.338 0.672 0 O-C-N 123.487 0.492 . . . . 0.0 113.687 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -65.66 -55.15 19.0 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -148.85 59.37 1.06 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.657 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.417 HG21 ' HG2' ' A' ' 12' ' ' PRO . 40.5 t -103.75 118.2 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.11 128.65 33.55 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.102 0.876 . . . . 0.0 109.807 -173.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 26.1 m0 -109.02 165.42 11.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.791 0.836 . . . . 0.0 109.904 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 47' ' ' TYR . 4.3 p -152.77 124.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.671 0.788 . . . . 0.0 109.908 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -72.42 130.14 40.0 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.722 0.409 . . . . 0.0 110.0 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.2 t -65.75 -49.32 68.8 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.16 0.912 . . . . 0.0 111.552 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 72.64 -43.14 0.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.227 1.411 . . . . 0.0 112.723 -173.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.85 -160.49 0.09 OUTLIER Glycine 0 C--N 1.362 1.98 0 N-CA-C 114.569 0.587 . . . . 0.0 114.569 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.6 p -80.83 72.83 7.84 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.857 0.863 . . . . 0.0 111.706 -165.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.8 p 175.26 -31.68 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.894 2.077 . . . . 0.0 106.997 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 75.33 -43.88 0.51 Allowed 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 126.447 1.899 . . . . 0.0 113.952 172.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -47.9 148.85 1.49 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.389 1.876 . . . . 0.0 114.105 -167.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -74.87 144.74 43.23 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.174 173.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -132.29 128.15 37.15 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.622 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.597 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -67.02 151.64 47.27 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 172.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.569 ' HA ' ' HB ' ' A' ' 37' ' ' VAL . 62.6 mt-30 -56.37 -41.01 75.49 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.053 0.454 . . . . 0.0 110.204 174.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.493 ' HB ' HD11 ' A' ' 10' ' ' LEU . 18.8 m -71.3 -17.4 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-N 114.849 -1.068 . . . . 0.0 112.669 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.597 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 2.5 t -80.06 -46.48 16.45 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.244 0.618 . . . . 0.0 111.335 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.494 HG21 HG22 ' A' ' 37' ' ' VAL . 2.5 m -119.41 9.78 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 123.654 0.782 . . . . 0.0 112.901 -169.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.01 36.96 92.7 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 122.672 0.177 . . . . 0.0 113.315 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 32' ' ' GLN . 10.2 t -78.71 134.55 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.282 0.633 . . . . 0.0 110.995 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.0 p -77.02 153.28 82.68 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.66 0.784 . . . . 0.0 109.778 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.76 -31.53 72.33 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.44 2.094 . . . . 0.0 112.039 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -57.57 -52.35 65.75 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.548 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.561 ' HB2' HG13 ' A' ' 37' ' ' VAL . 26.1 mmt -66.44 -36.89 83.92 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 123.543 0.527 . . . . 0.0 111.516 -176.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.21 -30.37 68.53 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.109 0.564 . . . . 0.0 111.781 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -89.44 -29.29 19.13 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.151 0.58 . . . . 0.0 111.265 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -83.18 -20.71 34.15 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.558 0.743 . . . . 0.0 111.085 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 69.41 -161.92 0.18 Allowed 'General case' 0 C--N 1.361 1.095 0 O-C-N 124.419 1.075 . . . . 0.0 108.658 -170.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 69.27 3.57 4.18 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.633 1.173 . . . . 0.0 113.036 171.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.415 ' HB3' HG23 ' A' ' 20' ' ' VAL . 93.3 t80 -74.39 98.53 3.3 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.7 mt -100.0 135.45 35.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 165.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -56.06 129.93 41.92 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 172.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -54.25 -35.12 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.36 0.664 . . . . 0.0 112.66 -167.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -68.65 -35.98 77.97 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.492 0.717 . . . . 0.0 110.988 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 84.2 m -64.68 -31.15 72.25 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.113 0.565 . . . . 0.0 111.384 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.9 m -70.3 -44.09 69.03 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.977 0.417 . . . . 0.0 109.976 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.0 t -69.5 -31.38 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.029 0.932 . . . . 0.0 110.763 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -115.39 28.57 8.59 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.526 0.679 . . . . 0.0 110.102 -175.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t70 . . . . . 0 N--CA 1.484 1.243 0 C-N-CA 123.908 0.883 . . . . 0.0 110.368 177.475 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.41 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 12.6 t . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 119.578 -0.248 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.68 -42.76 0.76 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.67 2.247 . . . . 0.0 113.303 -174.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 44.87 25.13 0.13 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 125.798 1.639 . . . . 0.0 115.061 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.1 t 60.46 -73.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.908 1.283 . . . . 0.0 109.992 -166.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.3 m -104.81 88.11 2.83 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.157 0.983 . . . . 0.0 108.935 170.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.42 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 42.4 t -79.43 84.62 5.31 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.213 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 33' ' ' VAL . 59.9 mt -64.98 101.6 0.52 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 167.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -112.01 96.52 34.51 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.172 0.989 . . . . 0.0 110.782 -166.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HG2' HG22 ' A' ' 17' ' ' VAL . 66.3 Cg_exo -53.66 150.23 29.24 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.056 2.504 . . . . 0.0 112.138 164.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.72 90.0 0.76 Allowed 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 122.027 0.918 . . . . 0.0 110.765 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.2 -149.46 32.48 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 114.497 -1.229 . . . . 0.0 113.475 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -101.07 82.64 2.39 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.026 0.93 . . . . 0.0 108.903 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -127.84 10.84 6.57 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.568 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.465 HG22 ' HG2' ' A' ' 12' ' ' PRO . 15.8 m -135.83 168.61 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.407 0.683 . . . . 0.0 111.733 -173.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -74.68 139.44 43.51 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.176 173.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -116.27 175.43 5.56 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.864 0.866 . . . . 0.0 109.96 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.469 HG12 HG11 ' A' ' 37' ' ' VAL . 12.7 p -161.08 138.21 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.183 0.993 . . . . 0.0 108.856 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -101.48 142.56 32.67 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 40.1 t -114.08 77.63 1.08 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.214 0.606 . . . . 0.0 110.671 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -78.78 80.8 5.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.81 -65.55 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.093 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.662 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 13.6 m -152.8 56.39 0.79 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.902 0.858 . . . . 0.0 109.233 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.0 m -161.61 -53.1 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 174.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.23 11.78 4.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.222 1.809 . . . . 0.0 113.467 173.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -107.04 166.61 10.49 Favored 'General case' 0 C--O 1.246 0.899 0 C-N-CA 123.419 0.688 . . . . 0.0 109.767 177.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -87.16 137.59 32.21 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.062 169.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -131.32 132.8 44.77 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.318 1.047 . . . . 0.0 108.884 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.624 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -56.99 147.03 25.08 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.836 0.854 . . . . 0.0 108.835 170.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -56.64 -45.18 81.71 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.153 0.981 . . . . 0.0 111.115 -173.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.41 ' O ' HD13 ' A' ' 10' ' ' LEU . 12.1 m -71.33 -29.57 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.722 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.624 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 13.2 t -54.17 -53.29 55.5 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.31 0.644 . . . . 0.0 112.556 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.1 m -96.12 -5.24 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.637 0.775 . . . . 0.0 111.06 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.74 37.52 94.96 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.612 -177.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.469 HG11 HG12 ' A' ' 20' ' ' VAL . 13.7 p -69.3 144.36 14.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.564 0.746 . . . . 0.0 110.684 -177.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.2 m -58.33 130.7 84.33 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.369 172.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -53.71 -26.71 39.33 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.241 2.627 . . . . 0.0 112.342 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.58 -52.17 64.47 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.788 0.835 . . . . 0.0 110.397 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.1 mmt -72.41 -30.65 64.84 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.088 0.555 . . . . 0.0 111.42 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.93 -44.83 83.97 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.798 0.839 . . . . 0.0 111.029 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -74.74 -25.8 59.35 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.549 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -75.73 -20.09 58.59 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 67.37 14.68 9.74 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.431 1.492 . . . . 0.0 112.303 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -134.96 89.23 2.5 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -171.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -119.42 106.84 12.65 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.914 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.98 110.2 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 174.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.7 m -57.92 158.05 7.02 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.958 0.503 . . . . 0.0 110.903 -176.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.8 -38.04 63.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 122.974 0.51 . . . . 0.0 110.428 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -56.78 -49.0 76.61 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.866 0.866 . . . . 0.0 111.251 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.662 ' SG ' ' HB2' ' A' ' 25' ' ' SER . 86.4 m -71.32 -27.1 63.16 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.095 0.958 . . . . 0.0 112.412 -174.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.8 m -85.19 -53.22 5.39 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.313 0.645 . . . . 0.0 110.678 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.62 -21.3 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.076 0.55 . . . . 0.0 111.421 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.63 -41.33 98.96 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-N 117.805 0.275 . . . . 0.0 110.723 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 N--CA 1.471 0.613 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.54 -179.766 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.0 t . . . . . 0 CA--C 1.551 0.999 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 72.8 Cg_endo -76.01 -38.86 1.05 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.73 2.287 . . . . 0.0 112.341 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 48.58 23.22 0.59 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 126.159 1.783 . . . . 0.0 115.79 169.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.4 t 62.5 -74.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 125.126 1.37 . . . . 0.0 110.278 -171.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.7 m -108.64 80.84 1.38 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.354 1.062 . . . . 0.0 108.464 174.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.436 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 41.8 t -84.56 87.79 7.28 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.736 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.5 mt -65.76 111.29 3.16 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 164.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -102.7 102.41 26.37 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.046 0.938 . . . . 0.0 110.456 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.23 -179.48 5.06 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 122.706 2.271 . . . . 0.0 110.848 164.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.46 23.5 10.99 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.396 0.679 . . . . 0.0 110.625 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.21 35.42 92.05 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.82 -63.97 0.98 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.377 1.471 . . . . 0.0 110.814 -169.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -142.54 19.42 2.03 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.81 1.244 . . . . 0.0 108.29 171.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 t -79.18 123.95 36.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.259 -164.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 32' ' ' GLN . 34.2 m-20 -83.19 146.72 28.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.524 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -115.5 128.4 55.97 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.336 0.655 . . . . 0.0 109.292 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 47' ' ' TYR . 5.3 p -103.86 126.27 58.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 123.608 0.763 . . . . 0.0 109.91 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -85.64 127.03 34.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.99 0.916 . . . . 0.0 108.973 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.8 t -85.49 80.94 8.9 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.01 -26.98 61.18 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.889 0.876 . . . . 0.0 112.258 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.534 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -71.57 104.61 1.48 Allowed Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.783 -1.009 . . . . 0.0 111.266 167.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.602 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 21.7 m 52.45 47.58 24.41 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.714 1.606 . . . . 0.0 113.558 161.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.0 m -161.77 -62.44 0.05 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.156 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.1 t30 70.42 3.51 4.51 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.186 1.394 . . . . 0.0 110.841 -173.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -87.06 143.25 27.41 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.977 0.911 . . . . 0.0 110.283 -172.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -87.63 112.24 22.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.988 0.915 . . . . 0.0 110.023 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -107.96 140.57 40.91 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.852 0.861 . . . . 0.0 109.059 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.595 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -68.63 154.55 41.7 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.031 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 27.2 tt0 -52.33 -50.11 62.94 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.071 1.348 . . . . 0.0 111.047 -177.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.9 m -72.08 -28.58 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 114.33 -1.304 . . . . 0.0 112.098 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.595 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.9 t -58.14 -49.46 76.91 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.813 0.845 . . . . 0.0 111.931 -175.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 m -95.63 2.57 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.462 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.72 19.89 76.99 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.247 0.342 . . . . 0.0 113.895 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.43 121.57 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.0 m -72.33 158.13 88.02 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.368 0.667 . . . . 0.0 110.325 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.93 -39.65 68.53 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.263 2.642 . . . . 0.0 113.371 176.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -64.24 -44.35 92.11 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.172 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 56.7 mtt -63.33 -48.19 79.05 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.756 0.822 . . . . 0.0 110.073 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.32 -26.95 68.71 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.573 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -83.97 -51.03 7.47 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.247 0.619 . . . . 0.0 111.125 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -91.4 -60.22 1.94 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.47 0.308 . . . . 0.0 110.714 -168.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -166.41 152.15 8.5 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.493 0.717 . . . . 0.0 111.957 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.7 t0 68.09 103.42 0.05 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.077 1.751 . . . . 0.0 112.807 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.533 ' HB2' HG23 ' A' ' 20' ' ' VAL . 3.2 p90 -150.93 14.52 0.73 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.47 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 52.6 mt -82.16 122.84 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.752 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 p -65.26 148.3 51.93 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.312 0.383 . . . . 0.0 110.367 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.7 t -45.25 -42.07 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 125.821 1.648 . . . . 0.0 113.275 -171.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -53.96 -50.01 67.46 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.885 0.874 . . . . 0.0 111.927 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 25' ' ' SER . 61.5 m -76.7 -24.97 53.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.581 -175.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.7 m -68.54 -47.53 66.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.313 0.645 . . . . 0.0 110.473 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.27 -29.99 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.925 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -62.31 -66.09 0.59 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.262 0.625 . . . . 0.0 110.423 173.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 N--CA 1.47 0.561 0 O-C-N 123.941 0.776 . . . . 0.0 109.718 -175.677 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 119.468 -0.301 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -64.45 85.18 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 123.005 2.47 . . . . 0.0 112.783 -175.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.16 171.14 13.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.761 1.224 . . . . 0.0 109.967 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.04 -38.86 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.597 0.759 . . . . 0.0 110.949 -175.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.9 p -156.68 109.76 2.6 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.605 0.762 . . . . 0.0 109.097 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.4 t -88.41 109.17 19.79 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.983 0.421 . . . . 0.0 110.75 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.661 HD22 HG21 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -69.57 158.55 35.05 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.478 164.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -102.42 93.64 4.22 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 171.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.64 112.95 1.93 Allowed 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.315 2.01 . . . . 0.0 110.897 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -85.87 52.12 2.39 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 122.718 1.246 . . . . 0.0 110.722 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 157.04 142.89 3.51 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 113.171 -1.832 . . . . 0.0 110.704 -173.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.84 22.59 0.75 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.207 1.003 . . . . 0.0 111.775 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -74.33 -16.32 60.92 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.454 1.102 . . . . 0.0 111.788 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -80.19 137.42 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -90.7 151.7 21.14 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -103.24 152.37 21.57 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.609 0.764 . . . . 0.0 110.607 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.54 124.29 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.014 1.326 . . . . 0.0 108.276 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.559 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 35.4 tt0 -85.29 141.83 29.8 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.63 151.69 46.87 Favored 'General case' 0 CA--C 1.552 1.023 0 O-C-N 123.624 0.577 . . . . 0.0 111.863 -167.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -71.74 -44.34 64.26 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.7 1.6 . . . . 0.0 112.715 -174.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.546 ' HA3' ' SG ' ' A' ' 52' ' ' CYS . . . -84.01 -129.06 1.66 Allowed Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.656 -167.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -120.31 75.63 1.12 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.8 m -114.17 -27.99 7.46 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.888 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.5 t30 77.3 -37.17 0.25 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.271 1.429 . . . . 0.0 112.208 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -85.16 148.59 26.03 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.614 0.721 . . . . 0.0 112.537 -166.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.559 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 12.0 p-90 -104.16 139.02 39.8 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.324 171.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 42.3 m-85 -123.11 162.98 21.42 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 124.413 1.085 . . . . 0.0 108.251 -175.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.639 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -69.24 146.79 52.04 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 160.202 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -58.35 -41.32 84.39 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.294 0.497 . . . . 0.0 110.707 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.661 HG21 HD22 ' A' ' 10' ' ' LEU . 27.8 m -67.47 -25.67 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.711 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.639 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.5 t -58.6 -39.12 79.51 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 123.835 0.854 . . . . 0.0 111.433 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.4 m -104.92 -0.97 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.998 0.919 . . . . 0.0 111.622 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.26 16.12 80.04 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 116.491 -0.322 . . . . 0.0 113.825 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.9 t -90.5 136.55 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.23 0.612 . . . . 0.0 109.802 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.0 m -90.34 152.44 45.61 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.814 0.846 . . . . 0.0 110.117 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -47.04 -56.74 2.78 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.898 3.065 . . . . 0.0 114.622 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.27 -27.88 67.56 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.913 0.485 . . . . 0.0 111.722 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.6 mtt -74.35 -31.27 62.35 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 122.614 0.365 . . . . 0.0 110.201 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.55 -35.3 60.69 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.347 0.659 . . . . 0.0 111.343 176.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.17 -48.87 12.47 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.585 0.754 . . . . 0.0 111.213 -176.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.34 -25.82 19.23 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.334 0.653 . . . . 0.0 112.046 -171.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -123.82 170.03 10.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.249 0.619 . . . . 0.0 110.204 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -85.48 123.71 31.22 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.627 178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -88.44 48.91 1.7 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.404 1.081 . . . . 0.0 110.911 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.1 mt -73.36 105.29 2.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.861 -177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 51' ' ' ARG . 2.3 p -69.16 162.22 27.49 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.012 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 67.1 t -54.2 -42.27 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.45 0.7 . . . . 0.0 111.122 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.516 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 2.8 mpt_? -58.41 -40.64 83.03 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.679 0.791 . . . . 0.0 111.494 176.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.546 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 35.0 m -72.34 -35.22 68.5 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.296 0.238 . . . . 0.0 111.578 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.1 m -70.33 -47.57 60.48 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.645 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.6 p -84.87 -44.5 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -84.1 -35.82 23.43 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 120.736 0.303 . . . . 0.0 110.206 -167.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 59.7 m-20 . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 121.538 0.685 . . . . 0.0 110.404 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.619 ' SG ' ' HA ' ' A' ' 11' ' ' GLN . 9.3 m . . . . . 0 CA--C 1.55 0.97 0 CA-C-O 120.203 0.049 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -93.16 -23.26 0.3 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.412 2.742 . . . . 0.0 114.847 -175.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 9' ' ' CYS . . . -63.53 147.99 49.93 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.158 0.583 . . . . 0.0 110.347 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -55.59 -34.04 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.933 0.893 . . . . 0.0 112.559 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.5 m -127.01 100.16 6.01 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 169.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.548 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 8.7 t -142.6 25.64 1.82 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.987 -166.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 21.1 mt 59.05 -65.16 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 165.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.619 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 27.5 mt-30 82.83 59.58 0.09 OUTLIER Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 127.597 2.359 . . . . 0.0 110.701 -168.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 11' ' ' GLN . 24.8 Cg_endo -93.86 96.04 0.13 Allowed 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.171 2.581 . . . . 0.0 110.908 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.12 83.97 2.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.43 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.38 122.52 1.1 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.593 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -65.45 -19.63 66.02 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.864 0.866 . . . . 0.0 111.956 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -77.09 1.53 17.81 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.853 0.861 . . . . 0.0 112.181 -174.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.6 m -79.39 137.35 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.023 0.44 . . . . 0.0 110.296 175.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -94.58 149.25 21.43 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.616 1.167 . . . . 0.0 110.148 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 1.0 OUTLIER -119.01 161.28 20.49 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.739 0.816 . . . . 0.0 111.419 -171.192 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.69 136.68 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.674 1.19 . . . . 0.0 108.255 171.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -76.4 152.25 36.31 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.26 0.624 . . . . 0.0 109.536 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.4 t -76.22 -21.26 56.62 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 76.26 -48.6 0.57 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.156 1.383 . . . . 0.0 112.292 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.525 ' HA3' ' SG ' ' A' ' 52' ' ' CYS . . . -57.41 178.8 0.94 Allowed Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.246 0.859 . . . . 0.0 115.246 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.8 m -65.47 -23.73 66.99 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.454 0.702 . . . . 0.0 112.456 -168.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.3 p -67.2 -34.42 77.46 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.062 0.545 . . . . 0.0 110.017 174.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.3 t30 65.33 12.68 8.27 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 125.11 1.364 . . . . 0.0 113.466 166.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -73.16 141.92 47.43 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.315 1.046 . . . . 0.0 112.063 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -92.6 118.12 30.68 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.092 0.957 . . . . 0.0 109.589 175.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -110.94 126.93 55.26 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.01 0.924 . . . . 0.0 109.229 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -53.06 123.69 12.33 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.386 0.675 . . . . 0.0 111.572 175.09 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.461 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 47.8 mt-30 -52.31 -47.22 66.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.34 1.456 . . . . 0.0 112.697 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 m -58.24 -36.58 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.609 0.719 . . . . 0.0 110.955 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 0.1 OUTLIER -74.72 -39.3 61.98 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.882 -175.057 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.426 HG22 HG23 ' A' ' 37' ' ' VAL . 35.1 m -100.94 6.57 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.563 -173.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.05 3.18 88.09 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 114.71 0.644 . . . . 0.0 114.71 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.461 ' O ' ' HB3' ' A' ' 32' ' ' GLN . 88.1 t -79.74 125.86 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.414 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 25.2 m -93.22 165.57 18.13 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 123.894 0.878 . . . . 0.0 109.965 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 38' ' ' SER . 10.9 Cg_endo -51.81 -52.19 9.51 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 123.174 2.583 . . . . 0.0 114.401 -174.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.08 -27.74 64.85 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.322 0.249 . . . . 0.0 111.628 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.1 mtt -69.15 -36.92 77.94 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.775 0.43 . . . . 0.0 110.53 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.34 -31.39 63.95 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.21 1.004 . . . . 0.0 110.603 176.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -70.95 -36.47 72.62 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.391 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -76.33 -52.48 9.85 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.367 0.667 . . . . 0.0 110.64 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -138.72 139.14 38.27 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.321 1.048 . . . . 0.0 109.52 -172.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -72.8 176.29 5.74 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 122.695 0.398 . . . . 0.0 109.937 171.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -88.54 77.5 8.0 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 175.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.22 105.61 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.8 p -73.07 160.48 31.96 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.229 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.6 p -52.95 -39.67 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.434 1.094 . . . . 0.0 113.766 -165.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -70.9 -30.57 66.96 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 118.015 0.37 . . . . 0.0 111.449 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.525 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 99.2 m -74.91 -26.21 59.48 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.158 0.583 . . . . 0.0 111.005 173.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.8 m -81.85 -39.01 24.56 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.083 0.553 . . . . 0.0 110.862 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.8 t -76.89 -32.23 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.046 0.939 . . . . 0.0 109.747 176.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -135.51 87.45 2.32 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.082 0.553 . . . . 0.0 110.501 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 166.853 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.567 1.622 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -52.84 -51.14 11.78 Favored 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 124.712 3.608 . . . . 0.0 116.994 -159.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.526 ' HB1' ' SG ' ' A' ' 9' ' ' CYS . . . -60.15 158.51 11.18 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -170.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -75.8 -42.56 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.119 0.568 . . . . 0.0 110.411 176.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.0 p -92.44 52.29 1.89 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.522 1.129 . . . . 0.0 109.115 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.526 ' SG ' ' HB1' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -93.35 119.67 32.74 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.196 -167.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.4 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 28.6 mt -69.49 178.48 2.45 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 160.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -115.69 83.0 10.82 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -81.89 134.23 8.27 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.098 2.532 . . . . 0.0 112.885 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -148.06 152.61 37.67 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.472 0.709 . . . . 0.0 110.002 175.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.9 -146.7 17.33 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -92.26 78.6 5.12 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.009 0.924 . . . . 0.0 109.798 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 69.1 121.62 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.441 1.496 . . . . 0.0 111.63 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.6 t -89.26 145.66 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.919 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.72 120.81 16.87 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 174.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.626 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 9.5 m95 -118.24 131.04 56.38 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.377 0.671 . . . . 0.0 111.566 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.493 ' HB ' ' HG2' ' A' ' 32' ' ' GLN . 5.7 p -104.35 123.2 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.793 174.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -82.47 137.99 34.49 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 173.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 36.7 t -84.62 81.94 8.64 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 170.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -54.35 -18.59 4.26 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.752 1.221 . . . . 0.0 112.293 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -51.47 177.52 0.07 OUTLIER Glycine 0 C--N 1.351 1.364 0 N-CA-C 114.671 0.628 . . . . 0.0 114.671 167.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.9 p -74.65 72.98 1.99 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.554 1.141 . . . . 0.0 111.18 -171.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.408 ' SG ' ' HG3' ' A' ' 28' ' ' GLN . 9.6 p -178.36 -42.58 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.388 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.402 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 14.5 m120 67.05 31.58 6.8 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 124.038 0.935 . . . . 0.0 110.69 175.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.408 ' HG3' ' SG ' ' A' ' 26' ' ' CYS . 92.1 mt-30 -72.18 121.32 19.12 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.283 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -87.68 108.21 18.99 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.573 0.749 . . . . 0.0 110.996 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -103.8 171.68 7.22 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.941 170.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -108.36 123.58 49.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.324 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.493 ' HG2' ' HB ' ' A' ' 20' ' ' VAL . 28.4 mt-30 -48.79 -56.65 8.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.916 1.286 . . . . 0.0 113.082 -177.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -62.3 -32.28 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-O 121.384 0.611 . . . . 0.0 111.112 -176.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.494 ' HB3' ' CD2' ' A' ' 31' ' ' HIS . 6.5 t -85.53 -20.38 29.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.204 -170.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.8 m -109.4 -16.49 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.093 0.557 . . . . 0.0 111.578 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.46 15.21 35.64 Favored Glycine 0 C--N 1.351 1.399 0 N-CA-C 114.171 0.428 . . . . 0.0 114.171 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.33 129.96 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.285 0.634 . . . . 0.0 109.709 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 88.7 p -82.49 164.45 47.41 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.072 0.549 . . . . 0.0 109.711 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.51 -26.17 70.09 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 121.945 1.763 . . . . 0.0 111.336 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -64.76 -52.22 58.1 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.929 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 66.8 mtt -62.49 -36.04 81.25 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.576 0.75 . . . . 0.0 111.636 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.47 -38.99 85.24 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.49 0.716 . . . . 0.0 112.098 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -85.07 -45.66 11.89 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.896 0.478 . . . . 0.0 111.301 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -68.97 -54.38 15.61 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.356 1.062 . . . . 0.0 110.378 -175.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -111.08 160.6 16.73 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.201 -175.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -85.14 135.35 34.01 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 163.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -73.77 81.94 1.61 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 168.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.7 mt -75.18 104.92 3.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.958 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.9 p -73.84 158.51 34.39 Favored 'General case' 0 C--O 1.252 1.19 0 O-C-N 123.923 0.764 . . . . 0.0 110.3 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.405 ' O ' HG21 ' A' ' 54' ' ' VAL . 18.9 m -52.91 -33.62 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.222 1.009 . . . . 0.0 113.016 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -61.28 -41.65 97.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.798 0.439 . . . . 0.0 111.389 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.8 m -68.78 -36.49 78.37 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.88 0.472 . . . . 0.0 110.818 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.6 m -64.2 -47.78 78.43 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.512 0.725 . . . . 0.0 111.378 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 50' ' ' VAL . 53.2 t -69.77 -38.34 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.269 0.628 . . . . 0.0 110.503 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -68.81 -38.76 80.12 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.919 0.888 . . . . 0.0 112.342 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 N--CA 1.476 0.869 0 C-N-CA 122.43 0.292 . . . . 0.0 110.782 -173.351 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.5 t . . . . . 0 CA--C 1.55 0.967 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.93 94.31 1.07 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.684 2.923 . . . . 0.0 112.941 -169.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.625 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -158.57 107.52 1.97 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.459 0.704 . . . . 0.0 110.362 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.2 t 60.45 -76.57 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 125.772 1.629 . . . . 0.0 112.021 174.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.6 t -146.35 -27.0 0.42 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.003 0.921 . . . . 0.0 110.734 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.8 t 65.67 81.09 0.21 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.772 1.229 . . . . 0.0 110.478 -177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 67.3 mt -65.64 -33.67 76.45 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.638 0.775 . . . . 0.0 111.638 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 61.09 74.06 0.55 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.814 1.246 . . . . 0.0 112.224 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.597 ' HD2' ' HD1' ' A' ' 31' ' ' HIS . 60.9 Cg_endo -71.48 122.92 9.05 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.253 1.969 . . . . 0.0 111.302 171.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.5 91.0 1.76 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.465 0.706 . . . . 0.0 109.974 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 167.48 123.49 0.66 Allowed Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.017 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -78.15 -2.5 37.84 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.797 0.839 . . . . 0.0 112.309 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.16 -18.37 64.4 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.043 0.937 . . . . 0.0 112.055 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.85 127.93 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.906 0.384 . . . . 0.0 110.158 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -79.35 145.99 33.12 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.474 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -116.51 124.72 50.61 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.251 0.62 . . . . 0.0 110.947 -174.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.54 121.9 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 124.289 1.036 . . . . 0.0 109.198 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -84.92 153.2 22.99 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.775 0.83 . . . . 0.0 110.004 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 43.7 t -103.2 72.9 1.19 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 165.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -53.1 -31.02 39.82 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.954 0.902 . . . . 0.0 111.437 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -64.51 92.82 0.13 Allowed Glycine 0 CA--C 1.534 1.241 0 CA-C-O 119.295 -0.725 . . . . 0.0 111.829 165.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 72.2 p 50.7 54.03 11.93 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.967 1.707 . . . . 0.0 113.724 164.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 51.7 m -161.76 -56.63 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.942 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 62.15 13.8 6.09 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.949 1.7 . . . . 0.0 112.814 176.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -85.15 138.54 32.32 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -87.62 110.52 20.45 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -99.73 142.79 30.75 Favored 'General case' 0 C--O 1.206 -1.209 0 C-N-CA 123.927 0.891 . . . . 0.0 109.931 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.597 ' HD1' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -89.48 154.31 20.12 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -169.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -43.68 -54.79 4.79 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.75 0.82 . . . . 0.0 112.438 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -76.19 -22.78 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.267 0.627 . . . . 0.0 111.838 -176.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.625 ' SG ' ' HB2' ' A' ' 6' ' ' ALA . 25.1 t -67.93 -31.55 71.39 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.721 0.409 . . . . 0.0 111.518 -178.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.9 m -115.85 -15.25 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.026 0.93 . . . . 0.0 112.098 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.93 37.1 39.54 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 123.333 0.396 . . . . 0.0 112.565 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.9 t -115.43 135.56 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.084 0.954 . . . . 0.0 110.081 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 m -71.41 148.23 93.24 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 123.907 0.883 . . . . 0.0 110.726 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 39.8 Cg_endo -62.11 -20.76 70.9 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.174 2.583 . . . . 0.0 113.796 -175.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -62.13 -49.34 76.28 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.541 0.736 . . . . 0.0 111.458 173.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 27.0 ttt -74.28 -29.83 61.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.391 1.076 . . . . 0.0 110.265 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 39' ' ' PRO . . . -70.24 -20.75 63.06 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.44 0.696 . . . . 0.0 112.009 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -92.18 -44.68 8.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.923 0.889 . . . . 0.0 110.667 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -73.33 -51.14 18.54 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.51 0.724 . . . . 0.0 112.097 -172.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -115.66 147.28 41.01 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.012 0.925 . . . . 0.0 111.175 -166.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.64 139.01 38.59 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 171.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -76.09 75.93 2.95 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.2 mt -77.88 100.06 2.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.8 p -75.96 148.08 38.41 Favored 'General case' 0 C--N 1.349 0.586 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.8 m -45.7 -35.59 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -165.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -63.38 -45.48 90.94 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.706 0.803 . . . . 0.0 110.699 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 24' ' ' GLY . 60.5 m -73.56 -28.09 61.68 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.693 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.8 m -67.0 -51.32 56.49 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.214 0.606 . . . . 0.0 110.74 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.61 -33.37 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.596 0.759 . . . . 0.0 111.81 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -110.79 35.0 3.67 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.74 0.781 . . . . 0.0 109.569 -175.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.975 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.6 p . . . . . 0 CA--C 1.541 0.622 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -74.07 66.87 5.12 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.65 2.233 . . . . 0.0 111.845 174.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.57 106.85 8.07 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.02 -44.83 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.6 m -72.69 93.47 1.64 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 166.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 51.1 t -139.67 113.13 8.4 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.931 0.492 . . . . 0.0 111.121 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.673 HD12 HG21 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -66.6 146.28 54.67 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 161.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -105.33 103.39 42.32 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.41 99.63 0.17 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.358 2.705 . . . . 0.0 112.573 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.23 -24.61 42.96 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.722 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.34 -19.88 56.0 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.308 175.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 72.76 -17.94 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.242 1.417 . . . . 0.0 113.846 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -82.98 67.5 9.09 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.951 0.881 . . . . 0.0 110.335 -171.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.35 138.52 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.69 1.196 . . . . 0.0 108.608 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -80.53 122.89 27.59 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -93.1 174.95 6.97 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.29 0.636 . . . . 0.0 111.036 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.42 ' HB ' HE22 ' A' ' 32' ' ' GLN . 14.8 p -159.98 129.1 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.424 0.69 . . . . 0.0 110.261 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -80.61 126.53 31.37 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.509 ' SG ' ' OD2' ' A' ' 23' ' ' ASP . 31.1 t -75.0 118.39 17.91 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 -164.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.509 ' OD2' ' SG ' ' A' ' 22' ' ' CYS . 4.5 p30 20.36 -71.08 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 127.986 2.514 . . . . 0.0 117.471 171.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.92 -95.24 0.15 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.211 -0.449 . . . . 0.0 113.723 -152.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -79.51 -51.93 8.69 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.197 -0.501 . . . . 0.0 111.598 -163.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.05 -35.5 64.3 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -173.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.2 t30 70.7 -26.83 0.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.284 1.434 . . . . 0.0 114.78 165.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.84 147.18 24.05 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.93 0.892 . . . . 0.0 111.562 -171.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -74.99 139.37 42.89 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.679 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -126.34 149.33 49.24 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 172.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.595 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -78.74 148.0 33.18 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 169.35 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.42 HE22 ' HB ' ' A' ' 20' ' ' VAL . 2.6 mp0 -58.77 -34.36 71.34 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.539 0.736 . . . . 0.0 110.424 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.673 HG21 HD12 ' A' ' 10' ' ' LEU . 35.1 m -76.06 -22.25 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.649 176.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.595 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.5 t -70.99 -37.25 72.7 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 123.399 0.68 . . . . 0.0 111.195 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.0 m -118.62 8.64 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.819 0.848 . . . . 0.0 112.338 -172.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.61 29.12 73.72 Favored Glycine 0 C--N 1.353 1.493 0 O-C-N 123.498 0.499 . . . . 0.0 114.262 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 77.0 t -92.97 143.73 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.57 0.748 . . . . 0.0 109.368 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.0 m -80.42 145.23 58.95 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.341 0.656 . . . . 0.0 109.856 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.89 -38.38 94.63 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.493 2.129 . . . . 0.0 112.221 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.21 -45.7 90.4 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.763 0.825 . . . . 0.0 111.029 173.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 50.2 mmm -60.85 -46.12 91.81 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.135 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.38 -35.6 81.43 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.621 0.768 . . . . 0.0 111.293 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -69.52 -38.75 77.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.42 0.688 . . . . 0.0 111.696 175.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -74.65 -44.24 51.37 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.404 0.681 . . . . 0.0 111.391 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -161.78 153.25 18.64 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.229 1.012 . . . . 0.0 109.755 -172.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -73.92 148.12 42.51 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.96 0.41 . . . . 0.0 111.841 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -72.48 125.85 28.42 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 166.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.409 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 11.2 mt -113.77 125.98 71.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.8 m -66.26 167.29 10.55 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 173.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.1 t -62.28 -48.93 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 173.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 3.6 mpt_? -62.67 -48.25 80.13 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.668 0.387 . . . . 0.0 110.099 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.6 m -48.4 -41.36 28.81 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.717 1.207 . . . . 0.0 112.902 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.9 t -82.97 -29.86 28.69 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.7 t -69.82 -29.68 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.661 0.784 . . . . 0.0 110.847 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 74.0 mmtt -62.54 -63.06 1.34 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.475 0.775 0 C-N-CA 124.555 1.142 . . . . 0.0 110.729 174.243 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.503 ' SG ' ' HD1' ' A' ' 30' ' ' PHE . 25.6 t . . . . . 0 CA--C 1.554 1.102 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.83 45.78 2.05 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.714 2.942 . . . . 0.0 112.972 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.91 129.74 35.73 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 170.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.88 -37.48 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 122.786 0.434 . . . . 0.0 110.683 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.8 p -97.17 69.81 2.33 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 169.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.744 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 21.5 t -84.06 79.07 9.63 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-O 121.078 0.466 . . . . 0.0 110.377 -177.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.1 mt -59.96 139.71 57.23 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.121 172.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -113.42 80.28 4.51 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.06 0.944 . . . . 0.0 109.915 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.25 142.87 7.53 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.292 2.661 . . . . 0.0 113.327 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.49 163.02 14.31 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.82 0.848 . . . . 0.0 109.517 172.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.34 152.87 28.86 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.981 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -82.54 -16.38 48.84 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.892 0.877 . . . . 0.0 111.914 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -58.2 -35.44 71.63 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.274 1.03 . . . . 0.0 112.018 -175.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 m -73.2 83.71 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 122.54 1.162 . . . . 0.0 110.295 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.45 140.8 54.09 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.627 -176.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -92.89 156.25 17.07 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.169 0.509 . . . . 0.0 110.91 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -137.87 126.96 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.771 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -77.39 129.26 35.56 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.145 0.978 . . . . 0.0 109.755 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -62.98 -36.87 84.97 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.992 0.517 . . . . 0.0 111.271 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t70 69.39 -72.5 0.1 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.818 1.647 . . . . 0.0 111.264 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.446 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -46.7 90.58 0.01 OUTLIER Glycine 0 C--N 1.353 1.511 0 C-N-CA 124.828 1.204 . . . . 0.0 115.904 -172.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 t 70.44 12.32 7.45 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.35 1.46 . . . . 0.0 112.908 162.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -155.16 -29.11 0.11 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.263 -175.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 80.2 -59.61 0.31 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.274 1.43 . . . . 0.0 111.599 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -4.22 114.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 129.012 2.925 . . . . 0.0 116.978 -173.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -79.86 116.52 20.07 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.187 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.503 ' HD1' ' SG ' ' A' ' 4' ' ' CYS . 50.7 m-85 -100.73 164.94 11.63 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 124.285 1.034 . . . . 0.0 109.696 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.495 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -106.51 149.08 27.46 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -176.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -47.97 -51.05 25.26 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.73 1.212 . . . . 0.0 112.643 -174.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.0 m -81.55 -28.45 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.205 0.602 . . . . 0.0 112.554 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.744 ' SG ' ' HA ' ' A' ' 9' ' ' CYS . 52.6 t -62.69 -36.09 81.82 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -174.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 m -114.5 -1.36 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.577 0.751 . . . . 0.0 111.712 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.3 30.66 71.46 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 113.665 0.226 . . . . 0.0 113.665 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.4 t -98.48 107.82 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.693 ' HB2' ' SD ' ' A' ' 41' ' ' MET . 45.6 m -73.14 163.1 71.01 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 123.696 0.799 . . . . 0.0 110.822 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -47.85 -45.71 23.65 Favored 'Trans proline' 0 C--N 1.396 3.04 0 C-N-CA 123.635 2.89 . . . . 0.0 114.999 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.85 -32.56 71.03 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 120.634 0.254 . . . . 0.0 111.348 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.693 ' SD ' ' HB2' ' A' ' 38' ' ' SER . 1.2 mpt? -69.76 -44.28 70.49 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.145 0.578 . . . . 0.0 109.94 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.29 69.47 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.587 0.755 . . . . 0.0 111.172 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.76 -48.51 46.32 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.365 1.066 . . . . 0.0 111.248 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -105.04 -61.18 1.51 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.906 -163.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -156.84 148.42 22.46 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -165.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 t70 67.17 76.43 0.29 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.966 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -148.32 5.18 0.72 Allowed 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.638 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.3 mp -95.09 117.52 39.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.0 p -59.73 147.19 38.67 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 123.297 0.373 . . . . 0.0 111.39 -171.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.6 t -54.9 -37.12 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -158.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -68.1 -27.87 66.85 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.667 0.387 . . . . 0.0 111.395 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 24' ' ' GLY . 82.3 m -79.24 -28.03 42.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.579 0.751 . . . . 0.0 111.154 173.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 m -73.5 -28.91 62.16 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 123.553 0.533 . . . . 0.0 110.196 175.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.1 t -72.21 -52.3 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.689 0.796 . . . . 0.0 109.389 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -94.77 55.47 1.89 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.03 0.919 . . . . 0.0 110.238 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.6 t70 . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 124.617 1.167 . . . . 0.0 109.396 177.964 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.5 p . . . . . 0 CA--C 1.549 0.941 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -90.1 -12.18 39.11 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.936 -0.478 . . . . 0.0 111.733 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.3 mmt -64.15 -14.17 53.21 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 123.575 0.75 . . . . 0.0 112.283 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 t -133.36 86.46 40.92 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 124.187 0.995 . . . . 0.0 108.835 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.76 80.96 0.61 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.101 2.534 . . . . 0.0 112.413 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.31 130.56 19.69 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.475 1.11 . . . . 0.0 108.894 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.43 -55.23 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.227 0.611 . . . . 0.0 109.693 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.7 m -78.12 74.21 4.67 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.499 0.719 . . . . 0.0 109.251 174.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.707 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 19.7 t -97.93 92.29 5.74 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.101 0.477 . . . . 0.0 110.491 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.3 mt -71.88 113.6 9.09 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.438 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -105.27 107.77 59.81 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.47 1.108 . . . . 0.0 109.491 -175.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.12 -145.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.459 2.773 . . . . 0.0 110.953 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -68.52 -6.66 26.47 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.669 0.388 . . . . 0.0 111.742 167.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.64 -86.14 0.41 Allowed Glycine 0 C--N 1.346 1.122 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -95.39 66.49 2.85 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.396 1.093 . . . . 0.0 108.841 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -114.8 -58.71 2.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.916 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -86.18 -177.87 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 124.742 1.217 . . . . 0.0 112.065 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -98.23 140.93 31.8 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.925 0.49 . . . . 0.0 110.313 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -105.71 -177.96 3.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.492 1.117 . . . . 0.0 110.803 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.574 HG12 HG23 ' A' ' 37' ' ' VAL . 7.5 p -157.94 136.57 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 125.162 1.385 . . . . 0.0 108.22 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -95.88 112.52 24.23 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.4 t -77.9 91.01 4.13 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -57.24 -80.34 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 O-C-N 123.942 0.776 . . . . 0.0 109.851 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 43.35 -83.8 0.01 OUTLIER Glycine 0 N--CA 1.484 1.883 0 C-N-CA 124.423 1.011 . . . . 0.0 115.309 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.8 p -159.81 26.96 0.18 Allowed 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.999 1.32 . . . . 0.0 110.222 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.8 p -143.11 -41.29 0.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.315 0.646 . . . . 0.0 111.387 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 65.29 19.29 11.64 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.029 0.931 . . . . 0.0 112.101 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -79.82 137.08 36.87 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.217 0.607 . . . . 0.0 111.059 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -86.59 128.61 35.0 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.465 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -129.33 143.39 50.83 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.284 1.034 . . . . 0.0 109.044 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.632 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -69.29 141.35 54.36 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 169.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -53.32 -40.47 64.84 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.935 0.494 . . . . 0.0 111.369 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.31 -38.24 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.55 0.74 . . . . 0.0 111.677 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.707 ' SG ' ' HA ' ' A' ' 9' ' ' CYS . 8.4 t -56.29 -50.22 72.02 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.073 0.949 . . . . 0.0 112.047 -175.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.1 m -109.26 5.91 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.283 -174.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.45 52.73 51.39 Favored Glycine 0 C--N 1.355 1.638 0 C-N-CA 123.575 0.607 . . . . 0.0 113.98 174.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.574 HG23 HG12 ' A' ' 20' ' ' VAL . 13.1 t -74.66 119.3 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.054 0.541 . . . . 0.0 109.581 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.606 ' HB2' ' SD ' ' A' ' 41' ' ' MET . 41.7 m -63.14 135.6 96.3 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 123.575 0.547 . . . . 0.0 109.589 175.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.69 -15.43 16.19 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.373 2.716 . . . . 0.0 114.499 -175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.03 -52.11 18.53 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.606 ' SD ' ' HB2' ' A' ' 38' ' ' SER . 1.4 mpt? -67.61 -33.36 74.83 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.109 0.964 . . . . 0.0 110.405 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.81 -36.37 70.24 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.178 0.991 . . . . 0.0 110.831 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.17 -45.23 85.72 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -70.61 -15.4 62.74 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.951 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 65.34 12.84 8.4 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.921 1.288 . . . . 0.0 110.979 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -102.34 91.61 4.34 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.099 1.359 . . . . 0.0 109.239 -170.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -132.23 106.59 8.04 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.9 mp -100.66 113.22 35.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.5 p -74.26 164.04 27.09 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.903 0.481 . . . . 0.0 110.475 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.4 t -50.54 -47.72 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 124.508 1.123 . . . . 0.0 112.441 -174.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -54.13 -44.12 71.09 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.071 0.549 . . . . 0.0 111.702 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 68.7 m -67.62 -36.11 80.19 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.044 0.537 . . . . 0.0 111.824 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.1 m -74.42 -44.15 53.13 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.181 0.593 . . . . 0.0 110.791 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.3 t -78.11 -16.11 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.229 1.011 . . . . 0.0 111.114 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -117.01 25.28 10.61 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.91 0.862 . . . . 0.0 109.696 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -79.35 -28.41 42.0 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.602 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 60.49 85.75 0.17 Allowed Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.351 1.06 . . . . 0.0 110.389 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.67 -179.94 5.85 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.728 2.286 . . . . 0.0 112.208 -174.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.1 t -80.92 -6.02 58.16 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.381 0.672 . . . . 0.0 110.821 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -150.26 117.03 5.85 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.413 ' HD3' ' N ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.561 1.368 0 C-N-CA 123.424 0.689 . . . . 0.0 109.551 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -123.97 99.58 6.33 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -57.74 -40.35 79.48 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.048 0.939 . . . . 0.0 110.92 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 82.1 m -164.26 158.42 15.82 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.304 1.441 . . . . 0.0 109.049 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.53 39.34 0.84 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.727 2.285 . . . . 0.0 111.061 162.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.26 108.72 8.93 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.1 t -63.76 -43.88 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 m -70.57 106.3 3.43 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 165.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.6 t -151.27 86.11 1.35 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.725 0.41 . . . . 0.0 111.149 -173.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.4 mt -71.12 114.44 9.18 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 166.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -93.11 107.11 22.7 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.709 1.204 . . . . 0.0 111.033 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.62 178.62 6.88 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.098 2.532 . . . . 0.0 111.052 168.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -74.49 -17.34 60.78 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.338 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.79 143.68 14.77 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.0 t70 58.59 34.04 23.55 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.293 1.044 . . . . 0.0 109.559 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -123.91 -71.96 0.7 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.057 -169.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.1 m -91.74 145.85 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -69.79 150.38 46.94 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.872 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -95.09 -178.12 4.37 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.712 0.805 . . . . 0.0 111.223 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.1 p -153.64 116.44 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.949 1.299 . . . . 0.0 108.706 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 52.0 tt0 -98.66 107.94 20.51 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.548 0.739 . . . . 0.0 109.392 -177.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 8.7 t -79.99 64.49 4.84 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.362 0.665 . . . . 0.0 111.278 -173.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -53.04 -36.3 60.44 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.215 1.406 . . . . 0.0 113.638 -169.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -39.35 -58.09 2.09 Favored Glycine 0 N--CA 1.477 1.392 0 O-C-N 124.865 1.353 . . . . 0.0 115.496 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.489 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 48.2 m -157.61 32.54 0.27 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.375 0.67 . . . . 0.0 110.672 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 75.4 m -132.74 -48.38 0.88 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 173.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 74.37 -6.65 1.83 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.939 1.296 . . . . 0.0 112.383 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -93.75 146.25 24.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.845 0.858 . . . . 0.0 109.882 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 8.3 p-90 -103.5 111.81 24.44 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.203 1.001 . . . . 0.0 109.635 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -100.71 163.24 12.42 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.627 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -63.32 145.71 55.0 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 166.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -62.85 -32.24 73.43 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 122.046 -0.409 . . . . 0.0 111.085 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.4 HG22 ' HB2' ' A' ' 31' ' ' HIS . 33.5 m -68.73 -26.8 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 C-N-CA 123.105 0.562 . . . . 0.0 111.815 174.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.627 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.2 t -61.43 -55.53 30.27 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 123.958 0.903 . . . . 0.0 111.819 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.42 HG23 HG22 ' A' ' 37' ' ' VAL . 18.4 m -101.43 -5.22 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.285 -168.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.66 31.86 20.27 Favored Glycine 0 C--N 1.348 1.245 0 O-C-N 123.204 0.315 . . . . 0.0 113.401 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.42 HG22 HG23 ' A' ' 35' ' ' VAL . 55.0 t -97.3 125.73 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.559 0.744 . . . . 0.0 109.577 175.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.6 m -82.89 159.29 63.44 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 123.891 0.876 . . . . 0.0 110.067 175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -45.82 -50.78 9.17 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.631 2.887 . . . . 0.0 114.439 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 47.5 mt-10 -71.85 -12.95 61.52 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.094 0.558 . . . . 0.0 112.322 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.6 mtt -79.3 -57.09 3.89 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . . . -61.48 -36.62 80.99 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.94 0.896 . . . . 0.0 112.14 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -87.39 -65.13 1.05 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.901 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 39.5 ttmt -81.68 -48.49 11.63 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.451 0.469 . . . . 0.0 112.215 -163.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -162.32 118.88 2.0 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -167.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.0 t70 61.74 107.18 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.618 1.567 . . . . 0.0 114.067 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.525 ' H ' HD12 ' A' ' 48' ' ' ILE . 42.0 p90 -126.29 12.55 7.63 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 114.297 -1.319 . . . . 0.0 108.677 165.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.525 HD12 ' H ' ' A' ' 47' ' ' TYR . 3.5 mp -85.13 106.16 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.129 -172.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.1 p -61.52 159.86 12.22 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 123.837 0.711 . . . . 0.0 111.771 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.4 t -52.44 -39.68 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.748 1.219 . . . . 0.0 112.538 -172.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 27.4 mmt180 -64.78 -44.83 88.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.316 0.646 . . . . 0.0 111.701 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 25' ' ' SER . 64.7 m -62.71 -38.85 92.08 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.682 0.393 . . . . 0.0 111.075 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.9 m -69.36 -45.13 70.11 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.928 0.891 . . . . 0.0 110.834 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.46 -25.98 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.261 0.624 . . . . 0.0 111.101 -173.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 51' ' ' ARG . 68.2 mttm -56.77 -50.94 70.8 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 123.317 0.385 . . . . 0.0 110.233 173.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 73.63 -35.34 0.31 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.243 1.417 . . . . 0.0 113.059 173.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -114.88 101.16 54.38 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.096 1.358 . . . . 0.0 108.583 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.91 84.29 0.85 Allowed 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.907 2.405 . . . . 0.0 110.922 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.3 t -65.56 121.2 14.38 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.303 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 69.76 120.77 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 O-C-N 124.877 1.361 . . . . 0.0 110.782 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.084 0 C-N-CA 123.864 0.865 . . . . 0.0 109.108 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.3 m . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -163.46 35.62 0.09 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.115 0.966 . . . . 0.0 109.815 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 66.65 169.11 0.24 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 125.027 1.331 . . . . 0.0 112.213 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.2 t 64.36 81.23 0.22 Allowed Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 123.879 0.872 . . . . 0.0 111.21 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.34 108.33 2.59 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.222 2.615 . . . . 0.0 113.756 -170.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.29 -170.88 2.15 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.148 0.979 . . . . 0.0 109.74 168.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.9 m -54.89 -31.35 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.159 0.984 . . . . 0.0 112.109 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.4 m -147.42 -35.79 0.23 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.202 1.401 . . . . 0.0 109.188 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.3 t 70.18 97.02 0.07 Allowed 'General case' 0 C--N 1.36 1.031 0 C-N-CA 125.231 1.412 . . . . 0.0 109.491 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.4 mt -80.43 100.47 8.51 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -85.78 105.67 7.71 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.378 1.071 . . . . 0.0 108.302 171.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.56 162.39 42.16 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 122.423 2.082 . . . . 0.0 111.112 172.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.75 -22.33 66.48 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.407 0.683 . . . . 0.0 111.677 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.9 136.17 4.45 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.15 66.53 7.78 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.297 1.048 . . . . 0.0 111.16 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.54 -9.23 55.03 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.976 164.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -63.16 151.62 8.27 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 C-N-CA 124.659 1.184 . . . . 0.0 110.143 165.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -85.39 149.3 25.52 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.056 0.455 . . . . 0.0 110.114 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 22.1 m0 -111.75 -179.95 3.84 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.537 1.135 . . . . 0.0 110.83 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -161.75 131.78 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.551 1.14 . . . . 0.0 109.549 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 63.5 tt0 -69.82 149.45 47.9 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.659 0.784 . . . . 0.0 110.067 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 0.7 OUTLIER -127.7 50.12 2.06 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.552 0.741 . . . . 0.0 110.164 -171.303 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -57.53 -21.45 38.26 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.913 1.685 . . . . 0.0 114.564 -174.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.24 -58.59 6.33 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 114.76 0.664 . . . . 0.0 114.76 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.714 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 40.6 m -161.36 60.32 0.28 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 89.5 m -155.85 -45.67 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.939 0.896 . . . . 0.0 108.818 173.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 68.93 20.76 7.78 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.427 1.091 . . . . 0.0 111.652 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -140.48 163.18 33.53 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.829 0.852 . . . . 0.0 109.867 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 23.9 m95 -82.93 151.6 25.86 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.203 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -139.85 141.1 36.67 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.16 1.384 . . . . 0.0 108.395 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.654 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -56.12 144.96 27.42 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.457 0.703 . . . . 0.0 109.285 166.159 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -57.4 -41.05 79.56 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.12 0.418 . . . . 0.0 111.327 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -63.25 -26.22 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.246 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.654 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.6 t -67.59 -45.37 75.7 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.789 0.835 . . . . 0.0 111.913 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.5 m -100.82 -8.59 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.354 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.21 16.02 72.81 Favored Glycine 0 CA--C 1.536 1.392 0 O-C-N 123.358 0.411 . . . . 0.0 113.67 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 68.8 t -84.25 131.56 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 123.649 0.78 . . . . 0.0 109.558 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.4 m -67.8 157.33 86.84 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 123.751 0.82 . . . . 0.0 111.324 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -49.48 -50.79 12.11 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.174 2.583 . . . . 0.0 113.49 174.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.02 -30.74 68.11 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.556 0.742 . . . . 0.0 111.44 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 74.9 mtp -68.34 -47.61 67.04 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.785 0.434 . . . . 0.0 110.351 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.6 -34.5 72.83 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.362 0.665 . . . . 0.0 110.221 176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -75.14 -43.54 51.97 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.522 -176.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -103.55 -59.78 1.67 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -173.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -172.75 165.16 5.33 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.222 0.609 . . . . 0.0 111.636 -170.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.4 t70 63.11 57.71 1.56 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.481 1.112 . . . . 0.0 110.279 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -104.58 6.97 34.97 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.414 -1.267 . . . . 0.0 110.038 168.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.5 mp -78.52 104.24 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -173.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 51' ' ' ARG . 13.0 p -66.37 164.7 15.61 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.556 -175.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.8 t -51.92 -46.15 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.94 0.896 . . . . 0.0 110.699 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.532 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 72.9 mtp180 -53.3 -43.55 67.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 123.937 0.773 . . . . 0.0 112.244 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 25' ' ' SER . 14.5 m -61.09 -47.3 86.95 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.825 0.703 . . . . 0.0 111.109 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.2 m -67.23 -45.21 77.45 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 124.015 0.822 . . . . 0.0 111.185 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.19 -34.2 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.025 0.93 . . . . 0.0 110.828 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -73.17 0.19 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -145.21 -76.43 0.21 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.706 0.802 . . . . 0.0 109.944 -172.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 45.55 90.53 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 C-N-CA 124.535 1.134 . . . . 0.0 112.684 -172.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.57 16.22 1.74 Allowed 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.458 2.105 . . . . 0.0 113.035 -177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.3 m -83.83 101.82 11.91 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.677 0.791 . . . . 0.0 110.352 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 67.86 -179.28 0.22 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 125.222 1.409 . . . . 0.0 113.257 174.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 pttp . . . . . 0 C--O 1.255 1.353 0 C-N-CA 124.086 0.954 . . . . 0.0 109.338 177.711 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -160.22 127.35 4.43 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.344 0.658 . . . . 0.0 109.792 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -111.23 35.66 3.49 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.073 0.949 . . . . 0.0 109.28 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m 68.22 157.14 0.15 Allowed Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 125.006 1.322 . . . . 0.0 110.744 -173.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -71.07 60.76 2.42 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.505 2.137 . . . . 0.0 111.922 165.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.55 108.45 2.72 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.437 1.095 . . . . 0.0 108.056 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -66.87 -17.06 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.904 0.882 . . . . 0.0 111.458 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.0 m -86.56 26.35 1.1 Allowed 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.527 1.131 . . . . 0.0 111.292 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.7 t -77.7 101.97 6.89 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.6 mt -62.3 -27.81 69.3 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.76 0.824 . . . . 0.0 112.297 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 58.8 60.04 5.37 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.342 1.057 . . . . 0.0 111.573 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -81.96 160.78 18.42 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.036 1.824 . . . . 0.0 111.59 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -23.25 59.05 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.614 170.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.47 -76.18 0.17 Allowed Glycine 0 C--N 1.343 0.952 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.3 t70 65.08 14.79 9.61 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.775 1.23 . . . . 0.0 112.359 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 64.86 61.07 0.8 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.084 1.353 . . . . 0.0 110.664 -176.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -101.34 134.99 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 170.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.57 160.99 22.42 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -114.3 164.91 13.28 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.45 0.643 . . . . 0.0 111.066 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 p -153.25 142.76 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.321 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -101.19 121.18 41.39 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.3 t -63.76 141.49 58.75 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.011 0.524 . . . . 0.0 110.155 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.438 ' H ' ' HE1' ' A' ' 47' ' ' TYR . 25.0 t70 -94.4 -78.55 0.44 Allowed 'General case' 0 C--O 1.239 0.509 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 154.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 33.04 -98.61 0.01 OUTLIER Glycine 0 C--N 1.357 1.732 0 O-C-N 125.039 1.462 . . . . 0.0 116.287 172.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.4 t -157.33 15.36 0.26 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.964 0.906 . . . . 0.0 109.898 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 14.1 p -159.21 57.37 0.41 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -49.87 80.49 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.528 1.931 . . . . 0.0 112.275 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -127.91 159.2 35.67 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 125.498 1.519 . . . . 0.0 107.402 170.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -82.16 108.48 15.66 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.491 0.663 . . . . 0.0 109.569 170.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -99.55 155.87 17.35 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.963 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.595 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -71.79 146.44 48.05 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 162.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -69.59 -22.26 63.53 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.36 0.527 . . . . 0.0 111.149 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.2 m -78.04 -19.99 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.366 0.667 . . . . 0.0 111.796 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.595 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 7.2 t -69.65 -28.02 65.54 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.596 0.758 . . . . 0.0 111.567 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 m -116.12 -8.53 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 124.364 1.066 . . . . 0.0 111.608 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.28 5.05 87.65 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 114.188 0.435 . . . . 0.0 114.188 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.2 t -80.12 138.26 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 123.282 0.633 . . . . 0.0 110.43 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 m -86.75 143.33 35.46 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.056 0.942 . . . . 0.0 109.709 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -50.38 -31.03 28.77 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 123.482 2.788 . . . . 0.0 114.407 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -58.24 -54.78 43.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.713 0.805 . . . . 0.0 109.505 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 72.2 mtm -71.99 -30.99 65.81 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.38 0.672 . . . . 0.0 111.47 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.51 -40.75 88.12 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.307 0.643 . . . . 0.0 110.937 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -82.51 -45.22 14.98 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.335 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -70.23 -56.47 6.7 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.885 0.474 . . . . 0.0 111.766 -166.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -174.49 127.68 0.33 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.355 0.662 . . . . 0.0 110.225 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.7 t70 73.16 133.83 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.906 1.682 . . . . 0.0 112.498 172.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.438 ' HE1' ' H ' ' A' ' 23' ' ' ASP . 14.5 p90 -151.25 20.77 0.75 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.569 1.548 . . . . 0.0 108.035 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.7 mt -88.82 133.91 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.273 -165.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.62 157.99 36.51 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.391 0.676 . . . . 0.0 110.627 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.7 m -56.65 -43.74 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.917 0.887 . . . . 0.0 113.072 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -69.8 -36.27 75.54 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.837 0.455 . . . . 0.0 110.869 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 96.3 m -68.41 -30.93 69.94 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.987 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.1 m -72.23 -42.86 65.2 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.268 1.027 . . . . 0.0 110.686 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.7 t -71.43 -32.65 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.076 0.55 . . . . 0.0 111.071 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -72.1 -17.37 61.99 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.825 0.45 . . . . 0.0 111.8 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -54.97 -35.09 63.92 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.279 0.562 . . . . 0.0 110.675 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.17 85.46 7.47 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.198 0.999 . . . . 0.0 108.582 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -64.64 95.21 0.23 Allowed 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.087 2.525 . . . . 0.0 110.91 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.8 p -144.37 173.23 11.96 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.105 0.962 . . . . 0.0 109.755 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 63.22 61.19 1.1 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.559 1.144 . . . . 0.0 110.051 -173.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HZ2' ' HB2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.23 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.733 -177.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 121.076 0.465 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 9' ' ' CYS . 91.7 m-70 -126.72 121.02 30.85 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.403 1.081 . . . . 0.0 108.512 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.45 ' SD ' ' N ' ' A' ' 4' ' ' CYS . 14.2 tmm? -79.97 172.23 14.05 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.024 0.93 . . . . 0.0 109.971 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.45 ' N ' ' SD ' ' A' ' 3' ' ' MET . 0.0 OUTLIER 76.0 156.51 0.15 Allowed Pre-proline 0 N--CA 1.488 1.433 0 C-N-CA 125.55 1.54 . . . . 0.0 110.942 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.61 7.9 3.63 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.821 2.347 . . . . 0.0 113.542 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.428 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -83.72 119.76 25.19 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.9 t -60.13 -47.9 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.83 0.852 . . . . 0.0 111.059 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -90.06 63.02 5.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.744 0.817 . . . . 0.0 109.544 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 2' ' ' HIS . 43.1 t -77.07 75.43 3.64 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.349 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.416 ' O ' HG21 ' A' ' 33' ' ' VAL . 68.7 mt -72.15 107.91 5.06 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 170.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -125.68 94.67 41.9 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.975 0.91 . . . . 0.0 110.261 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.64 148.1 92.45 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.956 2.438 . . . . 0.0 112.565 171.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.3 103.14 2.76 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.671 0.788 . . . . 0.0 109.281 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.98 -129.0 9.4 Favored Glycine 0 C--O 1.242 0.619 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -167.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -129.76 -80.73 0.55 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 53.51 12.22 0.35 Allowed 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 124.545 1.138 . . . . 0.0 112.487 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -142.29 153.23 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 125.116 1.367 . . . . 0.0 108.685 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -76.76 154.99 33.52 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -118.7 150.56 39.53 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.08 110.89 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.215 1.006 . . . . 0.0 108.753 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -88.76 143.5 26.87 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.602 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.8 t -85.42 101.33 12.52 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.19 -25.62 68.16 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.001 0.52 . . . . 0.0 110.384 170.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.18 164.71 9.9 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.653 170.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.9 t -75.07 80.09 2.24 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.623 1.169 . . . . 0.0 111.092 -159.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.8 p -176.01 -26.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.613 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.1 t30 70.2 9.29 6.98 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 124.788 1.235 . . . . 0.0 112.947 169.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -70.28 122.54 19.74 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.332 0.653 . . . . 0.0 111.588 -174.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -79.2 142.08 36.6 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.679 0.791 . . . . 0.0 109.31 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -132.26 120.61 22.39 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 122.847 0.459 . . . . 0.0 110.751 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.644 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -62.33 148.79 44.05 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 165.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -54.04 -41.03 67.62 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.015 0.926 . . . . 0.0 111.597 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 10' ' ' LEU . 27.5 m -80.69 -19.3 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.679 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.644 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 6.4 t -61.9 -36.26 80.78 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 123.311 0.644 . . . . 0.0 111.667 175.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -119.55 -13.93 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.247 1.019 . . . . 0.0 112.09 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.85 9.43 70.52 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-O 119.31 -0.717 . . . . 0.0 114.137 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.407 HG12 ' HB3' ' A' ' 47' ' ' TYR . 90.9 t -66.36 106.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 117.658 0.729 . . . . 0.0 110.096 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 m -64.98 145.41 99.09 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.517 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -47.69 -29.49 11.02 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.875 3.05 . . . . 0.0 114.476 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 35.5 tt0 -63.22 -53.82 47.11 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.061 0.544 . . . . 0.0 110.456 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 70.7 mtm -67.77 -36.76 81.06 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.057 0.543 . . . . 0.0 110.539 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.01 75.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.467 0.707 . . . . 0.0 111.081 176.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -73.13 -40.18 65.13 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.285 0.634 . . . . 0.0 110.237 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 1.2 mmmp? -77.4 -3.66 41.33 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.061 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 71.71 21.14 4.41 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.993 1.317 . . . . 0.0 111.463 174.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -89.78 77.9 6.97 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.568 172.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.407 ' HB3' HG12 ' A' ' 37' ' ' VAL . 35.8 p90 -149.58 1.11 0.51 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.597 175.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.03 135.28 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.1 m -56.89 145.84 28.53 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.588 0.755 . . . . 0.0 111.134 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.6 m -59.95 -32.34 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.667 0.787 . . . . 0.0 112.376 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -69.82 -44.72 69.4 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.143 0.577 . . . . 0.0 110.469 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 75.3 m -62.61 -34.02 76.17 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.851 176.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.7 m -73.69 -49.28 26.6 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.962 0.505 . . . . 0.0 110.852 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 p -67.34 -24.4 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 122.718 0.407 . . . . 0.0 112.058 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -55.06 -43.09 73.53 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -127.31 -35.8 2.17 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.07 0.462 . . . . 0.0 110.894 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 63.51 63.24 1.55 Allowed Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.32 1.448 . . . . 0.0 111.632 -171.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -89.63 -5.53 5.32 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.735 2.29 . . . . 0.0 112.19 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.4 m -72.84 113.73 10.2 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.103 0.961 . . . . 0.0 108.619 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 61.86 -174.28 0.14 Allowed 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 125.036 1.334 . . . . 0.0 110.69 -173.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.556 1.186 0 C-N-CA 123.159 0.584 . . . . 0.0 109.845 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -81.27 119.58 23.82 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.9 ttt -78.2 87.38 4.29 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.001 0.429 . . . . 0.0 110.123 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.0 t -172.68 67.26 0.38 Allowed Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.08 0.952 . . . . 0.0 109.441 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.38 112.16 2.95 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.541 2.161 . . . . 0.0 111.679 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.47 21.31 2.55 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.964 0.505 . . . . 0.0 111.962 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 85.6 t 62.62 -71.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.862 1.265 . . . . 0.0 110.533 -170.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -89.09 96.93 10.92 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 170.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.583 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 38.4 t -111.15 95.77 5.73 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.99 127.27 32.25 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.433 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -99.01 99.95 8.97 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.563 1.145 . . . . 0.0 108.543 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.492 ' HG3' HG23 ' A' ' 17' ' ' VAL . 88.3 Cg_endo -76.93 169.16 22.18 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.138 2.559 . . . . 0.0 111.284 170.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -91.34 16.09 10.79 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.299 0.639 . . . . 0.0 111.113 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.07 45.17 27.05 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -174.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.24 -72.19 0.19 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.179 0.992 . . . . 0.0 110.036 -174.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -162.37 25.83 0.11 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.218 0.607 . . . . 0.0 110.678 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.492 HG23 ' HG3' ' A' ' 12' ' ' PRO . 34.9 m -80.46 134.06 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 122.703 0.401 . . . . 0.0 110.258 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.473 ' HB3' ' NE2' ' A' ' 32' ' ' GLN . 28.9 t70 -98.24 141.36 31.24 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.774 0.83 . . . . 0.0 108.82 174.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -106.17 130.91 53.96 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.437 0.695 . . . . 0.0 110.082 -176.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.474 HG12 HG22 ' A' ' 37' ' ' VAL . 7.2 p -114.11 129.69 69.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 C-N-CA 124.735 1.214 . . . . 0.0 108.654 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 40.5 tt0 -103.09 128.96 49.8 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 41.9 t -65.13 -27.21 68.57 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 t70 62.41 -84.71 0.02 OUTLIER 'General case' 0 C--N 1.355 0.842 0 C-N-CA 125.294 1.438 . . . . 0.0 110.891 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.68 ' HA2' ' HA ' ' A' ' 58' ' ' PRO . . . -18.87 -83.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 C-N-CA 126.238 1.875 . . . . 0.0 116.754 -163.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.413 ' HG ' ' HG3' ' A' ' 55' ' ' LYS . 15.4 p -134.23 59.29 1.74 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.261 1.029 . . . . 0.0 108.52 174.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.503 ' HB3' ' HG2' ' A' ' 28' ' ' GLN . 94.1 m -146.28 -50.7 0.22 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 171.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 64.81 23.69 12.72 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.571 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.503 ' HG2' ' HB3' ' A' ' 26' ' ' CYS . 3.0 pt20 -130.35 142.9 50.51 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 124.376 1.07 . . . . 0.0 109.871 -175.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 12.5 p-90 -100.74 154.35 18.69 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.487 1.115 . . . . 0.0 110.466 -175.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -139.34 144.45 38.25 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.324 1.05 . . . . 0.0 108.931 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.61 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -68.47 150.6 47.91 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.071 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.473 ' NE2' ' HB3' ' A' ' 18' ' ' ASP . 72.1 mt-30 -55.08 -39.43 69.26 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.724 0.41 . . . . 0.0 111.31 176.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 31' ' ' HIS . 31.5 m -67.46 -29.66 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.479 0.712 . . . . 0.0 112.485 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.61 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.4 t -68.63 -46.93 67.91 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.723 0.809 . . . . 0.0 112.393 -174.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.461 HG22 HG23 ' A' ' 37' ' ' VAL . 6.9 m -118.65 16.85 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.793 0.837 . . . . 0.0 111.458 -172.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.82 24.42 69.89 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 114.182 0.433 . . . . 0.0 114.182 174.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 41' ' ' MET . 9.3 t -72.62 121.58 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.178 0.591 . . . . 0.0 110.102 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.3 p -75.31 157.72 84.52 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.094 0.958 . . . . 0.0 109.965 175.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -50.46 -27.17 18.02 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.973 2.449 . . . . 0.0 113.862 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.06 -50.66 65.31 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.944 0.898 . . . . 0.0 110.517 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.551 ' HB2' HG12 ' A' ' 37' ' ' VAL . 25.4 mmt -68.12 -33.38 74.39 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.788 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.19 -16.28 53.28 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.858 0.863 . . . . 0.0 112.239 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -80.87 -48.84 11.82 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.701 0.763 . . . . 0.0 109.473 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -70.27 -43.09 71.18 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.95 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 63.16 22.26 13.29 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.742 1.217 . . . . 0.0 113.444 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -89.31 20.35 3.86 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.076 0.55 . . . . 0.0 110.262 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -75.49 75.04 2.55 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 122.538 1.161 . . . . 0.0 110.736 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.09 105.63 19.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.1 p -58.39 155.83 11.25 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.107 0.563 . . . . 0.0 111.438 -173.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.45 -39.56 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.326 1.05 . . . . 0.0 113.09 -168.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -64.75 -37.34 87.26 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.206 0.603 . . . . 0.0 111.783 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.5 m -69.23 -30.57 68.74 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.229 0.611 . . . . 0.0 111.495 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 m -72.28 -33.92 67.8 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.206 0.602 . . . . 0.0 110.374 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.43 -41.88 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.975 0.91 . . . . 0.0 110.015 173.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.413 ' HG3' ' HG ' ' A' ' 25' ' ' SER . 73.2 mmtt -59.59 -36.84 77.04 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.586 0.754 . . . . 0.0 110.257 173.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.4 t70 59.1 33.9 23.09 Favored 'General case' 0 CA--C 1.558 1.264 0 O-C-N 124.461 1.1 . . . . 0.0 109.871 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.2 86.38 25.33 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.862 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.68 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 61.6 Cg_endo -86.17 160.63 9.98 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.63 2.22 . . . . 0.0 111.0 168.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.0 t -79.98 78.41 6.6 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -125.32 20.57 8.06 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.295 1.038 . . . . 0.0 110.13 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt . . . . . 0 C--O 1.255 1.355 0 C-N-CA 123.552 0.741 . . . . 0.0 109.888 -176.559 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.8 p . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -73.92 147.9 42.71 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 ptm -84.07 -10.9 57.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.799 0.44 . . . . 0.0 110.543 173.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.2 t -169.65 132.64 1.11 Allowed Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.669 0.788 . . . . 0.0 109.681 -170.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.83 -20.52 51.82 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.277 2.651 . . . . 0.0 113.976 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.96 114.47 15.78 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -173.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -60.03 -39.77 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.732 0.813 . . . . 0.0 111.435 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 t -85.23 104.48 15.13 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 166.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.4 t -145.0 106.61 4.24 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.584 0.354 . . . . 0.0 110.054 -176.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.5 mt -69.83 153.11 43.76 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.319 168.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -110.78 88.78 8.36 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.79 169.31 22.5 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.524 2.15 . . . . 0.0 111.615 173.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -80.11 111.09 16.13 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.61 87.76 0.01 OUTLIER Glycine 0 C--N 1.349 1.289 0 O-C-N 123.842 0.714 . . . . 0.0 114.053 -175.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -174.1 -61.64 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.559 1.143 . . . . 0.0 109.471 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -99.9 23.93 9.13 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.264 1.031 . . . . 0.0 110.544 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.0 t -80.89 127.71 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.078 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -99.96 141.2 33.11 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 11.0 m0 -116.64 174.24 6.18 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.068 0.947 . . . . 0.0 110.432 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.39 133.62 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.819 1.248 . . . . 0.0 108.765 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -77.89 141.21 39.21 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.356 0.662 . . . . 0.0 109.582 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.2 t -106.37 66.82 0.71 Allowed 'General case' 0 C--O 1.248 1.022 0 CA-C-O 121.223 0.535 . . . . 0.0 109.642 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -81.18 25.81 0.47 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.063 0.545 . . . . 0.0 112.052 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -82.44 35.08 2.64 Favored Glycine 0 C--N 1.355 1.62 0 CA-C-O 119.326 -0.708 . . . . 0.0 113.836 172.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.1 t 82.64 54.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.649 1.58 . . . . 0.0 109.913 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.4 p -164.77 -40.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.545 170.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 65.0 t30 72.71 14.17 5.08 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.074 0.95 . . . . 0.0 111.919 167.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -67.53 127.72 33.78 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.536 0.734 . . . . 0.0 109.753 171.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -89.02 123.12 33.03 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.432 0.693 . . . . 0.0 110.255 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -116.18 148.8 40.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.277 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.625 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -69.51 143.67 53.38 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 166.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 21.6 mt-30 -57.37 -40.61 78.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.712 0.405 . . . . 0.0 111.572 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.2 m -71.95 -23.09 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 123.19 0.596 . . . . 0.0 112.494 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.625 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.4 t -60.53 -46.32 90.6 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.61 0.764 . . . . 0.0 111.051 176.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.459 HG21 HG23 ' A' ' 37' ' ' VAL . 15.7 m -118.9 11.03 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.134 -166.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.63 17.43 76.5 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 114.477 0.551 . . . . 0.0 114.477 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 32' ' ' GLN . 56.0 t -71.32 110.77 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.122 0.487 . . . . 0.0 109.983 175.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.8 m -72.66 158.09 87.87 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.839 174.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -48.44 -34.85 26.81 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.798 2.332 . . . . 0.0 113.32 169.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -68.08 -41.98 81.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.199 0.6 . . . . 0.0 111.317 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 87.2 mtp -64.51 -41.04 96.65 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.92 0.488 . . . . 0.0 110.215 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.76 68.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.73 0.812 . . . . 0.0 111.128 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -73.17 -36.11 66.53 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.628 0.771 . . . . 0.0 111.013 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -71.79 -52.41 17.71 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.956 0.902 . . . . 0.0 109.302 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -164.07 -164.96 0.92 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.67 0.788 . . . . 0.0 109.405 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.98 173.81 10.25 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.203 0.601 . . . . 0.0 111.252 174.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -84.89 138.04 32.77 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.387 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.46 117.09 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 172.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.8 p -89.37 168.93 11.84 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.376 0.67 . . . . 0.0 110.647 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.37 -28.02 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.266 0.627 . . . . 0.0 111.856 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -64.67 -36.26 83.69 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.695 0.398 . . . . 0.0 110.514 172.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 24' ' ' GLY . 36.4 m -67.02 -42.99 83.96 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.991 0.516 . . . . 0.0 110.174 170.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.0 m -61.53 -43.83 98.15 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.089 0.556 . . . . 0.0 111.072 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.6 -26.36 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 O-C-N 121.925 -0.485 . . . . 0.0 111.259 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.423 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -73.32 -75.24 0.15 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.231 0.612 . . . . 0.0 112.372 177.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -96.43 -40.57 9.03 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -165.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.49 86.43 7.42 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 122.606 0.362 . . . . 0.0 111.26 -171.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.22 144.0 99.5 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.955 2.437 . . . . 0.0 113.059 176.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.2 t -89.46 39.5 0.95 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.033 0.933 . . . . 0.0 109.465 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 69.35 -10.75 0.53 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.844 1.657 . . . . 0.0 114.097 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.2 pttp . . . . . 0 CA--C 1.555 1.155 0 CA-C-O 118.573 -0.727 . . . . 0.0 109.204 -179.465 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.8 p . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 120.719 0.295 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -110.45 -164.75 0.94 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.587 0.755 . . . . 0.0 109.851 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.1 mtm -63.3 135.42 57.03 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.952 0.901 . . . . 0.0 111.471 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 50.71 93.77 0.05 OUTLIER Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 125.693 1.597 . . . . 0.0 112.426 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.11 99.84 0.29 Allowed 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.481 2.787 . . . . 0.0 112.455 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.05 -174.95 4.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.671 0.788 . . . . 0.0 110.763 -174.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.4 m -79.16 82.61 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 121.938 0.875 . . . . 0.0 109.903 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.9 m 70.06 107.83 0.06 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.529 1.532 . . . . 0.0 111.257 -177.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.8 t -76.93 79.69 3.49 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.55 145.84 54.5 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.324 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -109.02 86.75 4.11 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.513 ' HG3' HG23 ' A' ' 33' ' ' VAL . 44.6 Cg_endo -79.76 162.41 24.12 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.044 2.496 . . . . 0.0 112.578 -174.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -118.39 84.89 2.26 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 168.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.83 166.71 26.51 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.384 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.33 -25.03 11.65 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.836 0.854 . . . . 0.0 110.266 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.79 5.94 41.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.486 1.114 . . . . 0.0 111.681 -175.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.6 m -76.64 72.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 123.227 1.489 . . . . 0.0 111.236 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.89 166.19 22.67 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 113.362 -1.745 . . . . 0.0 109.314 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -105.83 127.37 53.07 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.261 0.624 . . . . 0.0 111.109 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.46 130.37 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 124.575 1.15 . . . . 0.0 110.061 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -77.59 153.39 33.3 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.973 0.909 . . . . 0.0 109.955 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.8 t -114.48 51.15 0.9 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.9 0.88 . . . . 0.0 109.691 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -48.27 -55.98 9.18 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.467 1.107 . . . . 0.0 112.744 -170.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -19.65 -56.92 0.01 OUTLIER Glycine 0 C--N 1.373 2.636 0 C-N-CA 126.268 1.889 . . . . 0.0 116.8 -172.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.531 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 26.2 t -165.22 65.51 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 169.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.2 m -156.77 -52.48 0.08 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.562 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 72.92 -6.06 1.77 Allowed 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 125.181 1.392 . . . . 0.0 111.323 -172.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -67.64 150.77 48.32 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.761 1.224 . . . . 0.0 111.131 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -100.26 131.18 46.35 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.758 0.823 . . . . 0.0 110.14 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -128.22 147.11 50.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.856 1.263 . . . . 0.0 108.489 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.6 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -70.4 148.54 48.27 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 165.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -57.01 -40.44 76.66 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.553 0.341 . . . . 0.0 110.504 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.513 HG23 ' HG3' ' A' ' 12' ' ' PRO . 21.0 m -69.45 -27.28 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.628 0.771 . . . . 0.0 112.359 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.6 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.8 t -60.38 -35.76 76.49 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 123.888 0.875 . . . . 0.0 110.167 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 m -115.96 6.46 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.165 -171.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.78 49.48 73.91 Favored Glycine 0 C--N 1.357 1.71 0 O-C-N 123.574 0.546 . . . . 0.0 113.539 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.7 t -119.17 137.94 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.152 1.381 . . . . 0.0 109.027 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 38.6 m -74.59 146.88 84.12 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 123.328 0.651 . . . . 0.0 109.989 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.78 -34.36 98.12 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.554 2.169 . . . . 0.0 113.101 174.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -70.4 -32.06 69.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.619 0.368 . . . . 0.0 111.204 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.4 ttt -67.86 -43.55 79.17 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.095 0.558 . . . . 0.0 110.066 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.95 -22.89 67.07 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.517 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -76.71 -43.87 35.74 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.13 0.972 . . . . 0.0 111.007 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -83.03 -22.05 33.66 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -171.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -150.78 165.97 31.89 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.139 0.495 . . . . 0.0 111.101 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -87.18 143.42 27.3 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.32 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -72.66 88.51 1.28 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.252 0.549 . . . . 0.0 109.552 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 66.7 mt -92.61 103.17 14.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.628 ' SG ' ' HB2' ' A' ' 51' ' ' ARG . 19.0 p -81.73 175.03 10.8 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.844 -178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.07 -37.63 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.479 173.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.628 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 49.5 mtt-85 -61.24 -32.48 72.28 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.973 0.509 . . . . 0.0 111.165 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.531 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 24.0 m -67.62 -53.94 23.84 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.856 0.462 . . . . 0.0 110.214 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 t -68.93 -33.45 73.75 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.24 -172.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.8 t -73.92 -39.33 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 123.206 0.603 . . . . 0.0 110.667 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -63.5 -27.51 69.32 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 171.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.0 t70 66.11 19.12 11.13 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 124.12 0.968 . . . . 0.0 110.83 171.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 57.19 88.53 0.12 Allowed Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 124.934 1.294 . . . . 0.0 110.681 -170.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.9 -11.97 13.75 Favored 'Trans proline' 0 C--N 1.394 2.947 0 C-N-CA 123.864 3.043 . . . . 0.0 114.25 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.4 t -116.2 94.92 4.85 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 169.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.38 -56.38 14.7 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 174.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 66.7 mttm . . . . . 0 CA--C 1.55 0.979 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.732 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.8 p . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 120.661 0.267 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -83.88 87.64 7.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.593 0.711 . . . . 0.0 110.9 -173.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.688 ' SD ' ' SG ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -136.81 142.01 42.91 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 172.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.688 ' SG ' ' SD ' ' A' ' 3' ' ' MET . 0.1 OUTLIER 56.63 101.08 0.04 OUTLIER Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 124.408 1.083 . . . . 0.0 110.814 -170.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -43.76 86.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.398 3.144 0 C-N-CA 125.272 3.982 . . . . 0.0 115.87 -172.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.22 -170.32 2.17 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.072 1.349 . . . . 0.0 109.649 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.5 t -64.97 -57.1 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.125 0.57 . . . . 0.0 109.98 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.2 t -137.86 -22.64 1.07 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.278 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.0 t 69.72 100.93 0.06 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.597 1.159 . . . . 0.0 111.341 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.0 155.36 27.75 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.332 0.653 . . . . 0.0 110.499 171.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -117.94 81.24 15.53 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.411 1.084 . . . . 0.0 109.728 -175.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.13 165.47 11.24 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.587 2.192 . . . . 0.0 112.218 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.13 97.36 3.45 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.606 0.717 . . . . 0.0 109.454 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.94 93.43 0.22 Allowed Glycine 0 C--N 1.345 1.063 0 CA-C-N 114.658 -1.155 . . . . 0.0 114.375 -170.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -158.58 -61.3 0.08 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.525 0.73 . . . . 0.0 109.78 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -100.56 13.76 33.59 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.323 0.649 . . . . 0.0 111.025 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.06 130.84 35.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 123.04 0.536 . . . . 0.0 110.042 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.95 137.78 54.06 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.454 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -121.66 165.31 15.94 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.547 0.739 . . . . 0.0 109.858 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.77 133.24 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.623 -173.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -87.85 113.62 23.68 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 173.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 45.9 t -82.17 82.55 7.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.61 0.764 . . . . 0.0 110.535 -177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.41 1.46 0.78 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.369 1.067 . . . . 0.0 113.26 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.15 -162.7 0.57 Allowed Glycine 0 CA--C 1.539 1.55 0 O-C-N 121.549 -0.72 . . . . 0.0 113.087 162.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.518 ' N ' ' SG ' ' A' ' 52' ' ' CYS . 29.5 p -82.15 69.91 8.97 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.695 0.759 . . . . 0.0 111.134 -171.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.2 p -174.56 -41.16 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.921 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 74.6 -3.19 2.63 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 124.187 0.995 . . . . 0.0 112.607 168.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -77.34 157.89 30.43 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.752 0.821 . . . . 0.0 112.025 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -84.98 133.95 34.25 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.866 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.502 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 78.8 m-85 -126.91 158.75 35.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.866 1.266 . . . . 0.0 108.005 176.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.61 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -68.97 152.61 45.05 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 162.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.468 ' NE2' ' HA ' ' A' ' 39' ' ' PRO . 26.9 tt0 -62.62 -35.67 80.31 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.435 0.694 . . . . 0.0 110.018 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.4 m -70.57 -28.9 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.767 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.61 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 5.0 t -60.7 -41.54 95.39 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 123.698 0.799 . . . . 0.0 111.415 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.4 m -96.64 -19.7 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.086 0.955 . . . . 0.0 111.598 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.91 15.75 79.58 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.238 0.336 . . . . 0.0 113.32 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 78.2 t -79.46 140.43 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.781 0.832 . . . . 0.0 109.826 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 m -67.7 148.49 98.53 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.687 0.795 . . . . 0.0 111.134 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.468 ' HA ' ' NE2' ' A' ' 32' ' ' GLN . 5.7 Cg_endo -47.99 -48.37 16.52 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.895 3.063 . . . . 0.0 115.071 -176.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -61.14 -49.78 75.85 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 120.956 0.408 . . . . 0.0 110.419 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.633 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 93.0 mmm -58.69 -35.77 73.15 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.304 -177.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.49 -36.61 71.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.939 0.896 . . . . 0.0 111.824 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -89.33 -29.62 19.01 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 122.846 0.459 . . . . 0.0 111.989 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -127.73 -45.2 1.47 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.7 0.8 . . . . 0.0 112.637 -159.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.633 ' HB2' ' HA ' ' A' ' 41' ' ' MET . 22.4 mm-40 -112.81 -144.38 0.39 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.256 0.623 . . . . 0.0 110.798 -167.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.86 139.84 53.13 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.424 0.69 . . . . 0.0 111.231 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.66 27.97 1.08 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.891 1.277 . . . . 0.0 109.817 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.46 120.0 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.651 1.18 . . . . 0.0 109.545 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.6 p -78.22 167.2 21.76 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.356 0.662 . . . . 0.0 110.883 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.99 -39.46 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 124.132 0.973 . . . . 0.0 112.549 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -41.83 85.88 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.494 1.117 . . . . 0.0 110.269 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 25' ' ' SER . 18.3 m -64.47 -49.5 71.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.812 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.8 t -66.8 -28.46 68.4 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -173.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 82.0 t -72.36 -33.41 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.108 0.563 . . . . 0.0 110.732 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -71.27 -43.67 66.74 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.084 0.554 . . . . 0.0 110.912 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.87 -27.66 65.01 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.957 0.903 . . . . 0.0 111.641 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.42 78.26 11.16 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.389 0.676 . . . . 0.0 109.637 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.24 85.36 1.56 Allowed 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.69 2.26 . . . . 0.0 111.288 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.9 p -54.18 -55.59 26.38 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.913 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -121.88 154.65 36.8 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.358 1.063 . . . . 0.0 108.154 171.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.434 ' HB3' ' HZ2' ' A' ' 61' ' ' LYS . 1.6 mmmp? . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.886 -0.578 . . . . 0.0 109.878 -174.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.6 m . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 44.6 m80 64.37 156.36 0.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.147 1.379 . . . . 0.0 112.781 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -85.02 173.64 10.36 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.916 173.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.62 158.15 34.04 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -73.34 69.45 4.11 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.493 2.129 . . . . 0.0 111.68 172.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.454 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -141.75 79.94 1.7 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.338 0.655 . . . . 0.0 109.85 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.7 t 63.76 -69.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 125.528 1.531 . . . . 0.0 110.97 -172.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.1 t -140.26 -83.66 0.24 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 170.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.6 t 147.9 117.16 0.0 OUTLIER 'General case' 0 C--N 1.361 1.102 0 C-N-CA 127.41 2.284 . . . . 0.0 107.344 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.5 mt -56.67 -36.09 69.17 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.806 0.843 . . . . 0.0 111.472 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 57.14 75.14 0.59 Allowed Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.747 1.219 . . . . 0.0 111.365 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -87.2 175.89 4.59 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.496 2.131 . . . . 0.0 111.717 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.5 -24.55 59.02 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.01 171.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.52 ' HA2' HG21 ' A' ' 17' ' ' VAL . . . 78.59 58.9 2.96 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.378 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -82.5 -49.13 10.25 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.163 0.585 . . . . 0.0 110.842 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -131.47 11.68 4.91 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.128 0.971 . . . . 0.0 111.844 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.52 HG21 ' HA2' ' A' ' 14' ' ' GLY . 18.7 m -78.94 124.57 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 118.47 0.577 . . . . 0.0 109.773 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -89.86 136.0 33.3 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 14.0 m0 -99.84 126.34 45.93 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.203 0.601 . . . . 0.0 110.798 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.71 115.55 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 C-N-CA 124.764 1.226 . . . . 0.0 110.297 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -83.78 127.41 33.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.569 0.748 . . . . 0.0 109.933 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.3 t -82.65 108.89 16.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 169.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.11 -80.08 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 24.18 -91.1 0.01 OUTLIER Glycine 0 C--N 1.37 2.442 0 O-C-N 125.104 1.502 . . . . 0.0 115.6 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.409 ' N ' ' SG ' ' A' ' 52' ' ' CYS . 10.5 m -149.98 46.09 0.92 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.748 1.219 . . . . 0.0 109.435 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.5 m -133.77 -61.48 0.8 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.622 0.769 . . . . 0.0 109.431 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 74.14 -2.48 2.78 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.221 1.409 . . . . 0.0 110.941 -172.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -81.73 141.24 33.74 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.73 0.812 . . . . 0.0 110.28 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -87.76 120.3 28.95 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.049 0.94 . . . . 0.0 109.371 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -115.79 124.06 49.8 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 123.172 0.589 . . . . 0.0 109.712 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.618 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -57.68 143.33 41.96 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 167.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -62.33 -32.08 72.79 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 118.298 0.499 . . . . 0.0 110.925 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.452 HG23 ' HB2' ' A' ' 31' ' ' HIS . 32.8 m -65.73 -29.63 47.58 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 123.221 0.608 . . . . 0.0 111.726 172.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.618 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 3.9 t -68.53 -40.01 80.92 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.521 0.728 . . . . 0.0 111.707 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.52 -2.66 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.525 0.73 . . . . 0.0 112.668 -171.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.29 3.81 54.35 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.814 -0.437 . . . . 0.0 114.058 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' A' ' 41' ' ' MET . 53.2 t -70.79 111.93 5.12 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 123.557 0.743 . . . . 0.0 109.453 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.7 m -69.17 156.11 92.22 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 123.611 0.764 . . . . 0.0 110.485 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.88 -32.39 29.84 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 123.402 2.735 . . . . 0.0 113.342 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -57.49 -52.9 63.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.649 1.18 . . . . 0.0 111.807 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.41 ' HB2' HG12 ' A' ' 37' ' ' VAL . 25.7 mmt -72.75 -30.95 64.57 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.449 0.643 . . . . 0.0 110.515 -177.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.9 -36.38 67.28 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.666 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -78.91 -36.62 41.63 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.999 0.519 . . . . 0.0 110.395 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -75.17 -20.46 59.33 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.345 0.403 . . . . 0.0 110.587 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.507 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 42.8 mt-10 73.09 21.76 3.08 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.093 1.357 . . . . 0.0 112.505 170.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -86.22 21.23 2.09 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.182 0.993 . . . . 0.0 111.74 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.507 ' CE2' ' HA ' ' A' ' 45' ' ' GLU . 11.6 p90 -82.4 25.87 0.59 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.089 0.955 . . . . 0.0 112.184 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mp -72.86 119.08 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 173.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.8 m -62.4 159.38 15.51 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.656 0.782 . . . . 0.0 110.418 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.455 ' O ' HG21 ' A' ' 54' ' ' VAL . 99.2 t -60.7 -42.73 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 175.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -62.51 -37.37 85.76 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.555 0.742 . . . . 0.0 111.666 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 25' ' ' SER . 5.7 m -64.38 -36.05 82.88 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.753 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.2 m -74.6 -25.62 59.38 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.277 0.631 . . . . 0.0 110.804 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 50' ' ' VAL . 80.0 t -67.26 -36.76 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 122.87 0.468 . . . . 0.0 110.3 173.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -74.64 -49.39 21.65 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.187 0.595 . . . . 0.0 110.599 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -64.77 -27.23 68.75 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 123.992 0.808 . . . . 0.0 111.313 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.66 82.52 12.46 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.809 0.844 . . . . 0.0 109.535 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.3 -42.42 17.68 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.666 2.244 . . . . 0.0 112.466 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.5 p -166.4 149.5 7.09 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.179 0.592 . . . . 0.0 110.667 174.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -141.58 91.42 2.37 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm . . . . . 0 C--O 1.246 0.921 0 C-N-CA 124.42 1.088 . . . . 0.0 108.217 177.192 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -123.71 6.64 8.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.694 0.798 . . . . 0.0 111.746 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.1 ptp -79.73 80.26 6.14 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 168.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 4' ' ' CYS . 4.0 t -168.37 64.72 0.63 Allowed Pre-proline 0 CA--C 1.556 1.2 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.386 -160.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.49 -28.1 53.93 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.608 2.205 . . . . 0.0 113.212 -173.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 50.27 -96.92 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.277 1.431 . . . . 0.0 112.668 -177.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 90.0 t -130.63 -57.65 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.0 t -135.19 107.15 7.07 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 164.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 4' ' ' CYS . 42.3 t -78.78 87.56 4.66 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.094 0.558 . . . . 0.0 111.142 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.07 109.84 5.39 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -106.67 99.17 23.66 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.665 0.786 . . . . 0.0 109.425 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.498 ' HG2' HG23 ' A' ' 17' ' ' VAL . 88.3 Cg_endo -76.6 -170.61 0.92 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.144 2.563 . . . . 0.0 112.05 174.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -75.1 107.56 7.26 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.27 69.93 3.05 Favored Glycine 0 N--CA 1.467 0.729 0 CA-C-N 115.091 -0.959 . . . . 0.0 113.486 -171.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -92.53 -53.51 4.17 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.732 0.813 . . . . 0.0 109.276 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.71 32.82 0.55 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.595 1.158 . . . . 0.0 110.636 -173.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.498 HG23 ' HG2' ' A' ' 12' ' ' PRO . 43.5 t -68.81 125.97 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.074 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -76.88 135.41 38.84 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 123.675 0.609 . . . . 0.0 109.929 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 35.3 m0 -113.69 171.51 7.53 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.079 0.952 . . . . 0.0 111.121 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.78 118.75 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.057 1.343 . . . . 0.0 108.186 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 62.1 tt0 -76.68 145.86 38.47 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.967 0.507 . . . . 0.0 110.401 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.6 t -75.84 128.45 35.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.021 0.439 . . . . 0.0 111.68 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.625 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . 11.4 t70 -87.07 79.18 8.76 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.14 -179.41 44.75 Favored Glycine 0 C--O 1.239 0.418 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.844 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t -79.73 73.72 6.44 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.539 0.736 . . . . 0.0 109.754 -176.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.703 ' SG ' ' HG2' ' A' ' 28' ' ' GLN . 4.0 p -173.12 -37.58 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.312 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 61.83 17.2 8.62 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.027 1.331 . . . . 0.0 113.215 173.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.703 ' HG2' ' SG ' ' A' ' 26' ' ' CYS . 4.3 pt20 -73.11 134.2 44.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.288 0.635 . . . . 0.0 111.049 -177.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 48.2 m95 -81.43 155.32 25.93 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.022 0.929 . . . . 0.0 110.885 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -138.67 134.18 33.31 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.803 0.841 . . . . 0.0 109.427 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.632 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -62.51 145.86 53.17 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 164.551 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -49.87 -49.47 49.28 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 120.952 0.406 . . . . 0.0 111.199 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -67.06 -25.63 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.414 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.632 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 7.8 t -59.99 -35.18 74.47 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.305 0.642 . . . . 0.0 111.72 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.25 -3.77 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.347 1.059 . . . . 0.0 111.58 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.0 39.58 97.4 Favored Glycine 0 C--N 1.353 1.518 0 C-N-CA 123.602 0.62 . . . . 0.0 114.221 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.46 131.63 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.392 0.677 . . . . 0.0 109.407 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.3 m -68.32 149.32 98.11 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.388 1.075 . . . . 0.0 110.961 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.39 -52.69 6.96 Favored 'Trans proline' 0 C--N 1.393 2.873 0 C-N-CA 123.916 3.077 . . . . 0.0 114.157 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -68.29 -36.77 79.88 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.291 0.636 . . . . 0.0 111.682 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 61.2 mtt -72.67 -31.38 65.02 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.694 0.398 . . . . 0.0 110.884 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.09 -33.66 50.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.489 0.716 . . . . 0.0 110.814 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -76.31 -42.2 45.99 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.301 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -71.9 -58.43 3.46 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.454 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -101.48 106.25 17.34 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.625 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . 4.5 m-20 -56.25 110.2 0.72 Allowed 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.064 173.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -62.29 111.05 1.83 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.081 0.467 . . . . 0.0 110.779 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 41.0 mt -88.85 117.24 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 172.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.3 p -73.23 154.57 40.17 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.3 t -52.52 -44.74 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 124.457 1.103 . . . . 0.0 112.589 -171.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -60.74 -31.74 71.04 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.151 0.58 . . . . 0.0 112.45 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.6 m -76.31 -42.68 44.38 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.333 0.253 . . . . 0.0 111.12 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 m -61.21 -40.8 95.35 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.592 0.757 . . . . 0.0 110.707 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.9 -49.83 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.322 1.049 . . . . 0.0 110.819 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -74.53 -11.88 60.33 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.925 0.49 . . . . 0.0 111.834 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.99 -30.38 71.55 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.617 0.767 . . . . 0.0 110.291 171.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.9 108.23 28.5 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.882 1.273 . . . . 0.0 108.642 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.05 137.15 65.05 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 123.668 2.912 . . . . 0.0 112.033 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.4 m -91.91 14.89 14.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.622 0.769 . . . . 0.0 112.561 -174.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 64.91 118.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.076 1.351 . . . . 0.0 111.779 -178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 90.7 mttt . . . . . 0 C--O 1.252 1.225 0 CA-C-O 118.427 -0.796 . . . . 0.0 109.446 179.058 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.9 p . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -79.4 107.12 11.93 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.213 0.605 . . . . 0.0 109.616 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.466 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 66.3 mtt 59.62 -80.61 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.171 1.389 . . . . 0.0 111.667 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.24 147.61 15.95 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.58 62.63 8.56 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 123.285 2.656 . . . . 0.0 112.304 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.75 177.78 4.72 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.212 176.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.77 -42.57 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 t -133.4 162.9 30.6 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.897 0.879 . . . . 0.0 109.188 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 3' ' ' MET . 28.4 t -153.6 94.46 1.79 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.229 0.538 . . . . 0.0 110.018 170.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.493 HD11 ' HB ' ' A' ' 33' ' ' VAL . 28.0 mt -61.72 -35.18 77.32 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.456 1.102 . . . . 0.0 111.049 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 52.49 65.77 5.72 Favored Pre-proline 0 CA--C 1.552 1.057 0 O-C-N 124.67 1.231 . . . . 0.0 110.071 -171.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HG2' HG21 ' A' ' 17' ' ' VAL . 61.4 Cg_endo -83.75 169.77 11.78 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.296 1.997 . . . . 0.0 112.39 -175.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -67.02 120.15 13.16 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.771 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.59 53.05 4.48 Favored Glycine 0 C--N 1.338 0.672 0 O-C-N 123.487 0.492 . . . . 0.0 113.687 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -65.66 -55.15 19.0 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -148.85 59.37 1.06 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.657 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.417 HG21 ' HG2' ' A' ' 12' ' ' PRO . 40.5 t -103.75 118.2 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.11 128.65 33.55 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.102 0.876 . . . . 0.0 109.807 -173.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 26.1 m0 -109.02 165.42 11.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.791 0.836 . . . . 0.0 109.904 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 47' ' ' TYR . 4.3 p -152.77 124.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.671 0.788 . . . . 0.0 109.908 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -72.42 130.14 40.0 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.722 0.409 . . . . 0.0 110.0 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.2 t -65.75 -49.32 68.8 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.16 0.912 . . . . 0.0 111.552 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 72.64 -43.14 0.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.227 1.411 . . . . 0.0 112.723 -173.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.85 -160.49 0.09 OUTLIER Glycine 0 C--N 1.362 1.98 0 N-CA-C 114.569 0.587 . . . . 0.0 114.569 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.6 p -80.83 72.83 7.84 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.857 0.863 . . . . 0.0 111.706 -165.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.8 p 175.26 -31.68 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.894 2.077 . . . . 0.0 106.997 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 75.33 -43.88 0.51 Allowed 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 126.447 1.899 . . . . 0.0 113.952 172.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -47.9 148.85 1.49 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.389 1.876 . . . . 0.0 114.105 -167.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -74.87 144.74 43.23 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.174 173.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -132.29 128.15 37.15 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.622 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.597 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -67.02 151.64 47.27 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 172.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.569 ' HA ' ' HB ' ' A' ' 37' ' ' VAL . 62.6 mt-30 -56.37 -41.01 75.49 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.053 0.454 . . . . 0.0 110.204 174.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.493 ' HB ' HD11 ' A' ' 10' ' ' LEU . 18.8 m -71.3 -17.4 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-N 114.849 -1.068 . . . . 0.0 112.669 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.597 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 2.5 t -80.06 -46.48 16.45 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.244 0.618 . . . . 0.0 111.335 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.494 HG21 HG22 ' A' ' 37' ' ' VAL . 2.5 m -119.41 9.78 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 123.654 0.782 . . . . 0.0 112.901 -169.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.01 36.96 92.7 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 122.672 0.177 . . . . 0.0 113.315 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 32' ' ' GLN . 10.2 t -78.71 134.55 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.282 0.633 . . . . 0.0 110.995 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.0 p -77.02 153.28 82.68 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.66 0.784 . . . . 0.0 109.778 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.76 -31.53 72.33 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.44 2.094 . . . . 0.0 112.039 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -57.57 -52.35 65.75 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.548 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.561 ' HB2' HG13 ' A' ' 37' ' ' VAL . 26.1 mmt -66.44 -36.89 83.92 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 123.543 0.527 . . . . 0.0 111.516 -176.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.21 -30.37 68.53 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.109 0.564 . . . . 0.0 111.781 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -89.44 -29.29 19.13 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.151 0.58 . . . . 0.0 111.265 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -83.18 -20.71 34.15 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.558 0.743 . . . . 0.0 111.085 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 69.41 -161.92 0.18 Allowed 'General case' 0 C--N 1.361 1.095 0 O-C-N 124.419 1.075 . . . . 0.0 108.658 -170.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 69.27 3.57 4.18 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.633 1.173 . . . . 0.0 113.036 171.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.415 ' HB3' HG23 ' A' ' 20' ' ' VAL . 93.3 t80 -74.39 98.53 3.3 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.7 mt -100.0 135.45 35.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 165.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -56.06 129.93 41.92 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 172.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -54.25 -35.12 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.36 0.664 . . . . 0.0 112.66 -167.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -68.65 -35.98 77.97 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.492 0.717 . . . . 0.0 110.988 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 84.2 m -64.68 -31.15 72.25 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.113 0.565 . . . . 0.0 111.384 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.9 m -70.3 -44.09 69.03 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.977 0.417 . . . . 0.0 109.976 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.404 ' O ' ' HE3' ' A' ' 61' ' ' LYS . 60.0 t -69.5 -31.38 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.029 0.932 . . . . 0.0 110.763 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -115.39 28.57 8.59 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.526 0.679 . . . . 0.0 110.102 -175.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -63.36 -40.27 96.81 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.908 0.883 . . . . 0.0 110.368 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.31 84.58 59.32 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.644 1.177 . . . . 0.0 107.867 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.44 89.73 0.4 Allowed 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 123.367 2.711 . . . . 0.0 112.471 -173.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.4 p -122.67 -73.05 0.66 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -165.65 149.39 8.09 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.894 0.878 . . . . 0.0 109.672 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 54' ' ' VAL . 72.5 mmtt . . . . . 0 C--O 1.247 0.942 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.2 p . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 120.578 0.228 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -106.71 107.34 18.3 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.213 0.605 . . . . 0.0 109.905 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.4 mtt -83.75 119.62 25.03 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 170.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.41 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 12.6 t 62.39 82.81 0.21 Allowed Pre-proline 0 N--CA 1.481 1.086 0 O-C-N 124.011 0.819 . . . . 0.0 110.695 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.68 -42.76 0.76 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.67 2.247 . . . . 0.0 113.303 -174.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 44.87 25.13 0.13 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 125.798 1.639 . . . . 0.0 115.061 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.1 t 60.46 -73.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.908 1.283 . . . . 0.0 109.992 -166.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.3 m -104.81 88.11 2.83 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.157 0.983 . . . . 0.0 108.935 170.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.42 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 42.4 t -79.43 84.62 5.31 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.213 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 33' ' ' VAL . 59.9 mt -64.98 101.6 0.52 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 167.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -112.01 96.52 34.51 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.172 0.989 . . . . 0.0 110.782 -166.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HG2' HG22 ' A' ' 17' ' ' VAL . 66.3 Cg_exo -53.66 150.23 29.24 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.056 2.504 . . . . 0.0 112.138 164.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.72 90.0 0.76 Allowed 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 122.027 0.918 . . . . 0.0 110.765 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.2 -149.46 32.48 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 114.497 -1.229 . . . . 0.0 113.475 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -101.07 82.64 2.39 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.026 0.93 . . . . 0.0 108.903 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -127.84 10.84 6.57 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.568 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.465 HG22 ' HG2' ' A' ' 12' ' ' PRO . 15.8 m -135.83 168.61 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.407 0.683 . . . . 0.0 111.733 -173.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -74.68 139.44 43.51 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.176 173.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -116.27 175.43 5.56 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.864 0.866 . . . . 0.0 109.96 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.469 HG12 HG11 ' A' ' 37' ' ' VAL . 12.7 p -161.08 138.21 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.183 0.993 . . . . 0.0 108.856 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -101.48 142.56 32.67 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 40.1 t -114.08 77.63 1.08 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.214 0.606 . . . . 0.0 110.671 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -78.78 80.8 5.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.81 -65.55 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.093 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.662 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 13.6 m -152.8 56.39 0.79 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.902 0.858 . . . . 0.0 109.233 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.0 m -161.61 -53.1 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 174.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.23 11.78 4.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.222 1.809 . . . . 0.0 113.467 173.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -107.04 166.61 10.49 Favored 'General case' 0 C--O 1.246 0.899 0 C-N-CA 123.419 0.688 . . . . 0.0 109.767 177.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -87.16 137.59 32.21 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.062 169.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -131.32 132.8 44.77 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.318 1.047 . . . . 0.0 108.884 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.624 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -56.99 147.03 25.08 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.836 0.854 . . . . 0.0 108.835 170.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -56.64 -45.18 81.71 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.153 0.981 . . . . 0.0 111.115 -173.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.41 ' O ' HD13 ' A' ' 10' ' ' LEU . 12.1 m -71.33 -29.57 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.722 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.624 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 13.2 t -54.17 -53.29 55.5 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.31 0.644 . . . . 0.0 112.556 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.1 m -96.12 -5.24 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.637 0.775 . . . . 0.0 111.06 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.74 37.52 94.96 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.612 -177.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.469 HG11 HG12 ' A' ' 20' ' ' VAL . 13.7 p -69.3 144.36 14.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.564 0.746 . . . . 0.0 110.684 -177.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.2 m -58.33 130.7 84.33 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.369 172.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -53.71 -26.71 39.33 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.241 2.627 . . . . 0.0 112.342 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.58 -52.17 64.47 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.788 0.835 . . . . 0.0 110.397 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.1 mmt -72.41 -30.65 64.84 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.088 0.555 . . . . 0.0 111.42 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.93 -44.83 83.97 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.798 0.839 . . . . 0.0 111.029 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -74.74 -25.8 59.35 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.549 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -75.73 -20.09 58.59 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 67.37 14.68 9.74 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.431 1.492 . . . . 0.0 112.303 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -134.96 89.23 2.5 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -171.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -119.42 106.84 12.65 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.914 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.98 110.2 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 174.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.7 m -57.92 158.05 7.02 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.958 0.503 . . . . 0.0 110.903 -176.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.8 -38.04 63.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 122.974 0.51 . . . . 0.0 110.428 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -56.78 -49.0 76.61 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.866 0.866 . . . . 0.0 111.251 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.662 ' SG ' ' HB2' ' A' ' 25' ' ' SER . 86.4 m -71.32 -27.1 63.16 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.095 0.958 . . . . 0.0 112.412 -174.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.8 m -85.19 -53.22 5.39 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.313 0.645 . . . . 0.0 110.678 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.62 -21.3 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.076 0.55 . . . . 0.0 111.421 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.63 -41.33 98.96 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-N 117.805 0.275 . . . . 0.0 110.723 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -163.15 -54.58 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.54 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 67.36 112.49 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 125.065 1.346 . . . . 0.0 110.721 -172.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.55 47.97 2.69 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.044 2.496 . . . . 0.0 111.853 171.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.6 m -86.09 -12.53 49.82 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.061 0.944 . . . . 0.0 112.138 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -75.4 82.87 2.49 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.244 0.618 . . . . 0.0 109.784 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.8 mttm . . . . . 0 CA--C 1.552 1.044 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.072 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -94.06 87.84 5.46 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.679 0.792 . . . . 0.0 109.801 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -69.97 -42.07 73.62 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 167.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.0 t -171.1 91.5 0.45 Allowed Pre-proline 0 CA--C 1.551 0.999 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.534 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 72.8 Cg_endo -76.01 -38.86 1.05 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.73 2.287 . . . . 0.0 112.341 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 48.58 23.22 0.59 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 126.159 1.783 . . . . 0.0 115.79 169.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.4 t 62.5 -74.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 125.126 1.37 . . . . 0.0 110.278 -171.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.7 m -108.64 80.84 1.38 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.354 1.062 . . . . 0.0 108.464 174.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.436 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 41.8 t -84.56 87.79 7.28 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.736 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.5 mt -65.76 111.29 3.16 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 164.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -102.7 102.41 26.37 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.046 0.938 . . . . 0.0 110.456 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.23 -179.48 5.06 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 122.706 2.271 . . . . 0.0 110.848 164.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.46 23.5 10.99 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.396 0.679 . . . . 0.0 110.625 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.21 35.42 92.05 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.82 -63.97 0.98 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.377 1.471 . . . . 0.0 110.814 -169.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -142.54 19.42 2.03 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.81 1.244 . . . . 0.0 108.29 171.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 t -79.18 123.95 36.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.259 -164.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 32' ' ' GLN . 34.2 m-20 -83.19 146.72 28.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.524 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -115.5 128.4 55.97 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.336 0.655 . . . . 0.0 109.292 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 47' ' ' TYR . 5.3 p -103.86 126.27 58.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 123.608 0.763 . . . . 0.0 109.91 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -85.64 127.03 34.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.99 0.916 . . . . 0.0 108.973 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.8 t -85.49 80.94 8.9 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.01 -26.98 61.18 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.889 0.876 . . . . 0.0 112.258 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.534 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -71.57 104.61 1.48 Allowed Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.783 -1.009 . . . . 0.0 111.266 167.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.602 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 21.7 m 52.45 47.58 24.41 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.714 1.606 . . . . 0.0 113.558 161.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.0 m -161.77 -62.44 0.05 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.156 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.1 t30 70.42 3.51 4.51 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.186 1.394 . . . . 0.0 110.841 -173.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -87.06 143.25 27.41 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.977 0.911 . . . . 0.0 110.283 -172.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -87.63 112.24 22.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.988 0.915 . . . . 0.0 110.023 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -107.96 140.57 40.91 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.852 0.861 . . . . 0.0 109.059 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.595 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -68.63 154.55 41.7 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.031 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 27.2 tt0 -52.33 -50.11 62.94 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.071 1.348 . . . . 0.0 111.047 -177.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.9 m -72.08 -28.58 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 114.33 -1.304 . . . . 0.0 112.098 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.595 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.9 t -58.14 -49.46 76.91 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.813 0.845 . . . . 0.0 111.931 -175.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 m -95.63 2.57 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.462 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.72 19.89 76.99 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.247 0.342 . . . . 0.0 113.895 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.43 121.57 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.0 m -72.33 158.13 88.02 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.368 0.667 . . . . 0.0 110.325 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.93 -39.65 68.53 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.263 2.642 . . . . 0.0 113.371 176.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -64.24 -44.35 92.11 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.172 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 56.7 mtt -63.33 -48.19 79.05 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.756 0.822 . . . . 0.0 110.073 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.32 -26.95 68.71 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.573 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -83.97 -51.03 7.47 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.247 0.619 . . . . 0.0 111.125 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -91.4 -60.22 1.94 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.47 0.308 . . . . 0.0 110.714 -168.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -166.41 152.15 8.5 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.493 0.717 . . . . 0.0 111.957 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.7 t0 68.09 103.42 0.05 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.077 1.751 . . . . 0.0 112.807 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.533 ' HB2' HG23 ' A' ' 20' ' ' VAL . 3.2 p90 -150.93 14.52 0.73 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.47 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 52.6 mt -82.16 122.84 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.752 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 p -65.26 148.3 51.93 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.312 0.383 . . . . 0.0 110.367 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.7 t -45.25 -42.07 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 125.821 1.648 . . . . 0.0 113.275 -171.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -53.96 -50.01 67.46 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.885 0.874 . . . . 0.0 111.927 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 25' ' ' SER . 61.5 m -76.7 -24.97 53.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.581 -175.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.7 m -68.54 -47.53 66.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.313 0.645 . . . . 0.0 110.473 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.27 -29.99 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.925 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -62.31 -66.09 0.59 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.262 0.625 . . . . 0.0 110.423 173.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -172.74 -55.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.941 0.776 . . . . 0.0 109.718 -175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 61.65 80.75 0.25 Allowed Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 124.657 1.223 . . . . 0.0 109.835 -167.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.36 81.49 0.96 Allowed 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.904 2.403 . . . . 0.0 112.704 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.4 m -101.78 7.0 41.93 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.691 170.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -64.97 155.8 33.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.181 1.392 . . . . 0.0 110.642 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 123.98 0.912 . . . . 0.0 111.082 -176.691 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.9 p . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -83.4 64.1 7.65 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.43 0.692 . . . . 0.0 110.322 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.427 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 1.1 mpt? 62.14 0.9 0.62 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.745 1.618 . . . . 0.0 114.484 173.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.87 123.13 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 C-N-CA 124.002 0.921 . . . . 0.0 111.03 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -64.45 85.18 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 123.005 2.47 . . . . 0.0 112.783 -175.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.16 171.14 13.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.761 1.224 . . . . 0.0 109.967 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.04 -38.86 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.597 0.759 . . . . 0.0 110.949 -175.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.9 p -156.68 109.76 2.6 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.605 0.762 . . . . 0.0 109.097 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 3' ' ' MET . 42.4 t -88.41 109.17 19.79 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.983 0.421 . . . . 0.0 110.75 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.661 HD22 HG21 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -69.57 158.55 35.05 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.478 164.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -102.42 93.64 4.22 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 171.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.64 112.95 1.93 Allowed 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.315 2.01 . . . . 0.0 110.897 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -85.87 52.12 2.39 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 122.718 1.246 . . . . 0.0 110.722 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 157.04 142.89 3.51 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 113.171 -1.832 . . . . 0.0 110.704 -173.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.84 22.59 0.75 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.207 1.003 . . . . 0.0 111.775 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -74.33 -16.32 60.92 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.454 1.102 . . . . 0.0 111.788 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -80.19 137.42 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -90.7 151.7 21.14 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -103.24 152.37 21.57 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.609 0.764 . . . . 0.0 110.607 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.54 124.29 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.014 1.326 . . . . 0.0 108.276 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.559 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 35.4 tt0 -85.29 141.83 29.8 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.63 151.69 46.87 Favored 'General case' 0 CA--C 1.552 1.023 0 O-C-N 123.624 0.577 . . . . 0.0 111.863 -167.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -71.74 -44.34 64.26 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.7 1.6 . . . . 0.0 112.715 -174.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.546 ' HA3' ' SG ' ' A' ' 52' ' ' CYS . . . -84.01 -129.06 1.66 Allowed Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.656 -167.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -120.31 75.63 1.12 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.8 m -114.17 -27.99 7.46 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.888 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.5 t30 77.3 -37.17 0.25 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.271 1.429 . . . . 0.0 112.208 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -85.16 148.59 26.03 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.614 0.721 . . . . 0.0 112.537 -166.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.559 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 12.0 p-90 -104.16 139.02 39.8 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.324 171.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 42.3 m-85 -123.11 162.98 21.42 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 124.413 1.085 . . . . 0.0 108.251 -175.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.639 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -69.24 146.79 52.04 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 160.202 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -58.35 -41.32 84.39 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.294 0.497 . . . . 0.0 110.707 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.661 HG21 HD22 ' A' ' 10' ' ' LEU . 27.8 m -67.47 -25.67 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.711 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.639 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.5 t -58.6 -39.12 79.51 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 123.835 0.854 . . . . 0.0 111.433 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.4 m -104.92 -0.97 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.998 0.919 . . . . 0.0 111.622 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.26 16.12 80.04 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 116.491 -0.322 . . . . 0.0 113.825 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.9 t -90.5 136.55 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.23 0.612 . . . . 0.0 109.802 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.0 m -90.34 152.44 45.61 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.814 0.846 . . . . 0.0 110.117 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -47.04 -56.74 2.78 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.898 3.065 . . . . 0.0 114.622 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.27 -27.88 67.56 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.913 0.485 . . . . 0.0 111.722 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.6 mtt -74.35 -31.27 62.35 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 122.614 0.365 . . . . 0.0 110.201 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.55 -35.3 60.69 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.347 0.659 . . . . 0.0 111.343 176.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.17 -48.87 12.47 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.585 0.754 . . . . 0.0 111.213 -176.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.34 -25.82 19.23 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.334 0.653 . . . . 0.0 112.046 -171.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -123.82 170.03 10.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.249 0.619 . . . . 0.0 110.204 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -85.48 123.71 31.22 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.627 178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -88.44 48.91 1.7 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.404 1.081 . . . . 0.0 110.911 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.1 mt -73.36 105.29 2.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.861 -177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 51' ' ' ARG . 2.3 p -69.16 162.22 27.49 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.012 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 67.1 t -54.2 -42.27 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.45 0.7 . . . . 0.0 111.122 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.516 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 2.8 mpt_? -58.41 -40.64 83.03 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.679 0.791 . . . . 0.0 111.494 176.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.546 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 35.0 m -72.34 -35.22 68.5 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.296 0.238 . . . . 0.0 111.578 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.1 m -70.33 -47.57 60.48 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.645 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.6 p -84.87 -44.5 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -84.1 -35.82 23.43 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 120.736 0.303 . . . . 0.0 110.206 -167.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 59.7 m-20 -90.72 35.05 0.89 Allowed 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.538 0.685 . . . . 0.0 110.404 177.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.76 98.3 5.31 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.772 1.229 . . . . 0.0 107.819 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.59 101.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.895 3.063 . . . . 0.0 113.693 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.1 m -142.09 141.55 32.74 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.681 0.792 . . . . 0.0 110.103 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -80.09 104.04 10.38 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.4 mttm . . . . . 0 CA--C 1.552 1.057 0 O-C-N 124.808 1.317 . . . . 0.0 110.265 -174.877 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -66.34 153.31 43.0 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 169.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.469 ' SD ' ' SG ' ' A' ' 4' ' ' CYS . 1.4 tmt? 80.3 -41.95 0.21 Allowed 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 125.235 1.414 . . . . 0.0 110.698 -175.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.619 ' SG ' ' HA ' ' A' ' 11' ' ' GLN . 9.3 m -128.19 74.58 79.33 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.542 0.737 . . . . 0.0 110.916 175.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -93.16 -23.26 0.3 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.412 2.742 . . . . 0.0 114.847 -175.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 9' ' ' CYS . . . -63.53 147.99 49.93 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.158 0.583 . . . . 0.0 110.347 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -55.59 -34.04 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.933 0.893 . . . . 0.0 112.559 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.5 m -127.01 100.16 6.01 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 169.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.548 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 8.7 t -142.6 25.64 1.82 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.987 -166.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 21.1 mt 59.05 -65.16 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 165.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.619 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 27.5 mt-30 82.83 59.58 0.09 OUTLIER Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 127.597 2.359 . . . . 0.0 110.701 -168.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 11' ' ' GLN . 24.8 Cg_endo -93.86 96.04 0.13 Allowed 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.171 2.581 . . . . 0.0 110.908 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.12 83.97 2.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.43 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.38 122.52 1.1 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.593 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -65.45 -19.63 66.02 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.864 0.866 . . . . 0.0 111.956 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -77.09 1.53 17.81 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.853 0.861 . . . . 0.0 112.181 -174.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.6 m -79.39 137.35 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.023 0.44 . . . . 0.0 110.296 175.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -94.58 149.25 21.43 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.616 1.167 . . . . 0.0 110.148 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 1.0 OUTLIER -119.01 161.28 20.49 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.739 0.816 . . . . 0.0 111.419 -171.192 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.69 136.68 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.674 1.19 . . . . 0.0 108.255 171.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -76.4 152.25 36.31 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.26 0.624 . . . . 0.0 109.536 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.4 t -76.22 -21.26 56.62 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 76.26 -48.6 0.57 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.156 1.383 . . . . 0.0 112.292 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.525 ' HA3' ' SG ' ' A' ' 52' ' ' CYS . . . -57.41 178.8 0.94 Allowed Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.246 0.859 . . . . 0.0 115.246 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.8 m -65.47 -23.73 66.99 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.454 0.702 . . . . 0.0 112.456 -168.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.3 p -67.2 -34.42 77.46 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.062 0.545 . . . . 0.0 110.017 174.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.3 t30 65.33 12.68 8.27 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 125.11 1.364 . . . . 0.0 113.466 166.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -73.16 141.92 47.43 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.315 1.046 . . . . 0.0 112.063 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -92.6 118.12 30.68 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.092 0.957 . . . . 0.0 109.589 175.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -110.94 126.93 55.26 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.01 0.924 . . . . 0.0 109.229 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -53.06 123.69 12.33 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.386 0.675 . . . . 0.0 111.572 175.09 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.461 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 47.8 mt-30 -52.31 -47.22 66.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.34 1.456 . . . . 0.0 112.697 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 m -58.24 -36.58 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.609 0.719 . . . . 0.0 110.955 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 0.1 OUTLIER -74.72 -39.3 61.98 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.882 -175.057 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.426 HG22 HG23 ' A' ' 37' ' ' VAL . 35.1 m -100.94 6.57 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.563 -173.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.05 3.18 88.09 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 114.71 0.644 . . . . 0.0 114.71 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.461 ' O ' ' HB3' ' A' ' 32' ' ' GLN . 88.1 t -79.74 125.86 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.414 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 25.2 m -93.22 165.57 18.13 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 123.894 0.878 . . . . 0.0 109.965 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 38' ' ' SER . 10.9 Cg_endo -51.81 -52.19 9.51 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 123.174 2.583 . . . . 0.0 114.401 -174.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.08 -27.74 64.85 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.322 0.249 . . . . 0.0 111.628 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.1 mtt -69.15 -36.92 77.94 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.775 0.43 . . . . 0.0 110.53 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.34 -31.39 63.95 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.21 1.004 . . . . 0.0 110.603 176.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -70.95 -36.47 72.62 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.391 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -76.33 -52.48 9.85 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.367 0.667 . . . . 0.0 110.64 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -138.72 139.14 38.27 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.321 1.048 . . . . 0.0 109.52 -172.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -72.8 176.29 5.74 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 122.695 0.398 . . . . 0.0 109.937 171.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -88.54 77.5 8.0 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 175.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.22 105.61 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.8 p -73.07 160.48 31.96 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.229 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.6 p -52.95 -39.67 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.434 1.094 . . . . 0.0 113.766 -165.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -70.9 -30.57 66.96 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 118.015 0.37 . . . . 0.0 111.449 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.525 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 99.2 m -74.91 -26.21 59.48 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.158 0.583 . . . . 0.0 111.005 173.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.8 m -81.85 -39.01 24.56 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.083 0.553 . . . . 0.0 110.862 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.8 t -76.89 -32.23 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.046 0.939 . . . . 0.0 109.747 176.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -135.51 87.45 2.32 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.082 0.553 . . . . 0.0 110.501 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -91.99 -23.45 19.54 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 166.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.16 88.4 26.21 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 124.004 0.921 . . . . 0.0 109.16 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.48 -23.51 50.37 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.041 2.494 . . . . 0.0 111.995 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.0 t -136.85 104.46 5.49 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -75.12 104.78 5.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.029 0.531 . . . . 0.0 110.418 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.254 1.325 0 C-N-CA 123.946 0.899 . . . . 0.0 110.193 178.468 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -155.79 92.59 1.39 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.118 0.485 . . . . 0.0 109.986 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ttt -154.46 6.85 0.29 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.064 0.946 . . . . 0.0 108.926 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.28 92.21 1.67 Allowed Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -170.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -52.84 -51.14 11.78 Favored 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 124.712 3.608 . . . . 0.0 116.994 -159.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.526 ' HB1' ' SG ' ' A' ' 9' ' ' CYS . . . -60.15 158.51 11.18 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -170.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -75.8 -42.56 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.119 0.568 . . . . 0.0 110.411 176.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.0 p -92.44 52.29 1.89 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.522 1.129 . . . . 0.0 109.115 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.526 ' SG ' ' HB1' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -93.35 119.67 32.74 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.196 -167.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.4 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 28.6 mt -69.49 178.48 2.45 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 160.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -115.69 83.0 10.82 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -81.89 134.23 8.27 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.098 2.532 . . . . 0.0 112.885 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -148.06 152.61 37.67 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.472 0.709 . . . . 0.0 110.002 175.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.9 -146.7 17.33 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -92.26 78.6 5.12 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.009 0.924 . . . . 0.0 109.798 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 69.1 121.62 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.441 1.496 . . . . 0.0 111.63 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.6 t -89.26 145.66 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.919 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.72 120.81 16.87 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 174.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.626 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 9.5 m95 -118.24 131.04 56.38 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.377 0.671 . . . . 0.0 111.566 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.493 ' HB ' ' HG2' ' A' ' 32' ' ' GLN . 5.7 p -104.35 123.2 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.793 174.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -82.47 137.99 34.49 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 173.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 36.7 t -84.62 81.94 8.64 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 170.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -54.35 -18.59 4.26 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.752 1.221 . . . . 0.0 112.293 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -51.47 177.52 0.07 OUTLIER Glycine 0 C--N 1.351 1.364 0 N-CA-C 114.671 0.628 . . . . 0.0 114.671 167.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.9 p -74.65 72.98 1.99 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.554 1.141 . . . . 0.0 111.18 -171.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.408 ' SG ' ' HG3' ' A' ' 28' ' ' GLN . 9.6 p -178.36 -42.58 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.388 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.402 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 14.5 m120 67.05 31.58 6.8 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 124.038 0.935 . . . . 0.0 110.69 175.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.408 ' HG3' ' SG ' ' A' ' 26' ' ' CYS . 92.1 mt-30 -72.18 121.32 19.12 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.283 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -87.68 108.21 18.99 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.573 0.749 . . . . 0.0 110.996 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -103.8 171.68 7.22 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.941 170.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -108.36 123.58 49.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.324 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.493 ' HG2' ' HB ' ' A' ' 20' ' ' VAL . 28.4 mt-30 -48.79 -56.65 8.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.916 1.286 . . . . 0.0 113.082 -177.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -62.3 -32.28 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-O 121.384 0.611 . . . . 0.0 111.112 -176.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.494 ' HB3' ' CD2' ' A' ' 31' ' ' HIS . 6.5 t -85.53 -20.38 29.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.204 -170.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.8 m -109.4 -16.49 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.093 0.557 . . . . 0.0 111.578 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.46 15.21 35.64 Favored Glycine 0 C--N 1.351 1.399 0 N-CA-C 114.171 0.428 . . . . 0.0 114.171 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.33 129.96 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.285 0.634 . . . . 0.0 109.709 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 88.7 p -82.49 164.45 47.41 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.072 0.549 . . . . 0.0 109.711 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.51 -26.17 70.09 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 121.945 1.763 . . . . 0.0 111.336 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -64.76 -52.22 58.1 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.929 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 66.8 mtt -62.49 -36.04 81.25 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.576 0.75 . . . . 0.0 111.636 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.47 -38.99 85.24 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.49 0.716 . . . . 0.0 112.098 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -85.07 -45.66 11.89 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.896 0.478 . . . . 0.0 111.301 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -68.97 -54.38 15.61 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.356 1.062 . . . . 0.0 110.378 -175.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -111.08 160.6 16.73 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.201 -175.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -85.14 135.35 34.01 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 163.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -73.77 81.94 1.61 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 168.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.7 mt -75.18 104.92 3.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.958 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.9 p -73.84 158.51 34.39 Favored 'General case' 0 C--O 1.252 1.19 0 O-C-N 123.923 0.764 . . . . 0.0 110.3 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.405 ' O ' HG21 ' A' ' 54' ' ' VAL . 18.9 m -52.91 -33.62 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.222 1.009 . . . . 0.0 113.016 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -61.28 -41.65 97.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.798 0.439 . . . . 0.0 111.389 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.8 m -68.78 -36.49 78.37 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.88 0.472 . . . . 0.0 110.818 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.6 m -64.2 -47.78 78.43 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.512 0.725 . . . . 0.0 111.378 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 50' ' ' VAL . 53.2 t -69.77 -38.34 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.269 0.628 . . . . 0.0 110.503 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -68.81 -38.76 80.12 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.919 0.888 . . . . 0.0 112.342 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -152.57 -59.8 0.15 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.43 0.292 . . . . 0.0 110.782 -173.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 63.55 97.01 0.04 OUTLIER Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.793 1.237 . . . . 0.0 110.275 -170.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.79 76.82 0.15 Allowed 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.011 2.474 . . . . 0.0 111.191 173.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.2 t -159.76 157.35 29.23 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.652 -169.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -79.69 139.13 37.48 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.765 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.8 pttp . . . . . 0 CA--C 1.564 1.485 0 C-N-CA 123.726 0.81 . . . . 0.0 109.158 178.227 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -152.69 161.77 42.13 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.008 0.523 . . . . 0.0 110.816 -177.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 49.9 ttp -167.53 157.12 10.34 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.545 1.138 . . . . 0.0 109.253 176.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.5 t -116.1 91.2 31.1 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 123.933 0.893 . . . . 0.0 108.886 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.93 94.31 1.07 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.684 2.923 . . . . 0.0 112.941 -169.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.625 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -158.57 107.52 1.97 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.459 0.704 . . . . 0.0 110.362 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.2 t 60.45 -76.57 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 125.772 1.629 . . . . 0.0 112.021 174.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.6 t -146.35 -27.0 0.42 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.003 0.921 . . . . 0.0 110.734 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.8 t 65.67 81.09 0.21 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.772 1.229 . . . . 0.0 110.478 -177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 67.3 mt -65.64 -33.67 76.45 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.638 0.775 . . . . 0.0 111.638 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 61.09 74.06 0.55 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.814 1.246 . . . . 0.0 112.224 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.597 ' HD2' ' HD1' ' A' ' 31' ' ' HIS . 60.9 Cg_endo -71.48 122.92 9.05 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.253 1.969 . . . . 0.0 111.302 171.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.5 91.0 1.76 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.465 0.706 . . . . 0.0 109.974 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 167.48 123.49 0.66 Allowed Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.017 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -78.15 -2.5 37.84 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.797 0.839 . . . . 0.0 112.309 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.16 -18.37 64.4 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.043 0.937 . . . . 0.0 112.055 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.85 127.93 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.906 0.384 . . . . 0.0 110.158 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -79.35 145.99 33.12 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.474 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -116.51 124.72 50.61 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.251 0.62 . . . . 0.0 110.947 -174.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.54 121.9 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 124.289 1.036 . . . . 0.0 109.198 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -84.92 153.2 22.99 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.775 0.83 . . . . 0.0 110.004 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 43.7 t -103.2 72.9 1.19 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 165.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -53.1 -31.02 39.82 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.954 0.902 . . . . 0.0 111.437 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -64.51 92.82 0.13 Allowed Glycine 0 CA--C 1.534 1.241 0 CA-C-O 119.295 -0.725 . . . . 0.0 111.829 165.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 72.2 p 50.7 54.03 11.93 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.967 1.707 . . . . 0.0 113.724 164.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 51.7 m -161.76 -56.63 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.942 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 62.15 13.8 6.09 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.949 1.7 . . . . 0.0 112.814 176.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -85.15 138.54 32.32 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -87.62 110.52 20.45 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -99.73 142.79 30.75 Favored 'General case' 0 C--O 1.206 -1.209 0 C-N-CA 123.927 0.891 . . . . 0.0 109.931 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.597 ' HD1' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -89.48 154.31 20.12 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -169.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -43.68 -54.79 4.79 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.75 0.82 . . . . 0.0 112.438 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -76.19 -22.78 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.267 0.627 . . . . 0.0 111.838 -176.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.625 ' SG ' ' HB2' ' A' ' 6' ' ' ALA . 25.1 t -67.93 -31.55 71.39 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.721 0.409 . . . . 0.0 111.518 -178.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.9 m -115.85 -15.25 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.026 0.93 . . . . 0.0 112.098 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.93 37.1 39.54 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 123.333 0.396 . . . . 0.0 112.565 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.9 t -115.43 135.56 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.084 0.954 . . . . 0.0 110.081 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 m -71.41 148.23 93.24 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 123.907 0.883 . . . . 0.0 110.726 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 39.8 Cg_endo -62.11 -20.76 70.9 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.174 2.583 . . . . 0.0 113.796 -175.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -62.13 -49.34 76.28 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.541 0.736 . . . . 0.0 111.458 173.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 27.0 ttt -74.28 -29.83 61.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.391 1.076 . . . . 0.0 110.265 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 39' ' ' PRO . . . -70.24 -20.75 63.06 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.44 0.696 . . . . 0.0 112.009 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -92.18 -44.68 8.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.923 0.889 . . . . 0.0 110.667 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -73.33 -51.14 18.54 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.51 0.724 . . . . 0.0 112.097 -172.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -115.66 147.28 41.01 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.012 0.925 . . . . 0.0 111.175 -166.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.64 139.01 38.59 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 171.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -76.09 75.93 2.95 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.2 mt -77.88 100.06 2.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.8 p -75.96 148.08 38.41 Favored 'General case' 0 C--N 1.349 0.586 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.8 m -45.7 -35.59 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -165.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -63.38 -45.48 90.94 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.706 0.803 . . . . 0.0 110.699 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 24' ' ' GLY . 60.5 m -73.56 -28.09 61.68 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.693 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.8 m -67.0 -51.32 56.49 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.214 0.606 . . . . 0.0 110.74 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.61 -33.37 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.596 0.759 . . . . 0.0 111.81 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -110.79 35.0 3.67 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.74 0.781 . . . . 0.0 109.569 -175.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.63 69.81 3.93 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 63.15 82.7 0.21 Allowed Pre-proline 0 CA--C 1.551 0.988 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.673 -171.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.74 -7.95 19.87 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.887 2.391 . . . . 0.0 113.562 -172.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.6 t -157.59 145.34 18.75 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.041 0.936 . . . . 0.0 109.03 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -152.55 164.53 37.44 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.559 0.744 . . . . 0.0 110.031 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.6 pttp . . . . . 0 CA--C 1.553 1.066 0 C-N-CA 123.823 0.849 . . . . 0.0 109.856 -175.659 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.8 m . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -82.06 167.09 19.17 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.181 0.592 . . . . 0.0 109.782 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.529 ' SD ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER 48.27 14.23 0.06 Allowed 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 126.116 1.766 . . . . 0.0 115.169 178.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.529 ' SG ' ' SD ' ' A' ' 3' ' ' MET . 25.6 p 164.01 113.51 0.02 OUTLIER Pre-proline 0 C--N 1.355 0.808 0 C-N-CA 125.595 1.558 . . . . 0.0 108.134 -176.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -74.07 66.87 5.12 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.65 2.233 . . . . 0.0 111.845 174.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.57 106.85 8.07 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.02 -44.83 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.6 m -72.69 93.47 1.64 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 166.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 51.1 t -139.67 113.13 8.4 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.931 0.492 . . . . 0.0 111.121 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.673 HD12 HG21 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -66.6 146.28 54.67 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 161.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -105.33 103.39 42.32 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.41 99.63 0.17 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.358 2.705 . . . . 0.0 112.573 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.23 -24.61 42.96 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.722 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.34 -19.88 56.0 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.308 175.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 72.76 -17.94 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.242 1.417 . . . . 0.0 113.846 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -82.98 67.5 9.09 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.951 0.881 . . . . 0.0 110.335 -171.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.35 138.52 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.69 1.196 . . . . 0.0 108.608 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -80.53 122.89 27.59 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -93.1 174.95 6.97 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.29 0.636 . . . . 0.0 111.036 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.42 ' HB ' HE22 ' A' ' 32' ' ' GLN . 14.8 p -159.98 129.1 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.424 0.69 . . . . 0.0 110.261 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -80.61 126.53 31.37 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.509 ' SG ' ' OD2' ' A' ' 23' ' ' ASP . 31.1 t -75.0 118.39 17.91 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 -164.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.509 ' OD2' ' SG ' ' A' ' 22' ' ' CYS . 4.5 p30 20.36 -71.08 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 127.986 2.514 . . . . 0.0 117.471 171.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.92 -95.24 0.15 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.211 -0.449 . . . . 0.0 113.723 -152.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -79.51 -51.93 8.69 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.197 -0.501 . . . . 0.0 111.598 -163.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.05 -35.5 64.3 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -173.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.2 t30 70.7 -26.83 0.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.284 1.434 . . . . 0.0 114.78 165.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.84 147.18 24.05 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.93 0.892 . . . . 0.0 111.562 -171.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -74.99 139.37 42.89 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.679 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -126.34 149.33 49.24 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 172.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.595 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -78.74 148.0 33.18 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 169.35 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.42 HE22 ' HB ' ' A' ' 20' ' ' VAL . 2.6 mp0 -58.77 -34.36 71.34 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.539 0.736 . . . . 0.0 110.424 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.673 HG21 HD12 ' A' ' 10' ' ' LEU . 35.1 m -76.06 -22.25 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.649 176.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.595 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.5 t -70.99 -37.25 72.7 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 123.399 0.68 . . . . 0.0 111.195 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.0 m -118.62 8.64 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.819 0.848 . . . . 0.0 112.338 -172.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.61 29.12 73.72 Favored Glycine 0 C--N 1.353 1.493 0 O-C-N 123.498 0.499 . . . . 0.0 114.262 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 77.0 t -92.97 143.73 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.57 0.748 . . . . 0.0 109.368 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.0 m -80.42 145.23 58.95 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.341 0.656 . . . . 0.0 109.856 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.89 -38.38 94.63 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.493 2.129 . . . . 0.0 112.221 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.21 -45.7 90.4 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.763 0.825 . . . . 0.0 111.029 173.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 50.2 mmm -60.85 -46.12 91.81 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.135 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.38 -35.6 81.43 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.621 0.768 . . . . 0.0 111.293 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -69.52 -38.75 77.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.42 0.688 . . . . 0.0 111.696 175.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -74.65 -44.24 51.37 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.404 0.681 . . . . 0.0 111.391 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -161.78 153.25 18.64 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.229 1.012 . . . . 0.0 109.755 -172.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -73.92 148.12 42.51 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.96 0.41 . . . . 0.0 111.841 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -72.48 125.85 28.42 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 166.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.409 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 11.2 mt -113.77 125.98 71.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.8 m -66.26 167.29 10.55 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 173.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.1 t -62.28 -48.93 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 173.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 3.6 mpt_? -62.67 -48.25 80.13 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.668 0.387 . . . . 0.0 110.099 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.6 m -48.4 -41.36 28.81 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.717 1.207 . . . . 0.0 112.902 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.692 ' HA ' ' HB3' ' A' ' 57' ' ' ALA . 5.9 t -82.97 -29.86 28.69 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -178.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.7 t -69.82 -29.68 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.661 0.784 . . . . 0.0 110.847 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 74.0 mmtt -62.54 -63.06 1.34 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -175.06 -28.75 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.555 1.142 . . . . 0.0 110.729 174.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.692 ' HB3' ' HA ' ' A' ' 53' ' ' THR . . . 65.35 78.36 0.26 Allowed Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 124.882 1.273 . . . . 0.0 110.991 -176.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -88.85 173.89 4.07 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.797 2.331 . . . . 0.0 112.221 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.0 p -83.73 -82.09 0.16 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 166.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 177.11 -69.31 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.716 1.206 . . . . 0.0 108.331 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt . . . . . 0 C--O 1.252 1.201 0 C-N-CA 124.605 1.162 . . . . 0.0 108.474 -177.467 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 120.884 0.373 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -98.08 157.5 16.1 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.122 0.569 . . . . 0.0 110.286 175.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.6 ttt 76.31 -39.82 0.37 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.659 1.584 . . . . 0.0 112.207 -175.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.503 ' SG ' ' HD1' ' A' ' 30' ' ' PHE . 25.6 t -149.67 84.28 6.06 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 122.704 0.401 . . . . 0.0 111.766 -177.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.83 45.78 2.05 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.714 2.942 . . . . 0.0 112.972 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.91 129.74 35.73 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 170.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.88 -37.48 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 122.786 0.434 . . . . 0.0 110.683 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.8 p -97.17 69.81 2.33 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 169.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.744 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 21.5 t -84.06 79.07 9.63 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-O 121.078 0.466 . . . . 0.0 110.377 -177.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.1 mt -59.96 139.71 57.23 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.121 172.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -113.42 80.28 4.51 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.06 0.944 . . . . 0.0 109.915 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.25 142.87 7.53 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.292 2.661 . . . . 0.0 113.327 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.49 163.02 14.31 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.82 0.848 . . . . 0.0 109.517 172.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.34 152.87 28.86 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.981 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -82.54 -16.38 48.84 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.892 0.877 . . . . 0.0 111.914 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -58.2 -35.44 71.63 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.274 1.03 . . . . 0.0 112.018 -175.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 m -73.2 83.71 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 122.54 1.162 . . . . 0.0 110.295 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.45 140.8 54.09 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.627 -176.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -92.89 156.25 17.07 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.169 0.509 . . . . 0.0 110.91 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -137.87 126.96 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.771 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -77.39 129.26 35.56 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.145 0.978 . . . . 0.0 109.755 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -62.98 -36.87 84.97 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.992 0.517 . . . . 0.0 111.271 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t70 69.39 -72.5 0.1 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.818 1.647 . . . . 0.0 111.264 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.446 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -46.7 90.58 0.01 OUTLIER Glycine 0 C--N 1.353 1.511 0 C-N-CA 124.828 1.204 . . . . 0.0 115.904 -172.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 t 70.44 12.32 7.45 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.35 1.46 . . . . 0.0 112.908 162.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -155.16 -29.11 0.11 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.263 -175.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 80.2 -59.61 0.31 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.274 1.43 . . . . 0.0 111.599 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -4.22 114.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 129.012 2.925 . . . . 0.0 116.978 -173.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -79.86 116.52 20.07 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.187 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.503 ' HD1' ' SG ' ' A' ' 4' ' ' CYS . 50.7 m-85 -100.73 164.94 11.63 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 124.285 1.034 . . . . 0.0 109.696 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.495 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -106.51 149.08 27.46 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -176.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -47.97 -51.05 25.26 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.73 1.212 . . . . 0.0 112.643 -174.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.0 m -81.55 -28.45 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.205 0.602 . . . . 0.0 112.554 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.744 ' SG ' ' HA ' ' A' ' 9' ' ' CYS . 52.6 t -62.69 -36.09 81.82 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -174.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 m -114.5 -1.36 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.577 0.751 . . . . 0.0 111.712 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.3 30.66 71.46 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 113.665 0.226 . . . . 0.0 113.665 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.4 t -98.48 107.82 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.693 ' HB2' ' SD ' ' A' ' 41' ' ' MET . 45.6 m -73.14 163.1 71.01 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 123.696 0.799 . . . . 0.0 110.822 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -47.85 -45.71 23.65 Favored 'Trans proline' 0 C--N 1.396 3.04 0 C-N-CA 123.635 2.89 . . . . 0.0 114.999 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.85 -32.56 71.03 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 120.634 0.254 . . . . 0.0 111.348 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.693 ' SD ' ' HB2' ' A' ' 38' ' ' SER . 1.2 mpt? -69.76 -44.28 70.49 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.145 0.578 . . . . 0.0 109.94 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.29 69.47 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.587 0.755 . . . . 0.0 111.172 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.76 -48.51 46.32 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.365 1.066 . . . . 0.0 111.248 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -105.04 -61.18 1.51 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.906 -163.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -156.84 148.42 22.46 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -165.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 t70 67.17 76.43 0.29 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.966 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -148.32 5.18 0.72 Allowed 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.638 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.3 mp -95.09 117.52 39.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.0 p -59.73 147.19 38.67 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 123.297 0.373 . . . . 0.0 111.39 -171.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.6 t -54.9 -37.12 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -158.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -68.1 -27.87 66.85 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.667 0.387 . . . . 0.0 111.395 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 24' ' ' GLY . 82.3 m -79.24 -28.03 42.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.579 0.751 . . . . 0.0 111.154 173.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 m -73.5 -28.91 62.16 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 123.553 0.533 . . . . 0.0 110.196 175.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.1 t -72.21 -52.3 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.689 0.796 . . . . 0.0 109.389 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -94.77 55.47 1.89 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.03 0.919 . . . . 0.0 110.238 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -103.95 21.95 15.45 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.617 1.167 . . . . 0.0 109.396 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 58.77 75.25 0.53 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.264 1.026 . . . . 0.0 110.03 -173.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -74.36 154.05 45.56 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.526 2.15 . . . . 0.0 111.394 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.8 m -72.8 -26.78 61.64 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.547 0.339 . . . . 0.0 110.316 173.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -83.93 115.48 22.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.737 0.815 . . . . 0.0 111.087 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp . . . . . 0 CA--C 1.564 1.497 0 C-N-CA 125.658 1.583 . . . . 0.0 112.739 170.808 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 t . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.76 80.96 0.61 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.101 2.534 . . . . 0.0 112.413 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.31 130.56 19.69 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.475 1.11 . . . . 0.0 108.894 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.43 -55.23 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.227 0.611 . . . . 0.0 109.693 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.7 m -78.12 74.21 4.67 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.499 0.719 . . . . 0.0 109.251 174.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.709 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 19.7 t -97.93 92.29 5.74 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.101 0.477 . . . . 0.0 110.491 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 33' ' ' VAL . 88.3 mt -71.88 113.6 9.09 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.438 172.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -105.27 107.77 59.81 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.47 1.108 . . . . 0.0 109.491 -175.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HG2' ' H ' ' A' ' 14' ' ' GLY . 97.9 Cg_endo -72.12 -145.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.459 2.773 . . . . 0.0 110.953 170.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -68.52 -6.66 26.47 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.669 0.388 . . . . 0.0 111.742 167.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.445 ' H ' ' HG2' ' A' ' 12' ' ' PRO . . . 116.64 -86.14 0.41 Allowed Glycine 0 C--N 1.346 1.122 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 174.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -95.39 66.49 2.85 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.396 1.093 . . . . 0.0 108.841 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -114.8 -58.71 2.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.916 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -86.18 -177.87 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 124.742 1.217 . . . . 0.0 112.065 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.44 ' HB3' HE21 ' A' ' 32' ' ' GLN . 33.2 t70 -98.23 140.93 31.8 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.925 0.49 . . . . 0.0 110.313 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -105.71 -177.96 3.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.492 1.117 . . . . 0.0 110.803 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 37' ' ' VAL . 7.5 p -157.94 136.57 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 125.162 1.385 . . . . 0.0 108.22 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -95.88 112.52 24.23 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.4 t -77.9 91.01 4.13 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -57.24 -80.34 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 O-C-N 123.942 0.776 . . . . 0.0 109.851 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 43.35 -83.8 0.01 OUTLIER Glycine 0 N--CA 1.484 1.883 0 C-N-CA 124.423 1.011 . . . . 0.0 115.309 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.8 p -159.81 26.96 0.18 Allowed 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.999 1.32 . . . . 0.0 110.222 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.8 p -143.11 -41.29 0.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.315 0.646 . . . . 0.0 111.387 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 65.29 19.29 11.64 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.029 0.931 . . . . 0.0 112.101 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -79.82 137.08 36.87 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.217 0.607 . . . . 0.0 111.059 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -86.59 128.61 35.0 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.465 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -129.33 143.39 50.83 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.284 1.034 . . . . 0.0 109.044 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.632 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -69.29 141.35 54.36 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 169.774 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.44 HE21 ' HB3' ' A' ' 18' ' ' ASP . 48.6 mt-30 -53.32 -40.47 64.84 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.935 0.494 . . . . 0.0 111.369 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.4 ' O ' HD12 ' A' ' 10' ' ' LEU . 33.3 m -65.31 -38.24 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.55 0.74 . . . . 0.0 111.677 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.709 ' SG ' ' HA ' ' A' ' 9' ' ' CYS . 8.4 t -56.29 -50.22 72.02 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.073 0.949 . . . . 0.0 112.047 -175.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.1 m -109.26 5.91 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.283 -174.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.45 52.73 51.39 Favored Glycine 0 C--N 1.355 1.638 0 C-N-CA 123.575 0.607 . . . . 0.0 113.98 174.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.584 HG21 HG11 ' A' ' 20' ' ' VAL . 13.1 t -74.66 119.3 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.054 0.541 . . . . 0.0 109.581 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.616 ' HB2' ' SD ' ' A' ' 41' ' ' MET . 41.7 m -63.14 135.6 96.3 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 123.575 0.547 . . . . 0.0 109.589 175.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.69 -15.43 16.19 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.373 2.716 . . . . 0.0 114.499 -175.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.03 -52.11 18.53 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.616 ' SD ' ' HB2' ' A' ' 38' ' ' SER . 1.4 mpt? -67.61 -33.36 74.83 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.109 0.964 . . . . 0.0 110.405 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.81 -36.37 70.24 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.178 0.991 . . . . 0.0 110.831 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.17 -45.23 85.72 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -70.61 -15.4 62.74 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.951 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 65.34 12.84 8.4 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.921 1.288 . . . . 0.0 110.979 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -102.34 91.61 4.34 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.099 1.359 . . . . 0.0 109.239 -170.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -132.23 106.59 8.04 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.9 mp -100.66 113.22 35.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.5 p -74.26 164.04 27.09 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.903 0.481 . . . . 0.0 110.475 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.4 t -50.54 -47.72 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 124.508 1.123 . . . . 0.0 112.441 -174.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -54.13 -44.12 71.09 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.071 0.549 . . . . 0.0 111.702 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 68.7 m -67.62 -36.11 80.19 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.044 0.537 . . . . 0.0 111.824 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.1 m -74.42 -44.15 53.13 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.181 0.593 . . . . 0.0 110.791 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.3 t -78.11 -16.11 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.229 1.011 . . . . 0.0 111.114 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -117.01 25.28 10.61 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.91 0.862 . . . . 0.0 109.696 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 . . . . . 0 N--CA 1.475 0.787 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.602 173.622 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 82.1 m . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.53 39.34 0.84 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.727 2.285 . . . . 0.0 111.061 162.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.26 108.72 8.93 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.1 t -63.76 -43.88 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 m -70.57 106.3 3.43 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 165.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.6 t -151.27 86.11 1.35 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.725 0.41 . . . . 0.0 111.149 -173.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.4 mt -71.12 114.44 9.18 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 166.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -93.11 107.11 22.7 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.709 1.204 . . . . 0.0 111.033 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.62 178.62 6.88 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.098 2.532 . . . . 0.0 111.052 168.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -74.49 -17.34 60.78 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.338 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.79 143.68 14.77 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.0 t70 58.59 34.04 23.55 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.293 1.044 . . . . 0.0 109.559 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -123.91 -71.96 0.7 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.057 -169.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.1 m -91.74 145.85 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -69.79 150.38 46.94 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.872 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -95.09 -178.12 4.37 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.712 0.805 . . . . 0.0 111.223 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.1 p -153.64 116.44 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.949 1.299 . . . . 0.0 108.706 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 52.0 tt0 -98.66 107.94 20.51 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.548 0.739 . . . . 0.0 109.392 -177.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 8.7 t -79.99 64.49 4.84 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.362 0.665 . . . . 0.0 111.278 -173.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -53.04 -36.3 60.44 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.215 1.406 . . . . 0.0 113.638 -169.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -39.35 -58.09 2.09 Favored Glycine 0 N--CA 1.477 1.392 0 O-C-N 124.865 1.353 . . . . 0.0 115.496 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.482 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 48.2 m -157.61 32.54 0.27 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.375 0.67 . . . . 0.0 110.672 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 75.4 m -132.74 -48.38 0.88 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 173.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 74.37 -6.65 1.83 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.939 1.296 . . . . 0.0 112.383 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -93.75 146.25 24.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.845 0.858 . . . . 0.0 109.882 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 8.3 p-90 -103.5 111.81 24.44 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.203 1.001 . . . . 0.0 109.635 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -100.71 163.24 12.42 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.627 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -63.32 145.71 55.0 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 166.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -62.85 -32.24 73.43 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 122.046 -0.409 . . . . 0.0 111.085 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 31' ' ' HIS . 33.5 m -68.73 -26.8 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 C-N-CA 123.105 0.562 . . . . 0.0 111.815 174.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.627 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.2 t -61.43 -55.53 30.27 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 123.958 0.903 . . . . 0.0 111.819 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 37' ' ' VAL . 18.4 m -101.43 -5.22 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.285 -168.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.66 31.86 20.27 Favored Glycine 0 C--N 1.348 1.245 0 O-C-N 123.204 0.315 . . . . 0.0 113.401 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 35' ' ' VAL . 55.0 t -97.3 125.73 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.559 0.744 . . . . 0.0 109.577 175.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.6 m -82.89 159.29 63.44 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 123.891 0.876 . . . . 0.0 110.067 175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -45.82 -50.78 9.17 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.631 2.887 . . . . 0.0 114.439 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 47.5 mt-10 -71.85 -12.95 61.52 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.094 0.558 . . . . 0.0 112.322 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.6 mtt -79.3 -57.09 3.89 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.528 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . . . -61.48 -36.62 80.99 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.94 0.896 . . . . 0.0 112.14 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -87.39 -65.13 1.05 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.901 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 39.5 ttmt -81.68 -48.49 11.63 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.451 0.469 . . . . 0.0 112.215 -163.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -162.32 118.88 2.0 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -167.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.0 t70 61.74 107.18 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.618 1.567 . . . . 0.0 114.067 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.582 ' H ' HD12 ' A' ' 48' ' ' ILE . 42.0 p90 -126.29 12.55 7.63 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 114.297 -1.319 . . . . 0.0 108.677 165.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.582 HD12 ' H ' ' A' ' 47' ' ' TYR . 3.5 mp -85.13 106.16 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.129 -172.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.1 p -61.52 159.86 12.22 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 123.837 0.711 . . . . 0.0 111.771 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.4 t -52.44 -39.68 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.748 1.219 . . . . 0.0 112.538 -172.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 27.4 mmt180 -64.78 -44.83 88.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.316 0.646 . . . . 0.0 111.701 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 25' ' ' SER . 64.7 m -62.71 -38.85 92.08 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.682 0.393 . . . . 0.0 111.075 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.9 m -69.36 -45.13 70.11 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.928 0.891 . . . . 0.0 110.834 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.46 -25.98 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.261 0.624 . . . . 0.0 111.101 -173.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 51' ' ' ARG . 68.2 mttm -56.77 -50.94 70.8 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 123.317 0.385 . . . . 0.0 110.233 173.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 . . . . . 0 N--CA 1.491 1.61 0 C-N-CA 125.243 1.417 . . . . 0.0 113.059 173.138 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.559 1.298 0 CA-C-O 120.471 0.177 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.34 108.33 2.59 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.222 2.615 . . . . 0.0 113.756 -170.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.29 -170.88 2.15 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.148 0.979 . . . . 0.0 109.74 168.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.9 m -54.89 -31.35 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.159 0.984 . . . . 0.0 112.109 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.4 m -147.42 -35.79 0.23 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.202 1.401 . . . . 0.0 109.188 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.3 t 70.18 97.02 0.07 Allowed 'General case' 0 C--N 1.36 1.031 0 C-N-CA 125.231 1.412 . . . . 0.0 109.491 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.4 mt -80.43 100.47 8.51 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -85.78 105.67 7.71 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.378 1.071 . . . . 0.0 108.302 171.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.56 162.39 42.16 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 122.423 2.082 . . . . 0.0 111.112 172.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.75 -22.33 66.48 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.407 0.683 . . . . 0.0 111.677 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.9 136.17 4.45 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.15 66.53 7.78 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.297 1.048 . . . . 0.0 111.16 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.54 -9.23 55.03 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.976 164.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -63.16 151.62 8.27 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 C-N-CA 124.659 1.184 . . . . 0.0 110.143 165.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -85.39 149.3 25.52 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.056 0.455 . . . . 0.0 110.114 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 22.1 m0 -111.75 -179.95 3.84 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.537 1.135 . . . . 0.0 110.83 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -161.75 131.78 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.551 1.14 . . . . 0.0 109.549 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 63.5 tt0 -69.82 149.45 47.9 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.659 0.784 . . . . 0.0 110.067 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 0.7 OUTLIER -127.7 50.12 2.06 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.552 0.741 . . . . 0.0 110.164 -171.303 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -57.53 -21.45 38.26 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.913 1.685 . . . . 0.0 114.564 -174.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.24 -58.59 6.33 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 114.76 0.664 . . . . 0.0 114.76 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.729 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 40.6 m -161.36 60.32 0.28 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 89.5 m -155.85 -45.67 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.939 0.896 . . . . 0.0 108.818 173.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 68.93 20.76 7.78 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.427 1.091 . . . . 0.0 111.652 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -140.48 163.18 33.53 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.829 0.852 . . . . 0.0 109.867 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 23.9 m95 -82.93 151.6 25.86 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.203 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -139.85 141.1 36.67 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.16 1.384 . . . . 0.0 108.395 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.658 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -56.12 144.96 27.42 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.457 0.703 . . . . 0.0 109.285 166.159 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -57.4 -41.05 79.56 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.12 0.418 . . . . 0.0 111.327 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -63.25 -26.22 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.246 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.658 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.6 t -67.59 -45.37 75.7 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.789 0.835 . . . . 0.0 111.913 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.5 m -100.82 -8.59 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.354 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.21 16.02 72.81 Favored Glycine 0 CA--C 1.536 1.392 0 O-C-N 123.358 0.411 . . . . 0.0 113.67 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 68.8 t -84.25 131.56 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 123.649 0.78 . . . . 0.0 109.558 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.4 m -67.8 157.33 86.84 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 123.751 0.82 . . . . 0.0 111.324 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -49.48 -50.79 12.11 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.174 2.583 . . . . 0.0 113.49 174.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.02 -30.74 68.11 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.556 0.742 . . . . 0.0 111.44 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 74.9 mtp -68.34 -47.61 67.04 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.785 0.434 . . . . 0.0 110.351 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.6 -34.5 72.83 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.362 0.665 . . . . 0.0 110.221 176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -75.14 -43.54 51.97 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.522 -176.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -103.55 -59.78 1.67 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -173.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -172.75 165.16 5.33 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.222 0.609 . . . . 0.0 111.636 -170.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.4 t70 63.11 57.71 1.56 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.481 1.112 . . . . 0.0 110.279 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -104.58 6.97 34.97 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.414 -1.267 . . . . 0.0 110.038 168.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.5 mp -78.52 104.24 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -173.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 51' ' ' ARG . 13.0 p -66.37 164.7 15.61 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.556 -175.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.8 t -51.92 -46.15 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.94 0.896 . . . . 0.0 110.699 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.532 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 72.9 mtp180 -53.3 -43.55 67.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 123.937 0.773 . . . . 0.0 112.244 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.729 ' HA ' ' HB2' ' A' ' 25' ' ' SER . 14.5 m -61.09 -47.3 86.95 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.825 0.703 . . . . 0.0 111.109 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.2 m -67.23 -45.21 77.45 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 124.015 0.822 . . . . 0.0 111.185 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.19 -34.2 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.025 0.93 . . . . 0.0 110.828 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -73.17 0.19 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 CA--C 1.538 0.499 0 C-N-CA 123.706 0.802 . . . . 0.0 109.944 -172.927 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.565 1.529 0 N-CA-C 110.744 -0.095 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -71.07 60.76 2.42 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.505 2.137 . . . . 0.0 111.922 165.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.55 108.45 2.72 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.437 1.095 . . . . 0.0 108.056 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -66.87 -17.06 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.904 0.882 . . . . 0.0 111.458 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.0 m -86.56 26.35 1.1 Allowed 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.527 1.131 . . . . 0.0 111.292 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.7 t -77.7 101.97 6.89 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.6 mt -62.3 -27.81 69.3 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.76 0.824 . . . . 0.0 112.297 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 58.8 60.04 5.37 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.342 1.057 . . . . 0.0 111.573 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -81.96 160.78 18.42 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.036 1.824 . . . . 0.0 111.59 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -23.25 59.05 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.614 170.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.47 -76.18 0.17 Allowed Glycine 0 C--N 1.343 0.952 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.3 t70 65.08 14.79 9.61 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.775 1.23 . . . . 0.0 112.359 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 64.86 61.07 0.8 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.084 1.353 . . . . 0.0 110.664 -176.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -101.34 134.99 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 170.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.57 160.99 22.42 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -114.3 164.91 13.28 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.45 0.643 . . . . 0.0 111.066 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 p -153.25 142.76 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.321 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -101.19 121.18 41.39 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.3 t -63.76 141.49 58.75 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.011 0.524 . . . . 0.0 110.155 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.432 ' H ' ' HE1' ' A' ' 47' ' ' TYR . 25.0 t70 -94.4 -78.55 0.44 Allowed 'General case' 0 C--O 1.239 0.509 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 154.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 33.04 -98.61 0.01 OUTLIER Glycine 0 C--N 1.357 1.732 0 O-C-N 125.039 1.462 . . . . 0.0 116.287 172.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.4 t -157.33 15.36 0.26 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.964 0.906 . . . . 0.0 109.898 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 14.1 p -159.21 57.37 0.41 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -49.87 80.49 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.528 1.931 . . . . 0.0 112.275 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -127.91 159.2 35.67 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 125.498 1.519 . . . . 0.0 107.402 170.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -82.16 108.48 15.66 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.491 0.663 . . . . 0.0 109.569 170.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -99.55 155.87 17.35 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.963 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.595 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -71.79 146.44 48.05 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 162.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -69.59 -22.26 63.53 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.36 0.527 . . . . 0.0 111.149 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.2 m -78.04 -19.99 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.366 0.667 . . . . 0.0 111.796 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.595 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 7.2 t -69.65 -28.02 65.54 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.596 0.758 . . . . 0.0 111.567 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 m -116.12 -8.53 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 124.364 1.066 . . . . 0.0 111.608 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.28 5.05 87.65 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 114.188 0.435 . . . . 0.0 114.188 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.2 t -80.12 138.26 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 123.282 0.633 . . . . 0.0 110.43 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 m -86.75 143.33 35.46 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.056 0.942 . . . . 0.0 109.709 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -50.38 -31.03 28.77 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 123.482 2.788 . . . . 0.0 114.407 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -58.24 -54.78 43.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.713 0.805 . . . . 0.0 109.505 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 72.2 mtm -71.99 -30.99 65.81 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.38 0.672 . . . . 0.0 111.47 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.51 -40.75 88.12 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.307 0.643 . . . . 0.0 110.937 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -82.51 -45.22 14.98 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.335 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -70.23 -56.47 6.7 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.885 0.474 . . . . 0.0 111.766 -166.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -174.49 127.68 0.33 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.355 0.662 . . . . 0.0 110.225 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.7 t70 73.16 133.83 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.906 1.682 . . . . 0.0 112.498 172.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.432 ' HE1' ' H ' ' A' ' 23' ' ' ASP . 14.5 p90 -151.25 20.77 0.75 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.569 1.548 . . . . 0.0 108.035 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.7 mt -88.82 133.91 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.273 -165.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.62 157.99 36.51 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.391 0.676 . . . . 0.0 110.627 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.7 m -56.65 -43.74 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.917 0.887 . . . . 0.0 113.072 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -69.8 -36.27 75.54 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.837 0.455 . . . . 0.0 110.869 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 96.3 m -68.41 -30.93 69.94 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.987 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.1 m -72.23 -42.86 65.2 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.268 1.027 . . . . 0.0 110.686 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.7 t -71.43 -32.65 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.076 0.55 . . . . 0.0 111.071 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -72.1 -17.37 61.99 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.825 0.45 . . . . 0.0 111.8 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t70 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 121.279 0.562 . . . . 0.0 110.675 174.361 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 119.957 -0.068 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.61 7.9 3.63 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.821 2.347 . . . . 0.0 113.542 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.422 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -83.72 119.76 25.19 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.9 t -60.13 -47.9 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.83 0.852 . . . . 0.0 111.059 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -90.06 63.02 5.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.744 0.817 . . . . 0.0 109.544 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.1 t -77.07 75.43 3.64 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.349 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 33' ' ' VAL . 68.7 mt -72.15 107.91 5.06 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 170.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -125.68 94.67 41.9 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.975 0.91 . . . . 0.0 110.261 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.64 148.1 92.45 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.956 2.438 . . . . 0.0 112.565 171.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.3 103.14 2.76 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.671 0.788 . . . . 0.0 109.281 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.98 -129.0 9.4 Favored Glycine 0 C--O 1.242 0.619 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -167.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -129.76 -80.73 0.55 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 53.51 12.22 0.35 Allowed 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 124.545 1.138 . . . . 0.0 112.487 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -142.29 153.23 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 125.116 1.367 . . . . 0.0 108.685 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -76.76 154.99 33.52 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -118.7 150.56 39.53 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.08 110.89 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.215 1.006 . . . . 0.0 108.753 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -88.76 143.5 26.87 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.602 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.8 t -85.42 101.33 12.52 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.19 -25.62 68.16 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.001 0.52 . . . . 0.0 110.384 170.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.18 164.71 9.9 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.653 170.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.9 t -75.07 80.09 2.24 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.623 1.169 . . . . 0.0 111.092 -159.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.8 p -176.01 -26.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.613 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.1 t30 70.2 9.29 6.98 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 124.788 1.235 . . . . 0.0 112.947 169.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -70.28 122.54 19.74 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.332 0.653 . . . . 0.0 111.588 -174.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -79.2 142.08 36.6 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.679 0.791 . . . . 0.0 109.31 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -132.26 120.61 22.39 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 122.847 0.459 . . . . 0.0 110.751 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.448 ' ND1' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -62.33 148.79 44.05 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 165.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -54.04 -41.03 67.62 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.015 0.926 . . . . 0.0 111.597 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 10' ' ' LEU . 27.5 m -80.69 -19.3 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.679 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.448 ' HB2' ' ND1' ' A' ' 31' ' ' HIS . 6.4 t -61.9 -36.26 80.78 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 123.311 0.644 . . . . 0.0 111.667 175.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -119.55 -13.93 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.247 1.019 . . . . 0.0 112.09 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.85 9.43 70.52 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-O 119.31 -0.717 . . . . 0.0 114.137 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.422 HG11 ' HB3' ' A' ' 47' ' ' TYR . 90.9 t -66.36 106.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 117.658 0.729 . . . . 0.0 110.096 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 m -64.98 145.41 99.09 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.517 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -47.69 -29.49 11.02 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.875 3.05 . . . . 0.0 114.476 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 35.5 tt0 -63.22 -53.82 47.11 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.061 0.544 . . . . 0.0 110.456 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 70.7 mtm -67.77 -36.76 81.06 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.057 0.543 . . . . 0.0 110.539 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.01 75.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.467 0.707 . . . . 0.0 111.081 176.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -73.13 -40.18 65.13 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.285 0.634 . . . . 0.0 110.237 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 1.2 mmmp? -77.4 -3.66 41.33 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.061 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 71.71 21.14 4.41 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.993 1.317 . . . . 0.0 111.463 174.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -89.78 77.9 6.97 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.568 172.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.422 ' HB3' HG11 ' A' ' 37' ' ' VAL . 35.8 p90 -149.58 1.11 0.51 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.597 175.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.03 135.28 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.1 m -56.89 145.84 28.53 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.588 0.755 . . . . 0.0 111.134 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.6 m -59.95 -32.34 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.667 0.787 . . . . 0.0 112.376 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -69.82 -44.72 69.4 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.143 0.577 . . . . 0.0 110.469 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 75.3 m -62.61 -34.02 76.17 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.851 176.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.7 m -73.69 -49.28 26.6 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.962 0.505 . . . . 0.0 110.852 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 p -67.34 -24.4 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 122.718 0.407 . . . . 0.0 112.058 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -55.06 -43.09 73.53 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.6 t70 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 121.07 0.462 . . . . 0.0 110.894 -177.505 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.663 ' HG ' ' HD1' ' A' ' 30' ' ' PHE . 12.0 t . . . . . 0 CA--C 1.558 1.279 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.38 112.16 2.95 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.541 2.161 . . . . 0.0 111.679 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.47 21.31 2.55 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.964 0.505 . . . . 0.0 111.962 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 85.6 t 62.62 -71.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.862 1.265 . . . . 0.0 110.533 -170.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -89.09 96.93 10.92 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 170.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.584 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 38.4 t -111.15 95.77 5.73 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.99 127.27 32.25 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.433 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -99.01 99.95 8.97 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.563 1.145 . . . . 0.0 108.543 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.513 ' HG3' HG21 ' A' ' 17' ' ' VAL . 88.3 Cg_endo -76.93 169.16 22.18 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.138 2.559 . . . . 0.0 111.284 170.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -91.34 16.09 10.79 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.299 0.639 . . . . 0.0 111.113 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.07 45.17 27.05 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -174.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.24 -72.19 0.19 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.179 0.992 . . . . 0.0 110.036 -174.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -162.37 25.83 0.11 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.218 0.607 . . . . 0.0 110.678 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.513 HG21 ' HG3' ' A' ' 12' ' ' PRO . 34.9 m -80.46 134.06 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 122.703 0.401 . . . . 0.0 110.258 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -98.24 141.36 31.24 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.774 0.83 . . . . 0.0 108.82 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -106.17 130.91 53.96 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.437 0.695 . . . . 0.0 110.082 -176.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.51 HG11 HG21 ' A' ' 37' ' ' VAL . 7.2 p -114.11 129.69 69.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 C-N-CA 124.735 1.214 . . . . 0.0 108.654 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 40.5 tt0 -103.09 128.96 49.8 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 41.9 t -65.13 -27.21 68.57 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 t70 62.41 -84.71 0.02 OUTLIER 'General case' 0 C--N 1.355 0.842 0 C-N-CA 125.294 1.438 . . . . 0.0 110.891 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -18.87 -83.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 C-N-CA 126.238 1.875 . . . . 0.0 116.754 -163.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 p -134.23 59.29 1.74 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.261 1.029 . . . . 0.0 108.52 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.534 ' HB3' ' HG2' ' A' ' 28' ' ' GLN . 94.1 m -146.28 -50.7 0.22 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 171.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 64.81 23.69 12.72 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.571 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.534 ' HG2' ' HB3' ' A' ' 26' ' ' CYS . 3.0 pt20 -130.35 142.9 50.51 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 124.376 1.07 . . . . 0.0 109.871 -175.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 12.5 p-90 -100.74 154.35 18.69 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.487 1.115 . . . . 0.0 110.466 -175.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.663 ' HD1' ' HG ' ' A' ' 4' ' ' CYS . 44.0 m-85 -139.34 144.45 38.25 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.324 1.05 . . . . 0.0 108.931 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.605 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -68.47 150.6 47.91 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.071 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -55.08 -39.43 69.26 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.724 0.41 . . . . 0.0 111.31 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 31' ' ' HIS . 31.5 m -67.46 -29.66 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.479 0.712 . . . . 0.0 112.485 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.605 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.4 t -68.63 -46.93 67.91 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.723 0.809 . . . . 0.0 112.393 -174.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.551 HG23 HG23 ' A' ' 37' ' ' VAL . 6.9 m -118.65 16.85 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.793 0.837 . . . . 0.0 111.458 -172.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.82 24.42 69.89 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 114.182 0.433 . . . . 0.0 114.182 174.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 41' ' ' MET . 9.3 t -72.62 121.58 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.178 0.591 . . . . 0.0 110.102 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.3 p -75.31 157.72 84.52 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.094 0.958 . . . . 0.0 109.965 175.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -50.46 -27.17 18.02 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.973 2.449 . . . . 0.0 113.862 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.06 -50.66 65.31 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.944 0.898 . . . . 0.0 110.517 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.575 ' HB2' HG13 ' A' ' 37' ' ' VAL . 25.4 mmt -68.12 -33.38 74.39 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.788 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.19 -16.28 53.28 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.858 0.863 . . . . 0.0 112.239 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -80.87 -48.84 11.82 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.701 0.763 . . . . 0.0 109.473 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -70.27 -43.09 71.18 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.95 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 63.16 22.26 13.29 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.742 1.217 . . . . 0.0 113.444 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -89.31 20.35 3.86 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.076 0.55 . . . . 0.0 110.262 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -75.49 75.04 2.55 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 122.538 1.161 . . . . 0.0 110.736 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.09 105.63 19.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.1 p -58.39 155.83 11.25 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.107 0.563 . . . . 0.0 111.438 -173.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.45 -39.56 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.326 1.05 . . . . 0.0 113.09 -168.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -64.75 -37.34 87.26 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.206 0.603 . . . . 0.0 111.783 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.5 m -69.23 -30.57 68.74 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.229 0.611 . . . . 0.0 111.495 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 m -72.28 -33.92 67.8 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.206 0.602 . . . . 0.0 110.374 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.43 -41.88 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.975 0.91 . . . . 0.0 110.015 173.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.59 -36.84 77.04 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.586 0.754 . . . . 0.0 110.257 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 CA--C 1.558 1.264 0 O-C-N 124.461 1.1 . . . . 0.0 109.871 179.904 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 50.2 t . . . . . 0 CA--C 1.551 0.981 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.681 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 17.2 Cg_exo -66.83 -20.52 51.82 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.277 2.651 . . . . 0.0 113.976 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.96 114.47 15.78 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -173.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -60.03 -39.77 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.732 0.813 . . . . 0.0 111.435 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 t -85.23 104.48 15.13 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 166.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.4 t -145.0 106.61 4.24 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.584 0.354 . . . . 0.0 110.054 -176.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.5 mt -69.83 153.11 43.76 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.319 168.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -110.78 88.78 8.36 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.79 169.31 22.5 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.524 2.15 . . . . 0.0 111.615 173.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -80.11 111.09 16.13 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.61 87.76 0.01 OUTLIER Glycine 0 C--N 1.349 1.289 0 O-C-N 123.842 0.714 . . . . 0.0 114.053 -175.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -174.1 -61.64 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.559 1.143 . . . . 0.0 109.471 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -99.9 23.93 9.13 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.264 1.031 . . . . 0.0 110.544 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.0 t -80.89 127.71 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.078 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -99.96 141.2 33.11 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 11.0 m0 -116.64 174.24 6.18 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.068 0.947 . . . . 0.0 110.432 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.39 133.62 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.819 1.248 . . . . 0.0 108.765 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -77.89 141.21 39.21 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.356 0.662 . . . . 0.0 109.582 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.2 t -106.37 66.82 0.71 Allowed 'General case' 0 C--O 1.248 1.022 0 CA-C-O 121.223 0.535 . . . . 0.0 109.642 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -81.18 25.81 0.47 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.063 0.545 . . . . 0.0 112.052 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -82.44 35.08 2.64 Favored Glycine 0 C--N 1.355 1.62 0 CA-C-O 119.326 -0.708 . . . . 0.0 113.836 172.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.1 t 82.64 54.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.649 1.58 . . . . 0.0 109.913 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.4 p -164.77 -40.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.545 170.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 65.0 t30 72.71 14.17 5.08 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.074 0.95 . . . . 0.0 111.919 167.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -67.53 127.72 33.78 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.536 0.734 . . . . 0.0 109.753 171.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -89.02 123.12 33.03 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.432 0.693 . . . . 0.0 110.255 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -116.18 148.8 40.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.277 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.62 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -69.51 143.67 53.38 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 166.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 72.1 mt-30 -57.37 -40.61 78.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.712 0.405 . . . . 0.0 111.572 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.2 m -71.95 -23.09 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 123.19 0.596 . . . . 0.0 112.494 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.62 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.4 t -60.53 -46.32 90.6 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.61 0.764 . . . . 0.0 111.051 176.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.552 HG23 HG23 ' A' ' 37' ' ' VAL . 15.7 m -118.9 11.03 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.134 -166.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.63 17.43 76.5 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 114.477 0.551 . . . . 0.0 114.477 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.552 HG23 HG23 ' A' ' 35' ' ' VAL . 56.0 t -71.32 110.77 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.122 0.487 . . . . 0.0 109.983 175.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.8 m -72.66 158.09 87.87 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.839 174.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -48.44 -34.85 26.81 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.798 2.332 . . . . 0.0 113.32 169.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -68.08 -41.98 81.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.199 0.6 . . . . 0.0 111.317 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 87.2 mtp -64.51 -41.04 96.65 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.92 0.488 . . . . 0.0 110.215 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.76 68.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.73 0.812 . . . . 0.0 111.128 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -73.17 -36.11 66.53 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.628 0.771 . . . . 0.0 111.013 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -71.79 -52.41 17.71 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.956 0.902 . . . . 0.0 109.302 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -164.07 -164.96 0.92 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.67 0.788 . . . . 0.0 109.405 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.98 173.81 10.25 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.203 0.601 . . . . 0.0 111.252 174.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -84.89 138.04 32.77 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.387 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.46 117.09 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 172.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.8 p -89.37 168.93 11.84 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.376 0.67 . . . . 0.0 110.647 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.37 -28.02 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.266 0.627 . . . . 0.0 111.856 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -64.67 -36.26 83.69 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.695 0.398 . . . . 0.0 110.514 172.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 24' ' ' GLY . 36.4 m -67.02 -42.99 83.96 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.991 0.516 . . . . 0.0 110.174 170.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.0 m -61.53 -43.83 98.15 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.089 0.556 . . . . 0.0 111.072 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.6 -26.36 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 O-C-N 121.925 -0.485 . . . . 0.0 111.259 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -73.32 -75.24 0.15 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.231 0.612 . . . . 0.0 112.372 177.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -165.808 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.56 1.347 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.11 99.84 0.29 Allowed 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.481 2.787 . . . . 0.0 112.455 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.05 -174.95 4.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.671 0.788 . . . . 0.0 110.763 -174.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.4 m -79.16 82.61 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 121.938 0.875 . . . . 0.0 109.903 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.9 m 70.06 107.83 0.06 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.529 1.532 . . . . 0.0 111.257 -177.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.8 t -76.93 79.69 3.49 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.55 145.84 54.5 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.324 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -109.02 86.75 4.11 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.499 ' HG3' HG21 ' A' ' 33' ' ' VAL . 44.6 Cg_endo -79.76 162.41 24.12 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.044 2.496 . . . . 0.0 112.578 -174.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -118.39 84.89 2.26 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 168.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.83 166.71 26.51 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.384 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.33 -25.03 11.65 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.836 0.854 . . . . 0.0 110.266 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.79 5.94 41.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.486 1.114 . . . . 0.0 111.681 -175.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.6 m -76.64 72.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 123.227 1.489 . . . . 0.0 111.236 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.89 166.19 22.67 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 113.362 -1.745 . . . . 0.0 109.314 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -105.83 127.37 53.07 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.261 0.624 . . . . 0.0 111.109 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.46 130.37 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 124.575 1.15 . . . . 0.0 110.061 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -77.59 153.39 33.3 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.973 0.909 . . . . 0.0 109.955 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.8 t -114.48 51.15 0.9 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.9 0.88 . . . . 0.0 109.691 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -48.27 -55.98 9.18 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.467 1.107 . . . . 0.0 112.744 -170.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -19.65 -56.92 0.01 OUTLIER Glycine 0 C--N 1.373 2.636 0 C-N-CA 126.268 1.889 . . . . 0.0 116.8 -172.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.532 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 26.2 t -165.22 65.51 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 169.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.2 m -156.77 -52.48 0.08 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.562 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 72.92 -6.06 1.77 Allowed 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 125.181 1.392 . . . . 0.0 111.323 -172.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -67.64 150.77 48.32 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.761 1.224 . . . . 0.0 111.131 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -100.26 131.18 46.35 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.758 0.823 . . . . 0.0 110.14 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -128.22 147.11 50.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.856 1.263 . . . . 0.0 108.489 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.592 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -70.4 148.54 48.27 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 165.547 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -57.01 -40.44 76.66 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.553 0.341 . . . . 0.0 110.504 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.499 HG21 ' HG3' ' A' ' 12' ' ' PRO . 21.0 m -69.45 -27.28 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.628 0.771 . . . . 0.0 112.359 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.592 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.8 t -60.38 -35.76 76.49 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 123.888 0.875 . . . . 0.0 110.167 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 m -115.96 6.46 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.165 -171.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.78 49.48 73.91 Favored Glycine 0 C--N 1.357 1.71 0 O-C-N 123.574 0.546 . . . . 0.0 113.539 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.7 t -119.17 137.94 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.152 1.381 . . . . 0.0 109.027 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 38.6 m -74.59 146.88 84.12 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 123.328 0.651 . . . . 0.0 109.989 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.78 -34.36 98.12 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.554 2.169 . . . . 0.0 113.101 174.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -70.4 -32.06 69.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.619 0.368 . . . . 0.0 111.204 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.4 ttt -67.86 -43.55 79.17 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.095 0.558 . . . . 0.0 110.066 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.95 -22.89 67.07 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.517 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -76.71 -43.87 35.74 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.13 0.972 . . . . 0.0 111.007 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -83.03 -22.05 33.66 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -171.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -150.78 165.97 31.89 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.139 0.495 . . . . 0.0 111.101 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -87.18 143.42 27.3 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.32 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -72.66 88.51 1.28 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.252 0.549 . . . . 0.0 109.552 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 66.7 mt -92.61 103.17 14.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 51' ' ' ARG . 19.0 p -81.73 175.03 10.8 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.844 -178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.07 -37.63 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.479 173.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.622 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 49.5 mtt-85 -61.24 -32.48 72.28 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.973 0.509 . . . . 0.0 111.165 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 24.0 m -67.62 -53.94 23.84 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.856 0.462 . . . . 0.0 110.214 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 t -68.93 -33.45 73.75 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.24 -172.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.8 t -73.92 -39.33 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 123.206 0.603 . . . . 0.0 110.667 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -63.5 -27.51 69.32 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 171.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 CA--C 1.56 1.351 0 C-N-CA 124.12 0.968 . . . . 0.0 110.83 171.952 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.563 1.473 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -43.76 86.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.398 3.144 0 C-N-CA 125.272 3.982 . . . . 0.0 115.87 -172.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.22 -170.32 2.17 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.072 1.349 . . . . 0.0 109.649 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.5 t -64.97 -57.1 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.125 0.57 . . . . 0.0 109.98 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.2 t -137.86 -22.64 1.07 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.278 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.0 t 69.72 100.93 0.06 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.597 1.159 . . . . 0.0 111.341 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.0 155.36 27.75 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.332 0.653 . . . . 0.0 110.499 171.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -117.94 81.24 15.53 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.411 1.084 . . . . 0.0 109.728 -175.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.13 165.47 11.24 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.587 2.192 . . . . 0.0 112.218 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.13 97.36 3.45 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.606 0.717 . . . . 0.0 109.454 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.94 93.43 0.22 Allowed Glycine 0 C--N 1.345 1.063 0 CA-C-N 114.658 -1.155 . . . . 0.0 114.375 -170.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -158.58 -61.3 0.08 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.525 0.73 . . . . 0.0 109.78 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -100.56 13.76 33.59 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.323 0.649 . . . . 0.0 111.025 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.06 130.84 35.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 123.04 0.536 . . . . 0.0 110.042 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.95 137.78 54.06 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.454 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -121.66 165.31 15.94 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.547 0.739 . . . . 0.0 109.858 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.77 133.24 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.623 -173.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -87.85 113.62 23.68 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 173.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 45.9 t -82.17 82.55 7.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.61 0.764 . . . . 0.0 110.535 -177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.41 1.46 0.78 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.369 1.067 . . . . 0.0 113.26 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.15 -162.7 0.57 Allowed Glycine 0 CA--C 1.539 1.55 0 O-C-N 121.549 -0.72 . . . . 0.0 113.087 162.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.518 ' N ' ' SG ' ' A' ' 52' ' ' CYS . 29.5 p -82.15 69.91 8.97 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.695 0.759 . . . . 0.0 111.134 -171.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.2 p -174.56 -41.16 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.921 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 74.6 -3.19 2.63 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 124.187 0.995 . . . . 0.0 112.607 168.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -77.34 157.89 30.43 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.752 0.821 . . . . 0.0 112.025 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -84.98 133.95 34.25 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.866 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 78.8 m-85 -126.91 158.75 35.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.866 1.266 . . . . 0.0 108.005 176.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.608 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -68.97 152.61 45.05 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 162.564 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -62.62 -35.67 80.31 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.435 0.694 . . . . 0.0 110.018 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.4 m -70.57 -28.9 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.767 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.608 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 5.0 t -60.7 -41.54 95.39 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 123.698 0.799 . . . . 0.0 111.415 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 37' ' ' VAL . 5.4 m -96.64 -19.7 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.086 0.955 . . . . 0.0 111.598 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.91 15.75 79.58 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.238 0.336 . . . . 0.0 113.32 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 35' ' ' VAL . 78.2 t -79.46 140.43 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.781 0.832 . . . . 0.0 109.826 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 m -67.7 148.49 98.53 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.687 0.795 . . . . 0.0 111.134 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.99 -48.37 16.52 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.895 3.063 . . . . 0.0 115.071 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -61.14 -49.78 75.85 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 120.956 0.408 . . . . 0.0 110.419 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.644 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 93.0 mmm -58.69 -35.77 73.15 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.304 -177.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . . . -71.49 -36.61 71.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.939 0.896 . . . . 0.0 111.824 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -89.33 -29.62 19.01 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 122.846 0.459 . . . . 0.0 111.989 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -127.73 -45.2 1.47 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.7 0.8 . . . . 0.0 112.637 -159.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.644 ' HB2' ' HA ' ' A' ' 41' ' ' MET . 22.4 mm-40 -112.81 -144.38 0.39 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.256 0.623 . . . . 0.0 110.798 -167.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.86 139.84 53.13 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.424 0.69 . . . . 0.0 111.231 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.402 ' HB3' ' HA ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -146.66 27.97 1.08 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.891 1.277 . . . . 0.0 109.817 178.359 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.46 120.0 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.651 1.18 . . . . 0.0 109.545 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.6 p -78.22 167.2 21.76 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.356 0.662 . . . . 0.0 110.883 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.99 -39.46 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 124.132 0.973 . . . . 0.0 112.549 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -41.83 85.88 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.494 1.117 . . . . 0.0 110.269 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 25' ' ' SER . 18.3 m -64.47 -49.5 71.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.812 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.8 t -66.8 -28.46 68.4 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -173.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 82.0 t -72.36 -33.41 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.108 0.563 . . . . 0.0 110.732 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -71.27 -43.67 66.74 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.084 0.554 . . . . 0.0 110.912 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.484 1.273 0 C-N-CA 123.957 0.903 . . . . 0.0 111.641 -177.568 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -73.34 69.45 4.11 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.493 2.129 . . . . 0.0 111.68 172.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.458 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -141.75 79.94 1.7 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.338 0.655 . . . . 0.0 109.85 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.7 t 63.76 -69.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 125.528 1.531 . . . . 0.0 110.97 -172.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.1 t -140.26 -83.66 0.24 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 170.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.6 t 147.9 117.16 0.0 OUTLIER 'General case' 0 C--N 1.361 1.102 0 C-N-CA 127.41 2.284 . . . . 0.0 107.344 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.5 mt -56.67 -36.09 69.17 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.806 0.843 . . . . 0.0 111.472 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 57.14 75.14 0.59 Allowed Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.747 1.219 . . . . 0.0 111.365 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -87.2 175.89 4.59 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.496 2.131 . . . . 0.0 111.717 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.5 -24.55 59.02 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.01 171.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.551 ' HA2' HG22 ' A' ' 17' ' ' VAL . . . 78.59 58.9 2.96 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.378 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -82.5 -49.13 10.25 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.163 0.585 . . . . 0.0 110.842 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -131.47 11.68 4.91 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.128 0.971 . . . . 0.0 111.844 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.551 HG22 ' HA2' ' A' ' 14' ' ' GLY . 18.7 m -78.94 124.57 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 118.47 0.577 . . . . 0.0 109.773 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -89.86 136.0 33.3 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 14.0 m0 -99.84 126.34 45.93 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.203 0.601 . . . . 0.0 110.798 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.71 115.55 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 C-N-CA 124.764 1.226 . . . . 0.0 110.297 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -83.78 127.41 33.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.569 0.748 . . . . 0.0 109.933 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.3 t -82.65 108.89 16.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 169.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.11 -80.08 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 24.18 -91.1 0.01 OUTLIER Glycine 0 C--N 1.37 2.442 0 O-C-N 125.104 1.502 . . . . 0.0 115.6 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.409 ' N ' ' SG ' ' A' ' 52' ' ' CYS . 10.5 m -149.98 46.09 0.92 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.748 1.219 . . . . 0.0 109.435 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.5 m -133.77 -61.48 0.8 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.622 0.769 . . . . 0.0 109.431 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 74.14 -2.48 2.78 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.221 1.409 . . . . 0.0 110.941 -172.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -81.73 141.24 33.74 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.73 0.812 . . . . 0.0 110.28 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -87.76 120.3 28.95 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.049 0.94 . . . . 0.0 109.371 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -115.79 124.06 49.8 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 123.172 0.589 . . . . 0.0 109.712 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.619 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -57.68 143.33 41.96 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 167.432 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -62.33 -32.08 72.79 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 118.298 0.499 . . . . 0.0 110.925 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 31' ' ' HIS . 32.8 m -65.73 -29.63 47.58 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 123.221 0.608 . . . . 0.0 111.726 172.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.619 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 3.9 t -68.53 -40.01 80.92 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.521 0.728 . . . . 0.0 111.707 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.52 -2.66 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.525 0.73 . . . . 0.0 112.668 -171.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.29 3.81 54.35 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.814 -0.437 . . . . 0.0 114.058 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.431 HG13 ' HB2' ' A' ' 41' ' ' MET . 53.2 t -70.79 111.93 5.12 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 123.557 0.743 . . . . 0.0 109.453 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.7 m -69.17 156.11 92.22 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 123.611 0.764 . . . . 0.0 110.485 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.88 -32.39 29.84 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 123.402 2.735 . . . . 0.0 113.342 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 37.6 tt0 -57.49 -52.9 63.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.649 1.18 . . . . 0.0 111.807 174.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.431 ' HB2' HG13 ' A' ' 37' ' ' VAL . 25.7 mmt -72.75 -30.95 64.57 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.449 0.643 . . . . 0.0 110.515 -177.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.9 -36.38 67.28 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.666 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -78.91 -36.62 41.63 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.999 0.519 . . . . 0.0 110.395 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 36.7 mmtm -75.17 -20.46 59.33 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.345 0.403 . . . . 0.0 110.587 176.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.524 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 42.8 mt-10 73.09 21.76 3.08 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.093 1.357 . . . . 0.0 112.505 170.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -86.22 21.23 2.09 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.182 0.993 . . . . 0.0 111.74 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.524 ' CE2' ' HA ' ' A' ' 45' ' ' GLU . 11.6 p90 -82.4 25.87 0.59 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.089 0.955 . . . . 0.0 112.184 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.435 HG23 ' HB3' ' A' ' 52' ' ' CYS . 4.5 mp -72.86 119.08 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 173.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.8 m -62.4 159.38 15.51 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.656 0.782 . . . . 0.0 110.418 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 54' ' ' VAL . 99.2 t -60.7 -42.73 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 175.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -62.51 -37.37 85.76 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.555 0.742 . . . . 0.0 111.666 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.435 ' HB3' HG23 ' A' ' 48' ' ' ILE . 5.7 m -64.38 -36.05 82.88 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.753 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.2 m -74.6 -25.62 59.38 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.277 0.631 . . . . 0.0 110.804 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 50' ' ' VAL . 80.0 t -67.26 -36.76 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 122.87 0.468 . . . . 0.0 110.3 173.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -74.64 -49.39 21.65 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.187 0.595 . . . . 0.0 110.599 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 . . . . . 0 N--CA 1.482 1.133 0 O-C-N 123.992 0.808 . . . . 0.0 111.313 -179.871 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.493 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 4.0 t . . . . . 0 CA--C 1.556 1.2 0 CA-C-O 119.761 -0.161 . . . . 0.0 111.386 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.49 -28.1 53.93 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.608 2.205 . . . . 0.0 113.212 -173.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 50.27 -96.92 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.277 1.431 . . . . 0.0 112.668 -177.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 90.0 t -130.63 -57.65 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.0 t -135.19 107.15 7.07 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 164.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 4' ' ' CYS . 42.3 t -78.78 87.56 4.66 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.094 0.558 . . . . 0.0 111.142 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.07 109.84 5.39 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -106.67 99.17 23.66 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.665 0.786 . . . . 0.0 109.425 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HG2' HG21 ' A' ' 17' ' ' VAL . 88.3 Cg_endo -76.6 -170.61 0.92 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.144 2.563 . . . . 0.0 112.05 174.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -75.1 107.56 7.26 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.27 69.93 3.05 Favored Glycine 0 N--CA 1.467 0.729 0 CA-C-N 115.091 -0.959 . . . . 0.0 113.486 -171.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -92.53 -53.51 4.17 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.732 0.813 . . . . 0.0 109.276 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.71 32.82 0.55 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.595 1.158 . . . . 0.0 110.636 -173.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.541 HG21 ' HG2' ' A' ' 12' ' ' PRO . 43.5 t -68.81 125.97 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.074 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -76.88 135.41 38.84 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 123.675 0.609 . . . . 0.0 109.929 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 35.3 m0 -113.69 171.51 7.53 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.079 0.952 . . . . 0.0 111.121 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.78 118.75 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.057 1.343 . . . . 0.0 108.186 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 62.1 tt0 -76.68 145.86 38.47 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.967 0.507 . . . . 0.0 110.401 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.6 t -75.84 128.45 35.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.021 0.439 . . . . 0.0 111.68 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.645 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . 11.4 t70 -87.07 79.18 8.76 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.14 -179.41 44.75 Favored Glycine 0 C--O 1.239 0.418 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.844 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t -79.73 73.72 6.44 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.539 0.736 . . . . 0.0 109.754 -176.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.7 ' SG ' ' HG2' ' A' ' 28' ' ' GLN . 4.0 p -173.12 -37.58 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.312 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 61.83 17.2 8.62 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.027 1.331 . . . . 0.0 113.215 173.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.7 ' HG2' ' SG ' ' A' ' 26' ' ' CYS . 24.6 pt20 -73.11 134.2 44.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.288 0.635 . . . . 0.0 111.049 -177.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 48.2 m95 -81.43 155.32 25.93 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.022 0.929 . . . . 0.0 110.885 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -138.67 134.18 33.31 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.803 0.841 . . . . 0.0 109.427 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.633 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -62.51 145.86 53.17 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 164.551 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -49.87 -49.47 49.28 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 120.952 0.406 . . . . 0.0 111.199 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -67.06 -25.63 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.414 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.633 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 7.8 t -59.99 -35.18 74.47 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.305 0.642 . . . . 0.0 111.72 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.25 -3.77 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.347 1.059 . . . . 0.0 111.58 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.0 39.58 97.4 Favored Glycine 0 C--N 1.353 1.518 0 C-N-CA 123.602 0.62 . . . . 0.0 114.221 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.46 131.63 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.392 0.677 . . . . 0.0 109.407 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.3 m -68.32 149.32 98.11 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.388 1.075 . . . . 0.0 110.961 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.39 -52.69 6.96 Favored 'Trans proline' 0 C--N 1.393 2.873 0 C-N-CA 123.916 3.077 . . . . 0.0 114.157 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -68.29 -36.77 79.88 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.291 0.636 . . . . 0.0 111.682 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 61.2 mtt -72.67 -31.38 65.02 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.694 0.398 . . . . 0.0 110.884 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.09 -33.66 50.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.489 0.716 . . . . 0.0 110.814 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -76.31 -42.2 45.99 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.301 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -71.9 -58.43 3.46 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.454 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -101.48 106.25 17.34 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.645 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . 4.5 m-20 -56.25 110.2 0.72 Allowed 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.064 173.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -62.29 111.05 1.83 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.081 0.467 . . . . 0.0 110.779 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 41.0 mt -88.85 117.24 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 172.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.3 p -73.23 154.57 40.17 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.3 t -52.52 -44.74 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 124.457 1.103 . . . . 0.0 112.589 -171.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -60.74 -31.74 71.04 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.151 0.58 . . . . 0.0 112.45 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.6 m -76.31 -42.68 44.38 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.333 0.253 . . . . 0.0 111.12 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 m -61.21 -40.8 95.35 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.592 0.757 . . . . 0.0 110.707 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.9 -49.83 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.322 1.049 . . . . 0.0 110.819 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -74.53 -11.88 60.33 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.925 0.49 . . . . 0.0 111.834 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 N--CA 1.479 0.993 0 C-N-CA 123.617 0.767 . . . . 0.0 110.291 171.481 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.554 1.129 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.58 62.63 8.56 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 123.285 2.656 . . . . 0.0 112.304 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.75 177.78 4.72 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.212 176.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.77 -42.57 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 t -133.4 162.9 30.6 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.897 0.879 . . . . 0.0 109.188 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.4 t -153.6 94.46 1.79 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.229 0.538 . . . . 0.0 110.018 170.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.501 HD12 ' HB ' ' A' ' 33' ' ' VAL . 28.0 mt -61.72 -35.18 77.32 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.456 1.102 . . . . 0.0 111.049 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 52.49 65.77 5.72 Favored Pre-proline 0 CA--C 1.552 1.057 0 O-C-N 124.67 1.231 . . . . 0.0 110.071 -171.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.437 ' HG2' HG21 ' A' ' 17' ' ' VAL . 61.4 Cg_endo -83.75 169.77 11.78 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.296 1.997 . . . . 0.0 112.39 -175.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -67.02 120.15 13.16 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.771 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.59 53.05 4.48 Favored Glycine 0 C--N 1.338 0.672 0 O-C-N 123.487 0.492 . . . . 0.0 113.687 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -65.66 -55.15 19.0 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -148.85 59.37 1.06 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.657 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.437 HG21 ' HG2' ' A' ' 12' ' ' PRO . 40.5 t -103.75 118.2 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.11 128.65 33.55 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.102 0.876 . . . . 0.0 109.807 -173.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 26.1 m0 -109.02 165.42 11.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.791 0.836 . . . . 0.0 109.904 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 47' ' ' TYR . 4.3 p -152.77 124.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.671 0.788 . . . . 0.0 109.908 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -72.42 130.14 40.0 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.722 0.409 . . . . 0.0 110.0 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.415 ' O ' HG12 ' A' ' 48' ' ' ILE . 37.2 t -65.75 -49.32 68.8 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.16 0.912 . . . . 0.0 111.552 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 72.64 -43.14 0.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.227 1.411 . . . . 0.0 112.723 -173.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.85 -160.49 0.09 OUTLIER Glycine 0 C--N 1.362 1.98 0 N-CA-C 114.569 0.587 . . . . 0.0 114.569 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.6 p -80.83 72.83 7.84 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.857 0.863 . . . . 0.0 111.706 -165.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.8 p 175.26 -31.68 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.894 2.077 . . . . 0.0 106.997 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 75.33 -43.88 0.51 Allowed 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 126.447 1.899 . . . . 0.0 113.952 172.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -47.9 148.85 1.49 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.389 1.876 . . . . 0.0 114.105 -167.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -74.87 144.74 43.23 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.174 173.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -132.29 128.15 37.15 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.622 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.594 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -67.02 151.64 47.27 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 172.701 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.591 ' HA ' ' HB ' ' A' ' 37' ' ' VAL . 62.6 mt-30 -56.37 -41.01 75.49 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.053 0.454 . . . . 0.0 110.204 174.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 10' ' ' LEU . 18.8 m -71.3 -17.4 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-N 114.849 -1.068 . . . . 0.0 112.669 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.594 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 2.5 t -80.06 -46.48 16.45 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.244 0.618 . . . . 0.0 111.335 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.677 HG23 HG23 ' A' ' 37' ' ' VAL . 2.5 m -119.41 9.78 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 123.654 0.782 . . . . 0.0 112.901 -169.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.01 36.96 92.7 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 122.672 0.177 . . . . 0.0 113.315 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.677 HG23 HG23 ' A' ' 35' ' ' VAL . 10.2 t -78.71 134.55 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.282 0.633 . . . . 0.0 110.995 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.0 p -77.02 153.28 82.68 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.66 0.784 . . . . 0.0 109.778 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.76 -31.53 72.33 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.44 2.094 . . . . 0.0 112.039 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -57.57 -52.35 65.75 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.548 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.585 ' HB2' HG13 ' A' ' 37' ' ' VAL . 26.1 mmt -66.44 -36.89 83.92 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 123.543 0.527 . . . . 0.0 111.516 -176.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.21 -30.37 68.53 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.109 0.564 . . . . 0.0 111.781 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -89.44 -29.29 19.13 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.151 0.58 . . . . 0.0 111.265 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -83.18 -20.71 34.15 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.558 0.743 . . . . 0.0 111.085 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 69.41 -161.92 0.18 Allowed 'General case' 0 C--N 1.361 1.095 0 O-C-N 124.419 1.075 . . . . 0.0 108.658 -170.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 69.27 3.57 4.18 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.633 1.173 . . . . 0.0 113.036 171.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.476 ' HB3' HG21 ' A' ' 20' ' ' VAL . 93.3 t80 -74.39 98.53 3.3 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 22' ' ' CYS . 44.7 mt -100.0 135.45 35.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 165.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -56.06 129.93 41.92 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 172.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -54.25 -35.12 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.36 0.664 . . . . 0.0 112.66 -167.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -68.65 -35.98 77.97 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.492 0.717 . . . . 0.0 110.988 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 84.2 m -64.68 -31.15 72.25 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.113 0.565 . . . . 0.0 111.384 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.9 m -70.3 -44.09 69.03 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.977 0.417 . . . . 0.0 109.976 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.0 t -69.5 -31.38 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.029 0.932 . . . . 0.0 110.763 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -115.39 28.57 8.59 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.526 0.679 . . . . 0.0 110.102 -175.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t70 . . . . . 0 N--CA 1.484 1.243 0 C-N-CA 123.908 0.883 . . . . 0.0 110.368 177.475 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.41 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 12.6 t . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 119.578 -0.248 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.68 -42.76 0.76 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.67 2.247 . . . . 0.0 113.303 -174.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 44.87 25.13 0.13 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 125.798 1.639 . . . . 0.0 115.061 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.1 t 60.46 -73.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.908 1.283 . . . . 0.0 109.992 -166.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.3 m -104.81 88.11 2.83 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.157 0.983 . . . . 0.0 108.935 170.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.431 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 42.4 t -79.43 84.62 5.31 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.213 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 33' ' ' VAL . 59.9 mt -64.98 101.6 0.52 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 167.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -112.01 96.52 34.51 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.172 0.989 . . . . 0.0 110.782 -166.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.479 ' HG2' HG21 ' A' ' 17' ' ' VAL . 66.3 Cg_exo -53.66 150.23 29.24 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.056 2.504 . . . . 0.0 112.138 164.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.72 90.0 0.76 Allowed 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 122.027 0.918 . . . . 0.0 110.765 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.2 -149.46 32.48 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 114.497 -1.229 . . . . 0.0 113.475 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -101.07 82.64 2.39 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.026 0.93 . . . . 0.0 108.903 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -127.84 10.84 6.57 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.568 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.479 HG21 ' HG2' ' A' ' 12' ' ' PRO . 15.8 m -135.83 168.61 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.407 0.683 . . . . 0.0 111.733 -173.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -74.68 139.44 43.51 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.176 173.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -116.27 175.43 5.56 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.864 0.866 . . . . 0.0 109.96 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.435 HG11 HG11 ' A' ' 37' ' ' VAL . 12.7 p -161.08 138.21 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.183 0.993 . . . . 0.0 108.856 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -101.48 142.56 32.67 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 40.1 t -114.08 77.63 1.08 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.214 0.606 . . . . 0.0 110.671 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -78.78 80.8 5.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.81 -65.55 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.093 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.673 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 13.6 m -152.8 56.39 0.79 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.902 0.858 . . . . 0.0 109.233 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.0 m -161.61 -53.1 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 174.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.23 11.78 4.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.222 1.809 . . . . 0.0 113.467 173.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -107.04 166.61 10.49 Favored 'General case' 0 C--O 1.246 0.899 0 C-N-CA 123.419 0.688 . . . . 0.0 109.767 177.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -87.16 137.59 32.21 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.062 169.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -131.32 132.8 44.77 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.318 1.047 . . . . 0.0 108.884 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.635 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -56.99 147.03 25.08 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.836 0.854 . . . . 0.0 108.835 170.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -56.64 -45.18 81.71 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.153 0.981 . . . . 0.0 111.115 -173.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.416 ' O ' HD12 ' A' ' 10' ' ' LEU . 12.1 m -71.33 -29.57 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.722 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.635 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 13.2 t -54.17 -53.29 55.5 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.31 0.644 . . . . 0.0 112.556 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.1 m -96.12 -5.24 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.637 0.775 . . . . 0.0 111.06 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.74 37.52 94.96 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.612 -177.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.435 HG11 HG11 ' A' ' 20' ' ' VAL . 13.7 p -69.3 144.36 14.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.564 0.746 . . . . 0.0 110.684 -177.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.2 m -58.33 130.7 84.33 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.369 172.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -53.71 -26.71 39.33 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.241 2.627 . . . . 0.0 112.342 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.58 -52.17 64.47 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.788 0.835 . . . . 0.0 110.397 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.1 mmt -72.41 -30.65 64.84 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.088 0.555 . . . . 0.0 111.42 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.93 -44.83 83.97 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.798 0.839 . . . . 0.0 111.029 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -74.74 -25.8 59.35 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.549 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -75.73 -20.09 58.59 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 67.37 14.68 9.74 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.431 1.492 . . . . 0.0 112.303 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -134.96 89.23 2.5 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -171.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -119.42 106.84 12.65 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.914 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 48' ' ' ILE . 3.1 mp -106.98 110.2 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.7 m -57.92 158.05 7.02 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.958 0.503 . . . . 0.0 110.903 -176.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.8 -38.04 63.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 122.974 0.51 . . . . 0.0 110.428 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -56.78 -49.0 76.61 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.866 0.866 . . . . 0.0 111.251 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.673 ' SG ' ' HB2' ' A' ' 25' ' ' SER . 86.4 m -71.32 -27.1 63.16 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.095 0.958 . . . . 0.0 112.412 -174.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.8 m -85.19 -53.22 5.39 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.313 0.645 . . . . 0.0 110.678 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.62 -21.3 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.076 0.55 . . . . 0.0 111.421 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.63 -41.33 98.96 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-N 117.805 0.275 . . . . 0.0 110.723 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 N--CA 1.471 0.613 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.54 -179.766 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.0 t . . . . . 0 CA--C 1.551 0.999 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 72.8 Cg_endo -76.01 -38.86 1.05 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.73 2.287 . . . . 0.0 112.341 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 48.58 23.22 0.59 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 126.159 1.783 . . . . 0.0 115.79 169.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.4 t 62.5 -74.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 125.126 1.37 . . . . 0.0 110.278 -171.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.7 m -108.64 80.84 1.38 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.354 1.062 . . . . 0.0 108.464 174.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 41.8 t -84.56 87.79 7.28 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.736 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.5 mt -65.76 111.29 3.16 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 164.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -102.7 102.41 26.37 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.046 0.938 . . . . 0.0 110.456 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.23 -179.48 5.06 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 122.706 2.271 . . . . 0.0 110.848 164.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.46 23.5 10.99 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.396 0.679 . . . . 0.0 110.625 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.21 35.42 92.05 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.82 -63.97 0.98 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.377 1.471 . . . . 0.0 110.814 -169.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -142.54 19.42 2.03 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.81 1.244 . . . . 0.0 108.29 171.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 t -79.18 123.95 36.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.259 -164.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 32' ' ' GLN . 34.2 m-20 -83.19 146.72 28.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.524 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -115.5 128.4 55.97 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.336 0.655 . . . . 0.0 109.292 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.557 HG21 ' HB2' ' A' ' 47' ' ' TYR . 5.3 p -103.86 126.27 58.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 123.608 0.763 . . . . 0.0 109.91 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -85.64 127.03 34.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.99 0.916 . . . . 0.0 108.973 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.8 t -85.49 80.94 8.9 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.01 -26.98 61.18 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.889 0.876 . . . . 0.0 112.258 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.57 104.61 1.48 Allowed Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.783 -1.009 . . . . 0.0 111.266 167.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.613 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 21.7 m 52.45 47.58 24.41 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.714 1.606 . . . . 0.0 113.558 161.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.0 m -161.77 -62.44 0.05 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.156 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.1 t30 70.42 3.51 4.51 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.186 1.394 . . . . 0.0 110.841 -173.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -87.06 143.25 27.41 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.977 0.911 . . . . 0.0 110.283 -172.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -87.63 112.24 22.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.988 0.915 . . . . 0.0 110.023 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -107.96 140.57 40.91 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.852 0.861 . . . . 0.0 109.059 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.598 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -68.63 154.55 41.7 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.031 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 27.2 tt0 -52.33 -50.11 62.94 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.071 1.348 . . . . 0.0 111.047 -177.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.9 m -72.08 -28.58 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 114.33 -1.304 . . . . 0.0 112.098 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.598 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.9 t -58.14 -49.46 76.91 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.813 0.845 . . . . 0.0 111.931 -175.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 m -95.63 2.57 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.462 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.72 19.89 76.99 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.247 0.342 . . . . 0.0 113.895 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.43 121.57 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.0 m -72.33 158.13 88.02 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.368 0.667 . . . . 0.0 110.325 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.93 -39.65 68.53 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.263 2.642 . . . . 0.0 113.371 176.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -64.24 -44.35 92.11 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.172 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 56.7 mtt -63.33 -48.19 79.05 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.756 0.822 . . . . 0.0 110.073 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.32 -26.95 68.71 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.573 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -83.97 -51.03 7.47 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.247 0.619 . . . . 0.0 111.125 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -91.4 -60.22 1.94 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.47 0.308 . . . . 0.0 110.714 -168.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -166.41 152.15 8.5 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.493 0.717 . . . . 0.0 111.957 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.7 t0 68.09 103.42 0.05 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.077 1.751 . . . . 0.0 112.807 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.557 ' HB2' HG21 ' A' ' 20' ' ' VAL . 3.2 p90 -150.93 14.52 0.73 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.47 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 52.6 mt -82.16 122.84 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.752 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 p -65.26 148.3 51.93 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.312 0.383 . . . . 0.0 110.367 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.7 t -45.25 -42.07 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 125.821 1.648 . . . . 0.0 113.275 -171.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -53.96 -50.01 67.46 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.885 0.874 . . . . 0.0 111.927 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 25' ' ' SER . 61.5 m -76.7 -24.97 53.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.581 -175.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.7 m -68.54 -47.53 66.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.313 0.645 . . . . 0.0 110.473 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.27 -29.99 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.925 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -62.31 -66.09 0.59 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.262 0.625 . . . . 0.0 110.423 173.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 N--CA 1.47 0.561 0 O-C-N 123.941 0.776 . . . . 0.0 109.718 -175.677 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 119.468 -0.301 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -64.45 85.18 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 123.005 2.47 . . . . 0.0 112.783 -175.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.16 171.14 13.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.761 1.224 . . . . 0.0 109.967 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.04 -38.86 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.597 0.759 . . . . 0.0 110.949 -175.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.9 p -156.68 109.76 2.6 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.605 0.762 . . . . 0.0 109.097 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.4 t -88.41 109.17 19.79 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.983 0.421 . . . . 0.0 110.75 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.713 HD21 HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -69.57 158.55 35.05 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.478 164.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -102.42 93.64 4.22 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 171.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.64 112.95 1.93 Allowed 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.315 2.01 . . . . 0.0 110.897 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -85.87 52.12 2.39 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 122.718 1.246 . . . . 0.0 110.722 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 157.04 142.89 3.51 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 113.171 -1.832 . . . . 0.0 110.704 -173.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.84 22.59 0.75 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.207 1.003 . . . . 0.0 111.775 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -74.33 -16.32 60.92 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.454 1.102 . . . . 0.0 111.788 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -80.19 137.42 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -90.7 151.7 21.14 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -103.24 152.37 21.57 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.609 0.764 . . . . 0.0 110.607 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.54 124.29 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.014 1.326 . . . . 0.0 108.276 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 35.4 tt0 -85.29 141.83 29.8 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.63 151.69 46.87 Favored 'General case' 0 CA--C 1.552 1.023 0 O-C-N 123.624 0.577 . . . . 0.0 111.863 -167.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -71.74 -44.34 64.26 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.7 1.6 . . . . 0.0 112.715 -174.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.518 ' HA3' ' SG ' ' A' ' 52' ' ' CYS . . . -84.01 -129.06 1.66 Allowed Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.656 -167.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -120.31 75.63 1.12 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.8 m -114.17 -27.99 7.46 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.888 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.5 t30 77.3 -37.17 0.25 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.271 1.429 . . . . 0.0 112.208 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -85.16 148.59 26.03 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.614 0.721 . . . . 0.0 112.537 -166.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 12.0 p-90 -104.16 139.02 39.8 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.324 171.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 42.3 m-85 -123.11 162.98 21.42 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 124.413 1.085 . . . . 0.0 108.251 -175.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.64 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -69.24 146.79 52.04 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 160.202 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -58.35 -41.32 84.39 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.294 0.497 . . . . 0.0 110.707 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.713 HG23 HD21 ' A' ' 10' ' ' LEU . 27.8 m -67.47 -25.67 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.711 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.64 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.5 t -58.6 -39.12 79.51 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 123.835 0.854 . . . . 0.0 111.433 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.4 m -104.92 -0.97 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.998 0.919 . . . . 0.0 111.622 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.26 16.12 80.04 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 116.491 -0.322 . . . . 0.0 113.825 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.9 t -90.5 136.55 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.23 0.612 . . . . 0.0 109.802 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.0 m -90.34 152.44 45.61 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.814 0.846 . . . . 0.0 110.117 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -47.04 -56.74 2.78 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.898 3.065 . . . . 0.0 114.622 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.27 -27.88 67.56 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.913 0.485 . . . . 0.0 111.722 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.6 mtt -74.35 -31.27 62.35 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 122.614 0.365 . . . . 0.0 110.201 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.55 -35.3 60.69 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.347 0.659 . . . . 0.0 111.343 176.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.17 -48.87 12.47 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.585 0.754 . . . . 0.0 111.213 -176.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.34 -25.82 19.23 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.334 0.653 . . . . 0.0 112.046 -171.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -123.82 170.03 10.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.249 0.619 . . . . 0.0 110.204 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -85.48 123.71 31.22 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.627 178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -88.44 48.91 1.7 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.404 1.081 . . . . 0.0 110.911 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.1 mt -73.36 105.29 2.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.861 -177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 51' ' ' ARG . 2.3 p -69.16 162.22 27.49 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.012 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 54' ' ' VAL . 67.1 t -54.2 -42.27 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.45 0.7 . . . . 0.0 111.122 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.525 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 2.8 mpt_? -58.41 -40.64 83.03 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.679 0.791 . . . . 0.0 111.494 176.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.518 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 35.0 m -72.34 -35.22 68.5 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.296 0.238 . . . . 0.0 111.578 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.1 m -70.33 -47.57 60.48 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.645 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 50' ' ' VAL . 13.6 p -84.87 -44.5 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -174.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -84.1 -35.82 23.43 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 120.736 0.303 . . . . 0.0 110.206 -167.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 59.7 m-20 . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 121.538 0.685 . . . . 0.0 110.404 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.609 ' SG ' ' HA ' ' A' ' 11' ' ' GLN . 9.3 m . . . . . 0 CA--C 1.55 0.97 0 CA-C-O 120.203 0.049 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -93.16 -23.26 0.3 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.412 2.742 . . . . 0.0 114.847 -175.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 9' ' ' CYS . . . -63.53 147.99 49.93 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.158 0.583 . . . . 0.0 110.347 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -55.59 -34.04 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.933 0.893 . . . . 0.0 112.559 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.5 m -127.01 100.16 6.01 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 169.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.548 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 8.7 t -142.6 25.64 1.82 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.987 -166.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.462 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 21.1 mt 59.05 -65.16 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 165.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.609 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 27.5 mt-30 82.83 59.58 0.09 OUTLIER Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 127.597 2.359 . . . . 0.0 110.701 -168.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HD3' ' H ' ' A' ' 11' ' ' GLN . 24.8 Cg_endo -93.86 96.04 0.13 Allowed 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.171 2.581 . . . . 0.0 110.908 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.12 83.97 2.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.43 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.38 122.52 1.1 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.593 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -65.45 -19.63 66.02 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.864 0.866 . . . . 0.0 111.956 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -77.09 1.53 17.81 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.853 0.861 . . . . 0.0 112.181 -174.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.6 m -79.39 137.35 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.023 0.44 . . . . 0.0 110.296 175.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -94.58 149.25 21.43 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.616 1.167 . . . . 0.0 110.148 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 1.0 OUTLIER -119.01 161.28 20.49 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.739 0.816 . . . . 0.0 111.419 -171.192 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.69 136.68 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.674 1.19 . . . . 0.0 108.255 171.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.42 ' HG2' ' H ' ' A' ' 23' ' ' ASP . 61.9 tt0 -76.4 152.25 36.31 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.26 0.624 . . . . 0.0 109.536 177.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.4 t -76.22 -21.26 56.62 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.42 ' H ' ' HG2' ' A' ' 21' ' ' GLN . 30.5 t70 76.26 -48.6 0.57 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.156 1.383 . . . . 0.0 112.292 -177.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.534 ' HA3' ' SG ' ' A' ' 52' ' ' CYS . . . -57.41 178.8 0.94 Allowed Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.246 0.859 . . . . 0.0 115.246 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.8 m -65.47 -23.73 66.99 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.454 0.702 . . . . 0.0 112.456 -168.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.3 p -67.2 -34.42 77.46 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.062 0.545 . . . . 0.0 110.017 174.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 65.33 12.68 8.27 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 125.11 1.364 . . . . 0.0 113.466 166.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -73.16 141.92 47.43 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.315 1.046 . . . . 0.0 112.063 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -92.6 118.12 30.68 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.092 0.957 . . . . 0.0 109.589 175.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -110.94 126.93 55.26 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.01 0.924 . . . . 0.0 109.229 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -53.06 123.69 12.33 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.386 0.675 . . . . 0.0 111.572 175.09 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 47.8 mt-30 -52.31 -47.22 66.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.34 1.456 . . . . 0.0 112.697 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 m -58.24 -36.58 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.609 0.719 . . . . 0.0 110.955 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 0.1 OUTLIER -74.72 -39.3 61.98 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.882 -175.057 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.454 HG23 HG23 ' A' ' 37' ' ' VAL . 35.1 m -100.94 6.57 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.563 -173.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.05 3.18 88.09 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 114.71 0.644 . . . . 0.0 114.71 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 32' ' ' GLN . 88.1 t -79.74 125.86 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.422 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 25.2 m -93.22 165.57 18.13 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 123.894 0.878 . . . . 0.0 109.965 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 38' ' ' SER . 10.9 Cg_endo -51.81 -52.19 9.51 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 123.174 2.583 . . . . 0.0 114.401 -174.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.08 -27.74 64.85 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.322 0.249 . . . . 0.0 111.628 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.1 mtt -69.15 -36.92 77.94 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.775 0.43 . . . . 0.0 110.53 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.34 -31.39 63.95 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.21 1.004 . . . . 0.0 110.603 176.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -70.95 -36.47 72.62 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.391 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -76.33 -52.48 9.85 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.367 0.667 . . . . 0.0 110.64 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -138.72 139.14 38.27 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.321 1.048 . . . . 0.0 109.52 -172.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -72.8 176.29 5.74 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 122.695 0.398 . . . . 0.0 109.937 171.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -88.54 77.5 8.0 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 175.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.22 105.61 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.8 p -73.07 160.48 31.96 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.229 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.6 p -52.95 -39.67 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.434 1.094 . . . . 0.0 113.766 -165.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -70.9 -30.57 66.96 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 118.015 0.37 . . . . 0.0 111.449 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.534 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 99.2 m -74.91 -26.21 59.48 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.158 0.583 . . . . 0.0 111.005 173.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.8 m -81.85 -39.01 24.56 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.083 0.553 . . . . 0.0 110.862 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.8 t -76.89 -32.23 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.046 0.939 . . . . 0.0 109.747 176.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -135.51 87.45 2.32 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.082 0.553 . . . . 0.0 110.501 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 166.853 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.567 1.622 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -52.84 -51.14 11.78 Favored 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 124.712 3.608 . . . . 0.0 116.994 -159.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.549 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -60.15 158.51 11.18 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -170.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -75.8 -42.56 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.119 0.568 . . . . 0.0 110.411 176.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.0 p -92.44 52.29 1.89 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.522 1.129 . . . . 0.0 109.115 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -93.35 119.67 32.74 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.196 -167.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.4 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 28.6 mt -69.49 178.48 2.45 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 160.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -115.69 83.0 10.82 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HD3' ' SG ' ' A' ' 34' ' ' CYS . 67.5 Cg_endo -81.89 134.23 8.27 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.098 2.532 . . . . 0.0 112.885 -178.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -148.06 152.61 37.67 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.472 0.709 . . . . 0.0 110.002 175.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.9 -146.7 17.33 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -92.26 78.6 5.12 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.009 0.924 . . . . 0.0 109.798 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 69.1 121.62 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.441 1.496 . . . . 0.0 111.63 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.6 t -89.26 145.66 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.919 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.72 120.81 16.87 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 174.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.625 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 9.5 m95 -118.24 131.04 56.38 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.377 0.671 . . . . 0.0 111.566 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.513 ' HB ' ' HG2' ' A' ' 32' ' ' GLN . 5.7 p -104.35 123.2 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.793 174.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -82.47 137.99 34.49 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 173.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 36.7 t -84.62 81.94 8.64 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 170.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -54.35 -18.59 4.26 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.752 1.221 . . . . 0.0 112.293 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -51.47 177.52 0.07 OUTLIER Glycine 0 C--N 1.351 1.364 0 N-CA-C 114.671 0.628 . . . . 0.0 114.671 167.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.9 p -74.65 72.98 1.99 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.554 1.141 . . . . 0.0 111.18 -171.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 27' ' ' ASN . 9.6 p -178.36 -42.58 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.388 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.402 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 14.5 m120 67.05 31.58 6.8 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 124.038 0.935 . . . . 0.0 110.69 175.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -72.18 121.32 19.12 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.283 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -87.68 108.21 18.99 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.573 0.749 . . . . 0.0 110.996 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -103.8 171.68 7.22 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.941 170.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -108.36 123.58 49.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.324 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.513 ' HG2' ' HB ' ' A' ' 20' ' ' VAL . 78.5 mt-30 -48.79 -56.65 8.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.916 1.286 . . . . 0.0 113.082 -177.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -62.3 -32.28 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-O 121.384 0.611 . . . . 0.0 111.112 -176.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.405 ' SG ' ' HD3' ' A' ' 12' ' ' PRO . 6.5 t -85.53 -20.38 29.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.204 -170.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.8 m -109.4 -16.49 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.093 0.557 . . . . 0.0 111.578 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.46 15.21 35.64 Favored Glycine 0 C--N 1.351 1.399 0 N-CA-C 114.171 0.428 . . . . 0.0 114.171 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.33 129.96 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.285 0.634 . . . . 0.0 109.709 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 88.7 p -82.49 164.45 47.41 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.072 0.549 . . . . 0.0 109.711 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.51 -26.17 70.09 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 121.945 1.763 . . . . 0.0 111.336 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -64.76 -52.22 58.1 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.929 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 66.8 mtt -62.49 -36.04 81.25 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.576 0.75 . . . . 0.0 111.636 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.47 -38.99 85.24 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.49 0.716 . . . . 0.0 112.098 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -85.07 -45.66 11.89 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.896 0.478 . . . . 0.0 111.301 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -68.97 -54.38 15.61 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.356 1.062 . . . . 0.0 110.378 -175.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -111.08 160.6 16.73 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.201 -175.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -85.14 135.35 34.01 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 163.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -73.77 81.94 1.61 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 168.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.7 mt -75.18 104.92 3.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.958 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.9 p -73.84 158.51 34.39 Favored 'General case' 0 C--O 1.252 1.19 0 O-C-N 123.923 0.764 . . . . 0.0 110.3 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 54' ' ' VAL . 18.9 m -52.91 -33.62 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.222 1.009 . . . . 0.0 113.016 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -61.28 -41.65 97.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.798 0.439 . . . . 0.0 111.389 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.8 m -68.78 -36.49 78.37 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.88 0.472 . . . . 0.0 110.818 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.6 m -64.2 -47.78 78.43 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.512 0.725 . . . . 0.0 111.378 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 50' ' ' VAL . 53.2 t -69.77 -38.34 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.269 0.628 . . . . 0.0 110.503 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -68.81 -38.76 80.12 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.919 0.888 . . . . 0.0 112.342 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 N--CA 1.476 0.869 0 C-N-CA 122.43 0.292 . . . . 0.0 110.782 -173.351 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.5 t . . . . . 0 CA--C 1.55 0.967 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.93 94.31 1.07 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.684 2.923 . . . . 0.0 112.941 -169.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.629 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -158.57 107.52 1.97 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.459 0.704 . . . . 0.0 110.362 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.2 t 60.45 -76.57 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 125.772 1.629 . . . . 0.0 112.021 174.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.6 t -146.35 -27.0 0.42 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.003 0.921 . . . . 0.0 110.734 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.8 t 65.67 81.09 0.21 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.772 1.229 . . . . 0.0 110.478 -177.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 67.3 mt -65.64 -33.67 76.45 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.638 0.775 . . . . 0.0 111.638 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 61.09 74.06 0.55 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.814 1.246 . . . . 0.0 112.224 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.48 122.92 9.05 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.253 1.969 . . . . 0.0 111.302 171.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.5 91.0 1.76 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.465 0.706 . . . . 0.0 109.974 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 167.48 123.49 0.66 Allowed Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.017 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -78.15 -2.5 37.84 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.797 0.839 . . . . 0.0 112.309 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.16 -18.37 64.4 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.043 0.937 . . . . 0.0 112.055 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.85 127.93 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.906 0.384 . . . . 0.0 110.158 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -79.35 145.99 33.12 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.474 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -116.51 124.72 50.61 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.251 0.62 . . . . 0.0 110.947 -174.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.54 121.9 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 124.289 1.036 . . . . 0.0 109.198 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -84.92 153.2 22.99 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.775 0.83 . . . . 0.0 110.004 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 43.7 t -103.2 72.9 1.19 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 165.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -53.1 -31.02 39.82 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.954 0.902 . . . . 0.0 111.437 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.438 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -64.51 92.82 0.13 Allowed Glycine 0 CA--C 1.534 1.241 0 CA-C-O 119.295 -0.725 . . . . 0.0 111.829 165.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 72.2 p 50.7 54.03 11.93 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.967 1.707 . . . . 0.0 113.724 164.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 51.7 m -161.76 -56.63 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.942 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 62.15 13.8 6.09 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.949 1.7 . . . . 0.0 112.814 176.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -85.15 138.54 32.32 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -87.62 110.52 20.45 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -99.73 142.79 30.75 Favored 'General case' 0 C--O 1.206 -1.209 0 C-N-CA 123.927 0.891 . . . . 0.0 109.931 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.575 ' CD2' ' H ' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -89.48 154.31 20.12 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -169.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -43.68 -54.79 4.79 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.75 0.82 . . . . 0.0 112.438 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -76.19 -22.78 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.267 0.627 . . . . 0.0 111.838 -176.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 6' ' ' ALA . 25.1 t -67.93 -31.55 71.39 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.721 0.409 . . . . 0.0 111.518 -178.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.9 m -115.85 -15.25 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.026 0.93 . . . . 0.0 112.098 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.93 37.1 39.54 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 123.333 0.396 . . . . 0.0 112.565 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.9 t -115.43 135.56 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.084 0.954 . . . . 0.0 110.081 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 m -71.41 148.23 93.24 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 123.907 0.883 . . . . 0.0 110.726 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.599 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 39.8 Cg_endo -62.11 -20.76 70.9 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.174 2.583 . . . . 0.0 113.796 -175.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -62.13 -49.34 76.28 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.541 0.736 . . . . 0.0 111.458 173.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 27.0 ttt -74.28 -29.83 61.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.391 1.076 . . . . 0.0 110.265 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 39' ' ' PRO . . . -70.24 -20.75 63.06 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.44 0.696 . . . . 0.0 112.009 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -92.18 -44.68 8.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.923 0.889 . . . . 0.0 110.667 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -73.33 -51.14 18.54 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.51 0.724 . . . . 0.0 112.097 -172.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -115.66 147.28 41.01 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.012 0.925 . . . . 0.0 111.175 -166.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.64 139.01 38.59 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 171.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -76.09 75.93 2.95 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.2 mt -77.88 100.06 2.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.8 p -75.96 148.08 38.41 Favored 'General case' 0 C--N 1.349 0.586 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.8 m -45.7 -35.59 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -165.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -63.38 -45.48 90.94 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.706 0.803 . . . . 0.0 110.699 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 24' ' ' GLY . 60.5 m -73.56 -28.09 61.68 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.693 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.8 m -67.0 -51.32 56.49 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.214 0.606 . . . . 0.0 110.74 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.61 -33.37 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.596 0.759 . . . . 0.0 111.81 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -110.79 35.0 3.67 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.74 0.781 . . . . 0.0 109.569 -175.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.975 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.6 p . . . . . 0 CA--C 1.541 0.622 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -74.07 66.87 5.12 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.65 2.233 . . . . 0.0 111.845 174.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.57 106.85 8.07 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.02 -44.83 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.6 m -72.69 93.47 1.64 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 166.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 51.1 t -139.67 113.13 8.4 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.931 0.492 . . . . 0.0 111.121 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.695 HD11 HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -66.6 146.28 54.67 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 161.889 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -105.33 103.39 42.32 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.41 99.63 0.17 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.358 2.705 . . . . 0.0 112.573 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.23 -24.61 42.96 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.722 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.34 -19.88 56.0 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.308 175.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 72.76 -17.94 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.242 1.417 . . . . 0.0 113.846 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -82.98 67.5 9.09 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.951 0.881 . . . . 0.0 110.335 -171.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.35 138.52 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.69 1.196 . . . . 0.0 108.608 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -80.53 122.89 27.59 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -93.1 174.95 6.97 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.29 0.636 . . . . 0.0 111.036 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.459 ' HB ' HE22 ' A' ' 32' ' ' GLN . 14.8 p -159.98 129.1 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.424 0.69 . . . . 0.0 110.261 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -80.61 126.53 31.37 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.477 ' SG ' ' OD2' ' A' ' 23' ' ' ASP . 31.1 t -75.0 118.39 17.91 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 -164.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.477 ' OD2' ' SG ' ' A' ' 22' ' ' CYS . 4.5 p30 20.36 -71.08 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 127.986 2.514 . . . . 0.0 117.471 171.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.92 -95.24 0.15 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.211 -0.449 . . . . 0.0 113.723 -152.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -79.51 -51.93 8.69 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.197 -0.501 . . . . 0.0 111.598 -163.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.05 -35.5 64.3 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -173.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.2 t30 70.7 -26.83 0.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.284 1.434 . . . . 0.0 114.78 165.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -56.84 147.18 24.05 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.93 0.892 . . . . 0.0 111.562 -171.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -74.99 139.37 42.89 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.679 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -126.34 149.33 49.24 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 172.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.598 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -78.74 148.0 33.18 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 169.35 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.459 HE22 ' HB ' ' A' ' 20' ' ' VAL . 2.6 mp0 -58.77 -34.36 71.34 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.539 0.736 . . . . 0.0 110.424 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.695 HG23 HD11 ' A' ' 10' ' ' LEU . 35.1 m -76.06 -22.25 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.649 176.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.598 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.5 t -70.99 -37.25 72.7 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 123.399 0.68 . . . . 0.0 111.195 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.464 HG23 HG23 ' A' ' 37' ' ' VAL . 6.0 m -118.62 8.64 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.819 0.848 . . . . 0.0 112.338 -172.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.61 29.12 73.72 Favored Glycine 0 C--N 1.353 1.493 0 O-C-N 123.498 0.499 . . . . 0.0 114.262 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.464 HG23 HG23 ' A' ' 35' ' ' VAL . 77.0 t -92.97 143.73 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.57 0.748 . . . . 0.0 109.368 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.0 m -80.42 145.23 58.95 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.341 0.656 . . . . 0.0 109.856 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.89 -38.38 94.63 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.493 2.129 . . . . 0.0 112.221 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.21 -45.7 90.4 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.763 0.825 . . . . 0.0 111.029 173.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 50.2 mmm -60.85 -46.12 91.81 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.135 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.38 -35.6 81.43 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.621 0.768 . . . . 0.0 111.293 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -69.52 -38.75 77.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.42 0.688 . . . . 0.0 111.696 175.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -74.65 -44.24 51.37 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.404 0.681 . . . . 0.0 111.391 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -161.78 153.25 18.64 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.229 1.012 . . . . 0.0 109.755 -172.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -73.92 148.12 42.51 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.96 0.41 . . . . 0.0 111.841 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -72.48 125.85 28.42 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 166.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.2 mt -113.77 125.98 71.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.8 m -66.26 167.29 10.55 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 173.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.1 t -62.28 -48.93 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 173.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 3.6 mpt_? -62.67 -48.25 80.13 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.668 0.387 . . . . 0.0 110.099 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.6 m -48.4 -41.36 28.81 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.717 1.207 . . . . 0.0 112.902 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.9 t -82.97 -29.86 28.69 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 50' ' ' VAL . 49.7 t -69.82 -29.68 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.661 0.784 . . . . 0.0 110.847 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 74.0 mmtt -62.54 -63.06 1.34 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.475 0.775 0 C-N-CA 124.555 1.142 . . . . 0.0 110.729 174.243 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.503 ' SG ' ' HD1' ' A' ' 30' ' ' PHE . 25.6 t . . . . . 0 CA--C 1.554 1.102 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.83 45.78 2.05 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.714 2.942 . . . . 0.0 112.972 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.91 129.74 35.73 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 170.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.88 -37.48 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 122.786 0.434 . . . . 0.0 110.683 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.8 p -97.17 69.81 2.33 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 169.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.739 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 21.5 t -84.06 79.07 9.63 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-O 121.078 0.466 . . . . 0.0 110.377 -177.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.1 mt -59.96 139.71 57.23 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.121 172.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -113.42 80.28 4.51 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.06 0.944 . . . . 0.0 109.915 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.442 ' HD2' ' HD2' ' A' ' 31' ' ' HIS . 42.5 Cg_endo -86.25 142.87 7.53 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.292 2.661 . . . . 0.0 113.327 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.49 163.02 14.31 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.82 0.848 . . . . 0.0 109.517 172.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.34 152.87 28.86 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.981 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -82.54 -16.38 48.84 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.892 0.877 . . . . 0.0 111.914 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -58.2 -35.44 71.63 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.274 1.03 . . . . 0.0 112.018 -175.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.403 HG21 ' HG2' ' A' ' 12' ' ' PRO . 14.3 m -73.2 83.71 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 122.54 1.162 . . . . 0.0 110.295 172.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.45 140.8 54.09 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.627 -176.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -92.89 156.25 17.07 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.169 0.509 . . . . 0.0 110.91 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -137.87 126.96 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.771 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -77.39 129.26 35.56 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.145 0.978 . . . . 0.0 109.755 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -62.98 -36.87 84.97 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.992 0.517 . . . . 0.0 111.271 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t70 69.39 -72.5 0.1 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.818 1.647 . . . . 0.0 111.264 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.42 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -46.7 90.58 0.01 OUTLIER Glycine 0 C--N 1.353 1.511 0 C-N-CA 124.828 1.204 . . . . 0.0 115.904 -172.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 t 70.44 12.32 7.45 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.35 1.46 . . . . 0.0 112.908 162.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -155.16 -29.11 0.11 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.263 -175.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 80.2 -59.61 0.31 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.274 1.43 . . . . 0.0 111.599 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -4.22 114.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 129.012 2.925 . . . . 0.0 116.978 -173.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -79.86 116.52 20.07 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.187 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.503 ' HD1' ' SG ' ' A' ' 4' ' ' CYS . 50.7 m-85 -100.73 164.94 11.63 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 124.285 1.034 . . . . 0.0 109.696 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.442 ' HD2' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -106.51 149.08 27.46 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -176.812 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -47.97 -51.05 25.26 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.73 1.212 . . . . 0.0 112.643 -174.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.0 m -81.55 -28.45 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.205 0.602 . . . . 0.0 112.554 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.739 ' SG ' ' HA ' ' A' ' 9' ' ' CYS . 52.6 t -62.69 -36.09 81.82 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -174.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 m -114.5 -1.36 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.577 0.751 . . . . 0.0 111.712 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.3 30.66 71.46 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 113.665 0.226 . . . . 0.0 113.665 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.413 HG11 ' HB3' ' A' ' 47' ' ' TYR . 90.4 t -98.48 107.82 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.702 ' HB2' ' SD ' ' A' ' 41' ' ' MET . 45.6 m -73.14 163.1 71.01 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 123.696 0.799 . . . . 0.0 110.822 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -47.85 -45.71 23.65 Favored 'Trans proline' 0 C--N 1.396 3.04 0 C-N-CA 123.635 2.89 . . . . 0.0 114.999 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.85 -32.56 71.03 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 120.634 0.254 . . . . 0.0 111.348 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.702 ' SD ' ' HB2' ' A' ' 38' ' ' SER . 1.2 mpt? -69.76 -44.28 70.49 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.145 0.578 . . . . 0.0 109.94 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.29 69.47 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.587 0.755 . . . . 0.0 111.172 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.76 -48.51 46.32 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.365 1.066 . . . . 0.0 111.248 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -105.04 -61.18 1.51 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.906 -163.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -156.84 148.42 22.46 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -165.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 t70 67.17 76.43 0.29 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.966 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.438 ' H ' HD12 ' A' ' 48' ' ' ILE . 35.8 p90 -148.32 5.18 0.72 Allowed 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.638 177.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.438 HD12 ' H ' ' A' ' 47' ' ' TYR . 4.3 mp -95.09 117.52 39.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.0 p -59.73 147.19 38.67 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 123.297 0.373 . . . . 0.0 111.39 -171.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.6 t -54.9 -37.12 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -158.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -68.1 -27.87 66.85 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.667 0.387 . . . . 0.0 111.395 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 24' ' ' GLY . 82.3 m -79.24 -28.03 42.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.579 0.751 . . . . 0.0 111.154 173.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 m -73.5 -28.91 62.16 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 123.553 0.533 . . . . 0.0 110.196 175.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.1 t -72.21 -52.3 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.689 0.796 . . . . 0.0 109.389 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -94.77 55.47 1.89 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.03 0.919 . . . . 0.0 110.238 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.6 t70 . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 124.617 1.167 . . . . 0.0 109.396 177.964 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.5 p . . . . . 0 CA--C 1.549 0.941 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -90.1 -12.18 39.11 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.936 -0.478 . . . . 0.0 111.733 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.3 mmt -64.15 -14.17 53.21 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 123.575 0.75 . . . . 0.0 112.283 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 t -133.36 86.46 40.92 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 124.187 0.995 . . . . 0.0 108.835 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.76 80.96 0.61 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.101 2.534 . . . . 0.0 112.413 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.31 130.56 19.69 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.475 1.11 . . . . 0.0 108.894 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.43 -55.23 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.227 0.611 . . . . 0.0 109.693 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.7 m -78.12 74.21 4.67 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.499 0.719 . . . . 0.0 109.251 174.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.709 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 19.7 t -97.93 92.29 5.74 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.101 0.477 . . . . 0.0 110.491 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 33' ' ' VAL . 88.3 mt -71.88 113.6 9.09 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.438 172.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -105.27 107.77 59.81 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.47 1.108 . . . . 0.0 109.491 -175.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HG2' ' H ' ' A' ' 14' ' ' GLY . 97.9 Cg_endo -72.12 -145.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.459 2.773 . . . . 0.0 110.953 170.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -68.52 -6.66 26.47 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.669 0.388 . . . . 0.0 111.742 167.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.445 ' H ' ' HG2' ' A' ' 12' ' ' PRO . . . 116.64 -86.14 0.41 Allowed Glycine 0 C--N 1.346 1.122 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 174.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -95.39 66.49 2.85 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.396 1.093 . . . . 0.0 108.841 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -114.8 -58.71 2.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.916 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -86.18 -177.87 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 124.742 1.217 . . . . 0.0 112.065 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.44 ' HB3' HE21 ' A' ' 32' ' ' GLN . 33.2 t70 -98.23 140.93 31.8 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.925 0.49 . . . . 0.0 110.313 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -105.71 -177.96 3.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.492 1.117 . . . . 0.0 110.803 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 37' ' ' VAL . 7.5 p -157.94 136.57 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 125.162 1.385 . . . . 0.0 108.22 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -95.88 112.52 24.23 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.4 t -77.9 91.01 4.13 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -57.24 -80.34 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 O-C-N 123.942 0.776 . . . . 0.0 109.851 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 43.35 -83.8 0.01 OUTLIER Glycine 0 N--CA 1.484 1.883 0 C-N-CA 124.423 1.011 . . . . 0.0 115.309 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.8 p -159.81 26.96 0.18 Allowed 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.999 1.32 . . . . 0.0 110.222 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.8 p -143.11 -41.29 0.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.315 0.646 . . . . 0.0 111.387 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 65.29 19.29 11.64 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.029 0.931 . . . . 0.0 112.101 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -79.82 137.08 36.87 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.217 0.607 . . . . 0.0 111.059 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -86.59 128.61 35.0 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.465 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -129.33 143.39 50.83 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.284 1.034 . . . . 0.0 109.044 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.632 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -69.29 141.35 54.36 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 169.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.44 HE21 ' HB3' ' A' ' 18' ' ' ASP . 48.6 mt-30 -53.32 -40.47 64.84 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.935 0.494 . . . . 0.0 111.369 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.4 ' O ' HD12 ' A' ' 10' ' ' LEU . 33.3 m -65.31 -38.24 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.55 0.74 . . . . 0.0 111.677 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.709 ' SG ' ' HA ' ' A' ' 9' ' ' CYS . 8.4 t -56.29 -50.22 72.02 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.073 0.949 . . . . 0.0 112.047 -175.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.1 m -109.26 5.91 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.283 -174.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.45 52.73 51.39 Favored Glycine 0 C--N 1.355 1.638 0 C-N-CA 123.575 0.607 . . . . 0.0 113.98 174.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.584 HG21 HG11 ' A' ' 20' ' ' VAL . 13.1 t -74.66 119.3 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.054 0.541 . . . . 0.0 109.581 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.616 ' HB2' ' SD ' ' A' ' 41' ' ' MET . 41.7 m -63.14 135.6 96.3 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 123.575 0.547 . . . . 0.0 109.589 175.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.69 -15.43 16.19 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.373 2.716 . . . . 0.0 114.499 -175.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.03 -52.11 18.53 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.616 ' SD ' ' HB2' ' A' ' 38' ' ' SER . 1.4 mpt? -67.61 -33.36 74.83 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.109 0.964 . . . . 0.0 110.405 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.81 -36.37 70.24 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.178 0.991 . . . . 0.0 110.831 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.17 -45.23 85.72 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -70.61 -15.4 62.74 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.951 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 65.34 12.84 8.4 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.921 1.288 . . . . 0.0 110.979 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -102.34 91.61 4.34 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.099 1.359 . . . . 0.0 109.239 -170.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -132.23 106.59 8.04 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.9 mp -100.66 113.22 35.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.5 p -74.26 164.04 27.09 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.903 0.481 . . . . 0.0 110.475 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.4 t -50.54 -47.72 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 124.508 1.123 . . . . 0.0 112.441 -174.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -54.13 -44.12 71.09 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.071 0.549 . . . . 0.0 111.702 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 68.7 m -67.62 -36.11 80.19 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.044 0.537 . . . . 0.0 111.824 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.1 m -74.42 -44.15 53.13 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.181 0.593 . . . . 0.0 110.791 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.3 t -78.11 -16.11 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.229 1.011 . . . . 0.0 111.114 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -117.01 25.28 10.61 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.91 0.862 . . . . 0.0 109.696 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -79.35 -28.41 42.0 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.602 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 60.49 85.75 0.17 Allowed Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.351 1.06 . . . . 0.0 110.389 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.67 -179.94 5.85 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.728 2.286 . . . . 0.0 112.208 -174.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.1 t -80.92 -6.02 58.16 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.381 0.672 . . . . 0.0 110.821 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -150.26 117.03 5.85 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.561 1.368 0 C-N-CA 123.424 0.689 . . . . 0.0 109.551 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -123.97 99.58 6.33 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -57.74 -40.35 79.48 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.048 0.939 . . . . 0.0 110.92 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 82.1 m -164.26 158.42 15.82 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.304 1.441 . . . . 0.0 109.049 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.53 39.34 0.84 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.727 2.285 . . . . 0.0 111.061 162.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.26 108.72 8.93 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.1 t -63.76 -43.88 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 m -70.57 106.3 3.43 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 165.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.6 t -151.27 86.11 1.35 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.725 0.41 . . . . 0.0 111.149 -173.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.4 mt -71.12 114.44 9.18 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 166.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -93.11 107.11 22.7 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.709 1.204 . . . . 0.0 111.033 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.62 178.62 6.88 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.098 2.532 . . . . 0.0 111.052 168.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -74.49 -17.34 60.78 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.338 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.79 143.68 14.77 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.0 t70 58.59 34.04 23.55 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.293 1.044 . . . . 0.0 109.559 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -123.91 -71.96 0.7 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.057 -169.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.1 m -91.74 145.85 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -69.79 150.38 46.94 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.872 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -95.09 -178.12 4.37 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.712 0.805 . . . . 0.0 111.223 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.1 p -153.64 116.44 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.949 1.299 . . . . 0.0 108.706 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 52.0 tt0 -98.66 107.94 20.51 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.548 0.739 . . . . 0.0 109.392 -177.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 8.7 t -79.99 64.49 4.84 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.362 0.665 . . . . 0.0 111.278 -173.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -53.04 -36.3 60.44 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.215 1.406 . . . . 0.0 113.638 -169.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -39.35 -58.09 2.09 Favored Glycine 0 N--CA 1.477 1.392 0 O-C-N 124.865 1.353 . . . . 0.0 115.496 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.482 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 48.2 m -157.61 32.54 0.27 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.375 0.67 . . . . 0.0 110.672 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 75.4 m -132.74 -48.38 0.88 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 173.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 74.37 -6.65 1.83 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.939 1.296 . . . . 0.0 112.383 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -93.75 146.25 24.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.845 0.858 . . . . 0.0 109.882 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 8.3 p-90 -103.5 111.81 24.44 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.203 1.001 . . . . 0.0 109.635 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -100.71 163.24 12.42 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.627 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -63.32 145.71 55.0 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 166.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -62.85 -32.24 73.43 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 122.046 -0.409 . . . . 0.0 111.085 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 31' ' ' HIS . 33.5 m -68.73 -26.8 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 C-N-CA 123.105 0.562 . . . . 0.0 111.815 174.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.627 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.2 t -61.43 -55.53 30.27 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 123.958 0.903 . . . . 0.0 111.819 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 37' ' ' VAL . 18.4 m -101.43 -5.22 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.285 -168.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.66 31.86 20.27 Favored Glycine 0 C--N 1.348 1.245 0 O-C-N 123.204 0.315 . . . . 0.0 113.401 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 35' ' ' VAL . 55.0 t -97.3 125.73 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.559 0.744 . . . . 0.0 109.577 175.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.6 m -82.89 159.29 63.44 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 123.891 0.876 . . . . 0.0 110.067 175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -45.82 -50.78 9.17 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.631 2.887 . . . . 0.0 114.439 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 47.5 mt-10 -71.85 -12.95 61.52 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.094 0.558 . . . . 0.0 112.322 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.6 mtt -79.3 -57.09 3.89 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.528 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . . . -61.48 -36.62 80.99 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.94 0.896 . . . . 0.0 112.14 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -87.39 -65.13 1.05 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.901 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 39.5 ttmt -81.68 -48.49 11.63 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.451 0.469 . . . . 0.0 112.215 -163.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -162.32 118.88 2.0 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -167.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.0 t70 61.74 107.18 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.618 1.567 . . . . 0.0 114.067 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.582 ' H ' HD12 ' A' ' 48' ' ' ILE . 42.0 p90 -126.29 12.55 7.63 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 114.297 -1.319 . . . . 0.0 108.677 165.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.582 HD12 ' H ' ' A' ' 47' ' ' TYR . 3.5 mp -85.13 106.16 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.129 -172.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.1 p -61.52 159.86 12.22 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 123.837 0.711 . . . . 0.0 111.771 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.4 t -52.44 -39.68 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.748 1.219 . . . . 0.0 112.538 -172.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 27.4 mmt180 -64.78 -44.83 88.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.316 0.646 . . . . 0.0 111.701 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 25' ' ' SER . 64.7 m -62.71 -38.85 92.08 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.682 0.393 . . . . 0.0 111.075 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.9 m -69.36 -45.13 70.11 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.928 0.891 . . . . 0.0 110.834 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.46 -25.98 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.261 0.624 . . . . 0.0 111.101 -173.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 51' ' ' ARG . 68.2 mttm -56.77 -50.94 70.8 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 123.317 0.385 . . . . 0.0 110.233 173.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 73.63 -35.34 0.31 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.243 1.417 . . . . 0.0 113.059 173.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -114.88 101.16 54.38 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.096 1.358 . . . . 0.0 108.583 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.91 84.29 0.85 Allowed 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.907 2.405 . . . . 0.0 110.922 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.3 t -65.56 121.2 14.38 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.303 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 69.76 120.77 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 O-C-N 124.877 1.361 . . . . 0.0 110.782 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.084 0 C-N-CA 123.864 0.865 . . . . 0.0 109.108 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.3 m . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -163.46 35.62 0.09 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.115 0.966 . . . . 0.0 109.815 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 66.65 169.11 0.24 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 125.027 1.331 . . . . 0.0 112.213 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.2 t 64.36 81.23 0.22 Allowed Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 123.879 0.872 . . . . 0.0 111.21 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.34 108.33 2.59 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.222 2.615 . . . . 0.0 113.756 -170.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.29 -170.88 2.15 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.148 0.979 . . . . 0.0 109.74 168.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.9 m -54.89 -31.35 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.159 0.984 . . . . 0.0 112.109 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.4 m -147.42 -35.79 0.23 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.202 1.401 . . . . 0.0 109.188 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.3 t 70.18 97.02 0.07 Allowed 'General case' 0 C--N 1.36 1.031 0 C-N-CA 125.231 1.412 . . . . 0.0 109.491 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.4 mt -80.43 100.47 8.51 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -85.78 105.67 7.71 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.378 1.071 . . . . 0.0 108.302 171.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.56 162.39 42.16 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 122.423 2.082 . . . . 0.0 111.112 172.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.75 -22.33 66.48 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.407 0.683 . . . . 0.0 111.677 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.9 136.17 4.45 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.15 66.53 7.78 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.297 1.048 . . . . 0.0 111.16 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.54 -9.23 55.03 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.976 164.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -63.16 151.62 8.27 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 C-N-CA 124.659 1.184 . . . . 0.0 110.143 165.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -85.39 149.3 25.52 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.056 0.455 . . . . 0.0 110.114 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 22.1 m0 -111.75 -179.95 3.84 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.537 1.135 . . . . 0.0 110.83 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -161.75 131.78 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.551 1.14 . . . . 0.0 109.549 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 63.5 tt0 -69.82 149.45 47.9 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.659 0.784 . . . . 0.0 110.067 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 0.7 OUTLIER -127.7 50.12 2.06 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.552 0.741 . . . . 0.0 110.164 -171.303 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -57.53 -21.45 38.26 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.913 1.685 . . . . 0.0 114.564 -174.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.24 -58.59 6.33 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 114.76 0.664 . . . . 0.0 114.76 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.729 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 40.6 m -161.36 60.32 0.28 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 89.5 m -155.85 -45.67 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.939 0.896 . . . . 0.0 108.818 173.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 68.93 20.76 7.78 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.427 1.091 . . . . 0.0 111.652 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -140.48 163.18 33.53 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.829 0.852 . . . . 0.0 109.867 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 23.9 m95 -82.93 151.6 25.86 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.203 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -139.85 141.1 36.67 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.16 1.384 . . . . 0.0 108.395 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.658 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -56.12 144.96 27.42 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.457 0.703 . . . . 0.0 109.285 166.159 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -57.4 -41.05 79.56 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.12 0.418 . . . . 0.0 111.327 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -63.25 -26.22 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.246 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.658 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.6 t -67.59 -45.37 75.7 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.789 0.835 . . . . 0.0 111.913 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.5 m -100.82 -8.59 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.354 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.21 16.02 72.81 Favored Glycine 0 CA--C 1.536 1.392 0 O-C-N 123.358 0.411 . . . . 0.0 113.67 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 68.8 t -84.25 131.56 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 123.649 0.78 . . . . 0.0 109.558 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.4 m -67.8 157.33 86.84 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 123.751 0.82 . . . . 0.0 111.324 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -49.48 -50.79 12.11 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.174 2.583 . . . . 0.0 113.49 174.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.02 -30.74 68.11 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.556 0.742 . . . . 0.0 111.44 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 74.9 mtp -68.34 -47.61 67.04 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.785 0.434 . . . . 0.0 110.351 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.6 -34.5 72.83 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.362 0.665 . . . . 0.0 110.221 176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -75.14 -43.54 51.97 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.522 -176.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -103.55 -59.78 1.67 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -173.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -172.75 165.16 5.33 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.222 0.609 . . . . 0.0 111.636 -170.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.4 t70 63.11 57.71 1.56 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.481 1.112 . . . . 0.0 110.279 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -104.58 6.97 34.97 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.414 -1.267 . . . . 0.0 110.038 168.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.5 mp -78.52 104.24 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -173.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 51' ' ' ARG . 13.0 p -66.37 164.7 15.61 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.556 -175.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.8 t -51.92 -46.15 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.94 0.896 . . . . 0.0 110.699 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.532 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 72.9 mtp180 -53.3 -43.55 67.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 123.937 0.773 . . . . 0.0 112.244 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.729 ' HA ' ' HB2' ' A' ' 25' ' ' SER . 14.5 m -61.09 -47.3 86.95 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.825 0.703 . . . . 0.0 111.109 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.2 m -67.23 -45.21 77.45 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 124.015 0.822 . . . . 0.0 111.185 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.19 -34.2 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.025 0.93 . . . . 0.0 110.828 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -73.17 0.19 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -145.21 -76.43 0.21 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.706 0.802 . . . . 0.0 109.944 -172.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 45.55 90.53 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 C-N-CA 124.535 1.134 . . . . 0.0 112.684 -172.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.57 16.22 1.74 Allowed 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.458 2.105 . . . . 0.0 113.035 -177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.3 m -83.83 101.82 11.91 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.677 0.791 . . . . 0.0 110.352 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 67.86 -179.28 0.22 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 125.222 1.409 . . . . 0.0 113.257 174.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 pttp . . . . . 0 C--O 1.255 1.353 0 C-N-CA 124.086 0.954 . . . . 0.0 109.338 177.711 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -160.22 127.35 4.43 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.344 0.658 . . . . 0.0 109.792 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -111.23 35.66 3.49 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.073 0.949 . . . . 0.0 109.28 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m 68.22 157.14 0.15 Allowed Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 125.006 1.322 . . . . 0.0 110.744 -173.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -71.07 60.76 2.42 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.505 2.137 . . . . 0.0 111.922 165.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.55 108.45 2.72 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.437 1.095 . . . . 0.0 108.056 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -66.87 -17.06 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.904 0.882 . . . . 0.0 111.458 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.0 m -86.56 26.35 1.1 Allowed 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.527 1.131 . . . . 0.0 111.292 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.7 t -77.7 101.97 6.89 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.6 mt -62.3 -27.81 69.3 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.76 0.824 . . . . 0.0 112.297 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 58.8 60.04 5.37 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.342 1.057 . . . . 0.0 111.573 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -81.96 160.78 18.42 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.036 1.824 . . . . 0.0 111.59 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -23.25 59.05 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.614 170.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.47 -76.18 0.17 Allowed Glycine 0 C--N 1.343 0.952 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.3 t70 65.08 14.79 9.61 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.775 1.23 . . . . 0.0 112.359 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 64.86 61.07 0.8 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.084 1.353 . . . . 0.0 110.664 -176.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -101.34 134.99 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 170.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.57 160.99 22.42 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -114.3 164.91 13.28 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.45 0.643 . . . . 0.0 111.066 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 p -153.25 142.76 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.321 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -101.19 121.18 41.39 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.3 t -63.76 141.49 58.75 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.011 0.524 . . . . 0.0 110.155 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.432 ' H ' ' HE1' ' A' ' 47' ' ' TYR . 25.0 t70 -94.4 -78.55 0.44 Allowed 'General case' 0 C--O 1.239 0.509 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 154.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 33.04 -98.61 0.01 OUTLIER Glycine 0 C--N 1.357 1.732 0 O-C-N 125.039 1.462 . . . . 0.0 116.287 172.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.4 t -157.33 15.36 0.26 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.964 0.906 . . . . 0.0 109.898 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 14.1 p -159.21 57.37 0.41 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -49.87 80.49 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.528 1.931 . . . . 0.0 112.275 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -127.91 159.2 35.67 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 125.498 1.519 . . . . 0.0 107.402 170.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -82.16 108.48 15.66 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.491 0.663 . . . . 0.0 109.569 170.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -99.55 155.87 17.35 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.963 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.595 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -71.79 146.44 48.05 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 162.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -69.59 -22.26 63.53 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.36 0.527 . . . . 0.0 111.149 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.2 m -78.04 -19.99 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.366 0.667 . . . . 0.0 111.796 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.595 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 7.2 t -69.65 -28.02 65.54 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.596 0.758 . . . . 0.0 111.567 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 m -116.12 -8.53 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 124.364 1.066 . . . . 0.0 111.608 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.28 5.05 87.65 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 114.188 0.435 . . . . 0.0 114.188 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.2 t -80.12 138.26 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 123.282 0.633 . . . . 0.0 110.43 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 m -86.75 143.33 35.46 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.056 0.942 . . . . 0.0 109.709 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -50.38 -31.03 28.77 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 123.482 2.788 . . . . 0.0 114.407 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -58.24 -54.78 43.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.713 0.805 . . . . 0.0 109.505 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 72.2 mtm -71.99 -30.99 65.81 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.38 0.672 . . . . 0.0 111.47 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.51 -40.75 88.12 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.307 0.643 . . . . 0.0 110.937 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -82.51 -45.22 14.98 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.335 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -70.23 -56.47 6.7 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.885 0.474 . . . . 0.0 111.766 -166.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -174.49 127.68 0.33 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.355 0.662 . . . . 0.0 110.225 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.7 t70 73.16 133.83 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.906 1.682 . . . . 0.0 112.498 172.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.432 ' HE1' ' H ' ' A' ' 23' ' ' ASP . 14.5 p90 -151.25 20.77 0.75 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.569 1.548 . . . . 0.0 108.035 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.7 mt -88.82 133.91 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.273 -165.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.62 157.99 36.51 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.391 0.676 . . . . 0.0 110.627 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.7 m -56.65 -43.74 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.917 0.887 . . . . 0.0 113.072 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -69.8 -36.27 75.54 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.837 0.455 . . . . 0.0 110.869 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 96.3 m -68.41 -30.93 69.94 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.987 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.1 m -72.23 -42.86 65.2 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.268 1.027 . . . . 0.0 110.686 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.7 t -71.43 -32.65 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.076 0.55 . . . . 0.0 111.071 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -72.1 -17.37 61.99 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.825 0.45 . . . . 0.0 111.8 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -54.97 -35.09 63.92 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.279 0.562 . . . . 0.0 110.675 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.17 85.46 7.47 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.198 0.999 . . . . 0.0 108.582 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -64.64 95.21 0.23 Allowed 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.087 2.525 . . . . 0.0 110.91 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.8 p -144.37 173.23 11.96 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.105 0.962 . . . . 0.0 109.755 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 63.22 61.19 1.1 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.559 1.144 . . . . 0.0 110.051 -173.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.413 ' NZ ' ' HB2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.23 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.733 -177.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 121.076 0.465 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 9' ' ' CYS . 91.7 m-70 -126.72 121.02 30.85 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.403 1.081 . . . . 0.0 108.512 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.45 ' SD ' ' N ' ' A' ' 4' ' ' CYS . 14.2 tmm? -79.97 172.23 14.05 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.024 0.93 . . . . 0.0 109.971 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.45 ' N ' ' SD ' ' A' ' 3' ' ' MET . 0.0 OUTLIER 76.0 156.51 0.15 Allowed Pre-proline 0 N--CA 1.488 1.433 0 C-N-CA 125.55 1.54 . . . . 0.0 110.942 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.61 7.9 3.63 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.821 2.347 . . . . 0.0 113.542 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.422 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -83.72 119.76 25.19 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.9 t -60.13 -47.9 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.83 0.852 . . . . 0.0 111.059 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -90.06 63.02 5.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.744 0.817 . . . . 0.0 109.544 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 2' ' ' HIS . 43.1 t -77.07 75.43 3.64 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.349 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 33' ' ' VAL . 68.7 mt -72.15 107.91 5.06 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 170.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -125.68 94.67 41.9 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.975 0.91 . . . . 0.0 110.261 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.64 148.1 92.45 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.956 2.438 . . . . 0.0 112.565 171.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.3 103.14 2.76 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.671 0.788 . . . . 0.0 109.281 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.98 -129.0 9.4 Favored Glycine 0 C--O 1.242 0.619 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -167.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -129.76 -80.73 0.55 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 53.51 12.22 0.35 Allowed 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 124.545 1.138 . . . . 0.0 112.487 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -142.29 153.23 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 125.116 1.367 . . . . 0.0 108.685 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -76.76 154.99 33.52 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -118.7 150.56 39.53 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.08 110.89 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.215 1.006 . . . . 0.0 108.753 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -88.76 143.5 26.87 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.602 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.8 t -85.42 101.33 12.52 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.19 -25.62 68.16 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.001 0.52 . . . . 0.0 110.384 170.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.18 164.71 9.9 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.653 170.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.9 t -75.07 80.09 2.24 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.623 1.169 . . . . 0.0 111.092 -159.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.8 p -176.01 -26.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.613 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.1 t30 70.2 9.29 6.98 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 124.788 1.235 . . . . 0.0 112.947 169.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -70.28 122.54 19.74 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.332 0.653 . . . . 0.0 111.588 -174.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -79.2 142.08 36.6 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.679 0.791 . . . . 0.0 109.31 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -132.26 120.61 22.39 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 122.847 0.459 . . . . 0.0 110.751 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.648 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -62.33 148.79 44.05 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 165.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -54.04 -41.03 67.62 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.015 0.926 . . . . 0.0 111.597 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 10' ' ' LEU . 27.5 m -80.69 -19.3 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.679 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.648 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 6.4 t -61.9 -36.26 80.78 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 123.311 0.644 . . . . 0.0 111.667 175.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -119.55 -13.93 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.247 1.019 . . . . 0.0 112.09 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.85 9.43 70.52 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-O 119.31 -0.717 . . . . 0.0 114.137 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.422 HG11 ' HB3' ' A' ' 47' ' ' TYR . 90.9 t -66.36 106.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 117.658 0.729 . . . . 0.0 110.096 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 m -64.98 145.41 99.09 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.517 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -47.69 -29.49 11.02 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.875 3.05 . . . . 0.0 114.476 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 35.5 tt0 -63.22 -53.82 47.11 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.061 0.544 . . . . 0.0 110.456 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 70.7 mtm -67.77 -36.76 81.06 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.057 0.543 . . . . 0.0 110.539 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.01 75.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.467 0.707 . . . . 0.0 111.081 176.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -73.13 -40.18 65.13 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.285 0.634 . . . . 0.0 110.237 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 1.2 mmmp? -77.4 -3.66 41.33 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.061 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 71.71 21.14 4.41 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.993 1.317 . . . . 0.0 111.463 174.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -89.78 77.9 6.97 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.568 172.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.422 ' HB3' HG11 ' A' ' 37' ' ' VAL . 35.8 p90 -149.58 1.11 0.51 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.597 175.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.03 135.28 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.1 m -56.89 145.84 28.53 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.588 0.755 . . . . 0.0 111.134 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.6 m -59.95 -32.34 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.667 0.787 . . . . 0.0 112.376 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -69.82 -44.72 69.4 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.143 0.577 . . . . 0.0 110.469 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 75.3 m -62.61 -34.02 76.17 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.851 176.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.7 m -73.69 -49.28 26.6 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.962 0.505 . . . . 0.0 110.852 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 p -67.34 -24.4 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 122.718 0.407 . . . . 0.0 112.058 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -55.06 -43.09 73.53 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -127.31 -35.8 2.17 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.07 0.462 . . . . 0.0 110.894 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 63.51 63.24 1.55 Allowed Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.32 1.448 . . . . 0.0 111.632 -171.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -89.63 -5.53 5.32 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.735 2.29 . . . . 0.0 112.19 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.4 m -72.84 113.73 10.2 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.103 0.961 . . . . 0.0 108.619 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 61.86 -174.28 0.14 Allowed 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 125.036 1.334 . . . . 0.0 110.69 -173.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.556 1.186 0 C-N-CA 123.159 0.584 . . . . 0.0 109.845 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -81.27 119.58 23.82 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.9 ttt -78.2 87.38 4.29 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.001 0.429 . . . . 0.0 110.123 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.407 ' SG ' ' HD1' ' A' ' 30' ' ' PHE . 12.0 t -172.68 67.26 0.38 Allowed Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.08 0.952 . . . . 0.0 109.441 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.38 112.16 2.95 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.541 2.161 . . . . 0.0 111.679 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.47 21.31 2.55 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.964 0.505 . . . . 0.0 111.962 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 85.6 t 62.62 -71.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.862 1.265 . . . . 0.0 110.533 -170.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -89.09 96.93 10.92 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 170.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.584 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 38.4 t -111.15 95.77 5.73 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.99 127.27 32.25 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.433 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.517 ' NE2' ' SG ' ' A' ' 9' ' ' CYS . 1.9 mp0 -99.01 99.95 8.97 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.563 1.145 . . . . 0.0 108.543 175.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.513 ' HG3' HG21 ' A' ' 17' ' ' VAL . 88.3 Cg_endo -76.93 169.16 22.18 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.138 2.559 . . . . 0.0 111.284 170.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -91.34 16.09 10.79 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.299 0.639 . . . . 0.0 111.113 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.07 45.17 27.05 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -174.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.24 -72.19 0.19 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.179 0.992 . . . . 0.0 110.036 -174.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -162.37 25.83 0.11 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.218 0.607 . . . . 0.0 110.678 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.513 HG21 ' HG3' ' A' ' 12' ' ' PRO . 34.9 m -80.46 134.06 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 122.703 0.401 . . . . 0.0 110.258 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -98.24 141.36 31.24 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.774 0.83 . . . . 0.0 108.82 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -106.17 130.91 53.96 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.437 0.695 . . . . 0.0 110.082 -176.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.51 HG11 HG21 ' A' ' 37' ' ' VAL . 7.2 p -114.11 129.69 69.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 C-N-CA 124.735 1.214 . . . . 0.0 108.654 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 40.5 tt0 -103.09 128.96 49.8 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 41.9 t -65.13 -27.21 68.57 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 t70 62.41 -84.71 0.02 OUTLIER 'General case' 0 C--N 1.355 0.842 0 C-N-CA 125.294 1.438 . . . . 0.0 110.891 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.704 ' HA2' ' HA ' ' A' ' 58' ' ' PRO . . . -18.87 -83.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 C-N-CA 126.238 1.875 . . . . 0.0 116.754 -163.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 p -134.23 59.29 1.74 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.261 1.029 . . . . 0.0 108.52 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.534 ' HB3' ' HG2' ' A' ' 28' ' ' GLN . 94.1 m -146.28 -50.7 0.22 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 171.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 64.81 23.69 12.72 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.571 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.534 ' HG2' ' HB3' ' A' ' 26' ' ' CYS . 3.0 pt20 -130.35 142.9 50.51 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 124.376 1.07 . . . . 0.0 109.871 -175.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 12.5 p-90 -100.74 154.35 18.69 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.487 1.115 . . . . 0.0 110.466 -175.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.407 ' HD1' ' SG ' ' A' ' 4' ' ' CYS . 44.0 m-85 -139.34 144.45 38.25 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.324 1.05 . . . . 0.0 108.931 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.605 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -68.47 150.6 47.91 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.071 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -55.08 -39.43 69.26 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.724 0.41 . . . . 0.0 111.31 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 31' ' ' HIS . 31.5 m -67.46 -29.66 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.479 0.712 . . . . 0.0 112.485 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.605 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.4 t -68.63 -46.93 67.91 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.723 0.809 . . . . 0.0 112.393 -174.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.551 HG23 HG23 ' A' ' 37' ' ' VAL . 6.9 m -118.65 16.85 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.793 0.837 . . . . 0.0 111.458 -172.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.82 24.42 69.89 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 114.182 0.433 . . . . 0.0 114.182 174.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 41' ' ' MET . 9.3 t -72.62 121.58 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.178 0.591 . . . . 0.0 110.102 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.3 p -75.31 157.72 84.52 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.094 0.958 . . . . 0.0 109.965 175.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -50.46 -27.17 18.02 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.973 2.449 . . . . 0.0 113.862 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.06 -50.66 65.31 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.944 0.898 . . . . 0.0 110.517 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.575 ' HB2' HG13 ' A' ' 37' ' ' VAL . 25.4 mmt -68.12 -33.38 74.39 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.788 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.19 -16.28 53.28 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.858 0.863 . . . . 0.0 112.239 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -80.87 -48.84 11.82 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.701 0.763 . . . . 0.0 109.473 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -70.27 -43.09 71.18 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.95 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 63.16 22.26 13.29 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.742 1.217 . . . . 0.0 113.444 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -89.31 20.35 3.86 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.076 0.55 . . . . 0.0 110.262 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -75.49 75.04 2.55 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 122.538 1.161 . . . . 0.0 110.736 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.09 105.63 19.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.1 p -58.39 155.83 11.25 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.107 0.563 . . . . 0.0 111.438 -173.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.45 -39.56 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.326 1.05 . . . . 0.0 113.09 -168.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -64.75 -37.34 87.26 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.206 0.603 . . . . 0.0 111.783 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.5 m -69.23 -30.57 68.74 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.229 0.611 . . . . 0.0 111.495 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 m -72.28 -33.92 67.8 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.206 0.602 . . . . 0.0 110.374 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.43 -41.88 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.975 0.91 . . . . 0.0 110.015 173.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.59 -36.84 77.04 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.586 0.754 . . . . 0.0 110.257 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.4 t70 59.1 33.9 23.09 Favored 'General case' 0 CA--C 1.558 1.264 0 O-C-N 124.461 1.1 . . . . 0.0 109.871 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.2 86.38 25.33 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.862 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.704 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 61.6 Cg_endo -86.17 160.63 9.98 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.63 2.22 . . . . 0.0 111.0 168.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.0 t -79.98 78.41 6.6 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -125.32 20.57 8.06 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.295 1.038 . . . . 0.0 110.13 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt . . . . . 0 C--O 1.255 1.355 0 C-N-CA 123.552 0.741 . . . . 0.0 109.888 -176.559 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.8 p . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -73.92 147.9 42.71 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 ptm -84.07 -10.9 57.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.799 0.44 . . . . 0.0 110.543 173.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 50.2 t -169.65 132.64 1.11 Allowed Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.669 0.788 . . . . 0.0 109.681 -170.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 17.2 Cg_exo -66.83 -20.52 51.82 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.277 2.651 . . . . 0.0 113.976 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.96 114.47 15.78 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -173.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -60.03 -39.77 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.732 0.813 . . . . 0.0 111.435 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 t -85.23 104.48 15.13 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 166.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.4 t -145.0 106.61 4.24 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.584 0.354 . . . . 0.0 110.054 -176.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.5 mt -69.83 153.11 43.76 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.319 168.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -110.78 88.78 8.36 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.79 169.31 22.5 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.524 2.15 . . . . 0.0 111.615 173.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -80.11 111.09 16.13 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.61 87.76 0.01 OUTLIER Glycine 0 C--N 1.349 1.289 0 O-C-N 123.842 0.714 . . . . 0.0 114.053 -175.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -174.1 -61.64 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.559 1.143 . . . . 0.0 109.471 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -99.9 23.93 9.13 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.264 1.031 . . . . 0.0 110.544 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.0 t -80.89 127.71 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.078 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -99.96 141.2 33.11 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 11.0 m0 -116.64 174.24 6.18 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.068 0.947 . . . . 0.0 110.432 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.39 133.62 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.819 1.248 . . . . 0.0 108.765 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -77.89 141.21 39.21 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.356 0.662 . . . . 0.0 109.582 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.2 t -106.37 66.82 0.71 Allowed 'General case' 0 C--O 1.248 1.022 0 CA-C-O 121.223 0.535 . . . . 0.0 109.642 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -81.18 25.81 0.47 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.063 0.545 . . . . 0.0 112.052 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -82.44 35.08 2.64 Favored Glycine 0 C--N 1.355 1.62 0 CA-C-O 119.326 -0.708 . . . . 0.0 113.836 172.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.1 t 82.64 54.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.649 1.58 . . . . 0.0 109.913 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.4 p -164.77 -40.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.545 170.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 65.0 t30 72.71 14.17 5.08 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.074 0.95 . . . . 0.0 111.919 167.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -67.53 127.72 33.78 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.536 0.734 . . . . 0.0 109.753 171.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -89.02 123.12 33.03 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.432 0.693 . . . . 0.0 110.255 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -116.18 148.8 40.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.277 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.62 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -69.51 143.67 53.38 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 166.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 72.1 mt-30 -57.37 -40.61 78.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.712 0.405 . . . . 0.0 111.572 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.2 m -71.95 -23.09 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 123.19 0.596 . . . . 0.0 112.494 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.62 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.4 t -60.53 -46.32 90.6 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.61 0.764 . . . . 0.0 111.051 176.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.552 HG23 HG23 ' A' ' 37' ' ' VAL . 15.7 m -118.9 11.03 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.134 -166.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.63 17.43 76.5 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 114.477 0.551 . . . . 0.0 114.477 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.552 HG23 HG23 ' A' ' 35' ' ' VAL . 56.0 t -71.32 110.77 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.122 0.487 . . . . 0.0 109.983 175.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.8 m -72.66 158.09 87.87 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.839 174.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -48.44 -34.85 26.81 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.798 2.332 . . . . 0.0 113.32 169.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -68.08 -41.98 81.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.199 0.6 . . . . 0.0 111.317 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 87.2 mtp -64.51 -41.04 96.65 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.92 0.488 . . . . 0.0 110.215 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.76 68.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.73 0.812 . . . . 0.0 111.128 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -73.17 -36.11 66.53 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.628 0.771 . . . . 0.0 111.013 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -71.79 -52.41 17.71 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.956 0.902 . . . . 0.0 109.302 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -164.07 -164.96 0.92 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.67 0.788 . . . . 0.0 109.405 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.98 173.81 10.25 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.203 0.601 . . . . 0.0 111.252 174.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -84.89 138.04 32.77 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.387 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.46 117.09 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 172.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.8 p -89.37 168.93 11.84 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.376 0.67 . . . . 0.0 110.647 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.37 -28.02 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.266 0.627 . . . . 0.0 111.856 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -64.67 -36.26 83.69 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.695 0.398 . . . . 0.0 110.514 172.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 24' ' ' GLY . 36.4 m -67.02 -42.99 83.96 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.991 0.516 . . . . 0.0 110.174 170.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.0 m -61.53 -43.83 98.15 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.089 0.556 . . . . 0.0 111.072 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.6 -26.36 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 O-C-N 121.925 -0.485 . . . . 0.0 111.259 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -73.32 -75.24 0.15 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.231 0.612 . . . . 0.0 112.372 177.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -96.43 -40.57 9.03 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -165.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.49 86.43 7.42 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 122.606 0.362 . . . . 0.0 111.26 -171.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.22 144.0 99.5 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.955 2.437 . . . . 0.0 113.059 176.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.2 t -89.46 39.5 0.95 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.033 0.933 . . . . 0.0 109.465 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 69.35 -10.75 0.53 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.844 1.657 . . . . 0.0 114.097 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.2 pttp . . . . . 0 CA--C 1.555 1.155 0 CA-C-O 118.573 -0.727 . . . . 0.0 109.204 -179.465 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.8 p . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 120.719 0.295 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -110.45 -164.75 0.94 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.587 0.755 . . . . 0.0 109.851 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.1 mtm -63.3 135.42 57.03 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.952 0.901 . . . . 0.0 111.471 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 50.71 93.77 0.05 OUTLIER Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 125.693 1.597 . . . . 0.0 112.426 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.11 99.84 0.29 Allowed 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.481 2.787 . . . . 0.0 112.455 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.05 -174.95 4.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.671 0.788 . . . . 0.0 110.763 -174.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.4 m -79.16 82.61 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 121.938 0.875 . . . . 0.0 109.903 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.9 m 70.06 107.83 0.06 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.529 1.532 . . . . 0.0 111.257 -177.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.8 t -76.93 79.69 3.49 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.55 145.84 54.5 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.324 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -109.02 86.75 4.11 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.499 ' HG3' HG21 ' A' ' 33' ' ' VAL . 44.6 Cg_endo -79.76 162.41 24.12 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.044 2.496 . . . . 0.0 112.578 -174.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -118.39 84.89 2.26 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 168.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.83 166.71 26.51 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.384 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.33 -25.03 11.65 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.836 0.854 . . . . 0.0 110.266 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.79 5.94 41.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.486 1.114 . . . . 0.0 111.681 -175.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.6 m -76.64 72.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 123.227 1.489 . . . . 0.0 111.236 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.89 166.19 22.67 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 113.362 -1.745 . . . . 0.0 109.314 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -105.83 127.37 53.07 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.261 0.624 . . . . 0.0 111.109 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.46 130.37 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 124.575 1.15 . . . . 0.0 110.061 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -77.59 153.39 33.3 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.973 0.909 . . . . 0.0 109.955 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.8 t -114.48 51.15 0.9 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.9 0.88 . . . . 0.0 109.691 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -48.27 -55.98 9.18 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.467 1.107 . . . . 0.0 112.744 -170.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -19.65 -56.92 0.01 OUTLIER Glycine 0 C--N 1.373 2.636 0 C-N-CA 126.268 1.889 . . . . 0.0 116.8 -172.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.532 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 26.2 t -165.22 65.51 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 169.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.2 m -156.77 -52.48 0.08 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.562 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 72.92 -6.06 1.77 Allowed 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 125.181 1.392 . . . . 0.0 111.323 -172.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -67.64 150.77 48.32 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.761 1.224 . . . . 0.0 111.131 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -100.26 131.18 46.35 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.758 0.823 . . . . 0.0 110.14 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -128.22 147.11 50.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.856 1.263 . . . . 0.0 108.489 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.592 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -70.4 148.54 48.27 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 165.547 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -57.01 -40.44 76.66 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.553 0.341 . . . . 0.0 110.504 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.499 HG21 ' HG3' ' A' ' 12' ' ' PRO . 21.0 m -69.45 -27.28 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.628 0.771 . . . . 0.0 112.359 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.592 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.8 t -60.38 -35.76 76.49 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 123.888 0.875 . . . . 0.0 110.167 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 m -115.96 6.46 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.165 -171.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.78 49.48 73.91 Favored Glycine 0 C--N 1.357 1.71 0 O-C-N 123.574 0.546 . . . . 0.0 113.539 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.7 t -119.17 137.94 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.152 1.381 . . . . 0.0 109.027 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 38.6 m -74.59 146.88 84.12 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 123.328 0.651 . . . . 0.0 109.989 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.78 -34.36 98.12 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.554 2.169 . . . . 0.0 113.101 174.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -70.4 -32.06 69.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.619 0.368 . . . . 0.0 111.204 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.4 ttt -67.86 -43.55 79.17 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.095 0.558 . . . . 0.0 110.066 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.95 -22.89 67.07 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.517 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -76.71 -43.87 35.74 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.13 0.972 . . . . 0.0 111.007 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -83.03 -22.05 33.66 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -171.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -150.78 165.97 31.89 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.139 0.495 . . . . 0.0 111.101 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -87.18 143.42 27.3 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.32 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -72.66 88.51 1.28 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.252 0.549 . . . . 0.0 109.552 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 66.7 mt -92.61 103.17 14.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 51' ' ' ARG . 19.0 p -81.73 175.03 10.8 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.844 -178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.07 -37.63 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.479 173.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.622 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 49.5 mtt-85 -61.24 -32.48 72.28 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.973 0.509 . . . . 0.0 111.165 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 24.0 m -67.62 -53.94 23.84 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.856 0.462 . . . . 0.0 110.214 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 t -68.93 -33.45 73.75 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.24 -172.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.8 t -73.92 -39.33 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 123.206 0.603 . . . . 0.0 110.667 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -63.5 -27.51 69.32 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 171.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.0 t70 66.11 19.12 11.13 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 124.12 0.968 . . . . 0.0 110.83 171.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 57.19 88.53 0.12 Allowed Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 124.934 1.294 . . . . 0.0 110.681 -170.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.9 -11.97 13.75 Favored 'Trans proline' 0 C--N 1.394 2.947 0 C-N-CA 123.864 3.043 . . . . 0.0 114.25 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.4 t -116.2 94.92 4.85 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 169.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.38 -56.38 14.7 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 174.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 66.7 mttm . . . . . 0 CA--C 1.55 0.979 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.732 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.8 p . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 120.661 0.267 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -83.88 87.64 7.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.593 0.711 . . . . 0.0 110.9 -173.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.688 ' SD ' ' SG ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -136.81 142.01 42.91 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 172.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.688 ' SG ' ' SD ' ' A' ' 3' ' ' MET . 0.1 OUTLIER 56.63 101.08 0.04 OUTLIER Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 124.408 1.083 . . . . 0.0 110.814 -170.488 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -43.76 86.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.398 3.144 0 C-N-CA 125.272 3.982 . . . . 0.0 115.87 -172.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.22 -170.32 2.17 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.072 1.349 . . . . 0.0 109.649 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.5 t -64.97 -57.1 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.125 0.57 . . . . 0.0 109.98 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.2 t -137.86 -22.64 1.07 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.278 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.0 t 69.72 100.93 0.06 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.597 1.159 . . . . 0.0 111.341 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.0 155.36 27.75 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.332 0.653 . . . . 0.0 110.499 171.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -117.94 81.24 15.53 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.411 1.084 . . . . 0.0 109.728 -175.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.13 165.47 11.24 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.587 2.192 . . . . 0.0 112.218 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.13 97.36 3.45 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.606 0.717 . . . . 0.0 109.454 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.94 93.43 0.22 Allowed Glycine 0 C--N 1.345 1.063 0 CA-C-N 114.658 -1.155 . . . . 0.0 114.375 -170.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -158.58 -61.3 0.08 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.525 0.73 . . . . 0.0 109.78 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -100.56 13.76 33.59 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.323 0.649 . . . . 0.0 111.025 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.06 130.84 35.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 123.04 0.536 . . . . 0.0 110.042 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.95 137.78 54.06 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.454 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -121.66 165.31 15.94 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.547 0.739 . . . . 0.0 109.858 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.77 133.24 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.623 -173.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -87.85 113.62 23.68 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 173.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 45.9 t -82.17 82.55 7.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.61 0.764 . . . . 0.0 110.535 -177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.41 1.46 0.78 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.369 1.067 . . . . 0.0 113.26 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.15 -162.7 0.57 Allowed Glycine 0 CA--C 1.539 1.55 0 O-C-N 121.549 -0.72 . . . . 0.0 113.087 162.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.518 ' N ' ' SG ' ' A' ' 52' ' ' CYS . 29.5 p -82.15 69.91 8.97 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.695 0.759 . . . . 0.0 111.134 -171.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.2 p -174.56 -41.16 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.921 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 74.6 -3.19 2.63 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 124.187 0.995 . . . . 0.0 112.607 168.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -77.34 157.89 30.43 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.752 0.821 . . . . 0.0 112.025 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -84.98 133.95 34.25 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.866 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 78.8 m-85 -126.91 158.75 35.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.866 1.266 . . . . 0.0 108.005 176.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.608 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -68.97 152.61 45.05 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 162.564 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -62.62 -35.67 80.31 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.435 0.694 . . . . 0.0 110.018 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.4 m -70.57 -28.9 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.767 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.608 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 5.0 t -60.7 -41.54 95.39 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 123.698 0.799 . . . . 0.0 111.415 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 37' ' ' VAL . 5.4 m -96.64 -19.7 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.086 0.955 . . . . 0.0 111.598 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.91 15.75 79.58 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.238 0.336 . . . . 0.0 113.32 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 35' ' ' VAL . 78.2 t -79.46 140.43 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.781 0.832 . . . . 0.0 109.826 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 m -67.7 148.49 98.53 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.687 0.795 . . . . 0.0 111.134 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.99 -48.37 16.52 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.895 3.063 . . . . 0.0 115.071 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -61.14 -49.78 75.85 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 120.956 0.408 . . . . 0.0 110.419 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.644 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 93.0 mmm -58.69 -35.77 73.15 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.304 -177.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . . . -71.49 -36.61 71.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.939 0.896 . . . . 0.0 111.824 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -89.33 -29.62 19.01 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 122.846 0.459 . . . . 0.0 111.989 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -127.73 -45.2 1.47 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.7 0.8 . . . . 0.0 112.637 -159.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.644 ' HB2' ' HA ' ' A' ' 41' ' ' MET . 22.4 mm-40 -112.81 -144.38 0.39 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.256 0.623 . . . . 0.0 110.798 -167.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.86 139.84 53.13 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.424 0.69 . . . . 0.0 111.231 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.402 ' HB3' ' HA ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -146.66 27.97 1.08 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.891 1.277 . . . . 0.0 109.817 178.359 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.46 120.0 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.651 1.18 . . . . 0.0 109.545 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.6 p -78.22 167.2 21.76 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.356 0.662 . . . . 0.0 110.883 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.99 -39.46 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 124.132 0.973 . . . . 0.0 112.549 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -41.83 85.88 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.494 1.117 . . . . 0.0 110.269 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 25' ' ' SER . 18.3 m -64.47 -49.5 71.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.812 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.8 t -66.8 -28.46 68.4 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -173.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 82.0 t -72.36 -33.41 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.108 0.563 . . . . 0.0 110.732 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -71.27 -43.67 66.74 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.084 0.554 . . . . 0.0 110.912 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.87 -27.66 65.01 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.957 0.903 . . . . 0.0 111.641 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.42 78.26 11.16 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.389 0.676 . . . . 0.0 109.637 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.24 85.36 1.56 Allowed 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.69 2.26 . . . . 0.0 111.288 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.9 p -54.18 -55.59 26.38 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.913 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -121.88 154.65 36.8 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.358 1.063 . . . . 0.0 108.154 171.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.886 -0.578 . . . . 0.0 109.878 -174.669 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.6 m . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 44.6 m80 64.37 156.36 0.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.147 1.379 . . . . 0.0 112.781 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -85.02 173.64 10.36 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.916 173.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.62 158.15 34.04 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -73.34 69.45 4.11 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.493 2.129 . . . . 0.0 111.68 172.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.458 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -141.75 79.94 1.7 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.338 0.655 . . . . 0.0 109.85 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.7 t 63.76 -69.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 125.528 1.531 . . . . 0.0 110.97 -172.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.1 t -140.26 -83.66 0.24 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 170.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.6 t 147.9 117.16 0.0 OUTLIER 'General case' 0 C--N 1.361 1.102 0 C-N-CA 127.41 2.284 . . . . 0.0 107.344 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.5 mt -56.67 -36.09 69.17 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.806 0.843 . . . . 0.0 111.472 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 57.14 75.14 0.59 Allowed Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.747 1.219 . . . . 0.0 111.365 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -87.2 175.89 4.59 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.496 2.131 . . . . 0.0 111.717 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.5 -24.55 59.02 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.01 171.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.551 ' HA2' HG22 ' A' ' 17' ' ' VAL . . . 78.59 58.9 2.96 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.378 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -82.5 -49.13 10.25 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.163 0.585 . . . . 0.0 110.842 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -131.47 11.68 4.91 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.128 0.971 . . . . 0.0 111.844 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.551 HG22 ' HA2' ' A' ' 14' ' ' GLY . 18.7 m -78.94 124.57 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 118.47 0.577 . . . . 0.0 109.773 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -89.86 136.0 33.3 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 14.0 m0 -99.84 126.34 45.93 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.203 0.601 . . . . 0.0 110.798 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.71 115.55 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 C-N-CA 124.764 1.226 . . . . 0.0 110.297 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -83.78 127.41 33.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.569 0.748 . . . . 0.0 109.933 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.3 t -82.65 108.89 16.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 169.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.11 -80.08 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 24.18 -91.1 0.01 OUTLIER Glycine 0 C--N 1.37 2.442 0 O-C-N 125.104 1.502 . . . . 0.0 115.6 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.409 ' N ' ' SG ' ' A' ' 52' ' ' CYS . 10.5 m -149.98 46.09 0.92 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.748 1.219 . . . . 0.0 109.435 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.5 m -133.77 -61.48 0.8 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.622 0.769 . . . . 0.0 109.431 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 74.14 -2.48 2.78 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.221 1.409 . . . . 0.0 110.941 -172.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -81.73 141.24 33.74 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.73 0.812 . . . . 0.0 110.28 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -87.76 120.3 28.95 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.049 0.94 . . . . 0.0 109.371 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -115.79 124.06 49.8 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 123.172 0.589 . . . . 0.0 109.712 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.619 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -57.68 143.33 41.96 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 167.432 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -62.33 -32.08 72.79 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 118.298 0.499 . . . . 0.0 110.925 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 31' ' ' HIS . 32.8 m -65.73 -29.63 47.58 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 123.221 0.608 . . . . 0.0 111.726 172.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.619 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 3.9 t -68.53 -40.01 80.92 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.521 0.728 . . . . 0.0 111.707 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.52 -2.66 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.525 0.73 . . . . 0.0 112.668 -171.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.29 3.81 54.35 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.814 -0.437 . . . . 0.0 114.058 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.431 HG13 ' HB2' ' A' ' 41' ' ' MET . 53.2 t -70.79 111.93 5.12 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 123.557 0.743 . . . . 0.0 109.453 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.7 m -69.17 156.11 92.22 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 123.611 0.764 . . . . 0.0 110.485 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.88 -32.39 29.84 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 123.402 2.735 . . . . 0.0 113.342 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 37.6 tt0 -57.49 -52.9 63.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.649 1.18 . . . . 0.0 111.807 174.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.431 ' HB2' HG13 ' A' ' 37' ' ' VAL . 25.7 mmt -72.75 -30.95 64.57 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.449 0.643 . . . . 0.0 110.515 -177.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.9 -36.38 67.28 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.666 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -78.91 -36.62 41.63 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.999 0.519 . . . . 0.0 110.395 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 36.7 mmtm -75.17 -20.46 59.33 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.345 0.403 . . . . 0.0 110.587 176.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.524 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 42.8 mt-10 73.09 21.76 3.08 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.093 1.357 . . . . 0.0 112.505 170.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -86.22 21.23 2.09 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.182 0.993 . . . . 0.0 111.74 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.524 ' CE2' ' HA ' ' A' ' 45' ' ' GLU . 11.6 p90 -82.4 25.87 0.59 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.089 0.955 . . . . 0.0 112.184 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.435 HG23 ' HB3' ' A' ' 52' ' ' CYS . 4.5 mp -72.86 119.08 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 173.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.8 m -62.4 159.38 15.51 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.656 0.782 . . . . 0.0 110.418 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 54' ' ' VAL . 99.2 t -60.7 -42.73 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 175.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -62.51 -37.37 85.76 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.555 0.742 . . . . 0.0 111.666 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.435 ' HB3' HG23 ' A' ' 48' ' ' ILE . 5.7 m -64.38 -36.05 82.88 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.753 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.2 m -74.6 -25.62 59.38 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.277 0.631 . . . . 0.0 110.804 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 50' ' ' VAL . 80.0 t -67.26 -36.76 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 122.87 0.468 . . . . 0.0 110.3 173.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -74.64 -49.39 21.65 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.187 0.595 . . . . 0.0 110.599 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -64.77 -27.23 68.75 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 123.992 0.808 . . . . 0.0 111.313 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.66 82.52 12.46 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.809 0.844 . . . . 0.0 109.535 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.3 -42.42 17.68 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.666 2.244 . . . . 0.0 112.466 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.5 p -166.4 149.5 7.09 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.179 0.592 . . . . 0.0 110.667 174.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -141.58 91.42 2.37 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm . . . . . 0 C--O 1.246 0.921 0 C-N-CA 124.42 1.088 . . . . 0.0 108.217 177.192 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -123.71 6.64 8.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.694 0.798 . . . . 0.0 111.746 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.1 ptp -79.73 80.26 6.14 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 168.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.493 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 4.0 t -168.37 64.72 0.63 Allowed Pre-proline 0 CA--C 1.556 1.2 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.386 -160.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.49 -28.1 53.93 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.608 2.205 . . . . 0.0 113.212 -173.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 50.27 -96.92 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.277 1.431 . . . . 0.0 112.668 -177.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 90.0 t -130.63 -57.65 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.0 t -135.19 107.15 7.07 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 164.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 4' ' ' CYS . 42.3 t -78.78 87.56 4.66 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.094 0.558 . . . . 0.0 111.142 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.07 109.84 5.39 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -106.67 99.17 23.66 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.665 0.786 . . . . 0.0 109.425 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HG2' HG21 ' A' ' 17' ' ' VAL . 88.3 Cg_endo -76.6 -170.61 0.92 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.144 2.563 . . . . 0.0 112.05 174.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -75.1 107.56 7.26 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.27 69.93 3.05 Favored Glycine 0 N--CA 1.467 0.729 0 CA-C-N 115.091 -0.959 . . . . 0.0 113.486 -171.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -92.53 -53.51 4.17 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.732 0.813 . . . . 0.0 109.276 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.71 32.82 0.55 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.595 1.158 . . . . 0.0 110.636 -173.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.541 HG21 ' HG2' ' A' ' 12' ' ' PRO . 43.5 t -68.81 125.97 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.074 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -76.88 135.41 38.84 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 123.675 0.609 . . . . 0.0 109.929 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 35.3 m0 -113.69 171.51 7.53 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.079 0.952 . . . . 0.0 111.121 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.78 118.75 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.057 1.343 . . . . 0.0 108.186 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 62.1 tt0 -76.68 145.86 38.47 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.967 0.507 . . . . 0.0 110.401 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.6 t -75.84 128.45 35.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.021 0.439 . . . . 0.0 111.68 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.645 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . 11.4 t70 -87.07 79.18 8.76 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.14 -179.41 44.75 Favored Glycine 0 C--O 1.239 0.418 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.844 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t -79.73 73.72 6.44 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.539 0.736 . . . . 0.0 109.754 -176.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.7 ' SG ' ' HG2' ' A' ' 28' ' ' GLN . 4.0 p -173.12 -37.58 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.312 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 61.83 17.2 8.62 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.027 1.331 . . . . 0.0 113.215 173.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.7 ' HG2' ' SG ' ' A' ' 26' ' ' CYS . 24.6 pt20 -73.11 134.2 44.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.288 0.635 . . . . 0.0 111.049 -177.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 48.2 m95 -81.43 155.32 25.93 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.022 0.929 . . . . 0.0 110.885 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -138.67 134.18 33.31 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.803 0.841 . . . . 0.0 109.427 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.633 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -62.51 145.86 53.17 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 164.551 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -49.87 -49.47 49.28 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 120.952 0.406 . . . . 0.0 111.199 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -67.06 -25.63 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.414 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.633 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 7.8 t -59.99 -35.18 74.47 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.305 0.642 . . . . 0.0 111.72 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.25 -3.77 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.347 1.059 . . . . 0.0 111.58 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.0 39.58 97.4 Favored Glycine 0 C--N 1.353 1.518 0 C-N-CA 123.602 0.62 . . . . 0.0 114.221 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.46 131.63 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.392 0.677 . . . . 0.0 109.407 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.3 m -68.32 149.32 98.11 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.388 1.075 . . . . 0.0 110.961 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.39 -52.69 6.96 Favored 'Trans proline' 0 C--N 1.393 2.873 0 C-N-CA 123.916 3.077 . . . . 0.0 114.157 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -68.29 -36.77 79.88 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.291 0.636 . . . . 0.0 111.682 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 61.2 mtt -72.67 -31.38 65.02 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.694 0.398 . . . . 0.0 110.884 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.09 -33.66 50.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.489 0.716 . . . . 0.0 110.814 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -76.31 -42.2 45.99 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.301 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -71.9 -58.43 3.46 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.454 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -101.48 106.25 17.34 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.645 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . 4.5 m-20 -56.25 110.2 0.72 Allowed 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.064 173.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -62.29 111.05 1.83 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.081 0.467 . . . . 0.0 110.779 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 41.0 mt -88.85 117.24 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 172.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.3 p -73.23 154.57 40.17 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.3 t -52.52 -44.74 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 124.457 1.103 . . . . 0.0 112.589 -171.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -60.74 -31.74 71.04 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.151 0.58 . . . . 0.0 112.45 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.6 m -76.31 -42.68 44.38 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.333 0.253 . . . . 0.0 111.12 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 m -61.21 -40.8 95.35 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.592 0.757 . . . . 0.0 110.707 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.9 -49.83 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.322 1.049 . . . . 0.0 110.819 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -74.53 -11.88 60.33 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.925 0.49 . . . . 0.0 111.834 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.99 -30.38 71.55 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.617 0.767 . . . . 0.0 110.291 171.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.9 108.23 28.5 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.882 1.273 . . . . 0.0 108.642 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.05 137.15 65.05 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 123.668 2.912 . . . . 0.0 112.033 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.4 m -91.91 14.89 14.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.622 0.769 . . . . 0.0 112.561 -174.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 64.91 118.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.076 1.351 . . . . 0.0 111.779 -178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 90.7 mttt . . . . . 0 C--O 1.252 1.225 0 CA-C-O 118.427 -0.796 . . . . 0.0 109.446 179.058 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.9 p . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -79.4 107.12 11.93 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.213 0.605 . . . . 0.0 109.616 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.474 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 66.3 mtt 59.62 -80.61 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.171 1.389 . . . . 0.0 111.667 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.24 147.61 15.95 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.58 62.63 8.56 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 123.285 2.656 . . . . 0.0 112.304 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.75 177.78 4.72 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.212 176.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.77 -42.57 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 t -133.4 162.9 30.6 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.897 0.879 . . . . 0.0 109.188 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 3' ' ' MET . 28.4 t -153.6 94.46 1.79 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.229 0.538 . . . . 0.0 110.018 170.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.501 HD12 ' HB ' ' A' ' 33' ' ' VAL . 28.0 mt -61.72 -35.18 77.32 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.456 1.102 . . . . 0.0 111.049 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 52.49 65.77 5.72 Favored Pre-proline 0 CA--C 1.552 1.057 0 O-C-N 124.67 1.231 . . . . 0.0 110.071 -171.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.437 ' HG2' HG21 ' A' ' 17' ' ' VAL . 61.4 Cg_endo -83.75 169.77 11.78 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.296 1.997 . . . . 0.0 112.39 -175.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -67.02 120.15 13.16 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.771 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.59 53.05 4.48 Favored Glycine 0 C--N 1.338 0.672 0 O-C-N 123.487 0.492 . . . . 0.0 113.687 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -65.66 -55.15 19.0 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -148.85 59.37 1.06 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.657 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.437 HG21 ' HG2' ' A' ' 12' ' ' PRO . 40.5 t -103.75 118.2 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.11 128.65 33.55 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.102 0.876 . . . . 0.0 109.807 -173.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 26.1 m0 -109.02 165.42 11.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.791 0.836 . . . . 0.0 109.904 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 47' ' ' TYR . 4.3 p -152.77 124.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.671 0.788 . . . . 0.0 109.908 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -72.42 130.14 40.0 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.722 0.409 . . . . 0.0 110.0 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.415 ' O ' HG12 ' A' ' 48' ' ' ILE . 37.2 t -65.75 -49.32 68.8 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.16 0.912 . . . . 0.0 111.552 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 72.64 -43.14 0.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.227 1.411 . . . . 0.0 112.723 -173.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.85 -160.49 0.09 OUTLIER Glycine 0 C--N 1.362 1.98 0 N-CA-C 114.569 0.587 . . . . 0.0 114.569 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.6 p -80.83 72.83 7.84 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.857 0.863 . . . . 0.0 111.706 -165.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.8 p 175.26 -31.68 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.894 2.077 . . . . 0.0 106.997 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 75.33 -43.88 0.51 Allowed 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 126.447 1.899 . . . . 0.0 113.952 172.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -47.9 148.85 1.49 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.389 1.876 . . . . 0.0 114.105 -167.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -74.87 144.74 43.23 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.174 173.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -132.29 128.15 37.15 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.622 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.594 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -67.02 151.64 47.27 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 172.701 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.591 ' HA ' ' HB ' ' A' ' 37' ' ' VAL . 62.6 mt-30 -56.37 -41.01 75.49 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.053 0.454 . . . . 0.0 110.204 174.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 10' ' ' LEU . 18.8 m -71.3 -17.4 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-N 114.849 -1.068 . . . . 0.0 112.669 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.594 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 2.5 t -80.06 -46.48 16.45 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.244 0.618 . . . . 0.0 111.335 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.677 HG23 HG23 ' A' ' 37' ' ' VAL . 2.5 m -119.41 9.78 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 123.654 0.782 . . . . 0.0 112.901 -169.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.01 36.96 92.7 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 122.672 0.177 . . . . 0.0 113.315 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.677 HG23 HG23 ' A' ' 35' ' ' VAL . 10.2 t -78.71 134.55 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.282 0.633 . . . . 0.0 110.995 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.0 p -77.02 153.28 82.68 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.66 0.784 . . . . 0.0 109.778 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.76 -31.53 72.33 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.44 2.094 . . . . 0.0 112.039 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -57.57 -52.35 65.75 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.548 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.585 ' HB2' HG13 ' A' ' 37' ' ' VAL . 26.1 mmt -66.44 -36.89 83.92 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 123.543 0.527 . . . . 0.0 111.516 -176.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.21 -30.37 68.53 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.109 0.564 . . . . 0.0 111.781 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -89.44 -29.29 19.13 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.151 0.58 . . . . 0.0 111.265 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -83.18 -20.71 34.15 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.558 0.743 . . . . 0.0 111.085 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 69.41 -161.92 0.18 Allowed 'General case' 0 C--N 1.361 1.095 0 O-C-N 124.419 1.075 . . . . 0.0 108.658 -170.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 69.27 3.57 4.18 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.633 1.173 . . . . 0.0 113.036 171.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.476 ' HB3' HG21 ' A' ' 20' ' ' VAL . 93.3 t80 -74.39 98.53 3.3 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 22' ' ' CYS . 44.7 mt -100.0 135.45 35.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 165.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -56.06 129.93 41.92 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 172.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -54.25 -35.12 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.36 0.664 . . . . 0.0 112.66 -167.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -68.65 -35.98 77.97 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.492 0.717 . . . . 0.0 110.988 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 84.2 m -64.68 -31.15 72.25 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.113 0.565 . . . . 0.0 111.384 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.9 m -70.3 -44.09 69.03 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.977 0.417 . . . . 0.0 109.976 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.424 ' O ' ' HE3' ' A' ' 61' ' ' LYS . 60.0 t -69.5 -31.38 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.029 0.932 . . . . 0.0 110.763 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -115.39 28.57 8.59 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.526 0.679 . . . . 0.0 110.102 -175.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -63.36 -40.27 96.81 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.908 0.883 . . . . 0.0 110.368 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.31 84.58 59.32 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.644 1.177 . . . . 0.0 107.867 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.44 89.73 0.4 Allowed 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 123.367 2.711 . . . . 0.0 112.471 -173.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.4 p -122.67 -73.05 0.66 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -165.65 149.39 8.09 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.894 0.878 . . . . 0.0 109.672 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HE3' ' O ' ' A' ' 54' ' ' VAL . 72.5 mmtt . . . . . 0 C--O 1.247 0.942 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.2 p . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 120.578 0.228 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -106.71 107.34 18.3 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.213 0.605 . . . . 0.0 109.905 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.4 mtt -83.75 119.62 25.03 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 170.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.41 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 12.6 t 62.39 82.81 0.21 Allowed Pre-proline 0 N--CA 1.481 1.086 0 O-C-N 124.011 0.819 . . . . 0.0 110.695 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.68 -42.76 0.76 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.67 2.247 . . . . 0.0 113.303 -174.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 44.87 25.13 0.13 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 125.798 1.639 . . . . 0.0 115.061 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.1 t 60.46 -73.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.908 1.283 . . . . 0.0 109.992 -166.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.3 m -104.81 88.11 2.83 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.157 0.983 . . . . 0.0 108.935 170.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.431 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 42.4 t -79.43 84.62 5.31 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.213 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 33' ' ' VAL . 59.9 mt -64.98 101.6 0.52 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 167.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -112.01 96.52 34.51 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.172 0.989 . . . . 0.0 110.782 -166.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.479 ' HG2' HG21 ' A' ' 17' ' ' VAL . 66.3 Cg_exo -53.66 150.23 29.24 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.056 2.504 . . . . 0.0 112.138 164.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.72 90.0 0.76 Allowed 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 122.027 0.918 . . . . 0.0 110.765 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.2 -149.46 32.48 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 114.497 -1.229 . . . . 0.0 113.475 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -101.07 82.64 2.39 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.026 0.93 . . . . 0.0 108.903 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -127.84 10.84 6.57 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.568 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.479 HG21 ' HG2' ' A' ' 12' ' ' PRO . 15.8 m -135.83 168.61 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.407 0.683 . . . . 0.0 111.733 -173.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -74.68 139.44 43.51 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.176 173.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -116.27 175.43 5.56 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.864 0.866 . . . . 0.0 109.96 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.435 HG11 HG11 ' A' ' 37' ' ' VAL . 12.7 p -161.08 138.21 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.183 0.993 . . . . 0.0 108.856 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -101.48 142.56 32.67 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 40.1 t -114.08 77.63 1.08 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.214 0.606 . . . . 0.0 110.671 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -78.78 80.8 5.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.81 -65.55 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.093 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.673 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 13.6 m -152.8 56.39 0.79 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.902 0.858 . . . . 0.0 109.233 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.0 m -161.61 -53.1 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 174.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.23 11.78 4.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.222 1.809 . . . . 0.0 113.467 173.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -107.04 166.61 10.49 Favored 'General case' 0 C--O 1.246 0.899 0 C-N-CA 123.419 0.688 . . . . 0.0 109.767 177.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -87.16 137.59 32.21 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.062 169.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -131.32 132.8 44.77 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.318 1.047 . . . . 0.0 108.884 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.635 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -56.99 147.03 25.08 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.836 0.854 . . . . 0.0 108.835 170.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -56.64 -45.18 81.71 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.153 0.981 . . . . 0.0 111.115 -173.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.416 ' O ' HD12 ' A' ' 10' ' ' LEU . 12.1 m -71.33 -29.57 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.722 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.635 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 13.2 t -54.17 -53.29 55.5 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.31 0.644 . . . . 0.0 112.556 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.1 m -96.12 -5.24 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.637 0.775 . . . . 0.0 111.06 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.74 37.52 94.96 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.612 -177.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.435 HG11 HG11 ' A' ' 20' ' ' VAL . 13.7 p -69.3 144.36 14.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.564 0.746 . . . . 0.0 110.684 -177.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.2 m -58.33 130.7 84.33 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.369 172.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -53.71 -26.71 39.33 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.241 2.627 . . . . 0.0 112.342 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.58 -52.17 64.47 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.788 0.835 . . . . 0.0 110.397 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.1 mmt -72.41 -30.65 64.84 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.088 0.555 . . . . 0.0 111.42 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.93 -44.83 83.97 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.798 0.839 . . . . 0.0 111.029 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -74.74 -25.8 59.35 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.549 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -75.73 -20.09 58.59 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 67.37 14.68 9.74 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.431 1.492 . . . . 0.0 112.303 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -134.96 89.23 2.5 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -171.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -119.42 106.84 12.65 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.914 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 48' ' ' ILE . 3.1 mp -106.98 110.2 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.7 m -57.92 158.05 7.02 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.958 0.503 . . . . 0.0 110.903 -176.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.8 -38.04 63.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 122.974 0.51 . . . . 0.0 110.428 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -56.78 -49.0 76.61 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.866 0.866 . . . . 0.0 111.251 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.673 ' SG ' ' HB2' ' A' ' 25' ' ' SER . 86.4 m -71.32 -27.1 63.16 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.095 0.958 . . . . 0.0 112.412 -174.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.8 m -85.19 -53.22 5.39 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.313 0.645 . . . . 0.0 110.678 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.62 -21.3 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.076 0.55 . . . . 0.0 111.421 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.63 -41.33 98.96 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-N 117.805 0.275 . . . . 0.0 110.723 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -163.15 -54.58 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.54 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 67.36 112.49 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 125.065 1.346 . . . . 0.0 110.721 -172.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.55 47.97 2.69 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.044 2.496 . . . . 0.0 111.853 171.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.6 m -86.09 -12.53 49.82 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.061 0.944 . . . . 0.0 112.138 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -75.4 82.87 2.49 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.244 0.618 . . . . 0.0 109.784 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.8 mttm . . . . . 0 CA--C 1.552 1.044 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.072 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -94.06 87.84 5.46 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.679 0.792 . . . . 0.0 109.801 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -69.97 -42.07 73.62 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 167.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.0 t -171.1 91.5 0.45 Allowed Pre-proline 0 CA--C 1.551 0.999 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.534 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 72.8 Cg_endo -76.01 -38.86 1.05 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.73 2.287 . . . . 0.0 112.341 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 48.58 23.22 0.59 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 126.159 1.783 . . . . 0.0 115.79 169.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.4 t 62.5 -74.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 125.126 1.37 . . . . 0.0 110.278 -171.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.7 m -108.64 80.84 1.38 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.354 1.062 . . . . 0.0 108.464 174.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 41.8 t -84.56 87.79 7.28 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.736 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.5 mt -65.76 111.29 3.16 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 164.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -102.7 102.41 26.37 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.046 0.938 . . . . 0.0 110.456 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.23 -179.48 5.06 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 122.706 2.271 . . . . 0.0 110.848 164.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.46 23.5 10.99 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.396 0.679 . . . . 0.0 110.625 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.21 35.42 92.05 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.82 -63.97 0.98 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.377 1.471 . . . . 0.0 110.814 -169.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -142.54 19.42 2.03 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.81 1.244 . . . . 0.0 108.29 171.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 t -79.18 123.95 36.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.259 -164.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 32' ' ' GLN . 34.2 m-20 -83.19 146.72 28.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.524 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -115.5 128.4 55.97 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.336 0.655 . . . . 0.0 109.292 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.557 HG21 ' HB2' ' A' ' 47' ' ' TYR . 5.3 p -103.86 126.27 58.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 123.608 0.763 . . . . 0.0 109.91 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -85.64 127.03 34.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.99 0.916 . . . . 0.0 108.973 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.8 t -85.49 80.94 8.9 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.01 -26.98 61.18 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.889 0.876 . . . . 0.0 112.258 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.534 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -71.57 104.61 1.48 Allowed Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.783 -1.009 . . . . 0.0 111.266 167.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.613 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 21.7 m 52.45 47.58 24.41 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.714 1.606 . . . . 0.0 113.558 161.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.0 m -161.77 -62.44 0.05 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.156 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.1 t30 70.42 3.51 4.51 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.186 1.394 . . . . 0.0 110.841 -173.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -87.06 143.25 27.41 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.977 0.911 . . . . 0.0 110.283 -172.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -87.63 112.24 22.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.988 0.915 . . . . 0.0 110.023 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -107.96 140.57 40.91 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.852 0.861 . . . . 0.0 109.059 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.598 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -68.63 154.55 41.7 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.031 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 27.2 tt0 -52.33 -50.11 62.94 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.071 1.348 . . . . 0.0 111.047 -177.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.9 m -72.08 -28.58 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 114.33 -1.304 . . . . 0.0 112.098 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.598 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.9 t -58.14 -49.46 76.91 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.813 0.845 . . . . 0.0 111.931 -175.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 m -95.63 2.57 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.462 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.72 19.89 76.99 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.247 0.342 . . . . 0.0 113.895 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.43 121.57 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.0 m -72.33 158.13 88.02 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.368 0.667 . . . . 0.0 110.325 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.93 -39.65 68.53 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.263 2.642 . . . . 0.0 113.371 176.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -64.24 -44.35 92.11 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.172 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 56.7 mtt -63.33 -48.19 79.05 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.756 0.822 . . . . 0.0 110.073 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.32 -26.95 68.71 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.573 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -83.97 -51.03 7.47 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.247 0.619 . . . . 0.0 111.125 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -91.4 -60.22 1.94 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.47 0.308 . . . . 0.0 110.714 -168.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -166.41 152.15 8.5 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.493 0.717 . . . . 0.0 111.957 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.7 t0 68.09 103.42 0.05 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.077 1.751 . . . . 0.0 112.807 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.557 ' HB2' HG21 ' A' ' 20' ' ' VAL . 3.2 p90 -150.93 14.52 0.73 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.47 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 52.6 mt -82.16 122.84 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.752 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 p -65.26 148.3 51.93 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.312 0.383 . . . . 0.0 110.367 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.7 t -45.25 -42.07 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 125.821 1.648 . . . . 0.0 113.275 -171.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -53.96 -50.01 67.46 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.885 0.874 . . . . 0.0 111.927 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 25' ' ' SER . 61.5 m -76.7 -24.97 53.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.581 -175.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.7 m -68.54 -47.53 66.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.313 0.645 . . . . 0.0 110.473 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.27 -29.99 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.925 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -62.31 -66.09 0.59 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.262 0.625 . . . . 0.0 110.423 173.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -172.74 -55.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.941 0.776 . . . . 0.0 109.718 -175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 61.65 80.75 0.25 Allowed Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 124.657 1.223 . . . . 0.0 109.835 -167.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.36 81.49 0.96 Allowed 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.904 2.403 . . . . 0.0 112.704 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.4 m -101.78 7.0 41.93 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.691 170.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -64.97 155.8 33.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.181 1.392 . . . . 0.0 110.642 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 123.98 0.912 . . . . 0.0 111.082 -176.691 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.9 p . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -83.4 64.1 7.65 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.43 0.692 . . . . 0.0 110.322 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.427 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 1.1 mpt? 62.14 0.9 0.62 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.745 1.618 . . . . 0.0 114.484 173.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.87 123.13 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 C-N-CA 124.002 0.921 . . . . 0.0 111.03 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -64.45 85.18 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 123.005 2.47 . . . . 0.0 112.783 -175.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.16 171.14 13.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.761 1.224 . . . . 0.0 109.967 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.04 -38.86 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.597 0.759 . . . . 0.0 110.949 -175.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.9 p -156.68 109.76 2.6 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.605 0.762 . . . . 0.0 109.097 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 3' ' ' MET . 42.4 t -88.41 109.17 19.79 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.983 0.421 . . . . 0.0 110.75 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.713 HD21 HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -69.57 158.55 35.05 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.478 164.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -102.42 93.64 4.22 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 171.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.64 112.95 1.93 Allowed 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.315 2.01 . . . . 0.0 110.897 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -85.87 52.12 2.39 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 122.718 1.246 . . . . 0.0 110.722 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 157.04 142.89 3.51 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 113.171 -1.832 . . . . 0.0 110.704 -173.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.84 22.59 0.75 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.207 1.003 . . . . 0.0 111.775 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -74.33 -16.32 60.92 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.454 1.102 . . . . 0.0 111.788 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -80.19 137.42 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -90.7 151.7 21.14 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -103.24 152.37 21.57 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.609 0.764 . . . . 0.0 110.607 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.54 124.29 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.014 1.326 . . . . 0.0 108.276 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 35.4 tt0 -85.29 141.83 29.8 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.63 151.69 46.87 Favored 'General case' 0 CA--C 1.552 1.023 0 O-C-N 123.624 0.577 . . . . 0.0 111.863 -167.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -71.74 -44.34 64.26 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.7 1.6 . . . . 0.0 112.715 -174.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.518 ' HA3' ' SG ' ' A' ' 52' ' ' CYS . . . -84.01 -129.06 1.66 Allowed Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.656 -167.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -120.31 75.63 1.12 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.8 m -114.17 -27.99 7.46 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.888 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.5 t30 77.3 -37.17 0.25 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.271 1.429 . . . . 0.0 112.208 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -85.16 148.59 26.03 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.614 0.721 . . . . 0.0 112.537 -166.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 12.0 p-90 -104.16 139.02 39.8 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.324 171.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 42.3 m-85 -123.11 162.98 21.42 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 124.413 1.085 . . . . 0.0 108.251 -175.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.64 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -69.24 146.79 52.04 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 160.202 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -58.35 -41.32 84.39 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.294 0.497 . . . . 0.0 110.707 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.713 HG23 HD21 ' A' ' 10' ' ' LEU . 27.8 m -67.47 -25.67 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.711 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.64 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.5 t -58.6 -39.12 79.51 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 123.835 0.854 . . . . 0.0 111.433 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.4 m -104.92 -0.97 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.998 0.919 . . . . 0.0 111.622 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.26 16.12 80.04 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 116.491 -0.322 . . . . 0.0 113.825 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.9 t -90.5 136.55 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.23 0.612 . . . . 0.0 109.802 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.0 m -90.34 152.44 45.61 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.814 0.846 . . . . 0.0 110.117 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -47.04 -56.74 2.78 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.898 3.065 . . . . 0.0 114.622 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.27 -27.88 67.56 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.913 0.485 . . . . 0.0 111.722 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.6 mtt -74.35 -31.27 62.35 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 122.614 0.365 . . . . 0.0 110.201 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.55 -35.3 60.69 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.347 0.659 . . . . 0.0 111.343 176.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.17 -48.87 12.47 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.585 0.754 . . . . 0.0 111.213 -176.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.34 -25.82 19.23 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.334 0.653 . . . . 0.0 112.046 -171.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -123.82 170.03 10.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.249 0.619 . . . . 0.0 110.204 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -85.48 123.71 31.22 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.627 178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -88.44 48.91 1.7 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.404 1.081 . . . . 0.0 110.911 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.1 mt -73.36 105.29 2.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.861 -177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 51' ' ' ARG . 2.3 p -69.16 162.22 27.49 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.012 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 54' ' ' VAL . 67.1 t -54.2 -42.27 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.45 0.7 . . . . 0.0 111.122 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.525 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 2.8 mpt_? -58.41 -40.64 83.03 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.679 0.791 . . . . 0.0 111.494 176.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.518 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 35.0 m -72.34 -35.22 68.5 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.296 0.238 . . . . 0.0 111.578 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.1 m -70.33 -47.57 60.48 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.645 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 50' ' ' VAL . 13.6 p -84.87 -44.5 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -174.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -84.1 -35.82 23.43 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 120.736 0.303 . . . . 0.0 110.206 -167.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 59.7 m-20 -90.72 35.05 0.89 Allowed 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.538 0.685 . . . . 0.0 110.404 177.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.76 98.3 5.31 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.772 1.229 . . . . 0.0 107.819 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.59 101.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.895 3.063 . . . . 0.0 113.693 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.1 m -142.09 141.55 32.74 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.681 0.792 . . . . 0.0 110.103 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -80.09 104.04 10.38 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.4 mttm . . . . . 0 CA--C 1.552 1.057 0 O-C-N 124.808 1.317 . . . . 0.0 110.265 -174.877 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -66.34 153.31 43.0 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 169.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.469 ' SD ' ' SG ' ' A' ' 4' ' ' CYS . 1.4 tmt? 80.3 -41.95 0.21 Allowed 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 125.235 1.414 . . . . 0.0 110.698 -175.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.609 ' SG ' ' HA ' ' A' ' 11' ' ' GLN . 9.3 m -128.19 74.58 79.33 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.542 0.737 . . . . 0.0 110.916 175.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -93.16 -23.26 0.3 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.412 2.742 . . . . 0.0 114.847 -175.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 9' ' ' CYS . . . -63.53 147.99 49.93 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.158 0.583 . . . . 0.0 110.347 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -55.59 -34.04 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.933 0.893 . . . . 0.0 112.559 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.5 m -127.01 100.16 6.01 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 169.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.548 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 8.7 t -142.6 25.64 1.82 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.987 -166.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.462 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 21.1 mt 59.05 -65.16 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 165.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.609 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 27.5 mt-30 82.83 59.58 0.09 OUTLIER Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 127.597 2.359 . . . . 0.0 110.701 -168.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HD3' ' H ' ' A' ' 11' ' ' GLN . 24.8 Cg_endo -93.86 96.04 0.13 Allowed 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.171 2.581 . . . . 0.0 110.908 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.12 83.97 2.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.43 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.38 122.52 1.1 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.593 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -65.45 -19.63 66.02 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.864 0.866 . . . . 0.0 111.956 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -77.09 1.53 17.81 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.853 0.861 . . . . 0.0 112.181 -174.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.6 m -79.39 137.35 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.023 0.44 . . . . 0.0 110.296 175.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -94.58 149.25 21.43 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.616 1.167 . . . . 0.0 110.148 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 1.0 OUTLIER -119.01 161.28 20.49 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.739 0.816 . . . . 0.0 111.419 -171.192 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.69 136.68 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.674 1.19 . . . . 0.0 108.255 171.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.42 ' HG2' ' H ' ' A' ' 23' ' ' ASP . 61.9 tt0 -76.4 152.25 36.31 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.26 0.624 . . . . 0.0 109.536 177.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.4 t -76.22 -21.26 56.62 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' H ' ' HG2' ' A' ' 21' ' ' GLN . 30.5 t70 76.26 -48.6 0.57 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.156 1.383 . . . . 0.0 112.292 -177.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.534 ' HA3' ' SG ' ' A' ' 52' ' ' CYS . . . -57.41 178.8 0.94 Allowed Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.246 0.859 . . . . 0.0 115.246 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.8 m -65.47 -23.73 66.99 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.454 0.702 . . . . 0.0 112.456 -168.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.3 p -67.2 -34.42 77.46 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.062 0.545 . . . . 0.0 110.017 174.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 65.33 12.68 8.27 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 125.11 1.364 . . . . 0.0 113.466 166.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -73.16 141.92 47.43 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.315 1.046 . . . . 0.0 112.063 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -92.6 118.12 30.68 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.092 0.957 . . . . 0.0 109.589 175.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -110.94 126.93 55.26 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.01 0.924 . . . . 0.0 109.229 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -53.06 123.69 12.33 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.386 0.675 . . . . 0.0 111.572 175.09 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 47.8 mt-30 -52.31 -47.22 66.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.34 1.456 . . . . 0.0 112.697 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 m -58.24 -36.58 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.609 0.719 . . . . 0.0 110.955 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 0.1 OUTLIER -74.72 -39.3 61.98 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.882 -175.057 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.454 HG23 HG23 ' A' ' 37' ' ' VAL . 35.1 m -100.94 6.57 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.563 -173.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.05 3.18 88.09 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 114.71 0.644 . . . . 0.0 114.71 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 32' ' ' GLN . 88.1 t -79.74 125.86 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.422 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 25.2 m -93.22 165.57 18.13 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 123.894 0.878 . . . . 0.0 109.965 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 38' ' ' SER . 10.9 Cg_endo -51.81 -52.19 9.51 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 123.174 2.583 . . . . 0.0 114.401 -174.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.08 -27.74 64.85 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.322 0.249 . . . . 0.0 111.628 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.1 mtt -69.15 -36.92 77.94 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.775 0.43 . . . . 0.0 110.53 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.34 -31.39 63.95 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.21 1.004 . . . . 0.0 110.603 176.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -70.95 -36.47 72.62 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.391 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -76.33 -52.48 9.85 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.367 0.667 . . . . 0.0 110.64 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -138.72 139.14 38.27 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.321 1.048 . . . . 0.0 109.52 -172.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -72.8 176.29 5.74 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 122.695 0.398 . . . . 0.0 109.937 171.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -88.54 77.5 8.0 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 175.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.22 105.61 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.8 p -73.07 160.48 31.96 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.229 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.6 p -52.95 -39.67 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.434 1.094 . . . . 0.0 113.766 -165.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -70.9 -30.57 66.96 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 118.015 0.37 . . . . 0.0 111.449 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.534 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 99.2 m -74.91 -26.21 59.48 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.158 0.583 . . . . 0.0 111.005 173.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.8 m -81.85 -39.01 24.56 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.083 0.553 . . . . 0.0 110.862 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.8 t -76.89 -32.23 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.046 0.939 . . . . 0.0 109.747 176.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -135.51 87.45 2.32 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.082 0.553 . . . . 0.0 110.501 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -91.99 -23.45 19.54 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 166.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.16 88.4 26.21 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 124.004 0.921 . . . . 0.0 109.16 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.48 -23.51 50.37 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.041 2.494 . . . . 0.0 111.995 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.0 t -136.85 104.46 5.49 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -75.12 104.78 5.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.029 0.531 . . . . 0.0 110.418 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.254 1.325 0 C-N-CA 123.946 0.899 . . . . 0.0 110.193 178.468 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -155.79 92.59 1.39 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.118 0.485 . . . . 0.0 109.986 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ttt -154.46 6.85 0.29 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.064 0.946 . . . . 0.0 108.926 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.28 92.21 1.67 Allowed Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -170.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -52.84 -51.14 11.78 Favored 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 124.712 3.608 . . . . 0.0 116.994 -159.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.549 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -60.15 158.51 11.18 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -170.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -75.8 -42.56 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.119 0.568 . . . . 0.0 110.411 176.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.0 p -92.44 52.29 1.89 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.522 1.129 . . . . 0.0 109.115 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -93.35 119.67 32.74 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.196 -167.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.4 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 28.6 mt -69.49 178.48 2.45 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 160.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -115.69 83.0 10.82 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HD3' ' SG ' ' A' ' 34' ' ' CYS . 67.5 Cg_endo -81.89 134.23 8.27 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.098 2.532 . . . . 0.0 112.885 -178.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -148.06 152.61 37.67 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.472 0.709 . . . . 0.0 110.002 175.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.9 -146.7 17.33 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -92.26 78.6 5.12 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.009 0.924 . . . . 0.0 109.798 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 69.1 121.62 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.441 1.496 . . . . 0.0 111.63 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.6 t -89.26 145.66 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.919 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.72 120.81 16.87 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 174.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.625 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 9.5 m95 -118.24 131.04 56.38 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.377 0.671 . . . . 0.0 111.566 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.513 ' HB ' ' HG2' ' A' ' 32' ' ' GLN . 5.7 p -104.35 123.2 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.793 174.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -82.47 137.99 34.49 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 173.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 36.7 t -84.62 81.94 8.64 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 170.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -54.35 -18.59 4.26 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.752 1.221 . . . . 0.0 112.293 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -51.47 177.52 0.07 OUTLIER Glycine 0 C--N 1.351 1.364 0 N-CA-C 114.671 0.628 . . . . 0.0 114.671 167.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.9 p -74.65 72.98 1.99 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.554 1.141 . . . . 0.0 111.18 -171.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 27' ' ' ASN . 9.6 p -178.36 -42.58 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.388 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.402 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 14.5 m120 67.05 31.58 6.8 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 124.038 0.935 . . . . 0.0 110.69 175.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -72.18 121.32 19.12 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.283 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -87.68 108.21 18.99 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.573 0.749 . . . . 0.0 110.996 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -103.8 171.68 7.22 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.941 170.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -108.36 123.58 49.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.324 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.513 ' HG2' ' HB ' ' A' ' 20' ' ' VAL . 78.5 mt-30 -48.79 -56.65 8.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.916 1.286 . . . . 0.0 113.082 -177.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -62.3 -32.28 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-O 121.384 0.611 . . . . 0.0 111.112 -176.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.477 ' HB3' ' CD2' ' A' ' 31' ' ' HIS . 6.5 t -85.53 -20.38 29.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.204 -170.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.8 m -109.4 -16.49 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.093 0.557 . . . . 0.0 111.578 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.46 15.21 35.64 Favored Glycine 0 C--N 1.351 1.399 0 N-CA-C 114.171 0.428 . . . . 0.0 114.171 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.33 129.96 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.285 0.634 . . . . 0.0 109.709 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 88.7 p -82.49 164.45 47.41 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.072 0.549 . . . . 0.0 109.711 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.51 -26.17 70.09 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 121.945 1.763 . . . . 0.0 111.336 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -64.76 -52.22 58.1 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.929 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 66.8 mtt -62.49 -36.04 81.25 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.576 0.75 . . . . 0.0 111.636 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.47 -38.99 85.24 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.49 0.716 . . . . 0.0 112.098 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -85.07 -45.66 11.89 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.896 0.478 . . . . 0.0 111.301 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -68.97 -54.38 15.61 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.356 1.062 . . . . 0.0 110.378 -175.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -111.08 160.6 16.73 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.201 -175.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -85.14 135.35 34.01 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 163.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -73.77 81.94 1.61 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 168.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.7 mt -75.18 104.92 3.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.958 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.9 p -73.84 158.51 34.39 Favored 'General case' 0 C--O 1.252 1.19 0 O-C-N 123.923 0.764 . . . . 0.0 110.3 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 54' ' ' VAL . 18.9 m -52.91 -33.62 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.222 1.009 . . . . 0.0 113.016 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -61.28 -41.65 97.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.798 0.439 . . . . 0.0 111.389 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.8 m -68.78 -36.49 78.37 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.88 0.472 . . . . 0.0 110.818 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.6 m -64.2 -47.78 78.43 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.512 0.725 . . . . 0.0 111.378 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 50' ' ' VAL . 53.2 t -69.77 -38.34 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.269 0.628 . . . . 0.0 110.503 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -68.81 -38.76 80.12 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.919 0.888 . . . . 0.0 112.342 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -152.57 -59.8 0.15 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.43 0.292 . . . . 0.0 110.782 -173.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 63.55 97.01 0.04 OUTLIER Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.793 1.237 . . . . 0.0 110.275 -170.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.79 76.82 0.15 Allowed 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.011 2.474 . . . . 0.0 111.191 173.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.2 t -159.76 157.35 29.23 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.652 -169.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -79.69 139.13 37.48 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.765 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.8 pttp . . . . . 0 CA--C 1.564 1.485 0 C-N-CA 123.726 0.81 . . . . 0.0 109.158 178.227 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -152.69 161.77 42.13 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.008 0.523 . . . . 0.0 110.816 -177.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 49.9 ttp -167.53 157.12 10.34 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.545 1.138 . . . . 0.0 109.253 176.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.5 t -116.1 91.2 31.1 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 123.933 0.893 . . . . 0.0 108.886 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.93 94.31 1.07 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.684 2.923 . . . . 0.0 112.941 -169.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.629 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -158.57 107.52 1.97 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.459 0.704 . . . . 0.0 110.362 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.2 t 60.45 -76.57 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 125.772 1.629 . . . . 0.0 112.021 174.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.6 t -146.35 -27.0 0.42 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.003 0.921 . . . . 0.0 110.734 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.8 t 65.67 81.09 0.21 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.772 1.229 . . . . 0.0 110.478 -177.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 67.3 mt -65.64 -33.67 76.45 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.638 0.775 . . . . 0.0 111.638 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 61.09 74.06 0.55 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.814 1.246 . . . . 0.0 112.224 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.656 ' HD2' ' HD1' ' A' ' 31' ' ' HIS . 60.9 Cg_endo -71.48 122.92 9.05 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.253 1.969 . . . . 0.0 111.302 171.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.5 91.0 1.76 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.465 0.706 . . . . 0.0 109.974 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 167.48 123.49 0.66 Allowed Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.017 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -78.15 -2.5 37.84 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.797 0.839 . . . . 0.0 112.309 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.16 -18.37 64.4 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.043 0.937 . . . . 0.0 112.055 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.85 127.93 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.906 0.384 . . . . 0.0 110.158 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -79.35 145.99 33.12 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.474 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -116.51 124.72 50.61 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.251 0.62 . . . . 0.0 110.947 -174.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.54 121.9 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 124.289 1.036 . . . . 0.0 109.198 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -84.92 153.2 22.99 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.775 0.83 . . . . 0.0 110.004 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 43.7 t -103.2 72.9 1.19 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 165.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -53.1 -31.02 39.82 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.954 0.902 . . . . 0.0 111.437 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -64.51 92.82 0.13 Allowed Glycine 0 CA--C 1.534 1.241 0 CA-C-O 119.295 -0.725 . . . . 0.0 111.829 165.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 72.2 p 50.7 54.03 11.93 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.967 1.707 . . . . 0.0 113.724 164.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 51.7 m -161.76 -56.63 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.942 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 62.15 13.8 6.09 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.949 1.7 . . . . 0.0 112.814 176.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -85.15 138.54 32.32 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -87.62 110.52 20.45 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -99.73 142.79 30.75 Favored 'General case' 0 C--O 1.206 -1.209 0 C-N-CA 123.927 0.891 . . . . 0.0 109.931 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.656 ' HD1' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -89.48 154.31 20.12 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -169.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -43.68 -54.79 4.79 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.75 0.82 . . . . 0.0 112.438 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -76.19 -22.78 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.267 0.627 . . . . 0.0 111.838 -176.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 6' ' ' ALA . 25.1 t -67.93 -31.55 71.39 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.721 0.409 . . . . 0.0 111.518 -178.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.9 m -115.85 -15.25 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.026 0.93 . . . . 0.0 112.098 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.93 37.1 39.54 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 123.333 0.396 . . . . 0.0 112.565 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.9 t -115.43 135.56 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.084 0.954 . . . . 0.0 110.081 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 m -71.41 148.23 93.24 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 123.907 0.883 . . . . 0.0 110.726 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.599 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 39.8 Cg_endo -62.11 -20.76 70.9 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.174 2.583 . . . . 0.0 113.796 -175.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -62.13 -49.34 76.28 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.541 0.736 . . . . 0.0 111.458 173.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 27.0 ttt -74.28 -29.83 61.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.391 1.076 . . . . 0.0 110.265 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 39' ' ' PRO . . . -70.24 -20.75 63.06 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.44 0.696 . . . . 0.0 112.009 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -92.18 -44.68 8.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.923 0.889 . . . . 0.0 110.667 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -73.33 -51.14 18.54 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.51 0.724 . . . . 0.0 112.097 -172.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -115.66 147.28 41.01 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.012 0.925 . . . . 0.0 111.175 -166.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.64 139.01 38.59 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 171.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -76.09 75.93 2.95 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.2 mt -77.88 100.06 2.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.8 p -75.96 148.08 38.41 Favored 'General case' 0 C--N 1.349 0.586 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.8 m -45.7 -35.59 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -165.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -63.38 -45.48 90.94 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.706 0.803 . . . . 0.0 110.699 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 24' ' ' GLY . 60.5 m -73.56 -28.09 61.68 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.693 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.8 m -67.0 -51.32 56.49 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.214 0.606 . . . . 0.0 110.74 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.61 -33.37 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.596 0.759 . . . . 0.0 111.81 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -110.79 35.0 3.67 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.74 0.781 . . . . 0.0 109.569 -175.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.63 69.81 3.93 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 63.15 82.7 0.21 Allowed Pre-proline 0 CA--C 1.551 0.988 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.673 -171.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.74 -7.95 19.87 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.887 2.391 . . . . 0.0 113.562 -172.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.6 t -157.59 145.34 18.75 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.041 0.936 . . . . 0.0 109.03 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -152.55 164.53 37.44 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.559 0.744 . . . . 0.0 110.031 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.6 pttp . . . . . 0 CA--C 1.553 1.066 0 C-N-CA 123.823 0.849 . . . . 0.0 109.856 -175.659 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.8 m . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -82.06 167.09 19.17 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.181 0.592 . . . . 0.0 109.782 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.529 ' SD ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER 48.27 14.23 0.06 Allowed 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 126.116 1.766 . . . . 0.0 115.169 178.727 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.529 ' SG ' ' SD ' ' A' ' 3' ' ' MET . 25.6 p 164.01 113.51 0.02 OUTLIER Pre-proline 0 C--N 1.355 0.808 0 C-N-CA 125.595 1.558 . . . . 0.0 108.134 -176.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -74.07 66.87 5.12 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.65 2.233 . . . . 0.0 111.845 174.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.57 106.85 8.07 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.02 -44.83 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.6 m -72.69 93.47 1.64 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 166.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 51.1 t -139.67 113.13 8.4 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.931 0.492 . . . . 0.0 111.121 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.695 HD11 HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -66.6 146.28 54.67 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 161.889 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -105.33 103.39 42.32 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.41 99.63 0.17 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.358 2.705 . . . . 0.0 112.573 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.23 -24.61 42.96 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.722 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.34 -19.88 56.0 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.308 175.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 72.76 -17.94 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.242 1.417 . . . . 0.0 113.846 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -82.98 67.5 9.09 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.951 0.881 . . . . 0.0 110.335 -171.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.35 138.52 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.69 1.196 . . . . 0.0 108.608 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -80.53 122.89 27.59 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -93.1 174.95 6.97 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.29 0.636 . . . . 0.0 111.036 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.459 ' HB ' HE22 ' A' ' 32' ' ' GLN . 14.8 p -159.98 129.1 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.424 0.69 . . . . 0.0 110.261 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -80.61 126.53 31.37 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.509 ' SG ' ' OD2' ' A' ' 23' ' ' ASP . 31.1 t -75.0 118.39 17.91 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 -164.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.509 ' OD2' ' SG ' ' A' ' 22' ' ' CYS . 4.5 p30 20.36 -71.08 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 127.986 2.514 . . . . 0.0 117.471 171.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.92 -95.24 0.15 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.211 -0.449 . . . . 0.0 113.723 -152.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -79.51 -51.93 8.69 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.197 -0.501 . . . . 0.0 111.598 -163.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.05 -35.5 64.3 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -173.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.2 t30 70.7 -26.83 0.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.284 1.434 . . . . 0.0 114.78 165.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -56.84 147.18 24.05 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.93 0.892 . . . . 0.0 111.562 -171.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -74.99 139.37 42.89 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.679 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -126.34 149.33 49.24 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 172.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.598 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -78.74 148.0 33.18 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 169.35 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.459 HE22 ' HB ' ' A' ' 20' ' ' VAL . 2.6 mp0 -58.77 -34.36 71.34 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.539 0.736 . . . . 0.0 110.424 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.695 HG23 HD11 ' A' ' 10' ' ' LEU . 35.1 m -76.06 -22.25 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.649 176.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.598 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.5 t -70.99 -37.25 72.7 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 123.399 0.68 . . . . 0.0 111.195 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.464 HG23 HG23 ' A' ' 37' ' ' VAL . 6.0 m -118.62 8.64 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.819 0.848 . . . . 0.0 112.338 -172.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.61 29.12 73.72 Favored Glycine 0 C--N 1.353 1.493 0 O-C-N 123.498 0.499 . . . . 0.0 114.262 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.464 HG23 HG23 ' A' ' 35' ' ' VAL . 77.0 t -92.97 143.73 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.57 0.748 . . . . 0.0 109.368 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.0 m -80.42 145.23 58.95 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.341 0.656 . . . . 0.0 109.856 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.89 -38.38 94.63 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.493 2.129 . . . . 0.0 112.221 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.21 -45.7 90.4 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.763 0.825 . . . . 0.0 111.029 173.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 50.2 mmm -60.85 -46.12 91.81 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.135 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.38 -35.6 81.43 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.621 0.768 . . . . 0.0 111.293 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -69.52 -38.75 77.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.42 0.688 . . . . 0.0 111.696 175.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -74.65 -44.24 51.37 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.404 0.681 . . . . 0.0 111.391 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -161.78 153.25 18.64 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.229 1.012 . . . . 0.0 109.755 -172.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -73.92 148.12 42.51 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.96 0.41 . . . . 0.0 111.841 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -72.48 125.85 28.42 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 166.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.2 mt -113.77 125.98 71.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.8 m -66.26 167.29 10.55 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 173.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.1 t -62.28 -48.93 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 173.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 3.6 mpt_? -62.67 -48.25 80.13 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.668 0.387 . . . . 0.0 110.099 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.6 m -48.4 -41.36 28.81 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.717 1.207 . . . . 0.0 112.902 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.693 ' HA ' ' HB2' ' A' ' 57' ' ' ALA . 5.9 t -82.97 -29.86 28.69 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -178.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 50' ' ' VAL . 49.7 t -69.82 -29.68 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.661 0.784 . . . . 0.0 110.847 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 74.0 mmtt -62.54 -63.06 1.34 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -175.06 -28.75 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.555 1.142 . . . . 0.0 110.729 174.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.693 ' HB2' ' HA ' ' A' ' 53' ' ' THR . . . 65.35 78.36 0.26 Allowed Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 124.882 1.273 . . . . 0.0 110.991 -176.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -88.85 173.89 4.07 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.797 2.331 . . . . 0.0 112.221 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.0 p -83.73 -82.09 0.16 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 166.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 177.11 -69.31 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.716 1.206 . . . . 0.0 108.331 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt . . . . . 0 C--O 1.252 1.201 0 C-N-CA 124.605 1.162 . . . . 0.0 108.474 -177.467 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 120.884 0.373 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -98.08 157.5 16.1 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.122 0.569 . . . . 0.0 110.286 175.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.6 ttt 76.31 -39.82 0.37 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.659 1.584 . . . . 0.0 112.207 -175.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.503 ' SG ' ' HD1' ' A' ' 30' ' ' PHE . 25.6 t -149.67 84.28 6.06 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 122.704 0.401 . . . . 0.0 111.766 -177.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.83 45.78 2.05 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.714 2.942 . . . . 0.0 112.972 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.91 129.74 35.73 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 170.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.88 -37.48 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 122.786 0.434 . . . . 0.0 110.683 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.8 p -97.17 69.81 2.33 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 169.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.739 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 21.5 t -84.06 79.07 9.63 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-O 121.078 0.466 . . . . 0.0 110.377 -177.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.1 mt -59.96 139.71 57.23 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.121 172.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -113.42 80.28 4.51 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.06 0.944 . . . . 0.0 109.915 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HG2' HG21 ' A' ' 17' ' ' VAL . 42.5 Cg_endo -86.25 142.87 7.53 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.292 2.661 . . . . 0.0 113.327 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.49 163.02 14.31 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.82 0.848 . . . . 0.0 109.517 172.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.34 152.87 28.86 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.981 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -82.54 -16.38 48.84 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.892 0.877 . . . . 0.0 111.914 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -58.2 -35.44 71.63 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.274 1.03 . . . . 0.0 112.018 -175.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.403 HG21 ' HG2' ' A' ' 12' ' ' PRO . 14.3 m -73.2 83.71 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 122.54 1.162 . . . . 0.0 110.295 172.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.45 140.8 54.09 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.627 -176.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -92.89 156.25 17.07 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.169 0.509 . . . . 0.0 110.91 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -137.87 126.96 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.771 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -77.39 129.26 35.56 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.145 0.978 . . . . 0.0 109.755 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -62.98 -36.87 84.97 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.992 0.517 . . . . 0.0 111.271 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t70 69.39 -72.5 0.1 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.818 1.647 . . . . 0.0 111.264 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.446 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -46.7 90.58 0.01 OUTLIER Glycine 0 C--N 1.353 1.511 0 C-N-CA 124.828 1.204 . . . . 0.0 115.904 -172.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 t 70.44 12.32 7.45 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.35 1.46 . . . . 0.0 112.908 162.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -155.16 -29.11 0.11 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.263 -175.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 80.2 -59.61 0.31 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.274 1.43 . . . . 0.0 111.599 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -4.22 114.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 129.012 2.925 . . . . 0.0 116.978 -173.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -79.86 116.52 20.07 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.187 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.503 ' HD1' ' SG ' ' A' ' 4' ' ' CYS . 50.7 m-85 -100.73 164.94 11.63 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 124.285 1.034 . . . . 0.0 109.696 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.495 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -106.51 149.08 27.46 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -176.812 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -47.97 -51.05 25.26 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.73 1.212 . . . . 0.0 112.643 -174.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.0 m -81.55 -28.45 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.205 0.602 . . . . 0.0 112.554 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.739 ' SG ' ' HA ' ' A' ' 9' ' ' CYS . 52.6 t -62.69 -36.09 81.82 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -174.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 m -114.5 -1.36 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.577 0.751 . . . . 0.0 111.712 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.3 30.66 71.46 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 113.665 0.226 . . . . 0.0 113.665 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.413 HG11 ' HB3' ' A' ' 47' ' ' TYR . 90.4 t -98.48 107.82 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.702 ' HB2' ' SD ' ' A' ' 41' ' ' MET . 45.6 m -73.14 163.1 71.01 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 123.696 0.799 . . . . 0.0 110.822 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -47.85 -45.71 23.65 Favored 'Trans proline' 0 C--N 1.396 3.04 0 C-N-CA 123.635 2.89 . . . . 0.0 114.999 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.85 -32.56 71.03 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 120.634 0.254 . . . . 0.0 111.348 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.702 ' SD ' ' HB2' ' A' ' 38' ' ' SER . 1.2 mpt? -69.76 -44.28 70.49 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.145 0.578 . . . . 0.0 109.94 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.29 69.47 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.587 0.755 . . . . 0.0 111.172 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.76 -48.51 46.32 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.365 1.066 . . . . 0.0 111.248 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -105.04 -61.18 1.51 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.906 -163.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -156.84 148.42 22.46 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -165.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 t70 67.17 76.43 0.29 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.966 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.438 ' H ' HD12 ' A' ' 48' ' ' ILE . 35.8 p90 -148.32 5.18 0.72 Allowed 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.638 177.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.438 HD12 ' H ' ' A' ' 47' ' ' TYR . 4.3 mp -95.09 117.52 39.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.0 p -59.73 147.19 38.67 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 123.297 0.373 . . . . 0.0 111.39 -171.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.6 t -54.9 -37.12 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -158.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -68.1 -27.87 66.85 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.667 0.387 . . . . 0.0 111.395 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 24' ' ' GLY . 82.3 m -79.24 -28.03 42.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.579 0.751 . . . . 0.0 111.154 173.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 m -73.5 -28.91 62.16 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 123.553 0.533 . . . . 0.0 110.196 175.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.1 t -72.21 -52.3 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.689 0.796 . . . . 0.0 109.389 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -94.77 55.47 1.89 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.03 0.919 . . . . 0.0 110.238 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -103.95 21.95 15.45 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.617 1.167 . . . . 0.0 109.396 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 58.77 75.25 0.53 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.264 1.026 . . . . 0.0 110.03 -173.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -74.36 154.05 45.56 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.526 2.15 . . . . 0.0 111.394 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.8 m -72.8 -26.78 61.64 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.547 0.339 . . . . 0.0 110.316 173.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -83.93 115.48 22.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.737 0.815 . . . . 0.0 111.087 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp . . . . . 0 CA--C 1.564 1.497 0 C-N-CA 125.658 1.583 . . . . 0.0 112.739 170.808 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 t . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.76 80.96 0.61 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.101 2.534 . . . . 0.0 112.413 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.31 130.56 19.69 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.475 1.11 . . . . 0.0 108.894 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.43 -55.23 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.227 0.611 . . . . 0.0 109.693 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.7 m -78.12 74.21 4.67 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.499 0.719 . . . . 0.0 109.251 174.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.709 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 19.7 t -97.93 92.29 5.74 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.101 0.477 . . . . 0.0 110.491 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 33' ' ' VAL . 88.3 mt -71.88 113.6 9.09 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.438 172.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -105.27 107.77 59.81 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.47 1.108 . . . . 0.0 109.491 -175.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HG2' ' H ' ' A' ' 14' ' ' GLY . 97.9 Cg_endo -72.12 -145.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.459 2.773 . . . . 0.0 110.953 170.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -68.52 -6.66 26.47 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.669 0.388 . . . . 0.0 111.742 167.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.445 ' H ' ' HG2' ' A' ' 12' ' ' PRO . . . 116.64 -86.14 0.41 Allowed Glycine 0 C--N 1.346 1.122 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 174.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -95.39 66.49 2.85 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.396 1.093 . . . . 0.0 108.841 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -114.8 -58.71 2.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.916 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -86.18 -177.87 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 124.742 1.217 . . . . 0.0 112.065 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.44 ' HB3' HE21 ' A' ' 32' ' ' GLN . 33.2 t70 -98.23 140.93 31.8 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.925 0.49 . . . . 0.0 110.313 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -105.71 -177.96 3.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.492 1.117 . . . . 0.0 110.803 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 37' ' ' VAL . 7.5 p -157.94 136.57 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 125.162 1.385 . . . . 0.0 108.22 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -95.88 112.52 24.23 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.4 t -77.9 91.01 4.13 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -57.24 -80.34 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 O-C-N 123.942 0.776 . . . . 0.0 109.851 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 43.35 -83.8 0.01 OUTLIER Glycine 0 N--CA 1.484 1.883 0 C-N-CA 124.423 1.011 . . . . 0.0 115.309 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.8 p -159.81 26.96 0.18 Allowed 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.999 1.32 . . . . 0.0 110.222 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.8 p -143.11 -41.29 0.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.315 0.646 . . . . 0.0 111.387 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 65.29 19.29 11.64 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.029 0.931 . . . . 0.0 112.101 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -79.82 137.08 36.87 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.217 0.607 . . . . 0.0 111.059 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -86.59 128.61 35.0 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.465 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -129.33 143.39 50.83 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.284 1.034 . . . . 0.0 109.044 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.632 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -69.29 141.35 54.36 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 169.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.44 HE21 ' HB3' ' A' ' 18' ' ' ASP . 48.6 mt-30 -53.32 -40.47 64.84 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.935 0.494 . . . . 0.0 111.369 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.4 ' O ' HD12 ' A' ' 10' ' ' LEU . 33.3 m -65.31 -38.24 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.55 0.74 . . . . 0.0 111.677 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.709 ' SG ' ' HA ' ' A' ' 9' ' ' CYS . 8.4 t -56.29 -50.22 72.02 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.073 0.949 . . . . 0.0 112.047 -175.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.1 m -109.26 5.91 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.283 -174.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.45 52.73 51.39 Favored Glycine 0 C--N 1.355 1.638 0 C-N-CA 123.575 0.607 . . . . 0.0 113.98 174.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.584 HG21 HG11 ' A' ' 20' ' ' VAL . 13.1 t -74.66 119.3 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.054 0.541 . . . . 0.0 109.581 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.616 ' HB2' ' SD ' ' A' ' 41' ' ' MET . 41.7 m -63.14 135.6 96.3 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 123.575 0.547 . . . . 0.0 109.589 175.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.69 -15.43 16.19 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.373 2.716 . . . . 0.0 114.499 -175.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.03 -52.11 18.53 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.616 ' SD ' ' HB2' ' A' ' 38' ' ' SER . 1.4 mpt? -67.61 -33.36 74.83 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.109 0.964 . . . . 0.0 110.405 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.81 -36.37 70.24 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.178 0.991 . . . . 0.0 110.831 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.17 -45.23 85.72 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -70.61 -15.4 62.74 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.951 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 65.34 12.84 8.4 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.921 1.288 . . . . 0.0 110.979 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -102.34 91.61 4.34 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.099 1.359 . . . . 0.0 109.239 -170.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -132.23 106.59 8.04 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.9 mp -100.66 113.22 35.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.5 p -74.26 164.04 27.09 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.903 0.481 . . . . 0.0 110.475 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.4 t -50.54 -47.72 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 124.508 1.123 . . . . 0.0 112.441 -174.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -54.13 -44.12 71.09 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.071 0.549 . . . . 0.0 111.702 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 68.7 m -67.62 -36.11 80.19 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.044 0.537 . . . . 0.0 111.824 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.1 m -74.42 -44.15 53.13 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.181 0.593 . . . . 0.0 110.791 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.3 t -78.11 -16.11 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.229 1.011 . . . . 0.0 111.114 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -117.01 25.28 10.61 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.91 0.862 . . . . 0.0 109.696 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 . . . . . 0 N--CA 1.475 0.787 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.602 173.622 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 82.1 m . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.53 39.34 0.84 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.727 2.285 . . . . 0.0 111.061 162.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.26 108.72 8.93 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.1 t -63.76 -43.88 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 m -70.57 106.3 3.43 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 165.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.6 t -151.27 86.11 1.35 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.725 0.41 . . . . 0.0 111.149 -173.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.4 mt -71.12 114.44 9.18 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 166.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -93.11 107.11 22.7 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.709 1.204 . . . . 0.0 111.033 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.62 178.62 6.88 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.098 2.532 . . . . 0.0 111.052 168.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -74.49 -17.34 60.78 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.338 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.79 143.68 14.77 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.0 t70 58.59 34.04 23.55 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.293 1.044 . . . . 0.0 109.559 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -123.91 -71.96 0.7 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.057 -169.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.1 m -91.74 145.85 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -69.79 150.38 46.94 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.872 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -95.09 -178.12 4.37 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.712 0.805 . . . . 0.0 111.223 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.1 p -153.64 116.44 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.949 1.299 . . . . 0.0 108.706 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 52.0 tt0 -98.66 107.94 20.51 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.548 0.739 . . . . 0.0 109.392 -177.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 8.7 t -79.99 64.49 4.84 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.362 0.665 . . . . 0.0 111.278 -173.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -53.04 -36.3 60.44 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.215 1.406 . . . . 0.0 113.638 -169.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -39.35 -58.09 2.09 Favored Glycine 0 N--CA 1.477 1.392 0 O-C-N 124.865 1.353 . . . . 0.0 115.496 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.482 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 48.2 m -157.61 32.54 0.27 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.375 0.67 . . . . 0.0 110.672 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 75.4 m -132.74 -48.38 0.88 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 173.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 74.37 -6.65 1.83 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.939 1.296 . . . . 0.0 112.383 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -93.75 146.25 24.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.845 0.858 . . . . 0.0 109.882 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 8.3 p-90 -103.5 111.81 24.44 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.203 1.001 . . . . 0.0 109.635 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -100.71 163.24 12.42 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.627 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -63.32 145.71 55.0 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 166.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -62.85 -32.24 73.43 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 122.046 -0.409 . . . . 0.0 111.085 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 31' ' ' HIS . 33.5 m -68.73 -26.8 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 C-N-CA 123.105 0.562 . . . . 0.0 111.815 174.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.627 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.2 t -61.43 -55.53 30.27 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 123.958 0.903 . . . . 0.0 111.819 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 37' ' ' VAL . 18.4 m -101.43 -5.22 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.285 -168.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.66 31.86 20.27 Favored Glycine 0 C--N 1.348 1.245 0 O-C-N 123.204 0.315 . . . . 0.0 113.401 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 35' ' ' VAL . 55.0 t -97.3 125.73 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.559 0.744 . . . . 0.0 109.577 175.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.6 m -82.89 159.29 63.44 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 123.891 0.876 . . . . 0.0 110.067 175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -45.82 -50.78 9.17 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.631 2.887 . . . . 0.0 114.439 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 47.5 mt-10 -71.85 -12.95 61.52 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.094 0.558 . . . . 0.0 112.322 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.6 mtt -79.3 -57.09 3.89 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.528 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . . . -61.48 -36.62 80.99 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.94 0.896 . . . . 0.0 112.14 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -87.39 -65.13 1.05 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.901 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 39.5 ttmt -81.68 -48.49 11.63 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.451 0.469 . . . . 0.0 112.215 -163.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -162.32 118.88 2.0 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -167.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.0 t70 61.74 107.18 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.618 1.567 . . . . 0.0 114.067 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.582 ' H ' HD12 ' A' ' 48' ' ' ILE . 42.0 p90 -126.29 12.55 7.63 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 114.297 -1.319 . . . . 0.0 108.677 165.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.582 HD12 ' H ' ' A' ' 47' ' ' TYR . 3.5 mp -85.13 106.16 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.129 -172.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.1 p -61.52 159.86 12.22 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 123.837 0.711 . . . . 0.0 111.771 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.4 t -52.44 -39.68 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.748 1.219 . . . . 0.0 112.538 -172.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 27.4 mmt180 -64.78 -44.83 88.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.316 0.646 . . . . 0.0 111.701 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 25' ' ' SER . 64.7 m -62.71 -38.85 92.08 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.682 0.393 . . . . 0.0 111.075 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.9 m -69.36 -45.13 70.11 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.928 0.891 . . . . 0.0 110.834 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.46 -25.98 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.261 0.624 . . . . 0.0 111.101 -173.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 51' ' ' ARG . 68.2 mttm -56.77 -50.94 70.8 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 123.317 0.385 . . . . 0.0 110.233 173.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 . . . . . 0 N--CA 1.491 1.61 0 C-N-CA 125.243 1.417 . . . . 0.0 113.059 173.138 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.559 1.298 0 CA-C-O 120.471 0.177 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.34 108.33 2.59 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.222 2.615 . . . . 0.0 113.756 -170.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.29 -170.88 2.15 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.148 0.979 . . . . 0.0 109.74 168.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.9 m -54.89 -31.35 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.159 0.984 . . . . 0.0 112.109 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.4 m -147.42 -35.79 0.23 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.202 1.401 . . . . 0.0 109.188 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.3 t 70.18 97.02 0.07 Allowed 'General case' 0 C--N 1.36 1.031 0 C-N-CA 125.231 1.412 . . . . 0.0 109.491 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.4 mt -80.43 100.47 8.51 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -85.78 105.67 7.71 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.378 1.071 . . . . 0.0 108.302 171.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.56 162.39 42.16 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 122.423 2.082 . . . . 0.0 111.112 172.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.75 -22.33 66.48 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.407 0.683 . . . . 0.0 111.677 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.9 136.17 4.45 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.15 66.53 7.78 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.297 1.048 . . . . 0.0 111.16 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.54 -9.23 55.03 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.976 164.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -63.16 151.62 8.27 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 C-N-CA 124.659 1.184 . . . . 0.0 110.143 165.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -85.39 149.3 25.52 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.056 0.455 . . . . 0.0 110.114 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 22.1 m0 -111.75 -179.95 3.84 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.537 1.135 . . . . 0.0 110.83 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -161.75 131.78 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.551 1.14 . . . . 0.0 109.549 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 63.5 tt0 -69.82 149.45 47.9 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.659 0.784 . . . . 0.0 110.067 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 0.7 OUTLIER -127.7 50.12 2.06 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.552 0.741 . . . . 0.0 110.164 -171.303 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -57.53 -21.45 38.26 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.913 1.685 . . . . 0.0 114.564 -174.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.24 -58.59 6.33 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 114.76 0.664 . . . . 0.0 114.76 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.729 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 40.6 m -161.36 60.32 0.28 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 89.5 m -155.85 -45.67 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.939 0.896 . . . . 0.0 108.818 173.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 68.93 20.76 7.78 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.427 1.091 . . . . 0.0 111.652 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -140.48 163.18 33.53 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.829 0.852 . . . . 0.0 109.867 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 23.9 m95 -82.93 151.6 25.86 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.203 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -139.85 141.1 36.67 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.16 1.384 . . . . 0.0 108.395 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.658 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -56.12 144.96 27.42 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.457 0.703 . . . . 0.0 109.285 166.159 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -57.4 -41.05 79.56 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.12 0.418 . . . . 0.0 111.327 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -63.25 -26.22 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.246 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.658 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.6 t -67.59 -45.37 75.7 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.789 0.835 . . . . 0.0 111.913 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.5 m -100.82 -8.59 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.354 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.21 16.02 72.81 Favored Glycine 0 CA--C 1.536 1.392 0 O-C-N 123.358 0.411 . . . . 0.0 113.67 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 68.8 t -84.25 131.56 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 123.649 0.78 . . . . 0.0 109.558 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.4 m -67.8 157.33 86.84 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 123.751 0.82 . . . . 0.0 111.324 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -49.48 -50.79 12.11 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.174 2.583 . . . . 0.0 113.49 174.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.02 -30.74 68.11 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.556 0.742 . . . . 0.0 111.44 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 74.9 mtp -68.34 -47.61 67.04 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.785 0.434 . . . . 0.0 110.351 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.6 -34.5 72.83 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.362 0.665 . . . . 0.0 110.221 176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -75.14 -43.54 51.97 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.522 -176.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -103.55 -59.78 1.67 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -173.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -172.75 165.16 5.33 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.222 0.609 . . . . 0.0 111.636 -170.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.4 t70 63.11 57.71 1.56 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.481 1.112 . . . . 0.0 110.279 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -104.58 6.97 34.97 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.414 -1.267 . . . . 0.0 110.038 168.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.5 mp -78.52 104.24 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -173.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 51' ' ' ARG . 13.0 p -66.37 164.7 15.61 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.556 -175.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.8 t -51.92 -46.15 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.94 0.896 . . . . 0.0 110.699 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.532 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 72.9 mtp180 -53.3 -43.55 67.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 123.937 0.773 . . . . 0.0 112.244 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.729 ' HA ' ' HB2' ' A' ' 25' ' ' SER . 14.5 m -61.09 -47.3 86.95 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.825 0.703 . . . . 0.0 111.109 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.2 m -67.23 -45.21 77.45 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 124.015 0.822 . . . . 0.0 111.185 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.19 -34.2 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.025 0.93 . . . . 0.0 110.828 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -73.17 0.19 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 CA--C 1.538 0.499 0 C-N-CA 123.706 0.802 . . . . 0.0 109.944 -172.927 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.565 1.529 0 N-CA-C 110.744 -0.095 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -71.07 60.76 2.42 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.505 2.137 . . . . 0.0 111.922 165.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.55 108.45 2.72 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.437 1.095 . . . . 0.0 108.056 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -66.87 -17.06 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.904 0.882 . . . . 0.0 111.458 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.0 m -86.56 26.35 1.1 Allowed 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.527 1.131 . . . . 0.0 111.292 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.7 t -77.7 101.97 6.89 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.6 mt -62.3 -27.81 69.3 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.76 0.824 . . . . 0.0 112.297 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 58.8 60.04 5.37 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.342 1.057 . . . . 0.0 111.573 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -81.96 160.78 18.42 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.036 1.824 . . . . 0.0 111.59 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -23.25 59.05 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.614 170.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.47 -76.18 0.17 Allowed Glycine 0 C--N 1.343 0.952 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.3 t70 65.08 14.79 9.61 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.775 1.23 . . . . 0.0 112.359 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 64.86 61.07 0.8 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.084 1.353 . . . . 0.0 110.664 -176.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -101.34 134.99 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 170.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.57 160.99 22.42 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -114.3 164.91 13.28 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.45 0.643 . . . . 0.0 111.066 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 p -153.25 142.76 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.321 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -101.19 121.18 41.39 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.3 t -63.76 141.49 58.75 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.011 0.524 . . . . 0.0 110.155 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.432 ' H ' ' HE1' ' A' ' 47' ' ' TYR . 25.0 t70 -94.4 -78.55 0.44 Allowed 'General case' 0 C--O 1.239 0.509 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 154.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 33.04 -98.61 0.01 OUTLIER Glycine 0 C--N 1.357 1.732 0 O-C-N 125.039 1.462 . . . . 0.0 116.287 172.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.4 t -157.33 15.36 0.26 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.964 0.906 . . . . 0.0 109.898 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 14.1 p -159.21 57.37 0.41 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -49.87 80.49 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.528 1.931 . . . . 0.0 112.275 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -127.91 159.2 35.67 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 125.498 1.519 . . . . 0.0 107.402 170.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -82.16 108.48 15.66 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.491 0.663 . . . . 0.0 109.569 170.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -99.55 155.87 17.35 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.963 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.595 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -71.79 146.44 48.05 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 162.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -69.59 -22.26 63.53 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.36 0.527 . . . . 0.0 111.149 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.2 m -78.04 -19.99 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.366 0.667 . . . . 0.0 111.796 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.595 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 7.2 t -69.65 -28.02 65.54 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.596 0.758 . . . . 0.0 111.567 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 m -116.12 -8.53 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 124.364 1.066 . . . . 0.0 111.608 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.28 5.05 87.65 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 114.188 0.435 . . . . 0.0 114.188 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.2 t -80.12 138.26 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 123.282 0.633 . . . . 0.0 110.43 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 m -86.75 143.33 35.46 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.056 0.942 . . . . 0.0 109.709 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -50.38 -31.03 28.77 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 123.482 2.788 . . . . 0.0 114.407 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -58.24 -54.78 43.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.713 0.805 . . . . 0.0 109.505 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 72.2 mtm -71.99 -30.99 65.81 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.38 0.672 . . . . 0.0 111.47 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.51 -40.75 88.12 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.307 0.643 . . . . 0.0 110.937 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -82.51 -45.22 14.98 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.335 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -70.23 -56.47 6.7 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.885 0.474 . . . . 0.0 111.766 -166.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -174.49 127.68 0.33 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.355 0.662 . . . . 0.0 110.225 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.7 t70 73.16 133.83 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.906 1.682 . . . . 0.0 112.498 172.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.432 ' HE1' ' H ' ' A' ' 23' ' ' ASP . 14.5 p90 -151.25 20.77 0.75 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.569 1.548 . . . . 0.0 108.035 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.7 mt -88.82 133.91 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.273 -165.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.62 157.99 36.51 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.391 0.676 . . . . 0.0 110.627 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.7 m -56.65 -43.74 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.917 0.887 . . . . 0.0 113.072 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -69.8 -36.27 75.54 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.837 0.455 . . . . 0.0 110.869 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 96.3 m -68.41 -30.93 69.94 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.987 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.1 m -72.23 -42.86 65.2 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.268 1.027 . . . . 0.0 110.686 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.7 t -71.43 -32.65 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.076 0.55 . . . . 0.0 111.071 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -72.1 -17.37 61.99 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.825 0.45 . . . . 0.0 111.8 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t70 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 121.279 0.562 . . . . 0.0 110.675 174.361 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 119.957 -0.068 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.61 7.9 3.63 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.821 2.347 . . . . 0.0 113.542 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.422 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -83.72 119.76 25.19 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.9 t -60.13 -47.9 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.83 0.852 . . . . 0.0 111.059 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -90.06 63.02 5.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.744 0.817 . . . . 0.0 109.544 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.1 t -77.07 75.43 3.64 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.349 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 33' ' ' VAL . 68.7 mt -72.15 107.91 5.06 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 170.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -125.68 94.67 41.9 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.975 0.91 . . . . 0.0 110.261 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.64 148.1 92.45 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.956 2.438 . . . . 0.0 112.565 171.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.3 103.14 2.76 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.671 0.788 . . . . 0.0 109.281 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.98 -129.0 9.4 Favored Glycine 0 C--O 1.242 0.619 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -167.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -129.76 -80.73 0.55 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 53.51 12.22 0.35 Allowed 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 124.545 1.138 . . . . 0.0 112.487 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -142.29 153.23 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 125.116 1.367 . . . . 0.0 108.685 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -76.76 154.99 33.52 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -118.7 150.56 39.53 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.08 110.89 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.215 1.006 . . . . 0.0 108.753 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -88.76 143.5 26.87 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.602 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.8 t -85.42 101.33 12.52 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.19 -25.62 68.16 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.001 0.52 . . . . 0.0 110.384 170.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.18 164.71 9.9 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.653 170.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.9 t -75.07 80.09 2.24 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.623 1.169 . . . . 0.0 111.092 -159.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.8 p -176.01 -26.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.613 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.1 t30 70.2 9.29 6.98 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 124.788 1.235 . . . . 0.0 112.947 169.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -70.28 122.54 19.74 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.332 0.653 . . . . 0.0 111.588 -174.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -79.2 142.08 36.6 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.679 0.791 . . . . 0.0 109.31 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -132.26 120.61 22.39 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 122.847 0.459 . . . . 0.0 110.751 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.648 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -62.33 148.79 44.05 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 165.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -54.04 -41.03 67.62 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.015 0.926 . . . . 0.0 111.597 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 10' ' ' LEU . 27.5 m -80.69 -19.3 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.679 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.648 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 6.4 t -61.9 -36.26 80.78 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 123.311 0.644 . . . . 0.0 111.667 175.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -119.55 -13.93 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.247 1.019 . . . . 0.0 112.09 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.85 9.43 70.52 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-O 119.31 -0.717 . . . . 0.0 114.137 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.422 HG11 ' HB3' ' A' ' 47' ' ' TYR . 90.9 t -66.36 106.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 117.658 0.729 . . . . 0.0 110.096 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 m -64.98 145.41 99.09 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.517 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -47.69 -29.49 11.02 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.875 3.05 . . . . 0.0 114.476 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 35.5 tt0 -63.22 -53.82 47.11 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.061 0.544 . . . . 0.0 110.456 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 70.7 mtm -67.77 -36.76 81.06 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.057 0.543 . . . . 0.0 110.539 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.01 75.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.467 0.707 . . . . 0.0 111.081 176.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -73.13 -40.18 65.13 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.285 0.634 . . . . 0.0 110.237 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 1.2 mmmp? -77.4 -3.66 41.33 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.061 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 71.71 21.14 4.41 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.993 1.317 . . . . 0.0 111.463 174.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -89.78 77.9 6.97 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.568 172.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.422 ' HB3' HG11 ' A' ' 37' ' ' VAL . 35.8 p90 -149.58 1.11 0.51 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.597 175.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.03 135.28 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.1 m -56.89 145.84 28.53 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.588 0.755 . . . . 0.0 111.134 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.6 m -59.95 -32.34 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.667 0.787 . . . . 0.0 112.376 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -69.82 -44.72 69.4 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.143 0.577 . . . . 0.0 110.469 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 75.3 m -62.61 -34.02 76.17 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.851 176.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.7 m -73.69 -49.28 26.6 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.962 0.505 . . . . 0.0 110.852 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 p -67.34 -24.4 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 122.718 0.407 . . . . 0.0 112.058 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -55.06 -43.09 73.53 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.6 t70 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 121.07 0.462 . . . . 0.0 110.894 -177.505 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.663 ' HG ' ' HD1' ' A' ' 30' ' ' PHE . 12.0 t . . . . . 0 CA--C 1.558 1.279 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.38 112.16 2.95 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.541 2.161 . . . . 0.0 111.679 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.47 21.31 2.55 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.964 0.505 . . . . 0.0 111.962 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 85.6 t 62.62 -71.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.862 1.265 . . . . 0.0 110.533 -170.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -89.09 96.93 10.92 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 170.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.584 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 38.4 t -111.15 95.77 5.73 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.99 127.27 32.25 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.433 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -99.01 99.95 8.97 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.563 1.145 . . . . 0.0 108.543 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.513 ' HG3' HG21 ' A' ' 17' ' ' VAL . 88.3 Cg_endo -76.93 169.16 22.18 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.138 2.559 . . . . 0.0 111.284 170.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -91.34 16.09 10.79 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.299 0.639 . . . . 0.0 111.113 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.07 45.17 27.05 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -174.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.24 -72.19 0.19 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.179 0.992 . . . . 0.0 110.036 -174.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -162.37 25.83 0.11 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.218 0.607 . . . . 0.0 110.678 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.513 HG21 ' HG3' ' A' ' 12' ' ' PRO . 34.9 m -80.46 134.06 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 122.703 0.401 . . . . 0.0 110.258 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.479 ' HB3' ' NE2' ' A' ' 32' ' ' GLN . 28.9 t70 -98.24 141.36 31.24 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.774 0.83 . . . . 0.0 108.82 174.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -106.17 130.91 53.96 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.437 0.695 . . . . 0.0 110.082 -176.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.51 HG11 HG21 ' A' ' 37' ' ' VAL . 7.2 p -114.11 129.69 69.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 C-N-CA 124.735 1.214 . . . . 0.0 108.654 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 40.5 tt0 -103.09 128.96 49.8 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 41.9 t -65.13 -27.21 68.57 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 t70 62.41 -84.71 0.02 OUTLIER 'General case' 0 C--N 1.355 0.842 0 C-N-CA 125.294 1.438 . . . . 0.0 110.891 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -18.87 -83.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 C-N-CA 126.238 1.875 . . . . 0.0 116.754 -163.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 p -134.23 59.29 1.74 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.261 1.029 . . . . 0.0 108.52 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.534 ' HB3' ' HG2' ' A' ' 28' ' ' GLN . 94.1 m -146.28 -50.7 0.22 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 171.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 64.81 23.69 12.72 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.571 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.534 ' HG2' ' HB3' ' A' ' 26' ' ' CYS . 3.0 pt20 -130.35 142.9 50.51 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 124.376 1.07 . . . . 0.0 109.871 -175.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 12.5 p-90 -100.74 154.35 18.69 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.487 1.115 . . . . 0.0 110.466 -175.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.663 ' HD1' ' HG ' ' A' ' 4' ' ' CYS . 44.0 m-85 -139.34 144.45 38.25 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.324 1.05 . . . . 0.0 108.931 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.605 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -68.47 150.6 47.91 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.071 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.479 ' NE2' ' HB3' ' A' ' 18' ' ' ASP . 72.1 mt-30 -55.08 -39.43 69.26 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.724 0.41 . . . . 0.0 111.31 176.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 31' ' ' HIS . 31.5 m -67.46 -29.66 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.479 0.712 . . . . 0.0 112.485 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.605 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.4 t -68.63 -46.93 67.91 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.723 0.809 . . . . 0.0 112.393 -174.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.551 HG23 HG23 ' A' ' 37' ' ' VAL . 6.9 m -118.65 16.85 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.793 0.837 . . . . 0.0 111.458 -172.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.82 24.42 69.89 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 114.182 0.433 . . . . 0.0 114.182 174.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 41' ' ' MET . 9.3 t -72.62 121.58 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.178 0.591 . . . . 0.0 110.102 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.3 p -75.31 157.72 84.52 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.094 0.958 . . . . 0.0 109.965 175.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -50.46 -27.17 18.02 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.973 2.449 . . . . 0.0 113.862 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.06 -50.66 65.31 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.944 0.898 . . . . 0.0 110.517 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.575 ' HB2' HG13 ' A' ' 37' ' ' VAL . 25.4 mmt -68.12 -33.38 74.39 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.788 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.19 -16.28 53.28 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.858 0.863 . . . . 0.0 112.239 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -80.87 -48.84 11.82 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.701 0.763 . . . . 0.0 109.473 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -70.27 -43.09 71.18 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.95 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 63.16 22.26 13.29 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.742 1.217 . . . . 0.0 113.444 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -89.31 20.35 3.86 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.076 0.55 . . . . 0.0 110.262 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -75.49 75.04 2.55 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 122.538 1.161 . . . . 0.0 110.736 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.09 105.63 19.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.1 p -58.39 155.83 11.25 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.107 0.563 . . . . 0.0 111.438 -173.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.45 -39.56 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.326 1.05 . . . . 0.0 113.09 -168.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -64.75 -37.34 87.26 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.206 0.603 . . . . 0.0 111.783 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.5 m -69.23 -30.57 68.74 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.229 0.611 . . . . 0.0 111.495 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 m -72.28 -33.92 67.8 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.206 0.602 . . . . 0.0 110.374 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.43 -41.88 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.975 0.91 . . . . 0.0 110.015 173.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.59 -36.84 77.04 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.586 0.754 . . . . 0.0 110.257 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 CA--C 1.558 1.264 0 O-C-N 124.461 1.1 . . . . 0.0 109.871 179.904 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 50.2 t . . . . . 0 CA--C 1.551 0.981 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.681 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 17.2 Cg_exo -66.83 -20.52 51.82 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.277 2.651 . . . . 0.0 113.976 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.96 114.47 15.78 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -173.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -60.03 -39.77 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.732 0.813 . . . . 0.0 111.435 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 t -85.23 104.48 15.13 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 166.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.4 t -145.0 106.61 4.24 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.584 0.354 . . . . 0.0 110.054 -176.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.5 mt -69.83 153.11 43.76 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.319 168.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -110.78 88.78 8.36 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.79 169.31 22.5 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.524 2.15 . . . . 0.0 111.615 173.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -80.11 111.09 16.13 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.61 87.76 0.01 OUTLIER Glycine 0 C--N 1.349 1.289 0 O-C-N 123.842 0.714 . . . . 0.0 114.053 -175.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -174.1 -61.64 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.559 1.143 . . . . 0.0 109.471 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -99.9 23.93 9.13 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.264 1.031 . . . . 0.0 110.544 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.0 t -80.89 127.71 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.078 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -99.96 141.2 33.11 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 11.0 m0 -116.64 174.24 6.18 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.068 0.947 . . . . 0.0 110.432 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.39 133.62 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.819 1.248 . . . . 0.0 108.765 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -77.89 141.21 39.21 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.356 0.662 . . . . 0.0 109.582 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.2 t -106.37 66.82 0.71 Allowed 'General case' 0 C--O 1.248 1.022 0 CA-C-O 121.223 0.535 . . . . 0.0 109.642 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -81.18 25.81 0.47 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.063 0.545 . . . . 0.0 112.052 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -82.44 35.08 2.64 Favored Glycine 0 C--N 1.355 1.62 0 CA-C-O 119.326 -0.708 . . . . 0.0 113.836 172.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.1 t 82.64 54.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.649 1.58 . . . . 0.0 109.913 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.4 p -164.77 -40.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.545 170.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 65.0 t30 72.71 14.17 5.08 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.074 0.95 . . . . 0.0 111.919 167.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -67.53 127.72 33.78 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.536 0.734 . . . . 0.0 109.753 171.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -89.02 123.12 33.03 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.432 0.693 . . . . 0.0 110.255 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -116.18 148.8 40.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.277 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.62 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -69.51 143.67 53.38 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 166.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 21.6 mt-30 -57.37 -40.61 78.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.712 0.405 . . . . 0.0 111.572 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.2 m -71.95 -23.09 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 123.19 0.596 . . . . 0.0 112.494 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.62 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.4 t -60.53 -46.32 90.6 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.61 0.764 . . . . 0.0 111.051 176.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.552 HG23 HG23 ' A' ' 37' ' ' VAL . 15.7 m -118.9 11.03 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.134 -166.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.63 17.43 76.5 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 114.477 0.551 . . . . 0.0 114.477 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.552 HG23 HG23 ' A' ' 35' ' ' VAL . 56.0 t -71.32 110.77 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.122 0.487 . . . . 0.0 109.983 175.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.8 m -72.66 158.09 87.87 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.839 174.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -48.44 -34.85 26.81 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.798 2.332 . . . . 0.0 113.32 169.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -68.08 -41.98 81.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.199 0.6 . . . . 0.0 111.317 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 87.2 mtp -64.51 -41.04 96.65 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.92 0.488 . . . . 0.0 110.215 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.76 68.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.73 0.812 . . . . 0.0 111.128 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -73.17 -36.11 66.53 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.628 0.771 . . . . 0.0 111.013 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -71.79 -52.41 17.71 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.956 0.902 . . . . 0.0 109.302 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -164.07 -164.96 0.92 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.67 0.788 . . . . 0.0 109.405 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.98 173.81 10.25 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.203 0.601 . . . . 0.0 111.252 174.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -84.89 138.04 32.77 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.387 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.46 117.09 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 172.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.8 p -89.37 168.93 11.84 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.376 0.67 . . . . 0.0 110.647 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.37 -28.02 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.266 0.627 . . . . 0.0 111.856 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -64.67 -36.26 83.69 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.695 0.398 . . . . 0.0 110.514 172.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 24' ' ' GLY . 36.4 m -67.02 -42.99 83.96 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.991 0.516 . . . . 0.0 110.174 170.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.0 m -61.53 -43.83 98.15 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.089 0.556 . . . . 0.0 111.072 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.6 -26.36 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 O-C-N 121.925 -0.485 . . . . 0.0 111.259 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -73.32 -75.24 0.15 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.231 0.612 . . . . 0.0 112.372 177.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -165.808 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.56 1.347 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.11 99.84 0.29 Allowed 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.481 2.787 . . . . 0.0 112.455 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.05 -174.95 4.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.671 0.788 . . . . 0.0 110.763 -174.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.4 m -79.16 82.61 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 121.938 0.875 . . . . 0.0 109.903 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.9 m 70.06 107.83 0.06 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.529 1.532 . . . . 0.0 111.257 -177.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.8 t -76.93 79.69 3.49 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.55 145.84 54.5 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.324 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -109.02 86.75 4.11 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.499 ' HG3' HG21 ' A' ' 33' ' ' VAL . 44.6 Cg_endo -79.76 162.41 24.12 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.044 2.496 . . . . 0.0 112.578 -174.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -118.39 84.89 2.26 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 168.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.83 166.71 26.51 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.384 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.33 -25.03 11.65 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.836 0.854 . . . . 0.0 110.266 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.79 5.94 41.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.486 1.114 . . . . 0.0 111.681 -175.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.6 m -76.64 72.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 123.227 1.489 . . . . 0.0 111.236 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.89 166.19 22.67 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 113.362 -1.745 . . . . 0.0 109.314 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -105.83 127.37 53.07 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.261 0.624 . . . . 0.0 111.109 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.46 130.37 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 124.575 1.15 . . . . 0.0 110.061 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -77.59 153.39 33.3 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.973 0.909 . . . . 0.0 109.955 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.8 t -114.48 51.15 0.9 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.9 0.88 . . . . 0.0 109.691 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -48.27 -55.98 9.18 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.467 1.107 . . . . 0.0 112.744 -170.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -19.65 -56.92 0.01 OUTLIER Glycine 0 C--N 1.373 2.636 0 C-N-CA 126.268 1.889 . . . . 0.0 116.8 -172.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.532 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 26.2 t -165.22 65.51 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 169.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.2 m -156.77 -52.48 0.08 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.562 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 72.92 -6.06 1.77 Allowed 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 125.181 1.392 . . . . 0.0 111.323 -172.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -67.64 150.77 48.32 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.761 1.224 . . . . 0.0 111.131 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -100.26 131.18 46.35 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.758 0.823 . . . . 0.0 110.14 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -128.22 147.11 50.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.856 1.263 . . . . 0.0 108.489 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.592 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -70.4 148.54 48.27 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 165.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -57.01 -40.44 76.66 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.553 0.341 . . . . 0.0 110.504 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.499 HG21 ' HG3' ' A' ' 12' ' ' PRO . 21.0 m -69.45 -27.28 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.628 0.771 . . . . 0.0 112.359 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.592 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.8 t -60.38 -35.76 76.49 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 123.888 0.875 . . . . 0.0 110.167 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 m -115.96 6.46 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.165 -171.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.78 49.48 73.91 Favored Glycine 0 C--N 1.357 1.71 0 O-C-N 123.574 0.546 . . . . 0.0 113.539 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.7 t -119.17 137.94 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.152 1.381 . . . . 0.0 109.027 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 38.6 m -74.59 146.88 84.12 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 123.328 0.651 . . . . 0.0 109.989 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.78 -34.36 98.12 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.554 2.169 . . . . 0.0 113.101 174.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -70.4 -32.06 69.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.619 0.368 . . . . 0.0 111.204 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.4 ttt -67.86 -43.55 79.17 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.095 0.558 . . . . 0.0 110.066 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.95 -22.89 67.07 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.517 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -76.71 -43.87 35.74 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.13 0.972 . . . . 0.0 111.007 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -83.03 -22.05 33.66 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -171.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -150.78 165.97 31.89 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.139 0.495 . . . . 0.0 111.101 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -87.18 143.42 27.3 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.32 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -72.66 88.51 1.28 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.252 0.549 . . . . 0.0 109.552 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 66.7 mt -92.61 103.17 14.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 51' ' ' ARG . 19.0 p -81.73 175.03 10.8 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.844 -178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.07 -37.63 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.479 173.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.622 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 49.5 mtt-85 -61.24 -32.48 72.28 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.973 0.509 . . . . 0.0 111.165 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 24.0 m -67.62 -53.94 23.84 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.856 0.462 . . . . 0.0 110.214 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 t -68.93 -33.45 73.75 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.24 -172.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.8 t -73.92 -39.33 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 123.206 0.603 . . . . 0.0 110.667 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -63.5 -27.51 69.32 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 171.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 CA--C 1.56 1.351 0 C-N-CA 124.12 0.968 . . . . 0.0 110.83 171.952 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.563 1.473 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -43.76 86.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.398 3.144 0 C-N-CA 125.272 3.982 . . . . 0.0 115.87 -172.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.22 -170.32 2.17 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.072 1.349 . . . . 0.0 109.649 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.5 t -64.97 -57.1 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.125 0.57 . . . . 0.0 109.98 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.2 t -137.86 -22.64 1.07 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.278 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.0 t 69.72 100.93 0.06 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.597 1.159 . . . . 0.0 111.341 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.0 155.36 27.75 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.332 0.653 . . . . 0.0 110.499 171.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -117.94 81.24 15.53 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.411 1.084 . . . . 0.0 109.728 -175.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.13 165.47 11.24 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.587 2.192 . . . . 0.0 112.218 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.13 97.36 3.45 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.606 0.717 . . . . 0.0 109.454 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.94 93.43 0.22 Allowed Glycine 0 C--N 1.345 1.063 0 CA-C-N 114.658 -1.155 . . . . 0.0 114.375 -170.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -158.58 -61.3 0.08 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.525 0.73 . . . . 0.0 109.78 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -100.56 13.76 33.59 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.323 0.649 . . . . 0.0 111.025 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.06 130.84 35.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 123.04 0.536 . . . . 0.0 110.042 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.95 137.78 54.06 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.454 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -121.66 165.31 15.94 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.547 0.739 . . . . 0.0 109.858 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.77 133.24 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.623 -173.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -87.85 113.62 23.68 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 173.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 45.9 t -82.17 82.55 7.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.61 0.764 . . . . 0.0 110.535 -177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.41 1.46 0.78 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.369 1.067 . . . . 0.0 113.26 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.15 -162.7 0.57 Allowed Glycine 0 CA--C 1.539 1.55 0 O-C-N 121.549 -0.72 . . . . 0.0 113.087 162.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.518 ' N ' ' SG ' ' A' ' 52' ' ' CYS . 29.5 p -82.15 69.91 8.97 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.695 0.759 . . . . 0.0 111.134 -171.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.2 p -174.56 -41.16 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.921 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 74.6 -3.19 2.63 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 124.187 0.995 . . . . 0.0 112.607 168.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -77.34 157.89 30.43 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.752 0.821 . . . . 0.0 112.025 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -84.98 133.95 34.25 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.866 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 78.8 m-85 -126.91 158.75 35.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.866 1.266 . . . . 0.0 108.005 176.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.608 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -68.97 152.61 45.05 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 162.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.441 ' NE2' ' HA ' ' A' ' 39' ' ' PRO . 26.9 tt0 -62.62 -35.67 80.31 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.435 0.694 . . . . 0.0 110.018 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.4 m -70.57 -28.9 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.767 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.608 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 5.0 t -60.7 -41.54 95.39 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 123.698 0.799 . . . . 0.0 111.415 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 37' ' ' VAL . 5.4 m -96.64 -19.7 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.086 0.955 . . . . 0.0 111.598 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.91 15.75 79.58 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.238 0.336 . . . . 0.0 113.32 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 35' ' ' VAL . 78.2 t -79.46 140.43 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.781 0.832 . . . . 0.0 109.826 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 m -67.7 148.49 98.53 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.687 0.795 . . . . 0.0 111.134 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.441 ' HA ' ' NE2' ' A' ' 32' ' ' GLN . 5.7 Cg_endo -47.99 -48.37 16.52 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.895 3.063 . . . . 0.0 115.071 -176.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -61.14 -49.78 75.85 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 120.956 0.408 . . . . 0.0 110.419 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.644 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 93.0 mmm -58.69 -35.77 73.15 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.304 -177.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . . . -71.49 -36.61 71.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.939 0.896 . . . . 0.0 111.824 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -89.33 -29.62 19.01 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 122.846 0.459 . . . . 0.0 111.989 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -127.73 -45.2 1.47 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.7 0.8 . . . . 0.0 112.637 -159.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.644 ' HB2' ' HA ' ' A' ' 41' ' ' MET . 22.4 mm-40 -112.81 -144.38 0.39 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.256 0.623 . . . . 0.0 110.798 -167.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.86 139.84 53.13 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.424 0.69 . . . . 0.0 111.231 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.402 ' HB3' ' HA ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -146.66 27.97 1.08 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.891 1.277 . . . . 0.0 109.817 178.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.46 120.0 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.651 1.18 . . . . 0.0 109.545 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.6 p -78.22 167.2 21.76 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.356 0.662 . . . . 0.0 110.883 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.99 -39.46 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 124.132 0.973 . . . . 0.0 112.549 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -41.83 85.88 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.494 1.117 . . . . 0.0 110.269 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 25' ' ' SER . 18.3 m -64.47 -49.5 71.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.812 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.8 t -66.8 -28.46 68.4 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -173.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 82.0 t -72.36 -33.41 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.108 0.563 . . . . 0.0 110.732 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -71.27 -43.67 66.74 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.084 0.554 . . . . 0.0 110.912 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.484 1.273 0 C-N-CA 123.957 0.903 . . . . 0.0 111.641 -177.568 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -73.34 69.45 4.11 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.493 2.129 . . . . 0.0 111.68 172.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.458 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -141.75 79.94 1.7 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.338 0.655 . . . . 0.0 109.85 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.7 t 63.76 -69.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 125.528 1.531 . . . . 0.0 110.97 -172.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.1 t -140.26 -83.66 0.24 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 170.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.6 t 147.9 117.16 0.0 OUTLIER 'General case' 0 C--N 1.361 1.102 0 C-N-CA 127.41 2.284 . . . . 0.0 107.344 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.5 mt -56.67 -36.09 69.17 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.806 0.843 . . . . 0.0 111.472 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 57.14 75.14 0.59 Allowed Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.747 1.219 . . . . 0.0 111.365 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -87.2 175.89 4.59 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.496 2.131 . . . . 0.0 111.717 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.5 -24.55 59.02 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.01 171.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.551 ' HA2' HG22 ' A' ' 17' ' ' VAL . . . 78.59 58.9 2.96 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.378 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -82.5 -49.13 10.25 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.163 0.585 . . . . 0.0 110.842 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -131.47 11.68 4.91 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.128 0.971 . . . . 0.0 111.844 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.551 HG22 ' HA2' ' A' ' 14' ' ' GLY . 18.7 m -78.94 124.57 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 118.47 0.577 . . . . 0.0 109.773 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -89.86 136.0 33.3 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 14.0 m0 -99.84 126.34 45.93 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.203 0.601 . . . . 0.0 110.798 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.71 115.55 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 C-N-CA 124.764 1.226 . . . . 0.0 110.297 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -83.78 127.41 33.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.569 0.748 . . . . 0.0 109.933 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.3 t -82.65 108.89 16.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 169.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.11 -80.08 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 24.18 -91.1 0.01 OUTLIER Glycine 0 C--N 1.37 2.442 0 O-C-N 125.104 1.502 . . . . 0.0 115.6 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.409 ' N ' ' SG ' ' A' ' 52' ' ' CYS . 10.5 m -149.98 46.09 0.92 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.748 1.219 . . . . 0.0 109.435 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.5 m -133.77 -61.48 0.8 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.622 0.769 . . . . 0.0 109.431 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 74.14 -2.48 2.78 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.221 1.409 . . . . 0.0 110.941 -172.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -81.73 141.24 33.74 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.73 0.812 . . . . 0.0 110.28 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -87.76 120.3 28.95 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.049 0.94 . . . . 0.0 109.371 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -115.79 124.06 49.8 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 123.172 0.589 . . . . 0.0 109.712 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.619 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -57.68 143.33 41.96 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 167.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -62.33 -32.08 72.79 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 118.298 0.499 . . . . 0.0 110.925 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 31' ' ' HIS . 32.8 m -65.73 -29.63 47.58 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 123.221 0.608 . . . . 0.0 111.726 172.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.619 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 3.9 t -68.53 -40.01 80.92 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.521 0.728 . . . . 0.0 111.707 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.52 -2.66 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.525 0.73 . . . . 0.0 112.668 -171.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.29 3.81 54.35 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.814 -0.437 . . . . 0.0 114.058 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.431 HG13 ' HB2' ' A' ' 41' ' ' MET . 53.2 t -70.79 111.93 5.12 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 123.557 0.743 . . . . 0.0 109.453 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.7 m -69.17 156.11 92.22 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 123.611 0.764 . . . . 0.0 110.485 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.88 -32.39 29.84 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 123.402 2.735 . . . . 0.0 113.342 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 37.6 tt0 -57.49 -52.9 63.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.649 1.18 . . . . 0.0 111.807 174.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.431 ' HB2' HG13 ' A' ' 37' ' ' VAL . 25.7 mmt -72.75 -30.95 64.57 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.449 0.643 . . . . 0.0 110.515 -177.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.9 -36.38 67.28 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.666 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -78.91 -36.62 41.63 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.999 0.519 . . . . 0.0 110.395 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 36.7 mmtm -75.17 -20.46 59.33 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.345 0.403 . . . . 0.0 110.587 176.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.524 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 42.8 mt-10 73.09 21.76 3.08 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.093 1.357 . . . . 0.0 112.505 170.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -86.22 21.23 2.09 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.182 0.993 . . . . 0.0 111.74 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.524 ' CE2' ' HA ' ' A' ' 45' ' ' GLU . 11.6 p90 -82.4 25.87 0.59 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.089 0.955 . . . . 0.0 112.184 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.435 HG23 ' HB3' ' A' ' 52' ' ' CYS . 4.5 mp -72.86 119.08 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 173.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.8 m -62.4 159.38 15.51 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.656 0.782 . . . . 0.0 110.418 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 54' ' ' VAL . 99.2 t -60.7 -42.73 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 175.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -62.51 -37.37 85.76 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.555 0.742 . . . . 0.0 111.666 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.435 ' HB3' HG23 ' A' ' 48' ' ' ILE . 5.7 m -64.38 -36.05 82.88 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.753 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.2 m -74.6 -25.62 59.38 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.277 0.631 . . . . 0.0 110.804 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 50' ' ' VAL . 80.0 t -67.26 -36.76 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 122.87 0.468 . . . . 0.0 110.3 173.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -74.64 -49.39 21.65 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.187 0.595 . . . . 0.0 110.599 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 . . . . . 0 N--CA 1.482 1.133 0 O-C-N 123.992 0.808 . . . . 0.0 111.313 -179.871 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 4' ' ' CYS . 4.0 t . . . . . 0 CA--C 1.556 1.2 0 CA-C-O 119.761 -0.161 . . . . 0.0 111.386 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.49 -28.1 53.93 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.608 2.205 . . . . 0.0 113.212 -173.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 50.27 -96.92 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.277 1.431 . . . . 0.0 112.668 -177.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 90.0 t -130.63 -57.65 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.0 t -135.19 107.15 7.07 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 164.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 4' ' ' CYS . 42.3 t -78.78 87.56 4.66 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.094 0.558 . . . . 0.0 111.142 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.07 109.84 5.39 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -106.67 99.17 23.66 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.665 0.786 . . . . 0.0 109.425 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HG2' HG21 ' A' ' 17' ' ' VAL . 88.3 Cg_endo -76.6 -170.61 0.92 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.144 2.563 . . . . 0.0 112.05 174.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -75.1 107.56 7.26 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.27 69.93 3.05 Favored Glycine 0 N--CA 1.467 0.729 0 CA-C-N 115.091 -0.959 . . . . 0.0 113.486 -171.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -92.53 -53.51 4.17 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.732 0.813 . . . . 0.0 109.276 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.71 32.82 0.55 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.595 1.158 . . . . 0.0 110.636 -173.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.541 HG21 ' HG2' ' A' ' 12' ' ' PRO . 43.5 t -68.81 125.97 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.074 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -76.88 135.41 38.84 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 123.675 0.609 . . . . 0.0 109.929 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 35.3 m0 -113.69 171.51 7.53 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.079 0.952 . . . . 0.0 111.121 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.78 118.75 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.057 1.343 . . . . 0.0 108.186 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 62.1 tt0 -76.68 145.86 38.47 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.967 0.507 . . . . 0.0 110.401 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.6 t -75.84 128.45 35.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.021 0.439 . . . . 0.0 111.68 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.645 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . 11.4 t70 -87.07 79.18 8.76 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.14 -179.41 44.75 Favored Glycine 0 C--O 1.239 0.418 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.844 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t -79.73 73.72 6.44 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.539 0.736 . . . . 0.0 109.754 -176.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.7 ' SG ' ' HG2' ' A' ' 28' ' ' GLN . 4.0 p -173.12 -37.58 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.312 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 61.83 17.2 8.62 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.027 1.331 . . . . 0.0 113.215 173.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.7 ' HG2' ' SG ' ' A' ' 26' ' ' CYS . 4.3 pt20 -73.11 134.2 44.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.288 0.635 . . . . 0.0 111.049 -177.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 48.2 m95 -81.43 155.32 25.93 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.022 0.929 . . . . 0.0 110.885 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -138.67 134.18 33.31 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.803 0.841 . . . . 0.0 109.427 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.633 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -62.51 145.86 53.17 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 164.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -49.87 -49.47 49.28 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 120.952 0.406 . . . . 0.0 111.199 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -67.06 -25.63 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.414 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.633 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 7.8 t -59.99 -35.18 74.47 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.305 0.642 . . . . 0.0 111.72 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.25 -3.77 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.347 1.059 . . . . 0.0 111.58 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.0 39.58 97.4 Favored Glycine 0 C--N 1.353 1.518 0 C-N-CA 123.602 0.62 . . . . 0.0 114.221 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.46 131.63 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.392 0.677 . . . . 0.0 109.407 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.3 m -68.32 149.32 98.11 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.388 1.075 . . . . 0.0 110.961 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.39 -52.69 6.96 Favored 'Trans proline' 0 C--N 1.393 2.873 0 C-N-CA 123.916 3.077 . . . . 0.0 114.157 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -68.29 -36.77 79.88 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.291 0.636 . . . . 0.0 111.682 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 61.2 mtt -72.67 -31.38 65.02 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.694 0.398 . . . . 0.0 110.884 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.09 -33.66 50.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.489 0.716 . . . . 0.0 110.814 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -76.31 -42.2 45.99 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.301 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -71.9 -58.43 3.46 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.454 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -101.48 106.25 17.34 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.645 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . 4.5 m-20 -56.25 110.2 0.72 Allowed 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.064 173.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -62.29 111.05 1.83 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.081 0.467 . . . . 0.0 110.779 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 41.0 mt -88.85 117.24 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 172.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.3 p -73.23 154.57 40.17 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.3 t -52.52 -44.74 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 124.457 1.103 . . . . 0.0 112.589 -171.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -60.74 -31.74 71.04 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.151 0.58 . . . . 0.0 112.45 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.6 m -76.31 -42.68 44.38 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.333 0.253 . . . . 0.0 111.12 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 m -61.21 -40.8 95.35 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.592 0.757 . . . . 0.0 110.707 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.9 -49.83 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.322 1.049 . . . . 0.0 110.819 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -74.53 -11.88 60.33 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.925 0.49 . . . . 0.0 111.834 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 N--CA 1.479 0.993 0 C-N-CA 123.617 0.767 . . . . 0.0 110.291 171.481 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.554 1.129 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.58 62.63 8.56 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 123.285 2.656 . . . . 0.0 112.304 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.75 177.78 4.72 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.212 176.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.77 -42.57 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 t -133.4 162.9 30.6 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.897 0.879 . . . . 0.0 109.188 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.4 t -153.6 94.46 1.79 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.229 0.538 . . . . 0.0 110.018 170.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.501 HD12 ' HB ' ' A' ' 33' ' ' VAL . 28.0 mt -61.72 -35.18 77.32 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.456 1.102 . . . . 0.0 111.049 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 52.49 65.77 5.72 Favored Pre-proline 0 CA--C 1.552 1.057 0 O-C-N 124.67 1.231 . . . . 0.0 110.071 -171.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.437 ' HG2' HG21 ' A' ' 17' ' ' VAL . 61.4 Cg_endo -83.75 169.77 11.78 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.296 1.997 . . . . 0.0 112.39 -175.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -67.02 120.15 13.16 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.771 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.59 53.05 4.48 Favored Glycine 0 C--N 1.338 0.672 0 O-C-N 123.487 0.492 . . . . 0.0 113.687 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -65.66 -55.15 19.0 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -148.85 59.37 1.06 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.657 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.437 HG21 ' HG2' ' A' ' 12' ' ' PRO . 40.5 t -103.75 118.2 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.11 128.65 33.55 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.102 0.876 . . . . 0.0 109.807 -173.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 26.1 m0 -109.02 165.42 11.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.791 0.836 . . . . 0.0 109.904 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 47' ' ' TYR . 4.3 p -152.77 124.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.671 0.788 . . . . 0.0 109.908 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -72.42 130.14 40.0 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.722 0.409 . . . . 0.0 110.0 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.415 ' O ' HG12 ' A' ' 48' ' ' ILE . 37.2 t -65.75 -49.32 68.8 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.16 0.912 . . . . 0.0 111.552 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 72.64 -43.14 0.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.227 1.411 . . . . 0.0 112.723 -173.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.85 -160.49 0.09 OUTLIER Glycine 0 C--N 1.362 1.98 0 N-CA-C 114.569 0.587 . . . . 0.0 114.569 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.6 p -80.83 72.83 7.84 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.857 0.863 . . . . 0.0 111.706 -165.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.8 p 175.26 -31.68 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.894 2.077 . . . . 0.0 106.997 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 75.33 -43.88 0.51 Allowed 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 126.447 1.899 . . . . 0.0 113.952 172.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -47.9 148.85 1.49 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.389 1.876 . . . . 0.0 114.105 -167.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -74.87 144.74 43.23 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.174 173.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -132.29 128.15 37.15 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.622 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.594 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -67.02 151.64 47.27 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 172.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.591 ' HA ' ' HB ' ' A' ' 37' ' ' VAL . 62.6 mt-30 -56.37 -41.01 75.49 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.053 0.454 . . . . 0.0 110.204 174.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 10' ' ' LEU . 18.8 m -71.3 -17.4 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-N 114.849 -1.068 . . . . 0.0 112.669 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.594 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 2.5 t -80.06 -46.48 16.45 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.244 0.618 . . . . 0.0 111.335 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.677 HG23 HG23 ' A' ' 37' ' ' VAL . 2.5 m -119.41 9.78 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 123.654 0.782 . . . . 0.0 112.901 -169.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.01 36.96 92.7 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 122.672 0.177 . . . . 0.0 113.315 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.677 HG23 HG23 ' A' ' 35' ' ' VAL . 10.2 t -78.71 134.55 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.282 0.633 . . . . 0.0 110.995 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.0 p -77.02 153.28 82.68 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.66 0.784 . . . . 0.0 109.778 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.76 -31.53 72.33 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.44 2.094 . . . . 0.0 112.039 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -57.57 -52.35 65.75 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.548 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.585 ' HB2' HG13 ' A' ' 37' ' ' VAL . 26.1 mmt -66.44 -36.89 83.92 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 123.543 0.527 . . . . 0.0 111.516 -176.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.21 -30.37 68.53 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.109 0.564 . . . . 0.0 111.781 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -89.44 -29.29 19.13 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.151 0.58 . . . . 0.0 111.265 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -83.18 -20.71 34.15 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.558 0.743 . . . . 0.0 111.085 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 69.41 -161.92 0.18 Allowed 'General case' 0 C--N 1.361 1.095 0 O-C-N 124.419 1.075 . . . . 0.0 108.658 -170.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 69.27 3.57 4.18 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.633 1.173 . . . . 0.0 113.036 171.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.476 ' HB3' HG21 ' A' ' 20' ' ' VAL . 93.3 t80 -74.39 98.53 3.3 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 22' ' ' CYS . 44.7 mt -100.0 135.45 35.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 165.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -56.06 129.93 41.92 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 172.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -54.25 -35.12 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.36 0.664 . . . . 0.0 112.66 -167.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -68.65 -35.98 77.97 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.492 0.717 . . . . 0.0 110.988 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 84.2 m -64.68 -31.15 72.25 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.113 0.565 . . . . 0.0 111.384 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.9 m -70.3 -44.09 69.03 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.977 0.417 . . . . 0.0 109.976 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.0 t -69.5 -31.38 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.029 0.932 . . . . 0.0 110.763 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -115.39 28.57 8.59 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.526 0.679 . . . . 0.0 110.102 -175.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t70 . . . . . 0 N--CA 1.484 1.243 0 C-N-CA 123.908 0.883 . . . . 0.0 110.368 177.475 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.41 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 12.6 t . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 119.578 -0.248 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.68 -42.76 0.76 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.67 2.247 . . . . 0.0 113.303 -174.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 44.87 25.13 0.13 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 125.798 1.639 . . . . 0.0 115.061 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.1 t 60.46 -73.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.908 1.283 . . . . 0.0 109.992 -166.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.3 m -104.81 88.11 2.83 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.157 0.983 . . . . 0.0 108.935 170.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.431 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 42.4 t -79.43 84.62 5.31 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.213 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 33' ' ' VAL . 59.9 mt -64.98 101.6 0.52 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 167.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -112.01 96.52 34.51 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.172 0.989 . . . . 0.0 110.782 -166.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.479 ' HG2' HG21 ' A' ' 17' ' ' VAL . 66.3 Cg_exo -53.66 150.23 29.24 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.056 2.504 . . . . 0.0 112.138 164.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.72 90.0 0.76 Allowed 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 122.027 0.918 . . . . 0.0 110.765 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.2 -149.46 32.48 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 114.497 -1.229 . . . . 0.0 113.475 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -101.07 82.64 2.39 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.026 0.93 . . . . 0.0 108.903 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -127.84 10.84 6.57 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.568 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.479 HG21 ' HG2' ' A' ' 12' ' ' PRO . 15.8 m -135.83 168.61 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.407 0.683 . . . . 0.0 111.733 -173.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -74.68 139.44 43.51 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.176 173.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -116.27 175.43 5.56 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.864 0.866 . . . . 0.0 109.96 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.435 HG11 HG11 ' A' ' 37' ' ' VAL . 12.7 p -161.08 138.21 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.183 0.993 . . . . 0.0 108.856 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -101.48 142.56 32.67 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 40.1 t -114.08 77.63 1.08 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.214 0.606 . . . . 0.0 110.671 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -78.78 80.8 5.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.81 -65.55 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.093 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.673 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 13.6 m -152.8 56.39 0.79 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.902 0.858 . . . . 0.0 109.233 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.0 m -161.61 -53.1 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 174.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.23 11.78 4.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.222 1.809 . . . . 0.0 113.467 173.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -107.04 166.61 10.49 Favored 'General case' 0 C--O 1.246 0.899 0 C-N-CA 123.419 0.688 . . . . 0.0 109.767 177.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -87.16 137.59 32.21 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.062 169.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -131.32 132.8 44.77 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.318 1.047 . . . . 0.0 108.884 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.635 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -56.99 147.03 25.08 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.836 0.854 . . . . 0.0 108.835 170.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -56.64 -45.18 81.71 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.153 0.981 . . . . 0.0 111.115 -173.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.416 ' O ' HD12 ' A' ' 10' ' ' LEU . 12.1 m -71.33 -29.57 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.722 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.635 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 13.2 t -54.17 -53.29 55.5 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.31 0.644 . . . . 0.0 112.556 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.1 m -96.12 -5.24 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.637 0.775 . . . . 0.0 111.06 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.74 37.52 94.96 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.612 -177.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.435 HG11 HG11 ' A' ' 20' ' ' VAL . 13.7 p -69.3 144.36 14.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.564 0.746 . . . . 0.0 110.684 -177.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.2 m -58.33 130.7 84.33 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.369 172.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -53.71 -26.71 39.33 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.241 2.627 . . . . 0.0 112.342 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.58 -52.17 64.47 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.788 0.835 . . . . 0.0 110.397 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.1 mmt -72.41 -30.65 64.84 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.088 0.555 . . . . 0.0 111.42 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.93 -44.83 83.97 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.798 0.839 . . . . 0.0 111.029 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -74.74 -25.8 59.35 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.549 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -75.73 -20.09 58.59 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 67.37 14.68 9.74 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.431 1.492 . . . . 0.0 112.303 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -134.96 89.23 2.5 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -171.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -119.42 106.84 12.65 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.914 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 48' ' ' ILE . 3.1 mp -106.98 110.2 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.7 m -57.92 158.05 7.02 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.958 0.503 . . . . 0.0 110.903 -176.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.8 -38.04 63.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 122.974 0.51 . . . . 0.0 110.428 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -56.78 -49.0 76.61 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.866 0.866 . . . . 0.0 111.251 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.673 ' SG ' ' HB2' ' A' ' 25' ' ' SER . 86.4 m -71.32 -27.1 63.16 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.095 0.958 . . . . 0.0 112.412 -174.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.8 m -85.19 -53.22 5.39 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.313 0.645 . . . . 0.0 110.678 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.62 -21.3 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.076 0.55 . . . . 0.0 111.421 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.63 -41.33 98.96 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-N 117.805 0.275 . . . . 0.0 110.723 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 N--CA 1.471 0.613 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.54 -179.766 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.0 t . . . . . 0 CA--C 1.551 0.999 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 72.8 Cg_endo -76.01 -38.86 1.05 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.73 2.287 . . . . 0.0 112.341 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 48.58 23.22 0.59 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 126.159 1.783 . . . . 0.0 115.79 169.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.4 t 62.5 -74.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 125.126 1.37 . . . . 0.0 110.278 -171.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.7 m -108.64 80.84 1.38 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.354 1.062 . . . . 0.0 108.464 174.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 41.8 t -84.56 87.79 7.28 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.736 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.5 mt -65.76 111.29 3.16 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 164.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -102.7 102.41 26.37 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.046 0.938 . . . . 0.0 110.456 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.23 -179.48 5.06 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 122.706 2.271 . . . . 0.0 110.848 164.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.46 23.5 10.99 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.396 0.679 . . . . 0.0 110.625 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.21 35.42 92.05 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.82 -63.97 0.98 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.377 1.471 . . . . 0.0 110.814 -169.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -142.54 19.42 2.03 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.81 1.244 . . . . 0.0 108.29 171.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 t -79.18 123.95 36.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.259 -164.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 32' ' ' GLN . 34.2 m-20 -83.19 146.72 28.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.524 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -115.5 128.4 55.97 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.336 0.655 . . . . 0.0 109.292 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.557 HG21 ' HB2' ' A' ' 47' ' ' TYR . 5.3 p -103.86 126.27 58.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 123.608 0.763 . . . . 0.0 109.91 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -85.64 127.03 34.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.99 0.916 . . . . 0.0 108.973 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.8 t -85.49 80.94 8.9 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.01 -26.98 61.18 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.889 0.876 . . . . 0.0 112.258 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.57 104.61 1.48 Allowed Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.783 -1.009 . . . . 0.0 111.266 167.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.613 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 21.7 m 52.45 47.58 24.41 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.714 1.606 . . . . 0.0 113.558 161.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.0 m -161.77 -62.44 0.05 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.156 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.1 t30 70.42 3.51 4.51 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.186 1.394 . . . . 0.0 110.841 -173.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -87.06 143.25 27.41 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.977 0.911 . . . . 0.0 110.283 -172.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -87.63 112.24 22.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.988 0.915 . . . . 0.0 110.023 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -107.96 140.57 40.91 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.852 0.861 . . . . 0.0 109.059 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.598 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -68.63 154.55 41.7 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.031 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 27.2 tt0 -52.33 -50.11 62.94 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.071 1.348 . . . . 0.0 111.047 -177.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.9 m -72.08 -28.58 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 114.33 -1.304 . . . . 0.0 112.098 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.598 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.9 t -58.14 -49.46 76.91 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.813 0.845 . . . . 0.0 111.931 -175.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 m -95.63 2.57 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.462 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.72 19.89 76.99 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.247 0.342 . . . . 0.0 113.895 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.43 121.57 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.0 m -72.33 158.13 88.02 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.368 0.667 . . . . 0.0 110.325 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.93 -39.65 68.53 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.263 2.642 . . . . 0.0 113.371 176.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -64.24 -44.35 92.11 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.172 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 56.7 mtt -63.33 -48.19 79.05 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.756 0.822 . . . . 0.0 110.073 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.32 -26.95 68.71 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.573 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -83.97 -51.03 7.47 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.247 0.619 . . . . 0.0 111.125 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -91.4 -60.22 1.94 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.47 0.308 . . . . 0.0 110.714 -168.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -166.41 152.15 8.5 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.493 0.717 . . . . 0.0 111.957 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.7 t0 68.09 103.42 0.05 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.077 1.751 . . . . 0.0 112.807 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.557 ' HB2' HG21 ' A' ' 20' ' ' VAL . 3.2 p90 -150.93 14.52 0.73 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.47 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 52.6 mt -82.16 122.84 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.752 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 p -65.26 148.3 51.93 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.312 0.383 . . . . 0.0 110.367 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.7 t -45.25 -42.07 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 125.821 1.648 . . . . 0.0 113.275 -171.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -53.96 -50.01 67.46 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.885 0.874 . . . . 0.0 111.927 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 25' ' ' SER . 61.5 m -76.7 -24.97 53.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.581 -175.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.7 m -68.54 -47.53 66.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.313 0.645 . . . . 0.0 110.473 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.27 -29.99 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.925 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -62.31 -66.09 0.59 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.262 0.625 . . . . 0.0 110.423 173.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 N--CA 1.47 0.561 0 O-C-N 123.941 0.776 . . . . 0.0 109.718 -175.677 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 119.468 -0.301 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -64.45 85.18 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 123.005 2.47 . . . . 0.0 112.783 -175.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.16 171.14 13.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.761 1.224 . . . . 0.0 109.967 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.04 -38.86 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.597 0.759 . . . . 0.0 110.949 -175.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.9 p -156.68 109.76 2.6 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.605 0.762 . . . . 0.0 109.097 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.4 t -88.41 109.17 19.79 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.983 0.421 . . . . 0.0 110.75 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.713 HD21 HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -69.57 158.55 35.05 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.478 164.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -102.42 93.64 4.22 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 171.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.64 112.95 1.93 Allowed 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.315 2.01 . . . . 0.0 110.897 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -85.87 52.12 2.39 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 122.718 1.246 . . . . 0.0 110.722 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 157.04 142.89 3.51 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 113.171 -1.832 . . . . 0.0 110.704 -173.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.84 22.59 0.75 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.207 1.003 . . . . 0.0 111.775 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -74.33 -16.32 60.92 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.454 1.102 . . . . 0.0 111.788 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -80.19 137.42 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -90.7 151.7 21.14 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -103.24 152.37 21.57 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.609 0.764 . . . . 0.0 110.607 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.54 124.29 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.014 1.326 . . . . 0.0 108.276 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 35.4 tt0 -85.29 141.83 29.8 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.63 151.69 46.87 Favored 'General case' 0 CA--C 1.552 1.023 0 O-C-N 123.624 0.577 . . . . 0.0 111.863 -167.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -71.74 -44.34 64.26 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.7 1.6 . . . . 0.0 112.715 -174.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.518 ' HA3' ' SG ' ' A' ' 52' ' ' CYS . . . -84.01 -129.06 1.66 Allowed Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.656 -167.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -120.31 75.63 1.12 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.8 m -114.17 -27.99 7.46 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.888 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.5 t30 77.3 -37.17 0.25 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.271 1.429 . . . . 0.0 112.208 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -85.16 148.59 26.03 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.614 0.721 . . . . 0.0 112.537 -166.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 12.0 p-90 -104.16 139.02 39.8 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.324 171.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 42.3 m-85 -123.11 162.98 21.42 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 124.413 1.085 . . . . 0.0 108.251 -175.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.64 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -69.24 146.79 52.04 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 160.202 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -58.35 -41.32 84.39 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.294 0.497 . . . . 0.0 110.707 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.713 HG23 HD21 ' A' ' 10' ' ' LEU . 27.8 m -67.47 -25.67 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.711 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.64 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.5 t -58.6 -39.12 79.51 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 123.835 0.854 . . . . 0.0 111.433 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.4 m -104.92 -0.97 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.998 0.919 . . . . 0.0 111.622 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.26 16.12 80.04 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 116.491 -0.322 . . . . 0.0 113.825 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.9 t -90.5 136.55 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.23 0.612 . . . . 0.0 109.802 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.0 m -90.34 152.44 45.61 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.814 0.846 . . . . 0.0 110.117 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -47.04 -56.74 2.78 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.898 3.065 . . . . 0.0 114.622 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.27 -27.88 67.56 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.913 0.485 . . . . 0.0 111.722 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.6 mtt -74.35 -31.27 62.35 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 122.614 0.365 . . . . 0.0 110.201 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.55 -35.3 60.69 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.347 0.659 . . . . 0.0 111.343 176.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.17 -48.87 12.47 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.585 0.754 . . . . 0.0 111.213 -176.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.34 -25.82 19.23 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.334 0.653 . . . . 0.0 112.046 -171.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -123.82 170.03 10.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.249 0.619 . . . . 0.0 110.204 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -85.48 123.71 31.22 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.627 178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -88.44 48.91 1.7 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.404 1.081 . . . . 0.0 110.911 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.1 mt -73.36 105.29 2.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.861 -177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 51' ' ' ARG . 2.3 p -69.16 162.22 27.49 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.012 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 54' ' ' VAL . 67.1 t -54.2 -42.27 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.45 0.7 . . . . 0.0 111.122 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.525 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 2.8 mpt_? -58.41 -40.64 83.03 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.679 0.791 . . . . 0.0 111.494 176.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.518 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 35.0 m -72.34 -35.22 68.5 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.296 0.238 . . . . 0.0 111.578 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.1 m -70.33 -47.57 60.48 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.645 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 50' ' ' VAL . 13.6 p -84.87 -44.5 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -174.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -84.1 -35.82 23.43 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 120.736 0.303 . . . . 0.0 110.206 -167.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 59.7 m-20 . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 121.538 0.685 . . . . 0.0 110.404 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.609 ' SG ' ' HA ' ' A' ' 11' ' ' GLN . 9.3 m . . . . . 0 CA--C 1.55 0.97 0 CA-C-O 120.203 0.049 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -93.16 -23.26 0.3 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.412 2.742 . . . . 0.0 114.847 -175.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 9' ' ' CYS . . . -63.53 147.99 49.93 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.158 0.583 . . . . 0.0 110.347 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -55.59 -34.04 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.933 0.893 . . . . 0.0 112.559 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.5 m -127.01 100.16 6.01 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 169.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.548 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 8.7 t -142.6 25.64 1.82 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.987 -166.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.462 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 21.1 mt 59.05 -65.16 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 165.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.609 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 27.5 mt-30 82.83 59.58 0.09 OUTLIER Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 127.597 2.359 . . . . 0.0 110.701 -168.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HD3' ' H ' ' A' ' 11' ' ' GLN . 24.8 Cg_endo -93.86 96.04 0.13 Allowed 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.171 2.581 . . . . 0.0 110.908 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.12 83.97 2.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.43 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.38 122.52 1.1 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.593 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -65.45 -19.63 66.02 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.864 0.866 . . . . 0.0 111.956 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -77.09 1.53 17.81 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.853 0.861 . . . . 0.0 112.181 -174.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.6 m -79.39 137.35 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.023 0.44 . . . . 0.0 110.296 175.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -94.58 149.25 21.43 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.616 1.167 . . . . 0.0 110.148 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 1.0 OUTLIER -119.01 161.28 20.49 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.739 0.816 . . . . 0.0 111.419 -171.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.69 136.68 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.674 1.19 . . . . 0.0 108.255 171.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.42 ' HG2' ' H ' ' A' ' 23' ' ' ASP . 61.9 tt0 -76.4 152.25 36.31 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.26 0.624 . . . . 0.0 109.536 177.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.4 t -76.22 -21.26 56.62 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.42 ' H ' ' HG2' ' A' ' 21' ' ' GLN . 30.5 t70 76.26 -48.6 0.57 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.156 1.383 . . . . 0.0 112.292 -177.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.534 ' HA3' ' SG ' ' A' ' 52' ' ' CYS . . . -57.41 178.8 0.94 Allowed Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.246 0.859 . . . . 0.0 115.246 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.8 m -65.47 -23.73 66.99 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.454 0.702 . . . . 0.0 112.456 -168.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.3 p -67.2 -34.42 77.46 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.062 0.545 . . . . 0.0 110.017 174.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.3 t30 65.33 12.68 8.27 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 125.11 1.364 . . . . 0.0 113.466 166.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -73.16 141.92 47.43 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.315 1.046 . . . . 0.0 112.063 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -92.6 118.12 30.68 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.092 0.957 . . . . 0.0 109.589 175.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -110.94 126.93 55.26 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.01 0.924 . . . . 0.0 109.229 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -53.06 123.69 12.33 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.386 0.675 . . . . 0.0 111.572 175.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 47.8 mt-30 -52.31 -47.22 66.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.34 1.456 . . . . 0.0 112.697 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 m -58.24 -36.58 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.609 0.719 . . . . 0.0 110.955 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 0.1 OUTLIER -74.72 -39.3 61.98 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.882 -175.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.454 HG23 HG23 ' A' ' 37' ' ' VAL . 35.1 m -100.94 6.57 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.563 -173.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.05 3.18 88.09 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 114.71 0.644 . . . . 0.0 114.71 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 32' ' ' GLN . 88.1 t -79.74 125.86 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.422 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 25.2 m -93.22 165.57 18.13 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 123.894 0.878 . . . . 0.0 109.965 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 38' ' ' SER . 10.9 Cg_endo -51.81 -52.19 9.51 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 123.174 2.583 . . . . 0.0 114.401 -174.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.08 -27.74 64.85 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.322 0.249 . . . . 0.0 111.628 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.1 mtt -69.15 -36.92 77.94 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.775 0.43 . . . . 0.0 110.53 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.34 -31.39 63.95 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.21 1.004 . . . . 0.0 110.603 176.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -70.95 -36.47 72.62 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.391 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -76.33 -52.48 9.85 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.367 0.667 . . . . 0.0 110.64 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -138.72 139.14 38.27 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.321 1.048 . . . . 0.0 109.52 -172.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -72.8 176.29 5.74 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 122.695 0.398 . . . . 0.0 109.937 171.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -88.54 77.5 8.0 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 175.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.22 105.61 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.8 p -73.07 160.48 31.96 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.229 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.6 p -52.95 -39.67 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.434 1.094 . . . . 0.0 113.766 -165.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -70.9 -30.57 66.96 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 118.015 0.37 . . . . 0.0 111.449 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.534 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 99.2 m -74.91 -26.21 59.48 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.158 0.583 . . . . 0.0 111.005 173.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.8 m -81.85 -39.01 24.56 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.083 0.553 . . . . 0.0 110.862 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.8 t -76.89 -32.23 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.046 0.939 . . . . 0.0 109.747 176.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -135.51 87.45 2.32 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.082 0.553 . . . . 0.0 110.501 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 166.853 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.567 1.622 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -52.84 -51.14 11.78 Favored 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 124.712 3.608 . . . . 0.0 116.994 -159.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.549 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -60.15 158.51 11.18 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -170.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -75.8 -42.56 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.119 0.568 . . . . 0.0 110.411 176.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.0 p -92.44 52.29 1.89 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.522 1.129 . . . . 0.0 109.115 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -93.35 119.67 32.74 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.196 -167.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.4 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 28.6 mt -69.49 178.48 2.45 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 160.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -115.69 83.0 10.82 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HD3' ' SG ' ' A' ' 34' ' ' CYS . 67.5 Cg_endo -81.89 134.23 8.27 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.098 2.532 . . . . 0.0 112.885 -178.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -148.06 152.61 37.67 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.472 0.709 . . . . 0.0 110.002 175.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.9 -146.7 17.33 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -92.26 78.6 5.12 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.009 0.924 . . . . 0.0 109.798 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 69.1 121.62 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.441 1.496 . . . . 0.0 111.63 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.6 t -89.26 145.66 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.919 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.72 120.81 16.87 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 174.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.625 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 9.5 m95 -118.24 131.04 56.38 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.377 0.671 . . . . 0.0 111.566 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.513 ' HB ' ' HG2' ' A' ' 32' ' ' GLN . 5.7 p -104.35 123.2 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.793 174.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.445 ' NE2' HD22 ' A' ' 27' ' ' ASN . 47.9 tt0 -82.47 137.99 34.49 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 173.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 36.7 t -84.62 81.94 8.64 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 170.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -54.35 -18.59 4.26 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.752 1.221 . . . . 0.0 112.293 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -51.47 177.52 0.07 OUTLIER Glycine 0 C--N 1.351 1.364 0 N-CA-C 114.671 0.628 . . . . 0.0 114.671 167.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.9 p -74.65 72.98 1.99 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.554 1.141 . . . . 0.0 111.18 -171.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 27' ' ' ASN . 9.6 p -178.36 -42.58 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.388 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.445 HD22 ' NE2' ' A' ' 21' ' ' GLN . 14.5 m120 67.05 31.58 6.8 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 124.038 0.935 . . . . 0.0 110.69 175.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -72.18 121.32 19.12 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.283 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -87.68 108.21 18.99 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.573 0.749 . . . . 0.0 110.996 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -103.8 171.68 7.22 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.941 170.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -108.36 123.58 49.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.324 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.513 ' HG2' ' HB ' ' A' ' 20' ' ' VAL . 28.4 mt-30 -48.79 -56.65 8.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.916 1.286 . . . . 0.0 113.082 -177.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -62.3 -32.28 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-O 121.384 0.611 . . . . 0.0 111.112 -176.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.477 ' HB3' ' CD2' ' A' ' 31' ' ' HIS . 6.5 t -85.53 -20.38 29.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.204 -170.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.8 m -109.4 -16.49 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.093 0.557 . . . . 0.0 111.578 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.46 15.21 35.64 Favored Glycine 0 C--N 1.351 1.399 0 N-CA-C 114.171 0.428 . . . . 0.0 114.171 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.33 129.96 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.285 0.634 . . . . 0.0 109.709 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 88.7 p -82.49 164.45 47.41 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.072 0.549 . . . . 0.0 109.711 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.51 -26.17 70.09 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 121.945 1.763 . . . . 0.0 111.336 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -64.76 -52.22 58.1 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.929 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 66.8 mtt -62.49 -36.04 81.25 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.576 0.75 . . . . 0.0 111.636 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.47 -38.99 85.24 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.49 0.716 . . . . 0.0 112.098 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -85.07 -45.66 11.89 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.896 0.478 . . . . 0.0 111.301 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -68.97 -54.38 15.61 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.356 1.062 . . . . 0.0 110.378 -175.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -111.08 160.6 16.73 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.201 -175.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -85.14 135.35 34.01 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 163.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -73.77 81.94 1.61 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 168.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.7 mt -75.18 104.92 3.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.958 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.9 p -73.84 158.51 34.39 Favored 'General case' 0 C--O 1.252 1.19 0 O-C-N 123.923 0.764 . . . . 0.0 110.3 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 54' ' ' VAL . 18.9 m -52.91 -33.62 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.222 1.009 . . . . 0.0 113.016 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -61.28 -41.65 97.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.798 0.439 . . . . 0.0 111.389 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.8 m -68.78 -36.49 78.37 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.88 0.472 . . . . 0.0 110.818 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.6 m -64.2 -47.78 78.43 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.512 0.725 . . . . 0.0 111.378 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 50' ' ' VAL . 53.2 t -69.77 -38.34 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.269 0.628 . . . . 0.0 110.503 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -68.81 -38.76 80.12 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.919 0.888 . . . . 0.0 112.342 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 N--CA 1.476 0.869 0 C-N-CA 122.43 0.292 . . . . 0.0 110.782 -173.351 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.5 t . . . . . 0 CA--C 1.55 0.967 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.93 94.31 1.07 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.684 2.923 . . . . 0.0 112.941 -169.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.629 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -158.57 107.52 1.97 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.459 0.704 . . . . 0.0 110.362 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.2 t 60.45 -76.57 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 125.772 1.629 . . . . 0.0 112.021 174.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.6 t -146.35 -27.0 0.42 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.003 0.921 . . . . 0.0 110.734 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.8 t 65.67 81.09 0.21 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.772 1.229 . . . . 0.0 110.478 -177.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 67.3 mt -65.64 -33.67 76.45 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.638 0.775 . . . . 0.0 111.638 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 61.09 74.06 0.55 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.814 1.246 . . . . 0.0 112.224 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.48 122.92 9.05 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.253 1.969 . . . . 0.0 111.302 171.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.5 91.0 1.76 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.465 0.706 . . . . 0.0 109.974 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 167.48 123.49 0.66 Allowed Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.017 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -78.15 -2.5 37.84 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.797 0.839 . . . . 0.0 112.309 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.16 -18.37 64.4 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.043 0.937 . . . . 0.0 112.055 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.85 127.93 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.906 0.384 . . . . 0.0 110.158 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.5 ' H ' HE21 ' A' ' 32' ' ' GLN . 6.1 m-20 -79.35 145.99 33.12 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.474 177.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -116.51 124.72 50.61 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.251 0.62 . . . . 0.0 110.947 -174.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.54 121.9 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 124.289 1.036 . . . . 0.0 109.198 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -84.92 153.2 22.99 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.775 0.83 . . . . 0.0 110.004 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 43.7 t -103.2 72.9 1.19 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 165.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -53.1 -31.02 39.82 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.954 0.902 . . . . 0.0 111.437 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.438 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -64.51 92.82 0.13 Allowed Glycine 0 CA--C 1.534 1.241 0 CA-C-O 119.295 -0.725 . . . . 0.0 111.829 165.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 72.2 p 50.7 54.03 11.93 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.967 1.707 . . . . 0.0 113.724 164.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 51.7 m -161.76 -56.63 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.942 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 62.15 13.8 6.09 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.949 1.7 . . . . 0.0 112.814 176.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -85.15 138.54 32.32 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -87.62 110.52 20.45 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -99.73 142.79 30.75 Favored 'General case' 0 C--O 1.206 -1.209 0 C-N-CA 123.927 0.891 . . . . 0.0 109.931 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.575 ' H ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -89.48 154.31 20.12 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -169.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.5 HE21 ' H ' ' A' ' 18' ' ' ASP . 79.8 mt-30 -43.68 -54.79 4.79 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.75 0.82 . . . . 0.0 112.438 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -76.19 -22.78 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.267 0.627 . . . . 0.0 111.838 -176.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 6' ' ' ALA . 25.1 t -67.93 -31.55 71.39 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.721 0.409 . . . . 0.0 111.518 -178.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.9 m -115.85 -15.25 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.026 0.93 . . . . 0.0 112.098 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.93 37.1 39.54 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 123.333 0.396 . . . . 0.0 112.565 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.9 t -115.43 135.56 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.084 0.954 . . . . 0.0 110.081 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 m -71.41 148.23 93.24 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 123.907 0.883 . . . . 0.0 110.726 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.599 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 39.8 Cg_endo -62.11 -20.76 70.9 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.174 2.583 . . . . 0.0 113.796 -175.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -62.13 -49.34 76.28 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.541 0.736 . . . . 0.0 111.458 173.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 27.0 ttt -74.28 -29.83 61.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.391 1.076 . . . . 0.0 110.265 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 39' ' ' PRO . . . -70.24 -20.75 63.06 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.44 0.696 . . . . 0.0 112.009 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -92.18 -44.68 8.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.923 0.889 . . . . 0.0 110.667 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -73.33 -51.14 18.54 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.51 0.724 . . . . 0.0 112.097 -172.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -115.66 147.28 41.01 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.012 0.925 . . . . 0.0 111.175 -166.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.64 139.01 38.59 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 171.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -76.09 75.93 2.95 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.2 mt -77.88 100.06 2.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.8 p -75.96 148.08 38.41 Favored 'General case' 0 C--N 1.349 0.586 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.8 m -45.7 -35.59 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -165.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -63.38 -45.48 90.94 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.706 0.803 . . . . 0.0 110.699 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 24' ' ' GLY . 60.5 m -73.56 -28.09 61.68 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.693 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.8 m -67.0 -51.32 56.49 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.214 0.606 . . . . 0.0 110.74 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.61 -33.37 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.596 0.759 . . . . 0.0 111.81 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -110.79 35.0 3.67 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.74 0.781 . . . . 0.0 109.569 -175.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.975 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.6 p . . . . . 0 CA--C 1.541 0.622 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -74.07 66.87 5.12 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.65 2.233 . . . . 0.0 111.845 174.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.57 106.85 8.07 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.02 -44.83 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.6 m -72.69 93.47 1.64 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 166.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 51.1 t -139.67 113.13 8.4 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.931 0.492 . . . . 0.0 111.121 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.695 HD11 HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -66.6 146.28 54.67 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 161.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -105.33 103.39 42.32 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.41 99.63 0.17 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.358 2.705 . . . . 0.0 112.573 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.23 -24.61 42.96 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.722 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.34 -19.88 56.0 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.308 175.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 72.76 -17.94 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.242 1.417 . . . . 0.0 113.846 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -82.98 67.5 9.09 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.951 0.881 . . . . 0.0 110.335 -171.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.35 138.52 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.69 1.196 . . . . 0.0 108.608 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -80.53 122.89 27.59 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -93.1 174.95 6.97 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.29 0.636 . . . . 0.0 111.036 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.459 ' HB ' HE22 ' A' ' 32' ' ' GLN . 14.8 p -159.98 129.1 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.424 0.69 . . . . 0.0 110.261 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -80.61 126.53 31.37 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.477 ' SG ' ' OD2' ' A' ' 23' ' ' ASP . 31.1 t -75.0 118.39 17.91 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 -164.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.477 ' OD2' ' SG ' ' A' ' 22' ' ' CYS . 4.5 p30 20.36 -71.08 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 127.986 2.514 . . . . 0.0 117.471 171.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.92 -95.24 0.15 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.211 -0.449 . . . . 0.0 113.723 -152.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -79.51 -51.93 8.69 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.197 -0.501 . . . . 0.0 111.598 -163.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.05 -35.5 64.3 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -173.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.2 t30 70.7 -26.83 0.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.284 1.434 . . . . 0.0 114.78 165.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.84 147.18 24.05 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.93 0.892 . . . . 0.0 111.562 -171.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -74.99 139.37 42.89 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.679 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -126.34 149.33 49.24 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 172.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.598 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -78.74 148.0 33.18 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 169.35 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.459 HE22 ' HB ' ' A' ' 20' ' ' VAL . 2.6 mp0 -58.77 -34.36 71.34 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.539 0.736 . . . . 0.0 110.424 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.695 HG23 HD11 ' A' ' 10' ' ' LEU . 35.1 m -76.06 -22.25 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.649 176.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.598 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.5 t -70.99 -37.25 72.7 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 123.399 0.68 . . . . 0.0 111.195 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.464 HG23 HG23 ' A' ' 37' ' ' VAL . 6.0 m -118.62 8.64 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.819 0.848 . . . . 0.0 112.338 -172.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.61 29.12 73.72 Favored Glycine 0 C--N 1.353 1.493 0 O-C-N 123.498 0.499 . . . . 0.0 114.262 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.464 HG23 HG23 ' A' ' 35' ' ' VAL . 77.0 t -92.97 143.73 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.57 0.748 . . . . 0.0 109.368 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.0 m -80.42 145.23 58.95 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.341 0.656 . . . . 0.0 109.856 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.89 -38.38 94.63 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.493 2.129 . . . . 0.0 112.221 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.21 -45.7 90.4 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.763 0.825 . . . . 0.0 111.029 173.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 50.2 mmm -60.85 -46.12 91.81 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.135 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.38 -35.6 81.43 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.621 0.768 . . . . 0.0 111.293 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -69.52 -38.75 77.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.42 0.688 . . . . 0.0 111.696 175.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -74.65 -44.24 51.37 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.404 0.681 . . . . 0.0 111.391 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -161.78 153.25 18.64 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.229 1.012 . . . . 0.0 109.755 -172.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -73.92 148.12 42.51 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.96 0.41 . . . . 0.0 111.841 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -72.48 125.85 28.42 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 166.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.2 mt -113.77 125.98 71.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.8 m -66.26 167.29 10.55 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 173.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.1 t -62.28 -48.93 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 173.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 3.6 mpt_? -62.67 -48.25 80.13 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.668 0.387 . . . . 0.0 110.099 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.6 m -48.4 -41.36 28.81 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.717 1.207 . . . . 0.0 112.902 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.9 t -82.97 -29.86 28.69 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 50' ' ' VAL . 49.7 t -69.82 -29.68 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.661 0.784 . . . . 0.0 110.847 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 74.0 mmtt -62.54 -63.06 1.34 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.475 0.775 0 C-N-CA 124.555 1.142 . . . . 0.0 110.729 174.243 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.503 ' SG ' ' HD1' ' A' ' 30' ' ' PHE . 25.6 t . . . . . 0 CA--C 1.554 1.102 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.83 45.78 2.05 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.714 2.942 . . . . 0.0 112.972 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.91 129.74 35.73 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 170.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.88 -37.48 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 122.786 0.434 . . . . 0.0 110.683 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.8 p -97.17 69.81 2.33 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 169.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.739 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 21.5 t -84.06 79.07 9.63 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-O 121.078 0.466 . . . . 0.0 110.377 -177.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.1 mt -59.96 139.71 57.23 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.121 172.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -113.42 80.28 4.51 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.06 0.944 . . . . 0.0 109.915 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HG2' HG21 ' A' ' 17' ' ' VAL . 42.5 Cg_endo -86.25 142.87 7.53 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.292 2.661 . . . . 0.0 113.327 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.49 163.02 14.31 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.82 0.848 . . . . 0.0 109.517 172.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.34 152.87 28.86 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.981 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -82.54 -16.38 48.84 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.892 0.877 . . . . 0.0 111.914 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -58.2 -35.44 71.63 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.274 1.03 . . . . 0.0 112.018 -175.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.403 HG21 ' HG2' ' A' ' 12' ' ' PRO . 14.3 m -73.2 83.71 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 122.54 1.162 . . . . 0.0 110.295 172.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.44 ' HB3' HE21 ' A' ' 32' ' ' GLN . 34.3 t70 -69.45 140.8 54.09 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.627 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -92.89 156.25 17.07 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.169 0.509 . . . . 0.0 110.91 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -137.87 126.96 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.771 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -77.39 129.26 35.56 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.145 0.978 . . . . 0.0 109.755 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -62.98 -36.87 84.97 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.992 0.517 . . . . 0.0 111.271 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t70 69.39 -72.5 0.1 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.818 1.647 . . . . 0.0 111.264 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.42 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -46.7 90.58 0.01 OUTLIER Glycine 0 C--N 1.353 1.511 0 C-N-CA 124.828 1.204 . . . . 0.0 115.904 -172.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 t 70.44 12.32 7.45 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.35 1.46 . . . . 0.0 112.908 162.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -155.16 -29.11 0.11 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.263 -175.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 80.2 -59.61 0.31 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.274 1.43 . . . . 0.0 111.599 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -4.22 114.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 129.012 2.925 . . . . 0.0 116.978 -173.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -79.86 116.52 20.07 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.187 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.503 ' HD1' ' SG ' ' A' ' 4' ' ' CYS . 50.7 m-85 -100.73 164.94 11.63 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 124.285 1.034 . . . . 0.0 109.696 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.495 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -106.51 149.08 27.46 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -176.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.44 HE21 ' HB3' ' A' ' 18' ' ' ASP . 9.0 tt0 -47.97 -51.05 25.26 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.73 1.212 . . . . 0.0 112.643 -174.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.0 m -81.55 -28.45 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.205 0.602 . . . . 0.0 112.554 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.739 ' SG ' ' HA ' ' A' ' 9' ' ' CYS . 52.6 t -62.69 -36.09 81.82 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -174.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 m -114.5 -1.36 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.577 0.751 . . . . 0.0 111.712 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.3 30.66 71.46 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 113.665 0.226 . . . . 0.0 113.665 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.413 HG11 ' HB3' ' A' ' 47' ' ' TYR . 90.4 t -98.48 107.82 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.702 ' HB2' ' SD ' ' A' ' 41' ' ' MET . 45.6 m -73.14 163.1 71.01 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 123.696 0.799 . . . . 0.0 110.822 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -47.85 -45.71 23.65 Favored 'Trans proline' 0 C--N 1.396 3.04 0 C-N-CA 123.635 2.89 . . . . 0.0 114.999 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.85 -32.56 71.03 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 120.634 0.254 . . . . 0.0 111.348 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.702 ' SD ' ' HB2' ' A' ' 38' ' ' SER . 1.2 mpt? -69.76 -44.28 70.49 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.145 0.578 . . . . 0.0 109.94 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.29 69.47 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.587 0.755 . . . . 0.0 111.172 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.76 -48.51 46.32 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.365 1.066 . . . . 0.0 111.248 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -105.04 -61.18 1.51 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.906 -163.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -156.84 148.42 22.46 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -165.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 t70 67.17 76.43 0.29 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.966 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.438 ' H ' HD12 ' A' ' 48' ' ' ILE . 35.8 p90 -148.32 5.18 0.72 Allowed 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.638 177.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.438 HD12 ' H ' ' A' ' 47' ' ' TYR . 4.3 mp -95.09 117.52 39.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.0 p -59.73 147.19 38.67 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 123.297 0.373 . . . . 0.0 111.39 -171.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.6 t -54.9 -37.12 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -158.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -68.1 -27.87 66.85 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.667 0.387 . . . . 0.0 111.395 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 24' ' ' GLY . 82.3 m -79.24 -28.03 42.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.579 0.751 . . . . 0.0 111.154 173.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 m -73.5 -28.91 62.16 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 123.553 0.533 . . . . 0.0 110.196 175.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.1 t -72.21 -52.3 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.689 0.796 . . . . 0.0 109.389 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -94.77 55.47 1.89 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.03 0.919 . . . . 0.0 110.238 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.6 t70 . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 124.617 1.167 . . . . 0.0 109.396 177.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.5 p . . . . . 0 CA--C 1.549 0.941 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -90.1 -12.18 39.11 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.936 -0.478 . . . . 0.0 111.733 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.3 mmt -64.15 -14.17 53.21 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 123.575 0.75 . . . . 0.0 112.283 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 t -133.36 86.46 40.92 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 124.187 0.995 . . . . 0.0 108.835 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.76 80.96 0.61 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.101 2.534 . . . . 0.0 112.413 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.31 130.56 19.69 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.475 1.11 . . . . 0.0 108.894 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.43 -55.23 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.227 0.611 . . . . 0.0 109.693 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.7 m -78.12 74.21 4.67 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.499 0.719 . . . . 0.0 109.251 174.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.709 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 19.7 t -97.93 92.29 5.74 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.101 0.477 . . . . 0.0 110.491 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 33' ' ' VAL . 88.3 mt -71.88 113.6 9.09 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.438 172.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -105.27 107.77 59.81 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.47 1.108 . . . . 0.0 109.491 -175.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HG2' ' H ' ' A' ' 14' ' ' GLY . 97.9 Cg_endo -72.12 -145.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.459 2.773 . . . . 0.0 110.953 170.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -68.52 -6.66 26.47 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.669 0.388 . . . . 0.0 111.742 167.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.445 ' H ' ' HG2' ' A' ' 12' ' ' PRO . . . 116.64 -86.14 0.41 Allowed Glycine 0 C--N 1.346 1.122 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 174.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -95.39 66.49 2.85 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.396 1.093 . . . . 0.0 108.841 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -114.8 -58.71 2.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.916 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -86.18 -177.87 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 124.742 1.217 . . . . 0.0 112.065 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.44 ' HB3' HE21 ' A' ' 32' ' ' GLN . 33.2 t70 -98.23 140.93 31.8 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.925 0.49 . . . . 0.0 110.313 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -105.71 -177.96 3.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.492 1.117 . . . . 0.0 110.803 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 37' ' ' VAL . 7.5 p -157.94 136.57 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 125.162 1.385 . . . . 0.0 108.22 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -95.88 112.52 24.23 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.4 t -77.9 91.01 4.13 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -57.24 -80.34 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 O-C-N 123.942 0.776 . . . . 0.0 109.851 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 43.35 -83.8 0.01 OUTLIER Glycine 0 N--CA 1.484 1.883 0 C-N-CA 124.423 1.011 . . . . 0.0 115.309 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.8 p -159.81 26.96 0.18 Allowed 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.999 1.32 . . . . 0.0 110.222 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.8 p -143.11 -41.29 0.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.315 0.646 . . . . 0.0 111.387 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 65.29 19.29 11.64 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.029 0.931 . . . . 0.0 112.101 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -79.82 137.08 36.87 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.217 0.607 . . . . 0.0 111.059 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -86.59 128.61 35.0 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.465 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -129.33 143.39 50.83 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.284 1.034 . . . . 0.0 109.044 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.632 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -69.29 141.35 54.36 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 169.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.44 HE21 ' HB3' ' A' ' 18' ' ' ASP . 48.6 mt-30 -53.32 -40.47 64.84 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.935 0.494 . . . . 0.0 111.369 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.4 ' O ' HD12 ' A' ' 10' ' ' LEU . 33.3 m -65.31 -38.24 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.55 0.74 . . . . 0.0 111.677 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.709 ' SG ' ' HA ' ' A' ' 9' ' ' CYS . 8.4 t -56.29 -50.22 72.02 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.073 0.949 . . . . 0.0 112.047 -175.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.1 m -109.26 5.91 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.283 -174.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.45 52.73 51.39 Favored Glycine 0 C--N 1.355 1.638 0 C-N-CA 123.575 0.607 . . . . 0.0 113.98 174.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.584 HG21 HG11 ' A' ' 20' ' ' VAL . 13.1 t -74.66 119.3 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.054 0.541 . . . . 0.0 109.581 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.616 ' HB2' ' SD ' ' A' ' 41' ' ' MET . 41.7 m -63.14 135.6 96.3 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 123.575 0.547 . . . . 0.0 109.589 175.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.69 -15.43 16.19 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.373 2.716 . . . . 0.0 114.499 -175.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.03 -52.11 18.53 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.616 ' SD ' ' HB2' ' A' ' 38' ' ' SER . 1.4 mpt? -67.61 -33.36 74.83 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.109 0.964 . . . . 0.0 110.405 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.81 -36.37 70.24 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.178 0.991 . . . . 0.0 110.831 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.17 -45.23 85.72 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -70.61 -15.4 62.74 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.951 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 65.34 12.84 8.4 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.921 1.288 . . . . 0.0 110.979 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -102.34 91.61 4.34 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.099 1.359 . . . . 0.0 109.239 -170.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -132.23 106.59 8.04 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.9 mp -100.66 113.22 35.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.5 p -74.26 164.04 27.09 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.903 0.481 . . . . 0.0 110.475 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.4 t -50.54 -47.72 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 124.508 1.123 . . . . 0.0 112.441 -174.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -54.13 -44.12 71.09 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.071 0.549 . . . . 0.0 111.702 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 68.7 m -67.62 -36.11 80.19 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.044 0.537 . . . . 0.0 111.824 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.1 m -74.42 -44.15 53.13 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.181 0.593 . . . . 0.0 110.791 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.3 t -78.11 -16.11 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.229 1.011 . . . . 0.0 111.114 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -117.01 25.28 10.61 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.91 0.862 . . . . 0.0 109.696 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -79.35 -28.41 42.0 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.602 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 60.49 85.75 0.17 Allowed Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.351 1.06 . . . . 0.0 110.389 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.67 -179.94 5.85 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.728 2.286 . . . . 0.0 112.208 -174.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.1 t -80.92 -6.02 58.16 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.381 0.672 . . . . 0.0 110.821 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -150.26 117.03 5.85 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.561 1.368 0 C-N-CA 123.424 0.689 . . . . 0.0 109.551 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -123.97 99.58 6.33 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -57.74 -40.35 79.48 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.048 0.939 . . . . 0.0 110.92 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 82.1 m -164.26 158.42 15.82 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.304 1.441 . . . . 0.0 109.049 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.53 39.34 0.84 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.727 2.285 . . . . 0.0 111.061 162.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.26 108.72 8.93 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.1 t -63.76 -43.88 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 m -70.57 106.3 3.43 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 165.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.6 t -151.27 86.11 1.35 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.725 0.41 . . . . 0.0 111.149 -173.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.4 mt -71.12 114.44 9.18 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 166.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -93.11 107.11 22.7 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.709 1.204 . . . . 0.0 111.033 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.62 178.62 6.88 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.098 2.532 . . . . 0.0 111.052 168.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -74.49 -17.34 60.78 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.338 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.79 143.68 14.77 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.0 t70 58.59 34.04 23.55 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.293 1.044 . . . . 0.0 109.559 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -123.91 -71.96 0.7 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.057 -169.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.1 m -91.74 145.85 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -69.79 150.38 46.94 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.872 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -95.09 -178.12 4.37 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.712 0.805 . . . . 0.0 111.223 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.1 p -153.64 116.44 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.949 1.299 . . . . 0.0 108.706 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 52.0 tt0 -98.66 107.94 20.51 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.548 0.739 . . . . 0.0 109.392 -177.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 8.7 t -79.99 64.49 4.84 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.362 0.665 . . . . 0.0 111.278 -173.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -53.04 -36.3 60.44 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.215 1.406 . . . . 0.0 113.638 -169.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -39.35 -58.09 2.09 Favored Glycine 0 N--CA 1.477 1.392 0 O-C-N 124.865 1.353 . . . . 0.0 115.496 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.482 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 48.2 m -157.61 32.54 0.27 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.375 0.67 . . . . 0.0 110.672 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 75.4 m -132.74 -48.38 0.88 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 173.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 74.37 -6.65 1.83 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.939 1.296 . . . . 0.0 112.383 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -93.75 146.25 24.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.845 0.858 . . . . 0.0 109.882 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 8.3 p-90 -103.5 111.81 24.44 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.203 1.001 . . . . 0.0 109.635 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -100.71 163.24 12.42 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.627 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -63.32 145.71 55.0 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 166.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -62.85 -32.24 73.43 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 122.046 -0.409 . . . . 0.0 111.085 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 31' ' ' HIS . 33.5 m -68.73 -26.8 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 C-N-CA 123.105 0.562 . . . . 0.0 111.815 174.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.627 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.2 t -61.43 -55.53 30.27 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 123.958 0.903 . . . . 0.0 111.819 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 37' ' ' VAL . 18.4 m -101.43 -5.22 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.285 -168.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.66 31.86 20.27 Favored Glycine 0 C--N 1.348 1.245 0 O-C-N 123.204 0.315 . . . . 0.0 113.401 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 35' ' ' VAL . 55.0 t -97.3 125.73 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.559 0.744 . . . . 0.0 109.577 175.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.6 m -82.89 159.29 63.44 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 123.891 0.876 . . . . 0.0 110.067 175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -45.82 -50.78 9.17 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.631 2.887 . . . . 0.0 114.439 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 47.5 mt-10 -71.85 -12.95 61.52 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.094 0.558 . . . . 0.0 112.322 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.6 mtt -79.3 -57.09 3.89 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.528 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . . . -61.48 -36.62 80.99 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.94 0.896 . . . . 0.0 112.14 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -87.39 -65.13 1.05 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.901 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 39.5 ttmt -81.68 -48.49 11.63 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.451 0.469 . . . . 0.0 112.215 -163.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -162.32 118.88 2.0 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -167.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.0 t70 61.74 107.18 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.618 1.567 . . . . 0.0 114.067 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.582 ' H ' HD12 ' A' ' 48' ' ' ILE . 42.0 p90 -126.29 12.55 7.63 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 114.297 -1.319 . . . . 0.0 108.677 165.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.582 HD12 ' H ' ' A' ' 47' ' ' TYR . 3.5 mp -85.13 106.16 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.129 -172.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.1 p -61.52 159.86 12.22 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 123.837 0.711 . . . . 0.0 111.771 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.4 t -52.44 -39.68 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.748 1.219 . . . . 0.0 112.538 -172.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 27.4 mmt180 -64.78 -44.83 88.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.316 0.646 . . . . 0.0 111.701 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 25' ' ' SER . 64.7 m -62.71 -38.85 92.08 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.682 0.393 . . . . 0.0 111.075 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.9 m -69.36 -45.13 70.11 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.928 0.891 . . . . 0.0 110.834 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.46 -25.98 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.261 0.624 . . . . 0.0 111.101 -173.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 51' ' ' ARG . 68.2 mttm -56.77 -50.94 70.8 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 123.317 0.385 . . . . 0.0 110.233 173.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 73.63 -35.34 0.31 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.243 1.417 . . . . 0.0 113.059 173.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -114.88 101.16 54.38 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.096 1.358 . . . . 0.0 108.583 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.91 84.29 0.85 Allowed 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.907 2.405 . . . . 0.0 110.922 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.3 t -65.56 121.2 14.38 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.303 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 69.76 120.77 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 O-C-N 124.877 1.361 . . . . 0.0 110.782 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.084 0 C-N-CA 123.864 0.865 . . . . 0.0 109.108 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.3 m . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -163.46 35.62 0.09 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.115 0.966 . . . . 0.0 109.815 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 66.65 169.11 0.24 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 125.027 1.331 . . . . 0.0 112.213 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.2 t 64.36 81.23 0.22 Allowed Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 123.879 0.872 . . . . 0.0 111.21 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.34 108.33 2.59 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.222 2.615 . . . . 0.0 113.756 -170.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.29 -170.88 2.15 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.148 0.979 . . . . 0.0 109.74 168.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.9 m -54.89 -31.35 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 124.159 0.984 . . . . 0.0 112.109 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.4 m -147.42 -35.79 0.23 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.202 1.401 . . . . 0.0 109.188 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.3 t 70.18 97.02 0.07 Allowed 'General case' 0 C--N 1.36 1.031 0 C-N-CA 125.231 1.412 . . . . 0.0 109.491 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.4 mt -80.43 100.47 8.51 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -85.78 105.67 7.71 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.378 1.071 . . . . 0.0 108.302 171.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.56 162.39 42.16 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 122.423 2.082 . . . . 0.0 111.112 172.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.75 -22.33 66.48 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.407 0.683 . . . . 0.0 111.677 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.9 136.17 4.45 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.15 66.53 7.78 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.297 1.048 . . . . 0.0 111.16 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.54 -9.23 55.03 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.976 164.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -63.16 151.62 8.27 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 C-N-CA 124.659 1.184 . . . . 0.0 110.143 165.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -85.39 149.3 25.52 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.056 0.455 . . . . 0.0 110.114 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 22.1 m0 -111.75 -179.95 3.84 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.537 1.135 . . . . 0.0 110.83 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -161.75 131.78 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.551 1.14 . . . . 0.0 109.549 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 63.5 tt0 -69.82 149.45 47.9 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.659 0.784 . . . . 0.0 110.067 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 0.7 OUTLIER -127.7 50.12 2.06 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.552 0.741 . . . . 0.0 110.164 -171.303 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -57.53 -21.45 38.26 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.913 1.685 . . . . 0.0 114.564 -174.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.24 -58.59 6.33 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 114.76 0.664 . . . . 0.0 114.76 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.729 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 40.6 m -161.36 60.32 0.28 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 89.5 m -155.85 -45.67 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.939 0.896 . . . . 0.0 108.818 173.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 68.93 20.76 7.78 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.427 1.091 . . . . 0.0 111.652 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -140.48 163.18 33.53 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.829 0.852 . . . . 0.0 109.867 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 23.9 m95 -82.93 151.6 25.86 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.203 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -139.85 141.1 36.67 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.16 1.384 . . . . 0.0 108.395 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.658 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -56.12 144.96 27.42 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.457 0.703 . . . . 0.0 109.285 166.159 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -57.4 -41.05 79.56 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.12 0.418 . . . . 0.0 111.327 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -63.25 -26.22 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.246 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.658 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.6 t -67.59 -45.37 75.7 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.789 0.835 . . . . 0.0 111.913 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.5 m -100.82 -8.59 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.354 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.21 16.02 72.81 Favored Glycine 0 CA--C 1.536 1.392 0 O-C-N 123.358 0.411 . . . . 0.0 113.67 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 68.8 t -84.25 131.56 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 123.649 0.78 . . . . 0.0 109.558 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.4 m -67.8 157.33 86.84 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 123.751 0.82 . . . . 0.0 111.324 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -49.48 -50.79 12.11 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.174 2.583 . . . . 0.0 113.49 174.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.02 -30.74 68.11 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.556 0.742 . . . . 0.0 111.44 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 74.9 mtp -68.34 -47.61 67.04 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.785 0.434 . . . . 0.0 110.351 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.6 -34.5 72.83 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.362 0.665 . . . . 0.0 110.221 176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -75.14 -43.54 51.97 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.522 -176.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -103.55 -59.78 1.67 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -173.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -172.75 165.16 5.33 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.222 0.609 . . . . 0.0 111.636 -170.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.4 t70 63.11 57.71 1.56 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.481 1.112 . . . . 0.0 110.279 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -104.58 6.97 34.97 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.414 -1.267 . . . . 0.0 110.038 168.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.5 mp -78.52 104.24 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -173.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 51' ' ' ARG . 13.0 p -66.37 164.7 15.61 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.556 -175.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.8 t -51.92 -46.15 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.94 0.896 . . . . 0.0 110.699 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.532 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 72.9 mtp180 -53.3 -43.55 67.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 123.937 0.773 . . . . 0.0 112.244 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.729 ' HA ' ' HB2' ' A' ' 25' ' ' SER . 14.5 m -61.09 -47.3 86.95 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.825 0.703 . . . . 0.0 111.109 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.2 m -67.23 -45.21 77.45 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 124.015 0.822 . . . . 0.0 111.185 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.19 -34.2 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.025 0.93 . . . . 0.0 110.828 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -73.17 0.19 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -145.21 -76.43 0.21 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.706 0.802 . . . . 0.0 109.944 -172.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 45.55 90.53 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 C-N-CA 124.535 1.134 . . . . 0.0 112.684 -172.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.57 16.22 1.74 Allowed 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.458 2.105 . . . . 0.0 113.035 -177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.3 m -83.83 101.82 11.91 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.677 0.791 . . . . 0.0 110.352 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 67.86 -179.28 0.22 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 125.222 1.409 . . . . 0.0 113.257 174.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 pttp . . . . . 0 C--O 1.255 1.353 0 C-N-CA 124.086 0.954 . . . . 0.0 109.338 177.711 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -160.22 127.35 4.43 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.344 0.658 . . . . 0.0 109.792 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -111.23 35.66 3.49 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.073 0.949 . . . . 0.0 109.28 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m 68.22 157.14 0.15 Allowed Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 125.006 1.322 . . . . 0.0 110.744 -173.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -71.07 60.76 2.42 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.505 2.137 . . . . 0.0 111.922 165.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.55 108.45 2.72 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.437 1.095 . . . . 0.0 108.056 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -66.87 -17.06 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.904 0.882 . . . . 0.0 111.458 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.0 m -86.56 26.35 1.1 Allowed 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.527 1.131 . . . . 0.0 111.292 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.7 t -77.7 101.97 6.89 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.6 mt -62.3 -27.81 69.3 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.76 0.824 . . . . 0.0 112.297 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 58.8 60.04 5.37 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.342 1.057 . . . . 0.0 111.573 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -81.96 160.78 18.42 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.036 1.824 . . . . 0.0 111.59 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -23.25 59.05 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.614 170.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.47 -76.18 0.17 Allowed Glycine 0 C--N 1.343 0.952 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.3 t70 65.08 14.79 9.61 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.775 1.23 . . . . 0.0 112.359 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 64.86 61.07 0.8 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.084 1.353 . . . . 0.0 110.664 -176.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -101.34 134.99 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 170.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.57 160.99 22.42 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -114.3 164.91 13.28 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.45 0.643 . . . . 0.0 111.066 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 p -153.25 142.76 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.321 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -101.19 121.18 41.39 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.3 t -63.76 141.49 58.75 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.011 0.524 . . . . 0.0 110.155 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.432 ' H ' ' HE1' ' A' ' 47' ' ' TYR . 25.0 t70 -94.4 -78.55 0.44 Allowed 'General case' 0 C--O 1.239 0.509 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 154.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 33.04 -98.61 0.01 OUTLIER Glycine 0 C--N 1.357 1.732 0 O-C-N 125.039 1.462 . . . . 0.0 116.287 172.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.4 t -157.33 15.36 0.26 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.964 0.906 . . . . 0.0 109.898 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 14.1 p -159.21 57.37 0.41 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -49.87 80.49 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.528 1.931 . . . . 0.0 112.275 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -127.91 159.2 35.67 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 125.498 1.519 . . . . 0.0 107.402 170.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -82.16 108.48 15.66 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.491 0.663 . . . . 0.0 109.569 170.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -99.55 155.87 17.35 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.963 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.595 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -71.79 146.44 48.05 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 162.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -69.59 -22.26 63.53 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.36 0.527 . . . . 0.0 111.149 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.2 m -78.04 -19.99 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.366 0.667 . . . . 0.0 111.796 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.595 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 7.2 t -69.65 -28.02 65.54 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.596 0.758 . . . . 0.0 111.567 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 m -116.12 -8.53 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 124.364 1.066 . . . . 0.0 111.608 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.28 5.05 87.65 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 114.188 0.435 . . . . 0.0 114.188 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.2 t -80.12 138.26 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 123.282 0.633 . . . . 0.0 110.43 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 m -86.75 143.33 35.46 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.056 0.942 . . . . 0.0 109.709 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -50.38 -31.03 28.77 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 123.482 2.788 . . . . 0.0 114.407 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -58.24 -54.78 43.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.713 0.805 . . . . 0.0 109.505 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 72.2 mtm -71.99 -30.99 65.81 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.38 0.672 . . . . 0.0 111.47 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.51 -40.75 88.12 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.307 0.643 . . . . 0.0 110.937 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -82.51 -45.22 14.98 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.335 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -70.23 -56.47 6.7 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.885 0.474 . . . . 0.0 111.766 -166.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -174.49 127.68 0.33 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.355 0.662 . . . . 0.0 110.225 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.7 t70 73.16 133.83 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.906 1.682 . . . . 0.0 112.498 172.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.432 ' HE1' ' H ' ' A' ' 23' ' ' ASP . 14.5 p90 -151.25 20.77 0.75 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.569 1.548 . . . . 0.0 108.035 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.7 mt -88.82 133.91 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.273 -165.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.62 157.99 36.51 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.391 0.676 . . . . 0.0 110.627 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.7 m -56.65 -43.74 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.917 0.887 . . . . 0.0 113.072 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -69.8 -36.27 75.54 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.837 0.455 . . . . 0.0 110.869 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 96.3 m -68.41 -30.93 69.94 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.987 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.1 m -72.23 -42.86 65.2 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.268 1.027 . . . . 0.0 110.686 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.7 t -71.43 -32.65 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.076 0.55 . . . . 0.0 111.071 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -72.1 -17.37 61.99 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.825 0.45 . . . . 0.0 111.8 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -54.97 -35.09 63.92 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.279 0.562 . . . . 0.0 110.675 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.17 85.46 7.47 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.198 0.999 . . . . 0.0 108.582 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -64.64 95.21 0.23 Allowed 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.087 2.525 . . . . 0.0 110.91 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.8 p -144.37 173.23 11.96 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.105 0.962 . . . . 0.0 109.755 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 63.22 61.19 1.1 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.559 1.144 . . . . 0.0 110.051 -173.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.413 ' NZ ' ' HB2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.23 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.733 -177.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 121.076 0.465 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 9' ' ' CYS . 91.7 m-70 -126.72 121.02 30.85 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.403 1.081 . . . . 0.0 108.512 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.45 ' SD ' ' N ' ' A' ' 4' ' ' CYS . 14.2 tmm? -79.97 172.23 14.05 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.024 0.93 . . . . 0.0 109.971 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.45 ' N ' ' SD ' ' A' ' 3' ' ' MET . 0.0 OUTLIER 76.0 156.51 0.15 Allowed Pre-proline 0 N--CA 1.488 1.433 0 C-N-CA 125.55 1.54 . . . . 0.0 110.942 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.61 7.9 3.63 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.821 2.347 . . . . 0.0 113.542 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.422 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -83.72 119.76 25.19 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.9 t -60.13 -47.9 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.83 0.852 . . . . 0.0 111.059 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -90.06 63.02 5.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.744 0.817 . . . . 0.0 109.544 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 2' ' ' HIS . 43.1 t -77.07 75.43 3.64 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.349 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 33' ' ' VAL . 68.7 mt -72.15 107.91 5.06 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 170.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -125.68 94.67 41.9 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.975 0.91 . . . . 0.0 110.261 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.64 148.1 92.45 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.956 2.438 . . . . 0.0 112.565 171.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.3 103.14 2.76 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.671 0.788 . . . . 0.0 109.281 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.98 -129.0 9.4 Favored Glycine 0 C--O 1.242 0.619 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -167.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -129.76 -80.73 0.55 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 53.51 12.22 0.35 Allowed 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 124.545 1.138 . . . . 0.0 112.487 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -142.29 153.23 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 125.116 1.367 . . . . 0.0 108.685 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -76.76 154.99 33.52 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -118.7 150.56 39.53 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.08 110.89 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.215 1.006 . . . . 0.0 108.753 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -88.76 143.5 26.87 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.602 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.8 t -85.42 101.33 12.52 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.19 -25.62 68.16 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.001 0.52 . . . . 0.0 110.384 170.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.18 164.71 9.9 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.653 170.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.9 t -75.07 80.09 2.24 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.623 1.169 . . . . 0.0 111.092 -159.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.8 p -176.01 -26.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.613 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.1 t30 70.2 9.29 6.98 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 124.788 1.235 . . . . 0.0 112.947 169.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -70.28 122.54 19.74 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.332 0.653 . . . . 0.0 111.588 -174.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -79.2 142.08 36.6 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.679 0.791 . . . . 0.0 109.31 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -132.26 120.61 22.39 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 122.847 0.459 . . . . 0.0 110.751 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.648 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -62.33 148.79 44.05 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 165.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -54.04 -41.03 67.62 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.015 0.926 . . . . 0.0 111.597 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 10' ' ' LEU . 27.5 m -80.69 -19.3 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.679 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.648 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 6.4 t -61.9 -36.26 80.78 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 123.311 0.644 . . . . 0.0 111.667 175.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -119.55 -13.93 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.247 1.019 . . . . 0.0 112.09 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.85 9.43 70.52 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-O 119.31 -0.717 . . . . 0.0 114.137 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.422 HG11 ' HB3' ' A' ' 47' ' ' TYR . 90.9 t -66.36 106.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 117.658 0.729 . . . . 0.0 110.096 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 m -64.98 145.41 99.09 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.517 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -47.69 -29.49 11.02 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.875 3.05 . . . . 0.0 114.476 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 35.5 tt0 -63.22 -53.82 47.11 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.061 0.544 . . . . 0.0 110.456 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 70.7 mtm -67.77 -36.76 81.06 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.057 0.543 . . . . 0.0 110.539 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.01 75.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.467 0.707 . . . . 0.0 111.081 176.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -73.13 -40.18 65.13 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.285 0.634 . . . . 0.0 110.237 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 1.2 mmmp? -77.4 -3.66 41.33 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.061 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 71.71 21.14 4.41 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.993 1.317 . . . . 0.0 111.463 174.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -89.78 77.9 6.97 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.568 172.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.422 ' HB3' HG11 ' A' ' 37' ' ' VAL . 35.8 p90 -149.58 1.11 0.51 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.597 175.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.03 135.28 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.1 m -56.89 145.84 28.53 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.588 0.755 . . . . 0.0 111.134 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.6 m -59.95 -32.34 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.667 0.787 . . . . 0.0 112.376 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -69.82 -44.72 69.4 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.143 0.577 . . . . 0.0 110.469 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 75.3 m -62.61 -34.02 76.17 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.851 176.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.7 m -73.69 -49.28 26.6 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.962 0.505 . . . . 0.0 110.852 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 p -67.34 -24.4 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 122.718 0.407 . . . . 0.0 112.058 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -55.06 -43.09 73.53 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -127.31 -35.8 2.17 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.07 0.462 . . . . 0.0 110.894 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 63.51 63.24 1.55 Allowed Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.32 1.448 . . . . 0.0 111.632 -171.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -89.63 -5.53 5.32 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.735 2.29 . . . . 0.0 112.19 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.4 m -72.84 113.73 10.2 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.103 0.961 . . . . 0.0 108.619 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 61.86 -174.28 0.14 Allowed 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 125.036 1.334 . . . . 0.0 110.69 -173.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.556 1.186 0 C-N-CA 123.159 0.584 . . . . 0.0 109.845 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -81.27 119.58 23.82 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.9 ttt -78.2 87.38 4.29 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.001 0.429 . . . . 0.0 110.123 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.407 ' SG ' ' HD1' ' A' ' 30' ' ' PHE . 12.0 t -172.68 67.26 0.38 Allowed Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.08 0.952 . . . . 0.0 109.441 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.38 112.16 2.95 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.541 2.161 . . . . 0.0 111.679 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.47 21.31 2.55 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.964 0.505 . . . . 0.0 111.962 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 85.6 t 62.62 -71.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.862 1.265 . . . . 0.0 110.533 -170.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -89.09 96.93 10.92 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 170.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.584 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 38.4 t -111.15 95.77 5.73 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.99 127.27 32.25 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.433 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -99.01 99.95 8.97 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.563 1.145 . . . . 0.0 108.543 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.513 ' HG3' HG21 ' A' ' 17' ' ' VAL . 88.3 Cg_endo -76.93 169.16 22.18 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.138 2.559 . . . . 0.0 111.284 170.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -91.34 16.09 10.79 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.299 0.639 . . . . 0.0 111.113 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.07 45.17 27.05 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -174.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.24 -72.19 0.19 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.179 0.992 . . . . 0.0 110.036 -174.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -162.37 25.83 0.11 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.218 0.607 . . . . 0.0 110.678 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.513 HG21 ' HG3' ' A' ' 12' ' ' PRO . 34.9 m -80.46 134.06 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 122.703 0.401 . . . . 0.0 110.258 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.479 ' HB3' ' NE2' ' A' ' 32' ' ' GLN . 28.9 t70 -98.24 141.36 31.24 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.774 0.83 . . . . 0.0 108.82 174.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -106.17 130.91 53.96 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.437 0.695 . . . . 0.0 110.082 -176.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.51 HG11 HG21 ' A' ' 37' ' ' VAL . 7.2 p -114.11 129.69 69.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 C-N-CA 124.735 1.214 . . . . 0.0 108.654 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 40.5 tt0 -103.09 128.96 49.8 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 41.9 t -65.13 -27.21 68.57 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 t70 62.41 -84.71 0.02 OUTLIER 'General case' 0 C--N 1.355 0.842 0 C-N-CA 125.294 1.438 . . . . 0.0 110.891 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.704 ' HA2' ' HA ' ' A' ' 58' ' ' PRO . . . -18.87 -83.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 C-N-CA 126.238 1.875 . . . . 0.0 116.754 -163.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 p -134.23 59.29 1.74 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.261 1.029 . . . . 0.0 108.52 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.534 ' HB3' ' HG2' ' A' ' 28' ' ' GLN . 94.1 m -146.28 -50.7 0.22 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 171.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 64.81 23.69 12.72 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.571 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.534 ' HG2' ' HB3' ' A' ' 26' ' ' CYS . 3.0 pt20 -130.35 142.9 50.51 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 124.376 1.07 . . . . 0.0 109.871 -175.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 12.5 p-90 -100.74 154.35 18.69 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.487 1.115 . . . . 0.0 110.466 -175.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.407 ' HD1' ' SG ' ' A' ' 4' ' ' CYS . 44.0 m-85 -139.34 144.45 38.25 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.324 1.05 . . . . 0.0 108.931 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.605 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -68.47 150.6 47.91 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.071 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.479 ' NE2' ' HB3' ' A' ' 18' ' ' ASP . 72.1 mt-30 -55.08 -39.43 69.26 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.724 0.41 . . . . 0.0 111.31 176.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 31' ' ' HIS . 31.5 m -67.46 -29.66 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.479 0.712 . . . . 0.0 112.485 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.605 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.4 t -68.63 -46.93 67.91 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.723 0.809 . . . . 0.0 112.393 -174.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.551 HG23 HG23 ' A' ' 37' ' ' VAL . 6.9 m -118.65 16.85 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.793 0.837 . . . . 0.0 111.458 -172.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.82 24.42 69.89 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 114.182 0.433 . . . . 0.0 114.182 174.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 41' ' ' MET . 9.3 t -72.62 121.58 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.178 0.591 . . . . 0.0 110.102 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.3 p -75.31 157.72 84.52 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.094 0.958 . . . . 0.0 109.965 175.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -50.46 -27.17 18.02 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.973 2.449 . . . . 0.0 113.862 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.06 -50.66 65.31 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.944 0.898 . . . . 0.0 110.517 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.575 ' HB2' HG13 ' A' ' 37' ' ' VAL . 25.4 mmt -68.12 -33.38 74.39 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.788 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.19 -16.28 53.28 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.858 0.863 . . . . 0.0 112.239 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -80.87 -48.84 11.82 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.701 0.763 . . . . 0.0 109.473 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -70.27 -43.09 71.18 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.95 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 63.16 22.26 13.29 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.742 1.217 . . . . 0.0 113.444 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -89.31 20.35 3.86 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.076 0.55 . . . . 0.0 110.262 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -75.49 75.04 2.55 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 122.538 1.161 . . . . 0.0 110.736 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.09 105.63 19.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.1 p -58.39 155.83 11.25 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.107 0.563 . . . . 0.0 111.438 -173.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.45 -39.56 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.326 1.05 . . . . 0.0 113.09 -168.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -64.75 -37.34 87.26 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.206 0.603 . . . . 0.0 111.783 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.5 m -69.23 -30.57 68.74 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.229 0.611 . . . . 0.0 111.495 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 m -72.28 -33.92 67.8 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.206 0.602 . . . . 0.0 110.374 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.43 -41.88 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.975 0.91 . . . . 0.0 110.015 173.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -59.59 -36.84 77.04 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.586 0.754 . . . . 0.0 110.257 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.4 t70 59.1 33.9 23.09 Favored 'General case' 0 CA--C 1.558 1.264 0 O-C-N 124.461 1.1 . . . . 0.0 109.871 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.2 86.38 25.33 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.862 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.704 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 61.6 Cg_endo -86.17 160.63 9.98 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.63 2.22 . . . . 0.0 111.0 168.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.0 t -79.98 78.41 6.6 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -125.32 20.57 8.06 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.295 1.038 . . . . 0.0 110.13 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt . . . . . 0 C--O 1.255 1.355 0 C-N-CA 123.552 0.741 . . . . 0.0 109.888 -176.559 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.8 p . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -73.92 147.9 42.71 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 ptm -84.07 -10.9 57.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.799 0.44 . . . . 0.0 110.543 173.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 50.2 t -169.65 132.64 1.11 Allowed Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.669 0.788 . . . . 0.0 109.681 -170.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 17.2 Cg_exo -66.83 -20.52 51.82 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.277 2.651 . . . . 0.0 113.976 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.96 114.47 15.78 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -173.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -60.03 -39.77 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.732 0.813 . . . . 0.0 111.435 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 t -85.23 104.48 15.13 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 166.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 44.4 t -145.0 106.61 4.24 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.584 0.354 . . . . 0.0 110.054 -176.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.5 mt -69.83 153.11 43.76 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.319 168.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -110.78 88.78 8.36 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.79 169.31 22.5 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.524 2.15 . . . . 0.0 111.615 173.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -80.11 111.09 16.13 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.61 87.76 0.01 OUTLIER Glycine 0 C--N 1.349 1.289 0 O-C-N 123.842 0.714 . . . . 0.0 114.053 -175.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -174.1 -61.64 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.559 1.143 . . . . 0.0 109.471 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -99.9 23.93 9.13 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.264 1.031 . . . . 0.0 110.544 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.0 t -80.89 127.71 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.078 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -99.96 141.2 33.11 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 11.0 m0 -116.64 174.24 6.18 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.068 0.947 . . . . 0.0 110.432 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.39 133.62 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.819 1.248 . . . . 0.0 108.765 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -77.89 141.21 39.21 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.356 0.662 . . . . 0.0 109.582 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.2 t -106.37 66.82 0.71 Allowed 'General case' 0 C--O 1.248 1.022 0 CA-C-O 121.223 0.535 . . . . 0.0 109.642 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -81.18 25.81 0.47 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.063 0.545 . . . . 0.0 112.052 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -82.44 35.08 2.64 Favored Glycine 0 C--N 1.355 1.62 0 CA-C-O 119.326 -0.708 . . . . 0.0 113.836 172.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.1 t 82.64 54.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.649 1.58 . . . . 0.0 109.913 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.4 p -164.77 -40.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.545 170.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 65.0 t30 72.71 14.17 5.08 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.074 0.95 . . . . 0.0 111.919 167.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -67.53 127.72 33.78 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.536 0.734 . . . . 0.0 109.753 171.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -89.02 123.12 33.03 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.432 0.693 . . . . 0.0 110.255 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -116.18 148.8 40.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.277 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.62 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -69.51 143.67 53.38 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 166.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 21.6 mt-30 -57.37 -40.61 78.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.712 0.405 . . . . 0.0 111.572 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.2 m -71.95 -23.09 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 123.19 0.596 . . . . 0.0 112.494 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.62 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.4 t -60.53 -46.32 90.6 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.61 0.764 . . . . 0.0 111.051 176.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.552 HG23 HG23 ' A' ' 37' ' ' VAL . 15.7 m -118.9 11.03 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.134 -166.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.63 17.43 76.5 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 114.477 0.551 . . . . 0.0 114.477 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.552 HG23 HG23 ' A' ' 35' ' ' VAL . 56.0 t -71.32 110.77 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.122 0.487 . . . . 0.0 109.983 175.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.8 m -72.66 158.09 87.87 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.839 174.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -48.44 -34.85 26.81 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.798 2.332 . . . . 0.0 113.32 169.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -68.08 -41.98 81.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.199 0.6 . . . . 0.0 111.317 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 87.2 mtp -64.51 -41.04 96.65 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.92 0.488 . . . . 0.0 110.215 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.76 68.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.73 0.812 . . . . 0.0 111.128 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -73.17 -36.11 66.53 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.628 0.771 . . . . 0.0 111.013 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -71.79 -52.41 17.71 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.956 0.902 . . . . 0.0 109.302 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -164.07 -164.96 0.92 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.67 0.788 . . . . 0.0 109.405 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.98 173.81 10.25 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.203 0.601 . . . . 0.0 111.252 174.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -84.89 138.04 32.77 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.387 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.46 117.09 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 172.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 25.8 p -89.37 168.93 11.84 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.376 0.67 . . . . 0.0 110.647 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.37 -28.02 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.266 0.627 . . . . 0.0 111.856 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -64.67 -36.26 83.69 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.695 0.398 . . . . 0.0 110.514 172.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 24' ' ' GLY . 36.4 m -67.02 -42.99 83.96 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.991 0.516 . . . . 0.0 110.174 170.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.0 m -61.53 -43.83 98.15 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.089 0.556 . . . . 0.0 111.072 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.6 -26.36 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 O-C-N 121.925 -0.485 . . . . 0.0 111.259 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -73.32 -75.24 0.15 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.231 0.612 . . . . 0.0 112.372 177.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -96.43 -40.57 9.03 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -165.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.49 86.43 7.42 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 122.606 0.362 . . . . 0.0 111.26 -171.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.22 144.0 99.5 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.955 2.437 . . . . 0.0 113.059 176.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.2 t -89.46 39.5 0.95 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.033 0.933 . . . . 0.0 109.465 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 69.35 -10.75 0.53 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.844 1.657 . . . . 0.0 114.097 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.2 pttp . . . . . 0 CA--C 1.555 1.155 0 CA-C-O 118.573 -0.727 . . . . 0.0 109.204 -179.465 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.8 p . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 120.719 0.295 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -110.45 -164.75 0.94 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.587 0.755 . . . . 0.0 109.851 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.1 mtm -63.3 135.42 57.03 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.952 0.901 . . . . 0.0 111.471 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 50.71 93.77 0.05 OUTLIER Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 125.693 1.597 . . . . 0.0 112.426 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.11 99.84 0.29 Allowed 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.481 2.787 . . . . 0.0 112.455 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.05 -174.95 4.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.671 0.788 . . . . 0.0 110.763 -174.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.4 m -79.16 82.61 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 121.938 0.875 . . . . 0.0 109.903 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.9 m 70.06 107.83 0.06 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.529 1.532 . . . . 0.0 111.257 -177.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.8 t -76.93 79.69 3.49 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.55 145.84 54.5 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.324 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -109.02 86.75 4.11 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.499 ' HG3' HG21 ' A' ' 33' ' ' VAL . 44.6 Cg_endo -79.76 162.41 24.12 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.044 2.496 . . . . 0.0 112.578 -174.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -118.39 84.89 2.26 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 168.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.83 166.71 26.51 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.384 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.33 -25.03 11.65 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.836 0.854 . . . . 0.0 110.266 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.79 5.94 41.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.486 1.114 . . . . 0.0 111.681 -175.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.6 m -76.64 72.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 123.227 1.489 . . . . 0.0 111.236 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.89 166.19 22.67 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 113.362 -1.745 . . . . 0.0 109.314 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -105.83 127.37 53.07 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.261 0.624 . . . . 0.0 111.109 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.46 130.37 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 124.575 1.15 . . . . 0.0 110.061 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -77.59 153.39 33.3 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.973 0.909 . . . . 0.0 109.955 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.8 t -114.48 51.15 0.9 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.9 0.88 . . . . 0.0 109.691 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -48.27 -55.98 9.18 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.467 1.107 . . . . 0.0 112.744 -170.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -19.65 -56.92 0.01 OUTLIER Glycine 0 C--N 1.373 2.636 0 C-N-CA 126.268 1.889 . . . . 0.0 116.8 -172.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.532 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 26.2 t -165.22 65.51 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 169.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.2 m -156.77 -52.48 0.08 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.562 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 72.92 -6.06 1.77 Allowed 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 125.181 1.392 . . . . 0.0 111.323 -172.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -67.64 150.77 48.32 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.761 1.224 . . . . 0.0 111.131 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -100.26 131.18 46.35 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.758 0.823 . . . . 0.0 110.14 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -128.22 147.11 50.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.856 1.263 . . . . 0.0 108.489 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.592 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -70.4 148.54 48.27 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 165.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -57.01 -40.44 76.66 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.553 0.341 . . . . 0.0 110.504 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.499 HG21 ' HG3' ' A' ' 12' ' ' PRO . 21.0 m -69.45 -27.28 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.628 0.771 . . . . 0.0 112.359 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.592 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.8 t -60.38 -35.76 76.49 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 123.888 0.875 . . . . 0.0 110.167 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 m -115.96 6.46 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.165 -171.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.78 49.48 73.91 Favored Glycine 0 C--N 1.357 1.71 0 O-C-N 123.574 0.546 . . . . 0.0 113.539 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.7 t -119.17 137.94 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.152 1.381 . . . . 0.0 109.027 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 38.6 m -74.59 146.88 84.12 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 123.328 0.651 . . . . 0.0 109.989 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.78 -34.36 98.12 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.554 2.169 . . . . 0.0 113.101 174.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -70.4 -32.06 69.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.619 0.368 . . . . 0.0 111.204 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.4 ttt -67.86 -43.55 79.17 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.095 0.558 . . . . 0.0 110.066 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.95 -22.89 67.07 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.517 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -76.71 -43.87 35.74 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.13 0.972 . . . . 0.0 111.007 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -83.03 -22.05 33.66 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -171.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -150.78 165.97 31.89 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.139 0.495 . . . . 0.0 111.101 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -87.18 143.42 27.3 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.32 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -72.66 88.51 1.28 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.252 0.549 . . . . 0.0 109.552 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 66.7 mt -92.61 103.17 14.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 51' ' ' ARG . 19.0 p -81.73 175.03 10.8 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.844 -178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.07 -37.63 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.479 173.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.622 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 49.5 mtt-85 -61.24 -32.48 72.28 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.973 0.509 . . . . 0.0 111.165 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 24.0 m -67.62 -53.94 23.84 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.856 0.462 . . . . 0.0 110.214 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 t -68.93 -33.45 73.75 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.24 -172.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.8 t -73.92 -39.33 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 123.206 0.603 . . . . 0.0 110.667 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -63.5 -27.51 69.32 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 171.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.0 t70 66.11 19.12 11.13 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 124.12 0.968 . . . . 0.0 110.83 171.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 57.19 88.53 0.12 Allowed Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 124.934 1.294 . . . . 0.0 110.681 -170.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.9 -11.97 13.75 Favored 'Trans proline' 0 C--N 1.394 2.947 0 C-N-CA 123.864 3.043 . . . . 0.0 114.25 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.4 t -116.2 94.92 4.85 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 169.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.38 -56.38 14.7 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 174.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 66.7 mttm . . . . . 0 CA--C 1.55 0.979 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.732 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.8 p . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 120.661 0.267 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -83.88 87.64 7.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.593 0.711 . . . . 0.0 110.9 -173.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.688 ' SD ' ' SG ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -136.81 142.01 42.91 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 172.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.688 ' SG ' ' SD ' ' A' ' 3' ' ' MET . 0.1 OUTLIER 56.63 101.08 0.04 OUTLIER Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 124.408 1.083 . . . . 0.0 110.814 -170.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -43.76 86.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.398 3.144 0 C-N-CA 125.272 3.982 . . . . 0.0 115.87 -172.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.22 -170.32 2.17 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.072 1.349 . . . . 0.0 109.649 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.5 t -64.97 -57.1 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.125 0.57 . . . . 0.0 109.98 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.2 t -137.86 -22.64 1.07 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.278 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.0 t 69.72 100.93 0.06 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.597 1.159 . . . . 0.0 111.341 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.0 155.36 27.75 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.332 0.653 . . . . 0.0 110.499 171.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -117.94 81.24 15.53 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.411 1.084 . . . . 0.0 109.728 -175.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.13 165.47 11.24 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.587 2.192 . . . . 0.0 112.218 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.13 97.36 3.45 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.606 0.717 . . . . 0.0 109.454 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.94 93.43 0.22 Allowed Glycine 0 C--N 1.345 1.063 0 CA-C-N 114.658 -1.155 . . . . 0.0 114.375 -170.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -158.58 -61.3 0.08 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.525 0.73 . . . . 0.0 109.78 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -100.56 13.76 33.59 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.323 0.649 . . . . 0.0 111.025 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.06 130.84 35.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 123.04 0.536 . . . . 0.0 110.042 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.95 137.78 54.06 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.454 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -121.66 165.31 15.94 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.547 0.739 . . . . 0.0 109.858 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.77 133.24 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.623 -173.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -87.85 113.62 23.68 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 173.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 45.9 t -82.17 82.55 7.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.61 0.764 . . . . 0.0 110.535 -177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.41 1.46 0.78 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.369 1.067 . . . . 0.0 113.26 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.15 -162.7 0.57 Allowed Glycine 0 CA--C 1.539 1.55 0 O-C-N 121.549 -0.72 . . . . 0.0 113.087 162.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.518 ' N ' ' SG ' ' A' ' 52' ' ' CYS . 29.5 p -82.15 69.91 8.97 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.695 0.759 . . . . 0.0 111.134 -171.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.2 p -174.56 -41.16 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.921 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 74.6 -3.19 2.63 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 124.187 0.995 . . . . 0.0 112.607 168.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -77.34 157.89 30.43 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.752 0.821 . . . . 0.0 112.025 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -84.98 133.95 34.25 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.866 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 78.8 m-85 -126.91 158.75 35.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.866 1.266 . . . . 0.0 108.005 176.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.608 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -68.97 152.61 45.05 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 162.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.441 ' NE2' ' HA ' ' A' ' 39' ' ' PRO . 26.9 tt0 -62.62 -35.67 80.31 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.435 0.694 . . . . 0.0 110.018 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.4 m -70.57 -28.9 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.767 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.608 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 5.0 t -60.7 -41.54 95.39 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 123.698 0.799 . . . . 0.0 111.415 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 37' ' ' VAL . 5.4 m -96.64 -19.7 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.086 0.955 . . . . 0.0 111.598 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.91 15.75 79.58 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.238 0.336 . . . . 0.0 113.32 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 35' ' ' VAL . 78.2 t -79.46 140.43 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.781 0.832 . . . . 0.0 109.826 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 m -67.7 148.49 98.53 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.687 0.795 . . . . 0.0 111.134 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.441 ' HA ' ' NE2' ' A' ' 32' ' ' GLN . 5.7 Cg_endo -47.99 -48.37 16.52 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.895 3.063 . . . . 0.0 115.071 -176.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -61.14 -49.78 75.85 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 120.956 0.408 . . . . 0.0 110.419 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.644 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 93.0 mmm -58.69 -35.77 73.15 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.304 -177.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . . . -71.49 -36.61 71.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.939 0.896 . . . . 0.0 111.824 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -89.33 -29.62 19.01 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 122.846 0.459 . . . . 0.0 111.989 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -127.73 -45.2 1.47 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.7 0.8 . . . . 0.0 112.637 -159.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.644 ' HB2' ' HA ' ' A' ' 41' ' ' MET . 22.4 mm-40 -112.81 -144.38 0.39 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.256 0.623 . . . . 0.0 110.798 -167.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.86 139.84 53.13 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.424 0.69 . . . . 0.0 111.231 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.402 ' HB3' ' HA ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -146.66 27.97 1.08 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.891 1.277 . . . . 0.0 109.817 178.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.46 120.0 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.651 1.18 . . . . 0.0 109.545 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.6 p -78.22 167.2 21.76 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.356 0.662 . . . . 0.0 110.883 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.99 -39.46 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 124.132 0.973 . . . . 0.0 112.549 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -41.83 85.88 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.494 1.117 . . . . 0.0 110.269 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 25' ' ' SER . 18.3 m -64.47 -49.5 71.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.812 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.8 t -66.8 -28.46 68.4 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -173.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 82.0 t -72.36 -33.41 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.108 0.563 . . . . 0.0 110.732 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -71.27 -43.67 66.74 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.084 0.554 . . . . 0.0 110.912 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.87 -27.66 65.01 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.957 0.903 . . . . 0.0 111.641 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.42 78.26 11.16 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.389 0.676 . . . . 0.0 109.637 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.24 85.36 1.56 Allowed 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.69 2.26 . . . . 0.0 111.288 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.9 p -54.18 -55.59 26.38 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.913 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -121.88 154.65 36.8 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.358 1.063 . . . . 0.0 108.154 171.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.886 -0.578 . . . . 0.0 109.878 -174.669 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.6 m . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 44.6 m80 64.37 156.36 0.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.147 1.379 . . . . 0.0 112.781 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -85.02 173.64 10.36 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.916 173.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.62 158.15 34.04 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -73.34 69.45 4.11 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.493 2.129 . . . . 0.0 111.68 172.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.458 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -141.75 79.94 1.7 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.338 0.655 . . . . 0.0 109.85 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.7 t 63.76 -69.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 125.528 1.531 . . . . 0.0 110.97 -172.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.1 t -140.26 -83.66 0.24 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 170.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.6 t 147.9 117.16 0.0 OUTLIER 'General case' 0 C--N 1.361 1.102 0 C-N-CA 127.41 2.284 . . . . 0.0 107.344 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.5 mt -56.67 -36.09 69.17 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.806 0.843 . . . . 0.0 111.472 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 57.14 75.14 0.59 Allowed Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.747 1.219 . . . . 0.0 111.365 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -87.2 175.89 4.59 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.496 2.131 . . . . 0.0 111.717 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.5 -24.55 59.02 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.01 171.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.551 ' HA2' HG22 ' A' ' 17' ' ' VAL . . . 78.59 58.9 2.96 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.378 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -82.5 -49.13 10.25 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.163 0.585 . . . . 0.0 110.842 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -131.47 11.68 4.91 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.128 0.971 . . . . 0.0 111.844 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.551 HG22 ' HA2' ' A' ' 14' ' ' GLY . 18.7 m -78.94 124.57 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 118.47 0.577 . . . . 0.0 109.773 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -89.86 136.0 33.3 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 14.0 m0 -99.84 126.34 45.93 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.203 0.601 . . . . 0.0 110.798 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.71 115.55 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 C-N-CA 124.764 1.226 . . . . 0.0 110.297 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -83.78 127.41 33.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.569 0.748 . . . . 0.0 109.933 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.3 t -82.65 108.89 16.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 169.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.11 -80.08 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 24.18 -91.1 0.01 OUTLIER Glycine 0 C--N 1.37 2.442 0 O-C-N 125.104 1.502 . . . . 0.0 115.6 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.409 ' N ' ' SG ' ' A' ' 52' ' ' CYS . 10.5 m -149.98 46.09 0.92 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.748 1.219 . . . . 0.0 109.435 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.5 m -133.77 -61.48 0.8 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.622 0.769 . . . . 0.0 109.431 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 74.14 -2.48 2.78 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.221 1.409 . . . . 0.0 110.941 -172.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -81.73 141.24 33.74 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.73 0.812 . . . . 0.0 110.28 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -87.76 120.3 28.95 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.049 0.94 . . . . 0.0 109.371 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -115.79 124.06 49.8 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 123.172 0.589 . . . . 0.0 109.712 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.619 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -57.68 143.33 41.96 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 167.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -62.33 -32.08 72.79 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 118.298 0.499 . . . . 0.0 110.925 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 31' ' ' HIS . 32.8 m -65.73 -29.63 47.58 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 123.221 0.608 . . . . 0.0 111.726 172.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.619 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 3.9 t -68.53 -40.01 80.92 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.521 0.728 . . . . 0.0 111.707 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.52 -2.66 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.525 0.73 . . . . 0.0 112.668 -171.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.29 3.81 54.35 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.814 -0.437 . . . . 0.0 114.058 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.431 HG13 ' HB2' ' A' ' 41' ' ' MET . 53.2 t -70.79 111.93 5.12 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 123.557 0.743 . . . . 0.0 109.453 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.7 m -69.17 156.11 92.22 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 123.611 0.764 . . . . 0.0 110.485 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.88 -32.39 29.84 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 123.402 2.735 . . . . 0.0 113.342 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 37.6 tt0 -57.49 -52.9 63.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.649 1.18 . . . . 0.0 111.807 174.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.431 ' HB2' HG13 ' A' ' 37' ' ' VAL . 25.7 mmt -72.75 -30.95 64.57 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.449 0.643 . . . . 0.0 110.515 -177.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.9 -36.38 67.28 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.666 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -78.91 -36.62 41.63 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.999 0.519 . . . . 0.0 110.395 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 36.7 mmtm -75.17 -20.46 59.33 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.345 0.403 . . . . 0.0 110.587 176.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.524 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 42.8 mt-10 73.09 21.76 3.08 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.093 1.357 . . . . 0.0 112.505 170.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -86.22 21.23 2.09 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.182 0.993 . . . . 0.0 111.74 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.524 ' CE2' ' HA ' ' A' ' 45' ' ' GLU . 11.6 p90 -82.4 25.87 0.59 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.089 0.955 . . . . 0.0 112.184 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.435 HG23 ' HB3' ' A' ' 52' ' ' CYS . 4.5 mp -72.86 119.08 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 173.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.8 m -62.4 159.38 15.51 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.656 0.782 . . . . 0.0 110.418 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 54' ' ' VAL . 99.2 t -60.7 -42.73 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 175.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -62.51 -37.37 85.76 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.555 0.742 . . . . 0.0 111.666 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.435 ' HB3' HG23 ' A' ' 48' ' ' ILE . 5.7 m -64.38 -36.05 82.88 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.753 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.2 m -74.6 -25.62 59.38 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.277 0.631 . . . . 0.0 110.804 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 50' ' ' VAL . 80.0 t -67.26 -36.76 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 122.87 0.468 . . . . 0.0 110.3 173.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -74.64 -49.39 21.65 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.187 0.595 . . . . 0.0 110.599 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -64.77 -27.23 68.75 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 123.992 0.808 . . . . 0.0 111.313 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.66 82.52 12.46 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.809 0.844 . . . . 0.0 109.535 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.3 -42.42 17.68 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.666 2.244 . . . . 0.0 112.466 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.5 p -166.4 149.5 7.09 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.179 0.592 . . . . 0.0 110.667 174.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -141.58 91.42 2.37 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm . . . . . 0 C--O 1.246 0.921 0 C-N-CA 124.42 1.088 . . . . 0.0 108.217 177.192 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -123.71 6.64 8.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.694 0.798 . . . . 0.0 111.746 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.1 ptp -79.73 80.26 6.14 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 168.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 4' ' ' CYS . 4.0 t -168.37 64.72 0.63 Allowed Pre-proline 0 CA--C 1.556 1.2 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.386 -160.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.49 -28.1 53.93 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.608 2.205 . . . . 0.0 113.212 -173.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 50.27 -96.92 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.277 1.431 . . . . 0.0 112.668 -177.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 90.0 t -130.63 -57.65 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.0 t -135.19 107.15 7.07 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 164.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 4' ' ' CYS . 42.3 t -78.78 87.56 4.66 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.094 0.558 . . . . 0.0 111.142 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.07 109.84 5.39 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -106.67 99.17 23.66 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.665 0.786 . . . . 0.0 109.425 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HG2' HG21 ' A' ' 17' ' ' VAL . 88.3 Cg_endo -76.6 -170.61 0.92 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.144 2.563 . . . . 0.0 112.05 174.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -75.1 107.56 7.26 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.27 69.93 3.05 Favored Glycine 0 N--CA 1.467 0.729 0 CA-C-N 115.091 -0.959 . . . . 0.0 113.486 -171.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -92.53 -53.51 4.17 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.732 0.813 . . . . 0.0 109.276 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.71 32.82 0.55 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.595 1.158 . . . . 0.0 110.636 -173.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.541 HG21 ' HG2' ' A' ' 12' ' ' PRO . 43.5 t -68.81 125.97 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.074 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -76.88 135.41 38.84 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 123.675 0.609 . . . . 0.0 109.929 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 35.3 m0 -113.69 171.51 7.53 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.079 0.952 . . . . 0.0 111.121 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.78 118.75 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.057 1.343 . . . . 0.0 108.186 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 62.1 tt0 -76.68 145.86 38.47 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.967 0.507 . . . . 0.0 110.401 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.6 t -75.84 128.45 35.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.021 0.439 . . . . 0.0 111.68 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.645 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . 11.4 t70 -87.07 79.18 8.76 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.14 -179.41 44.75 Favored Glycine 0 C--O 1.239 0.418 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.844 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t -79.73 73.72 6.44 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.539 0.736 . . . . 0.0 109.754 -176.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.7 ' SG ' ' HG2' ' A' ' 28' ' ' GLN . 4.0 p -173.12 -37.58 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.312 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 61.83 17.2 8.62 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.027 1.331 . . . . 0.0 113.215 173.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.7 ' HG2' ' SG ' ' A' ' 26' ' ' CYS . 4.3 pt20 -73.11 134.2 44.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.288 0.635 . . . . 0.0 111.049 -177.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 48.2 m95 -81.43 155.32 25.93 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.022 0.929 . . . . 0.0 110.885 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -138.67 134.18 33.31 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.803 0.841 . . . . 0.0 109.427 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.633 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -62.51 145.86 53.17 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 164.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -49.87 -49.47 49.28 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 120.952 0.406 . . . . 0.0 111.199 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -67.06 -25.63 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.414 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.633 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 7.8 t -59.99 -35.18 74.47 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.305 0.642 . . . . 0.0 111.72 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.25 -3.77 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.347 1.059 . . . . 0.0 111.58 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.0 39.58 97.4 Favored Glycine 0 C--N 1.353 1.518 0 C-N-CA 123.602 0.62 . . . . 0.0 114.221 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.46 131.63 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.392 0.677 . . . . 0.0 109.407 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.3 m -68.32 149.32 98.11 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.388 1.075 . . . . 0.0 110.961 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.39 -52.69 6.96 Favored 'Trans proline' 0 C--N 1.393 2.873 0 C-N-CA 123.916 3.077 . . . . 0.0 114.157 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -68.29 -36.77 79.88 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.291 0.636 . . . . 0.0 111.682 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 61.2 mtt -72.67 -31.38 65.02 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.694 0.398 . . . . 0.0 110.884 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.09 -33.66 50.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.489 0.716 . . . . 0.0 110.814 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -76.31 -42.2 45.99 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.301 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -71.9 -58.43 3.46 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.454 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -101.48 106.25 17.34 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.645 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . 4.5 m-20 -56.25 110.2 0.72 Allowed 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.064 173.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -62.29 111.05 1.83 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.081 0.467 . . . . 0.0 110.779 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 41.0 mt -88.85 117.24 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 172.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.3 p -73.23 154.57 40.17 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.3 t -52.52 -44.74 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 124.457 1.103 . . . . 0.0 112.589 -171.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -60.74 -31.74 71.04 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.151 0.58 . . . . 0.0 112.45 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.6 m -76.31 -42.68 44.38 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.333 0.253 . . . . 0.0 111.12 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 m -61.21 -40.8 95.35 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.592 0.757 . . . . 0.0 110.707 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.9 -49.83 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.322 1.049 . . . . 0.0 110.819 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -74.53 -11.88 60.33 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.925 0.49 . . . . 0.0 111.834 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.99 -30.38 71.55 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.617 0.767 . . . . 0.0 110.291 171.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.9 108.23 28.5 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.882 1.273 . . . . 0.0 108.642 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.05 137.15 65.05 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 123.668 2.912 . . . . 0.0 112.033 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.4 m -91.91 14.89 14.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.622 0.769 . . . . 0.0 112.561 -174.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 64.91 118.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.076 1.351 . . . . 0.0 111.779 -178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 90.7 mttt . . . . . 0 C--O 1.252 1.225 0 CA-C-O 118.427 -0.796 . . . . 0.0 109.446 179.058 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.9 p . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -79.4 107.12 11.93 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.213 0.605 . . . . 0.0 109.616 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.474 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 66.3 mtt 59.62 -80.61 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.171 1.389 . . . . 0.0 111.667 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.24 147.61 15.95 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.58 62.63 8.56 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 123.285 2.656 . . . . 0.0 112.304 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.75 177.78 4.72 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.212 176.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.77 -42.57 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 t -133.4 162.9 30.6 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.897 0.879 . . . . 0.0 109.188 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 3' ' ' MET . 28.4 t -153.6 94.46 1.79 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.229 0.538 . . . . 0.0 110.018 170.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.501 HD12 ' HB ' ' A' ' 33' ' ' VAL . 28.0 mt -61.72 -35.18 77.32 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.456 1.102 . . . . 0.0 111.049 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 52.49 65.77 5.72 Favored Pre-proline 0 CA--C 1.552 1.057 0 O-C-N 124.67 1.231 . . . . 0.0 110.071 -171.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.437 ' HG2' HG21 ' A' ' 17' ' ' VAL . 61.4 Cg_endo -83.75 169.77 11.78 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.296 1.997 . . . . 0.0 112.39 -175.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -67.02 120.15 13.16 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.771 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.59 53.05 4.48 Favored Glycine 0 C--N 1.338 0.672 0 O-C-N 123.487 0.492 . . . . 0.0 113.687 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -65.66 -55.15 19.0 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -148.85 59.37 1.06 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.657 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.437 HG21 ' HG2' ' A' ' 12' ' ' PRO . 40.5 t -103.75 118.2 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.11 128.65 33.55 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.102 0.876 . . . . 0.0 109.807 -173.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 26.1 m0 -109.02 165.42 11.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.791 0.836 . . . . 0.0 109.904 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 47' ' ' TYR . 4.3 p -152.77 124.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.671 0.788 . . . . 0.0 109.908 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -72.42 130.14 40.0 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.722 0.409 . . . . 0.0 110.0 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.415 ' O ' HG12 ' A' ' 48' ' ' ILE . 37.2 t -65.75 -49.32 68.8 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.16 0.912 . . . . 0.0 111.552 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 72.64 -43.14 0.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.227 1.411 . . . . 0.0 112.723 -173.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.85 -160.49 0.09 OUTLIER Glycine 0 C--N 1.362 1.98 0 N-CA-C 114.569 0.587 . . . . 0.0 114.569 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.6 p -80.83 72.83 7.84 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.857 0.863 . . . . 0.0 111.706 -165.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.8 p 175.26 -31.68 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.894 2.077 . . . . 0.0 106.997 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 75.33 -43.88 0.51 Allowed 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 126.447 1.899 . . . . 0.0 113.952 172.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -47.9 148.85 1.49 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.389 1.876 . . . . 0.0 114.105 -167.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -74.87 144.74 43.23 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.174 173.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -132.29 128.15 37.15 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.622 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.594 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -67.02 151.64 47.27 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 172.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.591 ' HA ' ' HB ' ' A' ' 37' ' ' VAL . 62.6 mt-30 -56.37 -41.01 75.49 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.053 0.454 . . . . 0.0 110.204 174.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 10' ' ' LEU . 18.8 m -71.3 -17.4 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-N 114.849 -1.068 . . . . 0.0 112.669 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.594 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 2.5 t -80.06 -46.48 16.45 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.244 0.618 . . . . 0.0 111.335 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.677 HG23 HG23 ' A' ' 37' ' ' VAL . 2.5 m -119.41 9.78 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 123.654 0.782 . . . . 0.0 112.901 -169.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.01 36.96 92.7 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 122.672 0.177 . . . . 0.0 113.315 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.677 HG23 HG23 ' A' ' 35' ' ' VAL . 10.2 t -78.71 134.55 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.282 0.633 . . . . 0.0 110.995 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.0 p -77.02 153.28 82.68 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.66 0.784 . . . . 0.0 109.778 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.76 -31.53 72.33 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.44 2.094 . . . . 0.0 112.039 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -57.57 -52.35 65.75 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.548 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.585 ' HB2' HG13 ' A' ' 37' ' ' VAL . 26.1 mmt -66.44 -36.89 83.92 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 123.543 0.527 . . . . 0.0 111.516 -176.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.21 -30.37 68.53 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.109 0.564 . . . . 0.0 111.781 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -89.44 -29.29 19.13 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.151 0.58 . . . . 0.0 111.265 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -83.18 -20.71 34.15 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.558 0.743 . . . . 0.0 111.085 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 69.41 -161.92 0.18 Allowed 'General case' 0 C--N 1.361 1.095 0 O-C-N 124.419 1.075 . . . . 0.0 108.658 -170.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 69.27 3.57 4.18 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.633 1.173 . . . . 0.0 113.036 171.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.476 ' HB3' HG21 ' A' ' 20' ' ' VAL . 93.3 t80 -74.39 98.53 3.3 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 22' ' ' CYS . 44.7 mt -100.0 135.45 35.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 165.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -56.06 129.93 41.92 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 172.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -54.25 -35.12 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.36 0.664 . . . . 0.0 112.66 -167.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -68.65 -35.98 77.97 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.492 0.717 . . . . 0.0 110.988 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 84.2 m -64.68 -31.15 72.25 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.113 0.565 . . . . 0.0 111.384 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.9 m -70.3 -44.09 69.03 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.977 0.417 . . . . 0.0 109.976 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.424 ' O ' ' HE3' ' A' ' 61' ' ' LYS . 60.0 t -69.5 -31.38 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.029 0.932 . . . . 0.0 110.763 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -115.39 28.57 8.59 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.526 0.679 . . . . 0.0 110.102 -175.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -63.36 -40.27 96.81 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.908 0.883 . . . . 0.0 110.368 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.31 84.58 59.32 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.644 1.177 . . . . 0.0 107.867 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.44 89.73 0.4 Allowed 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 123.367 2.711 . . . . 0.0 112.471 -173.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.4 p -122.67 -73.05 0.66 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -165.65 149.39 8.09 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.894 0.878 . . . . 0.0 109.672 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HE3' ' O ' ' A' ' 54' ' ' VAL . 72.5 mmtt . . . . . 0 C--O 1.247 0.942 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.2 p . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 120.578 0.228 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -106.71 107.34 18.3 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.213 0.605 . . . . 0.0 109.905 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.4 mtt -83.75 119.62 25.03 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 170.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.41 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 12.6 t 62.39 82.81 0.21 Allowed Pre-proline 0 N--CA 1.481 1.086 0 O-C-N 124.011 0.819 . . . . 0.0 110.695 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.68 -42.76 0.76 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.67 2.247 . . . . 0.0 113.303 -174.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 44.87 25.13 0.13 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 125.798 1.639 . . . . 0.0 115.061 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.1 t 60.46 -73.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.908 1.283 . . . . 0.0 109.992 -166.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.3 m -104.81 88.11 2.83 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.157 0.983 . . . . 0.0 108.935 170.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.431 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 42.4 t -79.43 84.62 5.31 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.213 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 33' ' ' VAL . 59.9 mt -64.98 101.6 0.52 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 167.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -112.01 96.52 34.51 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.172 0.989 . . . . 0.0 110.782 -166.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.479 ' HG2' HG21 ' A' ' 17' ' ' VAL . 66.3 Cg_exo -53.66 150.23 29.24 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.056 2.504 . . . . 0.0 112.138 164.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.72 90.0 0.76 Allowed 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 122.027 0.918 . . . . 0.0 110.765 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.2 -149.46 32.48 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 114.497 -1.229 . . . . 0.0 113.475 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -101.07 82.64 2.39 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.026 0.93 . . . . 0.0 108.903 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -127.84 10.84 6.57 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.568 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.479 HG21 ' HG2' ' A' ' 12' ' ' PRO . 15.8 m -135.83 168.61 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.407 0.683 . . . . 0.0 111.733 -173.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -74.68 139.44 43.51 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.176 173.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -116.27 175.43 5.56 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.864 0.866 . . . . 0.0 109.96 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.435 HG11 HG11 ' A' ' 37' ' ' VAL . 12.7 p -161.08 138.21 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.183 0.993 . . . . 0.0 108.856 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -101.48 142.56 32.67 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 40.1 t -114.08 77.63 1.08 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.214 0.606 . . . . 0.0 110.671 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -78.78 80.8 5.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.81 -65.55 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.093 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.673 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 13.6 m -152.8 56.39 0.79 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.902 0.858 . . . . 0.0 109.233 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.0 m -161.61 -53.1 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 174.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.23 11.78 4.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.222 1.809 . . . . 0.0 113.467 173.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -107.04 166.61 10.49 Favored 'General case' 0 C--O 1.246 0.899 0 C-N-CA 123.419 0.688 . . . . 0.0 109.767 177.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -87.16 137.59 32.21 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.062 169.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -131.32 132.8 44.77 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.318 1.047 . . . . 0.0 108.884 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.635 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -56.99 147.03 25.08 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.836 0.854 . . . . 0.0 108.835 170.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -56.64 -45.18 81.71 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.153 0.981 . . . . 0.0 111.115 -173.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.416 ' O ' HD12 ' A' ' 10' ' ' LEU . 12.1 m -71.33 -29.57 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.722 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.635 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 13.2 t -54.17 -53.29 55.5 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.31 0.644 . . . . 0.0 112.556 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.1 m -96.12 -5.24 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.637 0.775 . . . . 0.0 111.06 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.74 37.52 94.96 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.612 -177.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.435 HG11 HG11 ' A' ' 20' ' ' VAL . 13.7 p -69.3 144.36 14.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.564 0.746 . . . . 0.0 110.684 -177.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.2 m -58.33 130.7 84.33 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.369 172.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -53.71 -26.71 39.33 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.241 2.627 . . . . 0.0 112.342 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.58 -52.17 64.47 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.788 0.835 . . . . 0.0 110.397 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 25.1 mmt -72.41 -30.65 64.84 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.088 0.555 . . . . 0.0 111.42 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.93 -44.83 83.97 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.798 0.839 . . . . 0.0 111.029 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -74.74 -25.8 59.35 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.549 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -75.73 -20.09 58.59 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 67.37 14.68 9.74 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.431 1.492 . . . . 0.0 112.303 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -134.96 89.23 2.5 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -171.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -119.42 106.84 12.65 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.914 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 48' ' ' ILE . 3.1 mp -106.98 110.2 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.7 m -57.92 158.05 7.02 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.958 0.503 . . . . 0.0 110.903 -176.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.8 -38.04 63.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 122.974 0.51 . . . . 0.0 110.428 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -56.78 -49.0 76.61 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.866 0.866 . . . . 0.0 111.251 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.673 ' SG ' ' HB2' ' A' ' 25' ' ' SER . 86.4 m -71.32 -27.1 63.16 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.095 0.958 . . . . 0.0 112.412 -174.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.8 m -85.19 -53.22 5.39 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.313 0.645 . . . . 0.0 110.678 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.62 -21.3 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.076 0.55 . . . . 0.0 111.421 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.63 -41.33 98.96 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-N 117.805 0.275 . . . . 0.0 110.723 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -163.15 -54.58 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.54 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 67.36 112.49 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 125.065 1.346 . . . . 0.0 110.721 -172.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.55 47.97 2.69 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.044 2.496 . . . . 0.0 111.853 171.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.6 m -86.09 -12.53 49.82 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.061 0.944 . . . . 0.0 112.138 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -75.4 82.87 2.49 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.244 0.618 . . . . 0.0 109.784 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.8 mttm . . . . . 0 CA--C 1.552 1.044 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.072 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -94.06 87.84 5.46 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.679 0.792 . . . . 0.0 109.801 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -69.97 -42.07 73.62 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 167.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.0 t -171.1 91.5 0.45 Allowed Pre-proline 0 CA--C 1.551 0.999 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.534 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 72.8 Cg_endo -76.01 -38.86 1.05 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.73 2.287 . . . . 0.0 112.341 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 48.58 23.22 0.59 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 126.159 1.783 . . . . 0.0 115.79 169.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.4 t 62.5 -74.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 125.126 1.37 . . . . 0.0 110.278 -171.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.7 m -108.64 80.84 1.38 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.354 1.062 . . . . 0.0 108.464 174.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 41.8 t -84.56 87.79 7.28 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.736 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.5 mt -65.76 111.29 3.16 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 164.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -102.7 102.41 26.37 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.046 0.938 . . . . 0.0 110.456 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.23 -179.48 5.06 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 122.706 2.271 . . . . 0.0 110.848 164.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.46 23.5 10.99 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.396 0.679 . . . . 0.0 110.625 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.21 35.42 92.05 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.82 -63.97 0.98 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.377 1.471 . . . . 0.0 110.814 -169.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -142.54 19.42 2.03 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.81 1.244 . . . . 0.0 108.29 171.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 t -79.18 123.95 36.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.259 -164.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 32' ' ' GLN . 34.2 m-20 -83.19 146.72 28.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.524 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -115.5 128.4 55.97 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.336 0.655 . . . . 0.0 109.292 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.557 HG21 ' HB2' ' A' ' 47' ' ' TYR . 5.3 p -103.86 126.27 58.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 123.608 0.763 . . . . 0.0 109.91 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -85.64 127.03 34.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.99 0.916 . . . . 0.0 108.973 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.8 t -85.49 80.94 8.9 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.01 -26.98 61.18 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.889 0.876 . . . . 0.0 112.258 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.534 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -71.57 104.61 1.48 Allowed Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.783 -1.009 . . . . 0.0 111.266 167.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.613 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 21.7 m 52.45 47.58 24.41 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.714 1.606 . . . . 0.0 113.558 161.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.0 m -161.77 -62.44 0.05 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.156 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.1 t30 70.42 3.51 4.51 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.186 1.394 . . . . 0.0 110.841 -173.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -87.06 143.25 27.41 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.977 0.911 . . . . 0.0 110.283 -172.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -87.63 112.24 22.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.988 0.915 . . . . 0.0 110.023 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -107.96 140.57 40.91 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.852 0.861 . . . . 0.0 109.059 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.598 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -68.63 154.55 41.7 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.031 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 27.2 tt0 -52.33 -50.11 62.94 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.071 1.348 . . . . 0.0 111.047 -177.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.9 m -72.08 -28.58 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 114.33 -1.304 . . . . 0.0 112.098 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.598 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.9 t -58.14 -49.46 76.91 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.813 0.845 . . . . 0.0 111.931 -175.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 m -95.63 2.57 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.462 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.72 19.89 76.99 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.247 0.342 . . . . 0.0 113.895 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.43 121.57 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.0 m -72.33 158.13 88.02 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.368 0.667 . . . . 0.0 110.325 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.93 -39.65 68.53 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.263 2.642 . . . . 0.0 113.371 176.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -64.24 -44.35 92.11 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.172 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 56.7 mtt -63.33 -48.19 79.05 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.756 0.822 . . . . 0.0 110.073 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.32 -26.95 68.71 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.573 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -83.97 -51.03 7.47 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.247 0.619 . . . . 0.0 111.125 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -91.4 -60.22 1.94 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.47 0.308 . . . . 0.0 110.714 -168.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -166.41 152.15 8.5 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.493 0.717 . . . . 0.0 111.957 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.7 t0 68.09 103.42 0.05 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.077 1.751 . . . . 0.0 112.807 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.557 ' HB2' HG21 ' A' ' 20' ' ' VAL . 3.2 p90 -150.93 14.52 0.73 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.47 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 52.6 mt -82.16 122.84 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.752 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 p -65.26 148.3 51.93 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.312 0.383 . . . . 0.0 110.367 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.7 t -45.25 -42.07 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 125.821 1.648 . . . . 0.0 113.275 -171.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -53.96 -50.01 67.46 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.885 0.874 . . . . 0.0 111.927 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 25' ' ' SER . 61.5 m -76.7 -24.97 53.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.581 -175.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.7 m -68.54 -47.53 66.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.313 0.645 . . . . 0.0 110.473 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.27 -29.99 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.925 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -62.31 -66.09 0.59 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.262 0.625 . . . . 0.0 110.423 173.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -172.74 -55.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.941 0.776 . . . . 0.0 109.718 -175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 61.65 80.75 0.25 Allowed Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 124.657 1.223 . . . . 0.0 109.835 -167.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.36 81.49 0.96 Allowed 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.904 2.403 . . . . 0.0 112.704 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.4 m -101.78 7.0 41.93 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.691 170.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -64.97 155.8 33.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.181 1.392 . . . . 0.0 110.642 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 123.98 0.912 . . . . 0.0 111.082 -176.691 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.9 p . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -83.4 64.1 7.65 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.43 0.692 . . . . 0.0 110.322 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.427 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 1.1 mpt? 62.14 0.9 0.62 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.745 1.618 . . . . 0.0 114.484 173.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.87 123.13 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 C-N-CA 124.002 0.921 . . . . 0.0 111.03 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -64.45 85.18 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 123.005 2.47 . . . . 0.0 112.783 -175.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.16 171.14 13.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.761 1.224 . . . . 0.0 109.967 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.04 -38.86 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.597 0.759 . . . . 0.0 110.949 -175.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.9 p -156.68 109.76 2.6 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.605 0.762 . . . . 0.0 109.097 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 3' ' ' MET . 42.4 t -88.41 109.17 19.79 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.983 0.421 . . . . 0.0 110.75 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.713 HD21 HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -69.57 158.55 35.05 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.478 164.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -102.42 93.64 4.22 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 171.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.64 112.95 1.93 Allowed 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.315 2.01 . . . . 0.0 110.897 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -85.87 52.12 2.39 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 122.718 1.246 . . . . 0.0 110.722 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 157.04 142.89 3.51 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 113.171 -1.832 . . . . 0.0 110.704 -173.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.84 22.59 0.75 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.207 1.003 . . . . 0.0 111.775 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -74.33 -16.32 60.92 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.454 1.102 . . . . 0.0 111.788 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -80.19 137.42 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -90.7 151.7 21.14 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -103.24 152.37 21.57 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.609 0.764 . . . . 0.0 110.607 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.54 124.29 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.014 1.326 . . . . 0.0 108.276 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 29' ' ' TRP . 35.4 tt0 -85.29 141.83 29.8 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.63 151.69 46.87 Favored 'General case' 0 CA--C 1.552 1.023 0 O-C-N 123.624 0.577 . . . . 0.0 111.863 -167.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -71.74 -44.34 64.26 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.7 1.6 . . . . 0.0 112.715 -174.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.518 ' HA3' ' SG ' ' A' ' 52' ' ' CYS . . . -84.01 -129.06 1.66 Allowed Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.656 -167.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -120.31 75.63 1.12 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.8 m -114.17 -27.99 7.46 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.888 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.5 t30 77.3 -37.17 0.25 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.271 1.429 . . . . 0.0 112.208 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -85.16 148.59 26.03 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.614 0.721 . . . . 0.0 112.537 -166.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 12.0 p-90 -104.16 139.02 39.8 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.324 171.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 42.3 m-85 -123.11 162.98 21.42 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 124.413 1.085 . . . . 0.0 108.251 -175.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.64 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -69.24 146.79 52.04 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 160.202 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -58.35 -41.32 84.39 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.294 0.497 . . . . 0.0 110.707 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.713 HG23 HD21 ' A' ' 10' ' ' LEU . 27.8 m -67.47 -25.67 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.711 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.64 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 8.5 t -58.6 -39.12 79.51 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 123.835 0.854 . . . . 0.0 111.433 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.4 m -104.92 -0.97 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.998 0.919 . . . . 0.0 111.622 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.26 16.12 80.04 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 116.491 -0.322 . . . . 0.0 113.825 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.9 t -90.5 136.55 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.23 0.612 . . . . 0.0 109.802 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.0 m -90.34 152.44 45.61 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.814 0.846 . . . . 0.0 110.117 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -47.04 -56.74 2.78 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.898 3.065 . . . . 0.0 114.622 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.27 -27.88 67.56 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.913 0.485 . . . . 0.0 111.722 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.6 mtt -74.35 -31.27 62.35 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 122.614 0.365 . . . . 0.0 110.201 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.55 -35.3 60.69 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.347 0.659 . . . . 0.0 111.343 176.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.17 -48.87 12.47 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.585 0.754 . . . . 0.0 111.213 -176.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.34 -25.82 19.23 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.334 0.653 . . . . 0.0 112.046 -171.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -123.82 170.03 10.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.249 0.619 . . . . 0.0 110.204 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -85.48 123.71 31.22 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.627 178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -88.44 48.91 1.7 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.404 1.081 . . . . 0.0 110.911 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.1 mt -73.36 105.29 2.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.861 -177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 51' ' ' ARG . 2.3 p -69.16 162.22 27.49 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.012 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 54' ' ' VAL . 67.1 t -54.2 -42.27 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.45 0.7 . . . . 0.0 111.122 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.525 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . 2.8 mpt_? -58.41 -40.64 83.03 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.679 0.791 . . . . 0.0 111.494 176.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.518 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 35.0 m -72.34 -35.22 68.5 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.296 0.238 . . . . 0.0 111.578 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.1 m -70.33 -47.57 60.48 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.645 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 50' ' ' VAL . 13.6 p -84.87 -44.5 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -174.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -84.1 -35.82 23.43 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 120.736 0.303 . . . . 0.0 110.206 -167.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 59.7 m-20 -90.72 35.05 0.89 Allowed 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.538 0.685 . . . . 0.0 110.404 177.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.76 98.3 5.31 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.772 1.229 . . . . 0.0 107.819 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.59 101.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.895 3.063 . . . . 0.0 113.693 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.1 m -142.09 141.55 32.74 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.681 0.792 . . . . 0.0 110.103 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -80.09 104.04 10.38 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.4 mttm . . . . . 0 CA--C 1.552 1.057 0 O-C-N 124.808 1.317 . . . . 0.0 110.265 -174.877 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -66.34 153.31 43.0 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 169.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.469 ' SD ' ' SG ' ' A' ' 4' ' ' CYS . 1.4 tmt? 80.3 -41.95 0.21 Allowed 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 125.235 1.414 . . . . 0.0 110.698 -175.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.609 ' SG ' ' HA ' ' A' ' 11' ' ' GLN . 9.3 m -128.19 74.58 79.33 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.542 0.737 . . . . 0.0 110.916 175.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -93.16 -23.26 0.3 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.412 2.742 . . . . 0.0 114.847 -175.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 9' ' ' CYS . . . -63.53 147.99 49.93 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.158 0.583 . . . . 0.0 110.347 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -55.59 -34.04 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.933 0.893 . . . . 0.0 112.559 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.5 m -127.01 100.16 6.01 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 169.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.548 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 8.7 t -142.6 25.64 1.82 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.987 -166.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.462 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 21.1 mt 59.05 -65.16 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 165.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.609 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 27.5 mt-30 82.83 59.58 0.09 OUTLIER Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 127.597 2.359 . . . . 0.0 110.701 -168.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HD3' ' H ' ' A' ' 11' ' ' GLN . 24.8 Cg_endo -93.86 96.04 0.13 Allowed 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.171 2.581 . . . . 0.0 110.908 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.12 83.97 2.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.43 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.38 122.52 1.1 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.593 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -65.45 -19.63 66.02 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.864 0.866 . . . . 0.0 111.956 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -77.09 1.53 17.81 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.853 0.861 . . . . 0.0 112.181 -174.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.6 m -79.39 137.35 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.023 0.44 . . . . 0.0 110.296 175.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -94.58 149.25 21.43 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.616 1.167 . . . . 0.0 110.148 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 1.0 OUTLIER -119.01 161.28 20.49 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.739 0.816 . . . . 0.0 111.419 -171.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.69 136.68 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.674 1.19 . . . . 0.0 108.255 171.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.42 ' HG2' ' H ' ' A' ' 23' ' ' ASP . 61.9 tt0 -76.4 152.25 36.31 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.26 0.624 . . . . 0.0 109.536 177.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.4 t -76.22 -21.26 56.62 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' H ' ' HG2' ' A' ' 21' ' ' GLN . 30.5 t70 76.26 -48.6 0.57 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.156 1.383 . . . . 0.0 112.292 -177.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.534 ' HA3' ' SG ' ' A' ' 52' ' ' CYS . . . -57.41 178.8 0.94 Allowed Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.246 0.859 . . . . 0.0 115.246 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.8 m -65.47 -23.73 66.99 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.454 0.702 . . . . 0.0 112.456 -168.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.3 p -67.2 -34.42 77.46 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.062 0.545 . . . . 0.0 110.017 174.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.3 t30 65.33 12.68 8.27 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 125.11 1.364 . . . . 0.0 113.466 166.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -73.16 141.92 47.43 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.315 1.046 . . . . 0.0 112.063 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -92.6 118.12 30.68 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.092 0.957 . . . . 0.0 109.589 175.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -110.94 126.93 55.26 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.01 0.924 . . . . 0.0 109.229 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -53.06 123.69 12.33 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.386 0.675 . . . . 0.0 111.572 175.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 47.8 mt-30 -52.31 -47.22 66.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.34 1.456 . . . . 0.0 112.697 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 m -58.24 -36.58 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.609 0.719 . . . . 0.0 110.955 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 0.1 OUTLIER -74.72 -39.3 61.98 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.882 -175.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.454 HG23 HG23 ' A' ' 37' ' ' VAL . 35.1 m -100.94 6.57 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.563 -173.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.05 3.18 88.09 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 114.71 0.644 . . . . 0.0 114.71 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 32' ' ' GLN . 88.1 t -79.74 125.86 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.422 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 25.2 m -93.22 165.57 18.13 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 123.894 0.878 . . . . 0.0 109.965 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 38' ' ' SER . 10.9 Cg_endo -51.81 -52.19 9.51 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 123.174 2.583 . . . . 0.0 114.401 -174.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.08 -27.74 64.85 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.322 0.249 . . . . 0.0 111.628 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.1 mtt -69.15 -36.92 77.94 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.775 0.43 . . . . 0.0 110.53 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.34 -31.39 63.95 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.21 1.004 . . . . 0.0 110.603 176.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -70.95 -36.47 72.62 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.391 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -76.33 -52.48 9.85 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.367 0.667 . . . . 0.0 110.64 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -138.72 139.14 38.27 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.321 1.048 . . . . 0.0 109.52 -172.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -72.8 176.29 5.74 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 122.695 0.398 . . . . 0.0 109.937 171.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -88.54 77.5 8.0 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 175.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.22 105.61 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.8 p -73.07 160.48 31.96 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.229 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.6 p -52.95 -39.67 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.434 1.094 . . . . 0.0 113.766 -165.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -70.9 -30.57 66.96 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 118.015 0.37 . . . . 0.0 111.449 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.534 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 99.2 m -74.91 -26.21 59.48 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.158 0.583 . . . . 0.0 111.005 173.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.8 m -81.85 -39.01 24.56 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.083 0.553 . . . . 0.0 110.862 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.8 t -76.89 -32.23 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.046 0.939 . . . . 0.0 109.747 176.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -135.51 87.45 2.32 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.082 0.553 . . . . 0.0 110.501 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -91.99 -23.45 19.54 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 166.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.16 88.4 26.21 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 124.004 0.921 . . . . 0.0 109.16 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.48 -23.51 50.37 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.041 2.494 . . . . 0.0 111.995 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.0 t -136.85 104.46 5.49 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -75.12 104.78 5.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.029 0.531 . . . . 0.0 110.418 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.254 1.325 0 C-N-CA 123.946 0.899 . . . . 0.0 110.193 178.468 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -155.79 92.59 1.39 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.118 0.485 . . . . 0.0 109.986 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ttt -154.46 6.85 0.29 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.064 0.946 . . . . 0.0 108.926 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.28 92.21 1.67 Allowed Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -170.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -52.84 -51.14 11.78 Favored 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 124.712 3.608 . . . . 0.0 116.994 -159.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.549 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -60.15 158.51 11.18 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -170.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -75.8 -42.56 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.119 0.568 . . . . 0.0 110.411 176.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.0 p -92.44 52.29 1.89 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.522 1.129 . . . . 0.0 109.115 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -93.35 119.67 32.74 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.196 -167.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.4 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 28.6 mt -69.49 178.48 2.45 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 160.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -115.69 83.0 10.82 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HD3' ' SG ' ' A' ' 34' ' ' CYS . 67.5 Cg_endo -81.89 134.23 8.27 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.098 2.532 . . . . 0.0 112.885 -178.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -148.06 152.61 37.67 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.472 0.709 . . . . 0.0 110.002 175.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.9 -146.7 17.33 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -92.26 78.6 5.12 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.009 0.924 . . . . 0.0 109.798 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 69.1 121.62 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.441 1.496 . . . . 0.0 111.63 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.6 t -89.26 145.66 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.919 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.72 120.81 16.87 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 174.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.625 ' HA ' ' HA ' ' A' ' 31' ' ' HIS . 9.5 m95 -118.24 131.04 56.38 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.377 0.671 . . . . 0.0 111.566 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.513 ' HB ' ' HG2' ' A' ' 32' ' ' GLN . 5.7 p -104.35 123.2 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.793 174.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.445 ' NE2' HD22 ' A' ' 27' ' ' ASN . 47.9 tt0 -82.47 137.99 34.49 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 173.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 36.7 t -84.62 81.94 8.64 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 170.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -54.35 -18.59 4.26 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.752 1.221 . . . . 0.0 112.293 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -51.47 177.52 0.07 OUTLIER Glycine 0 C--N 1.351 1.364 0 N-CA-C 114.671 0.628 . . . . 0.0 114.671 167.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.9 p -74.65 72.98 1.99 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.554 1.141 . . . . 0.0 111.18 -171.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 27' ' ' ASN . 9.6 p -178.36 -42.58 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.388 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.445 HD22 ' NE2' ' A' ' 21' ' ' GLN . 14.5 m120 67.05 31.58 6.8 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 124.038 0.935 . . . . 0.0 110.69 175.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -72.18 121.32 19.12 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.283 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -87.68 108.21 18.99 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.573 0.749 . . . . 0.0 110.996 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -103.8 171.68 7.22 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.941 170.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -108.36 123.58 49.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.324 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.513 ' HG2' ' HB ' ' A' ' 20' ' ' VAL . 28.4 mt-30 -48.79 -56.65 8.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.916 1.286 . . . . 0.0 113.082 -177.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -62.3 -32.28 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-O 121.384 0.611 . . . . 0.0 111.112 -176.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.477 ' HB3' ' CD2' ' A' ' 31' ' ' HIS . 6.5 t -85.53 -20.38 29.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.204 -170.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.8 m -109.4 -16.49 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.093 0.557 . . . . 0.0 111.578 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.46 15.21 35.64 Favored Glycine 0 C--N 1.351 1.399 0 N-CA-C 114.171 0.428 . . . . 0.0 114.171 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.33 129.96 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.285 0.634 . . . . 0.0 109.709 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 88.7 p -82.49 164.45 47.41 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.072 0.549 . . . . 0.0 109.711 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.51 -26.17 70.09 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 121.945 1.763 . . . . 0.0 111.336 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -64.76 -52.22 58.1 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.929 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 66.8 mtt -62.49 -36.04 81.25 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.576 0.75 . . . . 0.0 111.636 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.47 -38.99 85.24 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.49 0.716 . . . . 0.0 112.098 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -85.07 -45.66 11.89 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.896 0.478 . . . . 0.0 111.301 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -68.97 -54.38 15.61 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.356 1.062 . . . . 0.0 110.378 -175.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -111.08 160.6 16.73 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.201 -175.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -85.14 135.35 34.01 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 163.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -73.77 81.94 1.61 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 168.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.7 mt -75.18 104.92 3.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.958 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.9 p -73.84 158.51 34.39 Favored 'General case' 0 C--O 1.252 1.19 0 O-C-N 123.923 0.764 . . . . 0.0 110.3 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 54' ' ' VAL . 18.9 m -52.91 -33.62 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.222 1.009 . . . . 0.0 113.016 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -61.28 -41.65 97.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.798 0.439 . . . . 0.0 111.389 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.8 m -68.78 -36.49 78.37 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.88 0.472 . . . . 0.0 110.818 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.6 m -64.2 -47.78 78.43 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.512 0.725 . . . . 0.0 111.378 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 50' ' ' VAL . 53.2 t -69.77 -38.34 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.269 0.628 . . . . 0.0 110.503 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -68.81 -38.76 80.12 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.919 0.888 . . . . 0.0 112.342 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -152.57 -59.8 0.15 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.43 0.292 . . . . 0.0 110.782 -173.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 63.55 97.01 0.04 OUTLIER Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.793 1.237 . . . . 0.0 110.275 -170.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.79 76.82 0.15 Allowed 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.011 2.474 . . . . 0.0 111.191 173.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.2 t -159.76 157.35 29.23 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.652 -169.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -79.69 139.13 37.48 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.765 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.8 pttp . . . . . 0 CA--C 1.564 1.485 0 C-N-CA 123.726 0.81 . . . . 0.0 109.158 178.227 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -152.69 161.77 42.13 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.008 0.523 . . . . 0.0 110.816 -177.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 49.9 ttp -167.53 157.12 10.34 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.545 1.138 . . . . 0.0 109.253 176.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.5 t -116.1 91.2 31.1 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 123.933 0.893 . . . . 0.0 108.886 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.93 94.31 1.07 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.684 2.923 . . . . 0.0 112.941 -169.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.629 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -158.57 107.52 1.97 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.459 0.704 . . . . 0.0 110.362 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.2 t 60.45 -76.57 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 125.772 1.629 . . . . 0.0 112.021 174.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.6 t -146.35 -27.0 0.42 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.003 0.921 . . . . 0.0 110.734 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.8 t 65.67 81.09 0.21 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.772 1.229 . . . . 0.0 110.478 -177.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 67.3 mt -65.64 -33.67 76.45 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.638 0.775 . . . . 0.0 111.638 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 61.09 74.06 0.55 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.814 1.246 . . . . 0.0 112.224 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.656 ' HD2' ' HD1' ' A' ' 31' ' ' HIS . 60.9 Cg_endo -71.48 122.92 9.05 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.253 1.969 . . . . 0.0 111.302 171.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.5 91.0 1.76 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.465 0.706 . . . . 0.0 109.974 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 167.48 123.49 0.66 Allowed Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.017 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -78.15 -2.5 37.84 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.797 0.839 . . . . 0.0 112.309 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.16 -18.37 64.4 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.043 0.937 . . . . 0.0 112.055 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.85 127.93 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.906 0.384 . . . . 0.0 110.158 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.5 ' H ' HE21 ' A' ' 32' ' ' GLN . 6.1 m-20 -79.35 145.99 33.12 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.474 177.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -116.51 124.72 50.61 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.251 0.62 . . . . 0.0 110.947 -174.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.54 121.9 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 124.289 1.036 . . . . 0.0 109.198 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -84.92 153.2 22.99 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.775 0.83 . . . . 0.0 110.004 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 43.7 t -103.2 72.9 1.19 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 165.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -53.1 -31.02 39.82 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.954 0.902 . . . . 0.0 111.437 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -64.51 92.82 0.13 Allowed Glycine 0 CA--C 1.534 1.241 0 CA-C-O 119.295 -0.725 . . . . 0.0 111.829 165.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 72.2 p 50.7 54.03 11.93 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.967 1.707 . . . . 0.0 113.724 164.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 51.7 m -161.76 -56.63 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.942 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 62.15 13.8 6.09 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.949 1.7 . . . . 0.0 112.814 176.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -85.15 138.54 32.32 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -87.62 110.52 20.45 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -99.73 142.79 30.75 Favored 'General case' 0 C--O 1.206 -1.209 0 C-N-CA 123.927 0.891 . . . . 0.0 109.931 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.656 ' HD1' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -89.48 154.31 20.12 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -169.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.5 HE21 ' H ' ' A' ' 18' ' ' ASP . 79.8 mt-30 -43.68 -54.79 4.79 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.75 0.82 . . . . 0.0 112.438 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -76.19 -22.78 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.267 0.627 . . . . 0.0 111.838 -176.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 6' ' ' ALA . 25.1 t -67.93 -31.55 71.39 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.721 0.409 . . . . 0.0 111.518 -178.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.9 m -115.85 -15.25 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.026 0.93 . . . . 0.0 112.098 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.93 37.1 39.54 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 123.333 0.396 . . . . 0.0 112.565 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.9 t -115.43 135.56 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.084 0.954 . . . . 0.0 110.081 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 m -71.41 148.23 93.24 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 123.907 0.883 . . . . 0.0 110.726 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.599 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 39.8 Cg_endo -62.11 -20.76 70.9 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.174 2.583 . . . . 0.0 113.796 -175.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -62.13 -49.34 76.28 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.541 0.736 . . . . 0.0 111.458 173.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 27.0 ttt -74.28 -29.83 61.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.391 1.076 . . . . 0.0 110.265 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 39' ' ' PRO . . . -70.24 -20.75 63.06 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.44 0.696 . . . . 0.0 112.009 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -92.18 -44.68 8.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.923 0.889 . . . . 0.0 110.667 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -73.33 -51.14 18.54 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.51 0.724 . . . . 0.0 112.097 -172.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -115.66 147.28 41.01 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.012 0.925 . . . . 0.0 111.175 -166.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.64 139.01 38.59 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 171.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -76.09 75.93 2.95 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.2 mt -77.88 100.06 2.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.8 p -75.96 148.08 38.41 Favored 'General case' 0 C--N 1.349 0.586 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.8 m -45.7 -35.59 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -165.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -63.38 -45.48 90.94 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.706 0.803 . . . . 0.0 110.699 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 24' ' ' GLY . 60.5 m -73.56 -28.09 61.68 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.693 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.8 m -67.0 -51.32 56.49 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.214 0.606 . . . . 0.0 110.74 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.61 -33.37 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.596 0.759 . . . . 0.0 111.81 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -110.79 35.0 3.67 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.74 0.781 . . . . 0.0 109.569 -175.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.63 69.81 3.93 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 63.15 82.7 0.21 Allowed Pre-proline 0 CA--C 1.551 0.988 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.673 -171.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.74 -7.95 19.87 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.887 2.391 . . . . 0.0 113.562 -172.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.6 t -157.59 145.34 18.75 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.041 0.936 . . . . 0.0 109.03 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -152.55 164.53 37.44 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.559 0.744 . . . . 0.0 110.031 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.6 pttp . . . . . 0 CA--C 1.553 1.066 0 C-N-CA 123.823 0.849 . . . . 0.0 109.856 -175.659 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.8 m . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -82.06 167.09 19.17 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.181 0.592 . . . . 0.0 109.782 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.529 ' SD ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER 48.27 14.23 0.06 Allowed 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 126.116 1.766 . . . . 0.0 115.169 178.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.529 ' SG ' ' SD ' ' A' ' 3' ' ' MET . 25.6 p 164.01 113.51 0.02 OUTLIER Pre-proline 0 C--N 1.355 0.808 0 C-N-CA 125.595 1.558 . . . . 0.0 108.134 -176.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -74.07 66.87 5.12 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.65 2.233 . . . . 0.0 111.845 174.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.57 106.85 8.07 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.02 -44.83 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.6 m -72.69 93.47 1.64 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 166.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 51.1 t -139.67 113.13 8.4 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.931 0.492 . . . . 0.0 111.121 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.695 HD11 HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -66.6 146.28 54.67 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 161.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -105.33 103.39 42.32 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.41 99.63 0.17 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.358 2.705 . . . . 0.0 112.573 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.23 -24.61 42.96 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.722 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.34 -19.88 56.0 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.308 175.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 72.76 -17.94 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.242 1.417 . . . . 0.0 113.846 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -82.98 67.5 9.09 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.951 0.881 . . . . 0.0 110.335 -171.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.35 138.52 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.69 1.196 . . . . 0.0 108.608 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -80.53 122.89 27.59 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -93.1 174.95 6.97 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.29 0.636 . . . . 0.0 111.036 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.459 ' HB ' HE22 ' A' ' 32' ' ' GLN . 14.8 p -159.98 129.1 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.424 0.69 . . . . 0.0 110.261 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -80.61 126.53 31.37 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.509 ' SG ' ' OD2' ' A' ' 23' ' ' ASP . 31.1 t -75.0 118.39 17.91 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 -164.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.509 ' OD2' ' SG ' ' A' ' 22' ' ' CYS . 4.5 p30 20.36 -71.08 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 127.986 2.514 . . . . 0.0 117.471 171.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.92 -95.24 0.15 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.211 -0.449 . . . . 0.0 113.723 -152.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -79.51 -51.93 8.69 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.197 -0.501 . . . . 0.0 111.598 -163.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.05 -35.5 64.3 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -173.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.2 t30 70.7 -26.83 0.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.284 1.434 . . . . 0.0 114.78 165.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.84 147.18 24.05 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.93 0.892 . . . . 0.0 111.562 -171.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -74.99 139.37 42.89 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.679 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -126.34 149.33 49.24 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 172.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.598 ' CD2' ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -78.74 148.0 33.18 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 169.35 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.459 HE22 ' HB ' ' A' ' 20' ' ' VAL . 2.6 mp0 -58.77 -34.36 71.34 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.539 0.736 . . . . 0.0 110.424 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.695 HG23 HD11 ' A' ' 10' ' ' LEU . 35.1 m -76.06 -22.25 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.649 176.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.598 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 4.5 t -70.99 -37.25 72.7 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 123.399 0.68 . . . . 0.0 111.195 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.464 HG23 HG23 ' A' ' 37' ' ' VAL . 6.0 m -118.62 8.64 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.819 0.848 . . . . 0.0 112.338 -172.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.61 29.12 73.72 Favored Glycine 0 C--N 1.353 1.493 0 O-C-N 123.498 0.499 . . . . 0.0 114.262 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.464 HG23 HG23 ' A' ' 35' ' ' VAL . 77.0 t -92.97 143.73 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.57 0.748 . . . . 0.0 109.368 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.0 m -80.42 145.23 58.95 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.341 0.656 . . . . 0.0 109.856 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.89 -38.38 94.63 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.493 2.129 . . . . 0.0 112.221 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.21 -45.7 90.4 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.763 0.825 . . . . 0.0 111.029 173.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 50.2 mmm -60.85 -46.12 91.81 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.135 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.38 -35.6 81.43 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.621 0.768 . . . . 0.0 111.293 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -69.52 -38.75 77.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.42 0.688 . . . . 0.0 111.696 175.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -74.65 -44.24 51.37 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.404 0.681 . . . . 0.0 111.391 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -161.78 153.25 18.64 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.229 1.012 . . . . 0.0 109.755 -172.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -73.92 148.12 42.51 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.96 0.41 . . . . 0.0 111.841 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -72.48 125.85 28.42 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 166.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.2 mt -113.77 125.98 71.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.8 m -66.26 167.29 10.55 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 173.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 54' ' ' VAL . 43.1 t -62.28 -48.93 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 173.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 3.6 mpt_? -62.67 -48.25 80.13 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.668 0.387 . . . . 0.0 110.099 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.6 m -48.4 -41.36 28.81 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.717 1.207 . . . . 0.0 112.902 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.693 ' HA ' ' HB2' ' A' ' 57' ' ' ALA . 5.9 t -82.97 -29.86 28.69 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -178.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 50' ' ' VAL . 49.7 t -69.82 -29.68 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.661 0.784 . . . . 0.0 110.847 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 74.0 mmtt -62.54 -63.06 1.34 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -175.06 -28.75 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.555 1.142 . . . . 0.0 110.729 174.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.693 ' HB2' ' HA ' ' A' ' 53' ' ' THR . . . 65.35 78.36 0.26 Allowed Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 124.882 1.273 . . . . 0.0 110.991 -176.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -88.85 173.89 4.07 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.797 2.331 . . . . 0.0 112.221 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.0 p -83.73 -82.09 0.16 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 166.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 177.11 -69.31 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.716 1.206 . . . . 0.0 108.331 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt . . . . . 0 C--O 1.252 1.201 0 C-N-CA 124.605 1.162 . . . . 0.0 108.474 -177.467 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 120.884 0.373 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -98.08 157.5 16.1 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.122 0.569 . . . . 0.0 110.286 175.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.6 ttt 76.31 -39.82 0.37 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.659 1.584 . . . . 0.0 112.207 -175.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.503 ' SG ' ' HD1' ' A' ' 30' ' ' PHE . 25.6 t -149.67 84.28 6.06 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 122.704 0.401 . . . . 0.0 111.766 -177.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.83 45.78 2.05 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.714 2.942 . . . . 0.0 112.972 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.91 129.74 35.73 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 170.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.88 -37.48 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 122.786 0.434 . . . . 0.0 110.683 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.8 p -97.17 69.81 2.33 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 169.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.739 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 21.5 t -84.06 79.07 9.63 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-O 121.078 0.466 . . . . 0.0 110.377 -177.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.1 mt -59.96 139.71 57.23 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.121 172.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -113.42 80.28 4.51 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.06 0.944 . . . . 0.0 109.915 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HG2' HG21 ' A' ' 17' ' ' VAL . 42.5 Cg_endo -86.25 142.87 7.53 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.292 2.661 . . . . 0.0 113.327 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.49 163.02 14.31 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.82 0.848 . . . . 0.0 109.517 172.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.34 152.87 28.86 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.981 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -82.54 -16.38 48.84 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.892 0.877 . . . . 0.0 111.914 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -58.2 -35.44 71.63 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.274 1.03 . . . . 0.0 112.018 -175.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.403 HG21 ' HG2' ' A' ' 12' ' ' PRO . 14.3 m -73.2 83.71 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 122.54 1.162 . . . . 0.0 110.295 172.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.44 ' HB3' HE21 ' A' ' 32' ' ' GLN . 34.3 t70 -69.45 140.8 54.09 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.627 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -92.89 156.25 17.07 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.169 0.509 . . . . 0.0 110.91 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -137.87 126.96 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.771 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -77.39 129.26 35.56 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.145 0.978 . . . . 0.0 109.755 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -62.98 -36.87 84.97 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.992 0.517 . . . . 0.0 111.271 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t70 69.39 -72.5 0.1 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.818 1.647 . . . . 0.0 111.264 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.446 ' O ' ' SG ' ' A' ' 52' ' ' CYS . . . -46.7 90.58 0.01 OUTLIER Glycine 0 C--N 1.353 1.511 0 C-N-CA 124.828 1.204 . . . . 0.0 115.904 -172.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 t 70.44 12.32 7.45 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.35 1.46 . . . . 0.0 112.908 162.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -155.16 -29.11 0.11 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.263 -175.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 80.2 -59.61 0.31 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.274 1.43 . . . . 0.0 111.599 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -4.22 114.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 129.012 2.925 . . . . 0.0 116.978 -173.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -79.86 116.52 20.07 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.187 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.503 ' HD1' ' SG ' ' A' ' 4' ' ' CYS . 50.7 m-85 -100.73 164.94 11.63 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 124.285 1.034 . . . . 0.0 109.696 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.495 ' N ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -106.51 149.08 27.46 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -176.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.44 HE21 ' HB3' ' A' ' 18' ' ' ASP . 9.0 tt0 -47.97 -51.05 25.26 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.73 1.212 . . . . 0.0 112.643 -174.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.0 m -81.55 -28.45 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.205 0.602 . . . . 0.0 112.554 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.739 ' SG ' ' HA ' ' A' ' 9' ' ' CYS . 52.6 t -62.69 -36.09 81.82 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -174.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 m -114.5 -1.36 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.577 0.751 . . . . 0.0 111.712 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.3 30.66 71.46 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 113.665 0.226 . . . . 0.0 113.665 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.413 HG11 ' HB3' ' A' ' 47' ' ' TYR . 90.4 t -98.48 107.82 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.702 ' HB2' ' SD ' ' A' ' 41' ' ' MET . 45.6 m -73.14 163.1 71.01 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 123.696 0.799 . . . . 0.0 110.822 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -47.85 -45.71 23.65 Favored 'Trans proline' 0 C--N 1.396 3.04 0 C-N-CA 123.635 2.89 . . . . 0.0 114.999 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.85 -32.56 71.03 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 120.634 0.254 . . . . 0.0 111.348 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.702 ' SD ' ' HB2' ' A' ' 38' ' ' SER . 1.2 mpt? -69.76 -44.28 70.49 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.145 0.578 . . . . 0.0 109.94 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.29 69.47 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.587 0.755 . . . . 0.0 111.172 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.76 -48.51 46.32 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.365 1.066 . . . . 0.0 111.248 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -105.04 -61.18 1.51 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.906 -163.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -156.84 148.42 22.46 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -165.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 t70 67.17 76.43 0.29 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.966 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.438 ' H ' HD12 ' A' ' 48' ' ' ILE . 35.8 p90 -148.32 5.18 0.72 Allowed 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.638 177.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.438 HD12 ' H ' ' A' ' 47' ' ' TYR . 4.3 mp -95.09 117.52 39.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.0 p -59.73 147.19 38.67 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 123.297 0.373 . . . . 0.0 111.39 -171.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.6 t -54.9 -37.12 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -158.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -68.1 -27.87 66.85 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.667 0.387 . . . . 0.0 111.395 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 24' ' ' GLY . 82.3 m -79.24 -28.03 42.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.579 0.751 . . . . 0.0 111.154 173.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 m -73.5 -28.91 62.16 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 123.553 0.533 . . . . 0.0 110.196 175.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.1 t -72.21 -52.3 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.689 0.796 . . . . 0.0 109.389 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -94.77 55.47 1.89 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.03 0.919 . . . . 0.0 110.238 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -103.95 21.95 15.45 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.617 1.167 . . . . 0.0 109.396 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 58.77 75.25 0.53 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.264 1.026 . . . . 0.0 110.03 -173.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -74.36 154.05 45.56 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.526 2.15 . . . . 0.0 111.394 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.8 m -72.8 -26.78 61.64 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.547 0.339 . . . . 0.0 110.316 173.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -83.93 115.48 22.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.737 0.815 . . . . 0.0 111.087 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp . . . . . 0 CA--C 1.564 1.497 0 C-N-CA 125.658 1.583 . . . . 0.0 112.739 170.808 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_